Sentence,class,file
J Neurophysiol  2010; 103:1646-57; PMID:20089816;  http://dx.doi.org/10.1152/jn.00950.2009 121.,Non-OADS,/arxiv_data1/oa_pdf/e8/35/cam-7-333.PMC3739809.pdf
Neuron 2011; 70:1165-77; PMID:21689602; http://dx.doi.org/10.1016/j.neuron.2011.05.023 123.,OADS,/arxiv_data1/oa_pdf/e8/35/cam-7-333.PMC3739809.pdf
Nat Methods 2010; 7:535-40; PMID:20526346; http://dx.doi.org/10.1038/nmeth.1468,OADS,/arxiv_data1/oa_pdf/e8/35/cam-7-333.PMC3739809.pdf
"J Biol Chem 2013; 288:4957-69; PMID:23266828; http://dx.doi.org/10.1074/jbc.M112.403774Keywords:  adhesion, cadherin, catenin,  vinculin, mechanosensing, strength,  force, cytoskeleton Abbreviations:  F-actin, filamentous  actin; VASP, vasodilator-stimulated  phosphoprotein; PKC, protein kinase C; VH, vinculin-homology; PIP2, Phosphatidylinositol 4,5-Bisphosphate; ZO-1, zonula occludens-1; Ipa-1, invasion plasmid antigen D of shigella; MDCK, Madin-Darby canine kidney cells; CHO, Chinese hamster ovary; Ncad-FC, N-cadherin-Fc fusion molecule; Ecad-FC, E-cadherin-Fc fusion molecule Submitted: 04/22/13Revised: 05/17/13Accepted: 05/22/13http://dx.doi.org/10.4161/cam.25139 *Correspondence to: Sylvie Dufour;   Email: Sylvie.Dufour@curie.frClassical cadherins play a crucial  role in establishing intercellular  adhesion, regulating cortical tension, and maintaining mechanical coupling between cells.",Non-OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Cell Biol  1998; 142:1105-19; PMID:9722621; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Cell 2000; 100:209-19; PMID:10660044; http://dx.doi.org/10.1016/S0092- 8674(00)81559-7 13.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Exp Cell Res 2007; 313:4025- 40; PMID:17765222; http://dx.doi.org/10.1016/j.yexcr.2007.07.035 15.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Cell Biol 1997; 137:1421-31; PMID:9182672;  http://dx.doi.org/10.1083/jcb.137.6.1421 16.,Non-OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Mol Biol Cell 2005; 16:4531-42; PMID:16030252; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Biol Chem 2002;  277:6708-18; PMID:11744701; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Curr Biol 2002; 12:379-82; PMID:11882288; http://dx.doi.org/10.1016/S0960-9822(02)00661-9 19.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Cell Biol 2004; 167:1183- 94; PMID:15596540; http://dx.doi.org/10.1083/ jcb.200403043 23.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Nat Rev  Mol Cell Biol 2009; 10:445-57; PMID:19546857;  http://dx.doi.org/10.1038/nrm2720 24.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Nature 2008; 453:751-6; PMID:18480755; http://dx.doi.org/10.1038/ nature06953 25.,Non-OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Mol Biol 2000; 299:551-72; PMID:10835267;  http://dx.doi.org/10.1006/jmbi.2000.3777 2.,Non-OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Int J Biochem Cell Biol  2009; 41:349-69; PMID:18848899; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Mol Biol Evol 2011; 28:647- 57; PMID:20817718; http://dx.doi.org/10.1093/ molbev/msq233 4.,Non-OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Nat Rev Mol Cell Biol  2005; 6:622-34; PMID:16025097; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Brain Res 2012; 1470:130- 44; PMID:22765916; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Oncogene 2008; 27:6920-9;  PMID:19029934; http://dx.doi.org/10.1038/ onc.2008.343 7.,Non-OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Invest Dermatol  2012; 132:776-84; PMID:22189787; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Proc Natl Acad Sci U S A 2009; 106:11594-9;  PMID:19553217; http://dx.doi.org/10.1073/ pnas.0905349106 9.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Nature 2011; 475:510-3; PMID:21796210; http://dx.doi.org/10.1038/nature10183 10.,Non-OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Biophys J 2010; 98:534- 42; PMID:20159149; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Proc Natl Acad Sci U S A 2012; 109:12568- 73; PMID:22802638; http://dx.doi.org/10.1073/ pnas.1204390109 56.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
EMBO J 2001; 20:3645-56; PMID:11447106; http://dx.doi.org/10.1093/emboj/20.14.3645 58.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Biol Chem 2002; 277:18868-74; PMID:11907041;  http://dx.doi.org/10.1074/jbc.M201463200 59.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
BMC Cell Biol 2011; 12:48;  PMID:22054176; http://dx.doi.org/10.1186/1471- 2121-12-48 60.,Non-OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Cell Biol  2012; 196:641-52; PMID:22391038; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
"Biol Open 2012; 1:1128-40; PMID:23213393; http://dx.doi.org/10.1242/bio.20122428 62. le Duc Q, Shi Q, Blonk I, Sonnenberg A, Wang N,  Leckband D, et al.",OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Cell Biol 2010; 189:1107- 15; PMID:20584916; http://dx.doi.org/10.1083/ jcb.201001149 63.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Biol Chem 2013; 288:4957- 69; PMID:23266828; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Phys Rev Lett 2005; 94:028102;  PMID:15698233; http://dx.doi.org/10.1103/ PhysRevLett.94.028102 65.,Non-OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Mol Biol Cell 2007; 18:189-200;  PMID:17093058; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Nat Struct Mol Biol 2013;  20:188-93; PMID:23292143; http://dx.doi.org/10.1038/nsmb.2479 43.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Proc Natl Acad Sci U  S A 2008; 105:13-9; PMID:18093941; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Cell Biol  1998; 141:755-64; PMID:9566974; http://dx.doi.org/10.1083/jcb.141.3.755 46.,Non-OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Biol Chem 2013; 288:4957- 69; PMID:23266828; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Theor Biol 2009; 257:480-8; PMID:19135061; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Biol  Chem 2012; 287:18492-9; PMID:22493458; http://dx.doi.org/10.1074/jbc.M112.351023 50.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Biol Chem 2012; 287:7728-37; PMID:22235119; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Cell Sci 2004; 117:257-70; PMID:14657280;  http://dx.doi.org/10.1242/jcs.00857 52.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Biol Cell 2006; 98:721-30;  PMID:16895521; http://dx.doi.org/10.1042/ BC20060039 53.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Mol Biol Cell 2005; 16:4531-42; PMID:16030252; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Curr Opin Cell Biol 2006; 18:472-81; PMID:16930976; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Cell Biol 1999; 144:687-99; PMID:10037790; http://dx.doi.org/10.1083/ jcb.144.4.687 28.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Nat Cell Biol 2013; 15:261-73; PMID:23417122; http://dx.doi.org/10.1038/ncb2685 29.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Nat  Rev Mol Cell Biol 2004; 5:614-25; PMID:15366705; http://dx.doi.org/10.1038/nrm1433 30.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Proc Natl Acad Sci U S A 1980; 77:4127-31; PMID:6776523; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Curr Opin Cell Biol  2001; 13:584-92; PMID:11544027; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Protoplasma 2012; 250:817-29; PMID:23274283;  http://dx.doi.org/10.1007/s00709-012-0475-6 33.,Non-OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Int Rev Cell Mol Biol 2011; 287:191-231; PMID:21414589; http://dx.doi.org/10.1016/B978- 0-12-386043-9.00005-0 34.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Nature  2004; 430:583-6; PMID:15195105; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Biol Chem 2006; 281:40389-98; PMID:17074767; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Biol Chem 1997; 272:32448-53; PMID:9405455; http://dx.doi.org/10.1074/ jbc.272.51.32448 38.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Cell Sci 2012; 125:233-45; PMID:22266901; http://dx.doi.org/10.1242/jcs.096644 39.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Cell 2005; 123:903-15; PMID:16325583;  http://dx.doi.org/10.1016/j.cell.2005.09.021 40.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Biol Chem 1997; 272:27301- 6; PMID:9341178; http://dx.doi.org/10.1074/ jbc.272.43.27301,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
Cell  Adhes Commun 1998; 5:49-59; PMID:9638341;  http://dx.doi.org/10.3109/15419069809005598 71.,Non-OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
J Cell Biol 2011;  194:643-56; PMID:21844208; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/7f/cam-7-345.PMC3739810.pdf
"To sense multiple navigational cues, individual neurons must express a variety of receptors, each of which is deployed at precise developmental stages and some of  *Correspondence to: Alvaro Sagasti; Email: sagasti@mcdb.ucla.edu Submitted: 04/01/13; Revised: 05/07/13; Accepted: 05/10/13http://dx.doi.org/10.4161/cam.25000The peripheral axons of vertebrate tactile somatosensory  neurons travel long distances from ganglia just outside the central nervous system to the skin.",Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Nature 2007; 445:858- 65; PMID:17314972; http://dx.doi.org/10.1038/ nature05662 3.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
J Exp Zool 1949; 111:457-501;  PMID:18142378; http://dx.doi.org/10.1002/ jez.1401110308 4.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Annu Rev Neurosci  2001; 24:677-736; PMID:11520916; http://dx.doi.org/10.1146/annurev.neuro.24.1.677 5.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Neuron 2000; 25:345-57; PMID:10719890; http://dx.doi.org/10.1016/S0896- 6273(00)80899-5 7.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Dev Dyn 1999; 214:13-25; PMID:9915572;  http://dx.doi.org/10.1002/(SICI)1097- 0177(199901)214:1<13::AID-DVDY2>3.0.CO;2-3 8.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Eur J Neurosci 2013; 37:519-31; PMID:23216618;  http://dx.doi.org/10.1111/ejn.1207510.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Dev Biol 2004; 265:169- 80; PMID:14697361; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Dev Biol  2004; 266:27-42; PMID:14729476; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Nature 1983; 306:786-8;  PMID:6656880; http://dx.doi.org/10.1038/306786a0,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Exp Neurol 1999; 158:504- 28; PMID:10415156; http://dx.doi.org/10.1006/ exnr.1999.7127 44.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Dev Dyn 1998; 213:207-19; PMID:9786421;  http://dx.doi.org/10.1002/(SICI)1097- 0177(199810)213:2<207::AID-AJA6>3.0.CO;2-K 45.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
J Physiol 2002; 545:43-50; PMID:12433948; http://dx.doi.org/10.1113/jphysiol.2002.027656 46.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
J Neurosci 2013; 33:2060- 70; PMID:23365243; http://dx.doi.org/10.1523/ JNEUROSCI.4012-12.2013 47.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Neuron 1992; 9:831-45;  PMID:1418998; http://dx.doi.org/10.1016/0896- 6273(92)90237-8 48.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Neuron 1997; 19:519-30; PMID:9331345;  http://dx.doi.org/10.1016/S0896-6273(00)80368-2 49.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Dev Cell 2003; 5:45-57; PMID:12852851; http://dx.doi.org/10.1016/S1534- 5807(03)00169-2 50.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Neuron  1997; 19:995-1005; PMID:9390514; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Neuron  2005; 45:513-23; PMID:15721238; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Proc R Soc  Lond B Biol Sci 1983; 218:49-59; PMID:6135211;  http://dx.doi.org/10.1098/rspb.1983.0025 53.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
J Comp  Neurol 1984; 226:336-45; PMID:6747026; http://dx.doi.org/10.1002/cne.902260304 55.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
J Comp Neurol 1987; 261:592-603; PMID:3611426; http://dx.doi.org/10.1002/cne.902610410 56.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Brain Res 1983; 259:177-80; PMID:6824932; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Neuron 2008; 58:532-45;  PMID:18498735; http://dx.doi.org/10.1016/j.neu- ron.2008.03.006 30.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Annu Rev Cell Dev Biol 2006; 22:651-75;  PMID:17029581; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Cell 1999; 96:771-84;  PMID:10102266; http://dx.doi.org/10.1016/S0092-8674(00)80588-7 32.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Mech Dev  2004; 121:315-24; PMID:15110042; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Development  2004; 131:3705-15; PMID:15229183; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
J Neurosci 2007; 27:6843-51; PMID:17581972; http://dx.doi.org/10.1523/ JNEUROSCI.1479-07.2007 35.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
BMC Dev Biol 2007; 7:59;  PMID:17540021; http://dx.doi.org/10.1186/1471-213X-7-59 36.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Science 2012; 338:1357-60; PMID:23224557; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
J Biol Chem  1997; 272:33111-7; PMID:9407096; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Nature 1997; 387:721-4; PMID:9192899;  http://dx.doi.org/10.1038/42729 40.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Neuron 1997; 18:793-802;  PMID:9182803; http://dx.doi.org/10.1016/S0896- 6273(00)80318-9 41.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
J Neurosci 2006; 26:1953-60;  PMID:16481427; http://dx.doi.org/10.1523/ JNEUROSCI.4065-05.2006 42.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Cell Tissue Res 2008; 333:353- 71; PMID:18629541; http://dx.doi.org/10.1007/ s00441-008-0634-414.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Neuron  1999; 24:165-78; PMID:10677035; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Curr Biol 2012; 22:373- 82; PMID:22326027; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Curr Biol  2005; 15:1701-11; PMID:16213816; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Neuron  2006; 49:517-31; PMID:16476662; http://dx.doi.org/10.1016/j.neuron.2006.01.026 18.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Mol Cell Biol 2002; 22:1881-92; PMID:11865065; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Neuron 2004; 44:947-60;  PMID:15603738; http://dx.doi.org/10.1016/j.neu- ron.2004.11.029 20.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Mech Dev 1998; 77:59-62; PMID:9784606;  http://dx.doi.org/10.1016/S0925-4773(98)00119-1 21.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Arch Histol Cytol 1988;  51:1-34; PMID:3137944; http://dx.doi.org/10.1679/ aohc.51.1 22.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
J  Neurophysiol 2010; 104:3568-75; PMID:20926608;  http://dx.doi.org/10.1152/jn.00415.2010 23.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Curr Biol 2013; 23:496-500; PMID:23477726;  http://dx.doi.org/10.1016/j.cub.2013.02.008 24.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Proc Natl Acad Sci U S A 1987; 84:6596-600; PMID:3306683; http://dx.doi.org/10.1073/ pnas.84.18.6596 27.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
J Comp Neurol 1997; 387:489- 506; PMID:9373009; http://dx.doi.org/10.1002/ (SICI)1096-9861(19971103)387:4<489::AID- CNE2>3.0.CO;2-Z,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
J Comp Neurol 2008; 511:543-56;  PMID:18839409; http://dx.doi.org/10.1002/ cne.2186260.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
J Neurosci  2007; 27:14404-14; PMID:18160648; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Neuron 2005; 45:17-25;  PMID:15629699; http://dx.doi.org/10.1016/j.neu- ron.2004.12.015 59.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
Cell  2011; 147:1615-27; PMID:22196735; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/7e/cam-7-388.PMC3739816.pdf
These were con-verted into FASTQ format using a Python script from Galaxy ( http://main.g2.bx.psu.edu/ ).,OADS,/arxiv_data1/oa_pdf/5e/83/10522_2013_Article_9433.PMC3739863.pdf
"doi: 10.1111/j.1600-0854.2005.00376.x United States Census Bureau (2012) Life expectancy by sex, age, and race: 2008. http://www.census.gov/compendia/ statab/2012/tables/12s0104.pdf .",OADS,/arxiv_data1/oa_pdf/5e/83/10522_2013_Article_9433.PMC3739863.pdf
"Published by Oxford University Press, on behalf of the Society of Systematic Biologists.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/49/syt029.PMC3739882.pdf
"SUPPLEMENTARY MATERIAL Supplementary material, including data ﬁles and online-only Appendices, can be found in theDryad data repository (doi:10.5061/dryad.s631d).Datamatrix and tree ﬁles are available in TreeBase(http://purl.org/phylo/treebase/phylows/study/TB2:S13927).",OADS,/arxiv_data1/oa_pdf/70/49/syt029.PMC3739882.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/11/nss053.PMC3739917.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ tobaccocontrol-2012-050815).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
"52In 2002, before T ea Party politics were widely discussed in the mainstream media, CSE started its US T ea Party (http://www.usteaparty.com) project, the website ofwhich stated ‘our US T ea Party is a national event, hosted con- tinuously online and open to all Americans who feel our taxesare too high and the tax code is too complicated.",Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
"Steve Milloy, who served as co-director of NCPPR ’sF r e e Enterprise Project with T om Borelli,150helped the industry contest the link between second-hand smoke and disease.29 Milloy directed The Advancement of Sound ScienceCoalition 151(TASSC, ﬁgure 1), which was created for Philip Morris in 1993 by the public relations ﬁrm APCO Associates, as part of the effort to undermine the EPA ’s second-hand smoke risk assessment.29Though TASSC was eventually disbanded, Milloy maintained http://junkscience.com as of 2012152(see online supplementary table S2).",Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Skocpol T, Williamson V. The Tea Party and the remaking of Republican conservatism .",Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2010. http://www.guardian.co.uk/commentisfree/cifamerica/2010/oct/25/ Tea-Party-koch-brothers (accessed 16 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2011. http://www.teapartypatriots.org/ about/ (accessed 5 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2012. http://www.sourcewatch.org/index.php/Astroturf (accessed 17 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2009. http://www.nytimes.com/2009/ 04/16/us/politics/16taxday.html (accessed 25 Oct 2011).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2011. http://www.americansforprosperity.org/090711-tea-party-express-stops-concord-thursday-september-8th (accessed 6 Jan2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2009. http://www.freedomworks.org/ blog/bstein80/cape-coral-tea-party-is-on (accessed 6 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2011. http://www.spartanburgteaparty.org/2011/06/08/spartanburg-tea-party-welcomes-americans-for-properity/ (accessed 6 Jan 2011).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2007. http://web.archive.org/web/20110215010801/http://www.americansforprosperity.org/smoking-ban-defeat-victory-private-property-rights(accessed 24 Oct 2011).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2009. http://www.freedomworks.org/publications/freedomworks-chairman-dick-armey-writes-to-governo (accessed 11 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2012. http://www.theblaze.com/stories/tea-party-goes-global-as-conservatives-from-around-the-world-get-trained-in-texas-by-freedomworks/ (accessed 27 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2010. http://dailycaller.com/2010/06/14/international-protest-groups-take- up-tea-party- ﬂag-in-moscow-tel-aviv-and-the-hague/ (accessed 27 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2011. http://www.usnews.,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2011. http://www.jpost.com/ DiplomacyAndPolitics/Article.aspx?id=235307 (accessed 26 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
Doug Goodyear: Managing Partner and Chief Executive Of ﬁcer 2011. http://www.dcigroup.com/who-we-are/our-people/doug- goodyear (accessed 19 March 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2002. http://web.archive.org/web/20020821185019/http://www.cse.org/tea/about.php(accessed 6 Apri 2012).,OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
http://www.capitolconnect.com/cse/ALERTS.asp?subject=72; http://legacy.library.ucsf.edu/tid/bwx12c00 (accessed 17 May 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
1996. http://web.archive.org/ web/19970109084341/http://www.cse.org/nj.html (accessed 9 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2008. http://www.forumstrategies.com/about/richard_frisch.html (accessed 2 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2008. http://www.forumstrategies.com/index.html (accessed 2 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2008. http://www.forumstrategies.com/about/jeff_sindone.html (accessed2 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2002. http://web.archive.org/web/20021202122120/ http://www.empoweramerica.org/about (accessed 20 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2004. http://web.archive.org/web/20040402121024/http://www.cse.org/armey/index.php (accessed 16 Mar 2012).,OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
http://www.freedomworks.org/ matt-kibbe-biography (accessed 20 Mar 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2004. http://web.archive.org/web/20041214151602/www.iwf.org/about_iwf/pfotenhauer.,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2008. http://web.archive.org/web/ 20110727204132/http://www.americansforprosperity.org/about/staff/tim-phillips(accessed 14 Nov 2011).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
http://web.archive.org/web/ 20040603164236/http://www.censtrat.com/staffbio.cfm?staff_id=13 (accessed 29May 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2011. http://www.mediaspeakstrategies.,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2008. http:// web.archive.org/web/20101119120703/http://americansforprosperity.org/ 012510-afp-texas-state-director-peggy-venable (accessed 9 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2011. http://americansforprosperity.org/newsroom/062711-americans-prosperity-welcomes-slade-obrien- ﬂorida-state-director-0/ (accessed 20 Mar 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2007. http://web.archive.org/web/20110215221427/http://www.americansforprosperity.org/statement-peggy- venable-afp-texas-director (accessed 11 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2010. http://www.inthesetimes.com/article/6439/tea_party_con ﬁdential/ (accessed 4 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
"Institute for Research & Education on Human Rights, 2010 19 October 2010. http://mail.teapartynationalism.com/issue-areas/tea-party-nationalism/the-report/origins-of-the-tea-parties (accessed 4Feb 2013).",Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2004. http://www.prwatch.org/prwissues/2004Q4/powers.html (accessed 9 Mar 2012).,OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2011. http://www.dcigroup.com/who-we-are/our-people (accessed 6 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2011. http://www.dcigroup.com/who-we-are/ our-people/dan-combs (accessed 6 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
http://www.nyc.gov/ lobbyistsearch/search (accessed 6 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
http://americansforprosperity.org/ ﬁles/ANPR%20Talking%20Points%201.2.pdf (accessed 11 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
archive.org/web/20110727201433/http://americansforprosperity.org/062011-obamacare-update (accessed 11 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
http://www.noon29.com/about-us (accessed 16 May 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
archive.org/web/20110625121912/http://www.americansforprosperity.org/state- leaders-want-it-both-ways-tobacco-tax-smoking-ban-illinois-chapter-americans-prosperity-says (accessed 25 Oct 2012).120 Brandon A.,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2008. http://web.archive.org/web/20110625043207/http://www.,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2006. http://www.freedomworks.org/press-releases/tell-gov-lingle-to-put- the-breaks-on-a-potentially (accessed 1 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2006. http://web.archive.org/web/20110725213644/http://americansforprosperity.org/testimony-peggy-venable-texas-tax-reform-commission(accessed 25 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2009. http://www.youtube.com/watch?v=631hQ45TdNc (accessed 25 May 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2008. http://web.archive.org/web/20110628220118/http:// www.americansforprosperity.org/print/11000 (accessed 24 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2007. http://web.archive.org/web/20110208195825/http://www.americansforprosperity.org/press-release-smoking-bans-limit-freedom-and-prosperity-citizen-group-opposes-intrusive-government-p (accessed 24 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2008. http://web.archive.org/web/20110131191539/http://www.americansforprosperity.org/hearing-freedom-issues (accessed 24 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
‘Occupy Occupy D.C. smoke-in ’set for Thursday 2012. http://www.nationalcenter.org/PR-SmokeIn_021512.html (accessed 24 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
http://blogs.freedomworks.org/ DiverseTea/?p=15 (accessed 16 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
http://www.nationalcenter.org/ bios/gattuso.html (accessed 16 Feb 2012).,OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
http://www.nationalcenter.org/PR-Free_Enterprise_Project_100108.html (accessed 2 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
n.d. http://junkscience.com/about-steve-milloy/ (accessed 24 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2002. http://web.archive.org/web/ 20020124091734/http://guestchoice.com/index.html (accessed 24 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2010. http://www.cato.org/about/reports/ annual_report_2010.pdf 160 American Enterprise Institute.,OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2011. http://www.prwatch.org/news/ 2011/07/10787/alec-and-tobacco-industry (accessed 15 Jul 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2012. http://www.guardian.co.uk/society/2012/jul/15/cigarettes-plain-packets-alec-koch-brothers (accessed 27 Sep 2012).166 Nagourney A.,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2012. http://www.nytimes.com/2012/06/04/us/in-california-a-battle-over-a-plan-for-1-a- pack-cigarette-tax.html?_r=0 (accessed 28 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2011. http://www.kochfacts.com/kf/ americans-for-prosperity/ (accessed 16 May 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
http://www.kochind.com/About_Koch/ default.aspx (accessed 22 Aug 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
1999. http://web.archive.org/web/19991012224707/http://cse.org/cse/environment.,OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
2009. http://web.archive.,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
org/web/20090314094647/http://www.hotairtour.org/ (accessed 22 Aug 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
http://www.campaignlegalcenter.org/attachments/CLC_501c_disclosure_chart.pdf (accessed 26 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/29/tobaccocontrol-2012-050815.PMC3740007.pdf
"The Journal of Tehran University Heart Center 101 TEHRAN HEART CENTER J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Evaluation of Cardiovascular Diseases and Their Risk  Factors in Hospitalized Patients in East Azerbaijan Province, Northwest Iran: A Review of 18323 Cases *Corresponding Author: Naser Safaie, Cardiovascular Research Center, Tabriz University of Medical Sciences, Daneshghah Street, Tabriz, Iran.",Non-OADS,/arxiv_data1/oa_pdf/fa/f2/jthc-8-101.PMC3740106.pdf
"102The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Introduction Coronary heart disease, also named coronary artery  disease (CAD), is accountable for more than 30% of deaths  the world over and is, consequently, regarded as the most significant factor in disease burden in the world.",Non-OADS,/arxiv_data1/oa_pdf/fa/f2/jthc-8-101.PMC3740106.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 103 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013demographic or clinical data and were, therefore, excluded  from the study.",Non-OADS,/arxiv_data1/oa_pdf/fa/f2/jthc-8-101.PMC3740106.pdf
"104The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013underwent different surgical procedures (Table 3), and  13.99% (2564/18324) received cardiovascular interventional therapy (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/fa/f2/jthc-8-101.PMC3740106.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 105 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 20132009, a total of 600 patients scheduled for cardiac surgery  were evaluated in a tertiary referral educational hospital, and the frequency of the risk factors was as follows: cigarette smoking (42.1%); opium abuse (12.0%); and alcohol consumption (8.1%).",Non-OADS,/arxiv_data1/oa_pdf/fa/f2/jthc-8-101.PMC3740106.pdf
http://www.clarify- registry.com/download/CLARIFY_About_CAD.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fa/f2/jthc-8-101.PMC3740106.pdf
"106The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Case Report Hemi-Fontan or Bidirectional Cavopulmonary Shunt for  Right Ventricular Failure after Mitral Valve Replacement and Acute Ascending Aortic Dissection:  Report of Two Cases *Corresponding Author: Hassan Teimouri, Associate Professor of Anesthesiology, Lorestan University of Medical Sciences Shahid, Madani Hospital,  Imam Khomeini Street, Daneshgah Street, Lorestan, Iran.",Non-OADS,/arxiv_data1/oa_pdf/ae/cb/jthc-8-106.PMC3740107.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 107 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013or hemi-Fontan, to wean 2 patients from cardiopulmonary  bypass (CPB).",Non-OADS,/arxiv_data1/oa_pdf/ae/cb/jthc-8-106.PMC3740107.pdf
"108The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013sufficient reperfusion and time so as to allow contractility to  resume, RV contractility was still impaired.",Non-OADS,/arxiv_data1/oa_pdf/ae/cb/jthc-8-106.PMC3740107.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 109 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013be helpful in severe RV failure.17 We would not recommend  this method for RV failure because response to this method  in RV failure is variable; consequently, atrial septostomy should be deemed palliative.",Non-OADS,/arxiv_data1/oa_pdf/ae/cb/jthc-8-106.PMC3740107.pdf
"110The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 201310.",Non-OADS,/arxiv_data1/oa_pdf/ae/cb/jthc-8-106.PMC3740107.pdf
"The Journal of Tehran University Heart Center 111 TEHRAN HEART CENTER J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Case Report Radiofrequency Ablation of Accessory Pathways in Chil- dren with Complex Congenital Cardiac Lesions: A Report of Three Cases *Corresponding Author: Mohammad Dalili, Department of Pediatric Cardiology, Rajaie Cardiovascular, Medical and Research Center, Vali- Asr Street.",Non-OADS,/arxiv_data1/oa_pdf/06/f2/jthc-8-111.PMC3740108.pdf
"112The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013palpitations and documented narrow complex tachycardia.",Non-OADS,/arxiv_data1/oa_pdf/06/f2/jthc-8-111.PMC3740108.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 113 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013fenestration, atria, and left ventricle, respectively; and 2) via  the retrograde aortic approach.",Non-OADS,/arxiv_data1/oa_pdf/06/f2/jthc-8-111.PMC3740108.pdf
"114The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Discussion Some forms of congenital heart diseases such as Ebstein’s  anomaly, “corrected” transposition of the great vessels,  and tricuspid atresia are associated with a higher incidence of APs.",Non-OADS,/arxiv_data1/oa_pdf/06/f2/jthc-8-111.PMC3740108.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 115 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013White syndrome: evaluation methodology and successful surgical  treatment of the combined disorders.",Non-OADS,/arxiv_data1/oa_pdf/06/f2/jthc-8-111.PMC3740108.pdf
"116The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Case Report Endovascular Treatment of Isolated Bilateral Internal Ili- ac Artery Aneurysms with a Branched Endograft: A Case Report *Corresponding Author: Seyed Ebrahim Kassaian, Associate Professor of Interventional Cardiology, Tehran University of Medical Sciences,  Tehran Heart Center, North Kargar, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/bd/61/jthc-8-116.PMC3740109.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 117 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013endoluminal stenting.",Non-OADS,/arxiv_data1/oa_pdf/bd/61/jthc-8-116.PMC3740109.pdf
"118The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013the left CIA because the internal iliac covered bridging stent  could not be inserted from the right CIA and up and over through the main body bifurcation (alternatively, the covered bridging stent could be inserted through the brachial access, but documented complication rates are as high as 7 – 11%); 6-8  and d) the patient preferred to undergo one treatment instead of several.",Non-OADS,/arxiv_data1/oa_pdf/bd/61/jthc-8-116.PMC3740109.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 119 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Letter to the Editor Localized Treatment of Chest  Pain is Still Common in Rural Areas Description This is the case of a 45-year-old man with documented  coronary artery disease, who refused a referral for coronary  artery bypass grafting surgery (CABG) and preferred instead to seek leech therapy (Figure 1).",Non-OADS,/arxiv_data1/oa_pdf/a5/a1/jthc-8-119.PMC3740110.pdf
"120The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 20132007;39:103-107.",Non-OADS,/arxiv_data1/oa_pdf/a5/a1/jthc-8-119.PMC3740110.pdf
"The Journal of Tehran University Heart Center 65 TEHRAN HEART CENTER J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Original Article Noninvasive Localization of Accessory Pathways in  Patients with Wolff-Parkinson-White Syndrome: A Strain Imaging Study       *Corresponding Author: Majid Maleki, Professor of Cardiology, Echocardiography Research Center, Rajaie Cardiovascular, Medical and Research  Center, Iran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/d1/f2/jthc-8-65.PMC3740111.pdf
"66The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Maryam Esmaeilzadeh et al.",Non-OADS,/arxiv_data1/oa_pdf/d1/f2/jthc-8-65.PMC3740111.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 67 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013The site of successful radiofrequency ablation in one out  of the five regions of left lateral (LL), left posteroseptal  (LPS), right posteroseptal (RPS), right lateral (RL), and right anteroseptal (RAS) was used as the reference location for comparison with echocardiographic and electrocardiographic localization techniques.",Non-OADS,/arxiv_data1/oa_pdf/d1/f2/jthc-8-65.PMC3740111.pdf
"68The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013(δ-ε) for the localization of the APs in the LPS, RAS, RPS,  and RL was 100%, as opposed to 66.6% in the LL.",Non-OADS,/arxiv_data1/oa_pdf/d1/f2/jthc-8-65.PMC3740111.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 69 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013diagnostic accuracy.",Non-OADS,/arxiv_data1/oa_pdf/d1/f2/jthc-8-65.PMC3740111.pdf
"70The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Can a New Antiseptic Agent Reduce the Bacterial  Colonization Rate of Central Venous Lines in Post-Cardiac Surgery Patients?",Non-OADS,/arxiv_data1/oa_pdf/b0/f5/jthc-8-70.PMC3740112.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 71 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Introduction Central venous (CV) catheters play an essential role in  the modern management of critically ill patients, especially  in the Intensive Care Unit (ICU).",Non-OADS,/arxiv_data1/oa_pdf/b0/f5/jthc-8-70.PMC3740112.pdf
"72The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Fardin Yousefshahi et al.",Non-OADS,/arxiv_data1/oa_pdf/b0/f5/jthc-8-70.PMC3740112.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 73 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013patients, there were 2 positive CV line cultures with  staphylococcus hemolyticus: one in the intervention group and the other one in the control group.",Non-OADS,/arxiv_data1/oa_pdf/b0/f5/jthc-8-70.PMC3740112.pdf
"74The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013staphylococcus aureus (2 [3.6%]), and streptococcus (1  [1.8%]).",Non-OADS,/arxiv_data1/oa_pdf/b0/f5/jthc-8-70.PMC3740112.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 75 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Epidemiol 1994;15:227-230.",Non-OADS,/arxiv_data1/oa_pdf/b0/f5/jthc-8-70.PMC3740112.pdf
"76The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Coronary Arteries Bypass Grafting Surgery in Elderly  Patients *Corresponding Author: Feridoun Sabzi, Associate Professor of Cardiac Surgery, Kermanshah University of Medical Sciences, Imam Ali Hospital,  Shaheed Beheshti Ave., Kermanshah, Iran.",Non-OADS,/arxiv_data1/oa_pdf/dd/be/jthc-8-76.PMC3740113.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 77 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Introduction The development of the health care system has led to a  continuous growth in the elderly population in Iran, which  has been allied with a rise in the number of candidates for coronary artery bypass grafting surgery (CABG).",Non-OADS,/arxiv_data1/oa_pdf/dd/be/jthc-8-76.PMC3740113.pdf
"78The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013support beyond 3 days or the occurrence of adult respiratory  distress syndrome or the need for tracheostomy.",Non-OADS,/arxiv_data1/oa_pdf/dd/be/jthc-8-76.PMC3740113.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 79 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Coronary Arteries Bypass Grafting Surgery in Elderly Patients smoking, opium use, left internal mammary artery use,  clamp time, pump time, hematocrit, and peripheral vascular disease were almost the same in both groups.",Non-OADS,/arxiv_data1/oa_pdf/dd/be/jthc-8-76.PMC3740113.pdf
"80The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013respiratory complications, and inotropic drug use in the total  study population and opium use (OR = 2.24), ASA use (OR = 0.22), preoperative PO 2 (OR = 0.96), COPD (OR = 0.27), and weight (OR = 0.94) in the elderly subjects (Table 5).",Non-OADS,/arxiv_data1/oa_pdf/dd/be/jthc-8-76.PMC3740113.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 81 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013analysis were postoperative atrial fibrillation (OR = 11.4),  re-intubation (OR = 2.5), death (OR = 10), IABP use (OR =  2.7), left main CAD (OR = 0.5), sex (OR = 0.2), and ejection fraction (OR = 0.9) in the total study population; nonetheless, in the elderly patients, these factors were reduced to four: preoperative myocardial infarction (OR = 4.1); left main CAD (OR = 8.8); death (OR = 5.4); and atrial fibrillation (OR = 7.4).",Non-OADS,/arxiv_data1/oa_pdf/dd/be/jthc-8-76.PMC3740113.pdf
"82The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013elderly patients, and the predicting factors for the occurrence  of atrial fibrillation in the logistic regression analysis were diabetes, re-exploration for bleeding, infection, and re-intubation.",Non-OADS,/arxiv_data1/oa_pdf/dd/be/jthc-8-76.PMC3740113.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 83 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013addiction and re-exploration for postoperative bleeding  than  our elderly females, who had more preoperative creatinine greater than 1.5 mg,  lower  body  surface  area, lower  weight,  lower  preoperative  PO 2 higher preoperative PCO2, higher  hypercholesterolemia, higher prevalence of IABP insertion, lower opium use, lower ejection fraction, lower preoperative hematocrit, lower number of grafts ,lower pump time, lower clamp time, higher mortality, and higher postoperative low cardiac output syndrome.",Non-OADS,/arxiv_data1/oa_pdf/dd/be/jthc-8-76.PMC3740113.pdf
"84The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013was a risk factor for in-hospital mortality in the elderly; this  variable reached statistical significance in our study.",Non-OADS,/arxiv_data1/oa_pdf/dd/be/jthc-8-76.PMC3740113.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 85 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013iced slush/cooling of the atria,41 beta-blocker withdrawal,42  hypothyroidism, withdrawal of thyroid hormone replacement  therapy in the preoperative period,43 pericarditis, and many  other factors.44, 45 Suture line, hematoma, and other traumatic  causes of atrial fibrillation lead to a lack of uniformity in the atrial refractory period, and dispersion of refractoriness is the underlying mechanism causing vulnerability of the atrial tissue to develop atrial fibrillation.",Non-OADS,/arxiv_data1/oa_pdf/dd/be/jthc-8-76.PMC3740113.pdf
"86The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013results.",Non-OADS,/arxiv_data1/oa_pdf/dd/be/jthc-8-76.PMC3740113.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 87 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 20131988;55:23-34.",Non-OADS,/arxiv_data1/oa_pdf/dd/be/jthc-8-76.PMC3740113.pdf
"88The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 201352.",Non-OADS,/arxiv_data1/oa_pdf/dd/be/jthc-8-76.PMC3740113.pdf
"The Journal of Tehran University Heart Center 89 TEHRAN HEART CENTER J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Angiotensin- Converting Enzyme Insertion/Deletion  Polymorphism and Its Association with Coronary Artery Disease in an Iranian Population *Corresponding Author: Mohammad Ali Boroumand, Associate Professor of Clinical Pathology, Molecular Pathology Department, Tehran Heart  Center, North Kargar Street, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/3f/8e/jthc-8-89.PMC3740114.pdf
"90The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Introduction Individuals suffering from coronary artery disease (CAD)  show different types of signs and symptoms and mostly they  show no evidence for decades.",Non-OADS,/arxiv_data1/oa_pdf/3f/8e/jthc-8-89.PMC3740114.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 91 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013tients’ blood samples using a salting out method,18 a single  polymerase chain reaction (PCR) method using oligonucle- otide primers 5’-CTGGAGACCACTCCCATCCTTTCT-3’ (forward) and 5’-GATGTGGCCATCACATTCGTCA-GAT-3’ (reverse) specific to a 490bp DNA fragment in in-tron 16 was performed for genotyping.",Non-OADS,/arxiv_data1/oa_pdf/3f/8e/jthc-8-89.PMC3740114.pdf
"92The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013The results of the genotyping of ACE gene (Figure 1)  and its relationship with CAD are depicted in Table 2.",OADS,/arxiv_data1/oa_pdf/3f/8e/jthc-8-89.PMC3740114.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 93 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013After random repeating of genotyping on 20% of the  1050 total specimens by a technician blinded to the previous  results, only 6 specimens (< 3%) had different results, showing the good precision of our techniques.",Non-OADS,/arxiv_data1/oa_pdf/3f/8e/jthc-8-89.PMC3740114.pdf
"94The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013References 1.",Non-OADS,/arxiv_data1/oa_pdf/3f/8e/jthc-8-89.PMC3740114.pdf
"The Journal of Tehran University Heart Center 95 TEHRAN HEART CENTER J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Comparison of Echocardiographic Markers of Cardiac  Dyssynchrony and Latest Left Ventricular Activation Site in Heart Failure Patients with and without Left Bundle Branch Block *Corresponding Author: Hakimeh Sadeghian, Associate Professor of Cardiology, Tehran University of Medical Sciences, Tehran Heart Center, North  Kargar Street, Tehran, Iran.1411713138.",Non-OADS,/arxiv_data1/oa_pdf/78/8d/jthc-8-95.PMC3740115.pdf
"96The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Introduction Cardiomyopathy is characterized by the progressive  remodeling of the ventricles and affects the conduction  pathway.",Non-OADS,/arxiv_data1/oa_pdf/78/8d/jthc-8-95.PMC3740115.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 97 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013longest Ts in 12 LV segments (105 msec);4 Basal segments  delay (Ts-delay basal segments): delay between shortest and  longest Ts in LV basal segments (78 msec);4 All segments  standard deviation (Ts-SD all segments): SD of the time-to-peak myocardial systolic velocity of 12 LV basal and mid segments (34.4 msec); 4 Basal segments SD: (Ts-SD  basal segments) SD of the time-to-peak myocardial systolic velocity of 6 LV basal segments (34.5 msec); 4 Septal-lateral  delay: maximum delay between peak systolic velocities between the basal interventricular septum and the lateral wall (60 msec); 17 and Anteroseptal-posterior delay: absolute  difference in Ts between the basal posterior and anteroseptal segments (65 msec).",Non-OADS,/arxiv_data1/oa_pdf/78/8d/jthc-8-95.PMC3740115.pdf
"98The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013± 38.3 msec in the non-LBBB patients; p value < 0.001.",Non-OADS,/arxiv_data1/oa_pdf/78/8d/jthc-8-95.PMC3740115.pdf
"TEHRAN HEART CENTER The Journal of Tehran University Heart Center 99 J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Discussion According to the results of our study on cardiomyopathy  patients, 29.3% of the non-LBBB and 10.8% of the LBBB  patients had no marker of dyssynchrony, regardless of the etiology of cardiomyopathy in each group.",Non-OADS,/arxiv_data1/oa_pdf/78/8d/jthc-8-95.PMC3740115.pdf
"100The Journal of Tehran University Heart Center J Teh Univ Heart Ctr 8(2) http://jthc.tums.ac.ir APRIL 28, 2013Conclusion There was a delay of activation in all LV segments  in the LBBB compared to the non-LBBB patients with  impaired systolic function.",Non-OADS,/arxiv_data1/oa_pdf/78/8d/jthc-8-95.PMC3740115.pdf
"Email : fghafoor99@hotmail.com      Received: 06 Sep 2012  Accepted: 23 Jan 2013  Published: 05 Apr 2013   J Med Ethics Hist Med, 2013, 6:4 http://journals.tums.ac.ir/abs/23423    © 2013 Shaila Tahir et al.",Non-OADS,/arxiv_data1/oa_pdf/f8/64/jmehm-6-4.PMC3740192.pdf
"Tel: +98 711- 6474254,  Fax: +98 711-6474252  E-mail: molazem@sums.ac.ir      Received: 09 Jan 2013  Accepted: 02 Mar 2013  Published: 06 Apr 2013    J Med Ethics Hist Med, 2013, 6:5 http://journals.tums.ac.ir/abs/23424    © 2013 Zahra Molazem et al.",Non-OADS,/arxiv_data1/oa_pdf/fc/2a/jmehm-6-5.PMC3740193.pdf
"Corresponding Author :   Bagher Larijani   E.mail: emrc@tums.ac.ir     Published: 02 May 2013   J Med Ethics Hist Med, 2013, 6:6  http://journals.tums.ac.ir/abs/23609    © 2013 Pooneh Salari et al.",Non-OADS,/arxiv_data1/oa_pdf/3e/bf/jmehm-6-6.PMC3740194.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ gutjnl-2012-303207).,OADS,/arxiv_data1/oa_pdf/3d/4b/gutjnl-2012-303207.PMC3740207.pdf
"1Department of Medical Biochemistry, University ofGothenburg, Gothenburg, Sweden 2Cardiovascular Biology Research Program, OklahomaMedical Research Foundation, Oklahoma City, Oklahoma, USA 3Department of Pediatrics, University of Arizona Health Sciences Center, Tucson, Arizona, USA 4Department of Biology, Georgia State University, Atlanta, Georgia, USA 5Department Internal Medicine, University of Gothenburg,Gothenburg, Sweden Correspondence to Dr Gunnar C Hansson,Department of MedicalBiochemistry, University of Gothenburg, Box 440, Gothenburg 405 30, Sweden;gunnar.hansson@medkem.gu.se Received 29 June 2012 Accepted 28 January 2013 Published Online First20 February 2013 ▸http://dx.doi.org/10.1136/ gutjnl-2012-304602.pdf To cite: Johansson MEV, Gustafsson JK, Holmén-Larsson J, et al.Gut 2014; 63:281–291.ABSTRACT Objective The inner mucus layer in mouse colon normally separates bacteria from the epithelium.",Non-OADS,/arxiv_data1/oa_pdf/3d/4b/gutjnl-2012-303207.PMC3740207.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Xavier RJ, Podolsky DK.",Non-OADS,/arxiv_data1/oa_pdf/3d/4b/gutjnl-2012-303207.PMC3740207.pdf
"Journal of  Preventive Medicine  & Public Health155 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:155-164   •  http://dx.doi.org/10.3961/jpmph.2013.46.4.155 Burden of Noncommunicable Diseases and National  Strategies to Control Them in Korea Young-Ho Khang Department of Preventive Medicine, University of Ulsan College of Medicine, Seoul, KoreaSpecial Article Noncommunicable diseases (NCDs) are the most important causes of premature mortality and disability-adjusted life years in Korea.",Non-OADS,/arxiv_data1/oa_pdf/79/a9/jpmph-46-155.PMC3740220.pdf
"Key words: Alcohol drinking, Diet, Korea, Noncommunicable disease, Policy, Smoking Received:  July 1, 2013 Accepted:  July 15, 2013 Corresponding author:  Young-Ho Khang, MD, PhD 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea  Tel: +82-2-3010-4290, Fax: +82-2-477-2898  E-mail : youngk@amc.seoul.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.INTRODUCTION: WHY NONCOMMUNICA - BLE DISEASE?",Non-OADS,/arxiv_data1/oa_pdf/79/a9/jpmph-46-155.PMC3740220.pdf
Available from: http://www.who.int/ncdnet/about/en/.,OADS,/arxiv_data1/oa_pdf/79/a9/jpmph-46-155.PMC3740220.pdf
Available from: http://www.ncdalliance.org/who-we-are.,Non-OADS,/arxiv_data1/oa_pdf/79/a9/jpmph-46-155.PMC3740220.pdf
Available from: http://ncdalliance.org/sites/default/files/rfiles/GMF_Final%20Table%20of%20Targets.pdf.,OADS,/arxiv_data1/oa_pdf/79/a9/jpmph-46-155.PMC3740220.pdf
Avail-able from: https://rio20.un.org/sites/rio20.un.org/files/a-conf.,Non-OADS,/arxiv_data1/oa_pdf/79/a9/jpmph-46-155.PMC3740220.pdf
Available from: http://www.health-metricsandevaluation.org/gbd/visualizations/gbd-arrow-dia-gram.,Non-OADS,/arxiv_data1/oa_pdf/79/a9/jpmph-46-155.PMC3740220.pdf
Available from: http://www.cancer.go.kr/mbs/cancer/subview.jsp?id =cancer_040101000000 (Korean).,Non-OADS,/arxiv_data1/oa_pdf/79/a9/jpmph-46-155.PMC3740220.pdf
Available from: http://www.chsc.or.kr/xe/?document_srl =69567 (Korean).,Non-OADS,/arxiv_data1/oa_pdf/79/a9/jpmph-46-155.PMC3740220.pdf
"Journal of  Preventive Medicine  & Public Health165 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:165-172   •  http://dx.doi.org/10.3961/jpmph.2013.46.4.165 Noncommunicable Diseases: Current Status of Major  Modifiable Risk Factors in Korea  Hyeon Chang Kim1, Sun Min Oh2  1Department of Preventive Medicine, Yonsei University College of Medicine, Seoul; 2Medical Affairs, Novartis Korea Oncology, Seoul, KoreaSpecial Article A noncommunicable disease (NCD) is a medical condition or disease that is by definition non-infectious and non-transmissible among  people.",Non-OADS,/arxiv_data1/oa_pdf/9e/27/jpmph-46-165.PMC3740221.pdf
"Key words: Noncommunicable disease, Risk factors, Prevalence, Trend, Korea Received:  July 11, 2013; Accepted:  July 19, 2013 Corresponding author:  Hyeon Chang Kim, MD, PhD 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Korea  Tel: +82-2-2228-1873, Fax: +82-2-392-8133  E-mail : hckim@yuhs.ac This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.INTRODUCTION A noncommunicable disease (NCD) is a medical condition or  disease that is by definition non-infectious and non-transmis- sible among people.",Non-OADS,/arxiv_data1/oa_pdf/9e/27/jpmph-46-165.PMC3740221.pdf
Available from: http://www.who.int/chp/chronic_disease_report/en.,Non-OADS,/arxiv_data1/oa_pdf/9e/27/jpmph-46-165.PMC3740221.pdf
Available from: http://www.who.int/gho/ncd/mortality_morbidity/ncd_total/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/9e/27/jpmph-46-165.PMC3740221.pdf
Available from: http://www.who.int/gho/ncd/mortality_morbidity/en/.,Non-OADS,/arxiv_data1/oa_pdf/9e/27/jpmph-46-165.PMC3740221.pdf
Avail-able from: http://www.who.int/whr/2002/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/9e/27/jpmph-46-165.PMC3740221.pdf
Available from: http://www.who.int/substance_abuse/publications/global_status_report_2004_overview.pdf.,OADS,/arxiv_data1/oa_pdf/9e/27/jpmph-46-165.PMC3740221.pdf
Available from: http://www.who.int/dietphysicalactivity/factsheet_inactivity/en/in-dex.html.,Non-OADS,/arxiv_data1/oa_pdf/9e/27/jpmph-46-165.PMC3740221.pdf
"Journal of  Preventive Medicine  & Public Health173 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:173-182   •  http://dx.doi.org/10.3961/jpmph.2013.46.4.173 Overview of Noncommunicable Diseases in Korean   Children and Adolescents: Focus on Obesity and Its Effect  on Metabolic Syndrome Hye Ah Lee, Hyesook Park Department of Preventive Medicine, Ewha Womans University School of Medicine, Seoul, KoreaSpecial Article Obesity during childhood is a dominant risk factor for noncommunicable diseases (NCDs), and is itself considered a disease that needs  to be treated.",Non-OADS,/arxiv_data1/oa_pdf/97/c4/jpmph-46-173.PMC3740222.pdf
"Key words:  Adolescents, Children, Noncommunicable diseases, Metabolic syndrome, Obesity Received:  June 24, 2013; Accepted:  July 15, 2013 Corresponding author:  Hyesook Park, MD, PhD  1071 Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, Korea   Tel: +82-2-2650-5753, Fax: +82-2-2652-8325   E-mail : hpark@ewha.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Obesity is caused by multiple factors, including genetic, so - cio-economic, behavioral, and environmental factors, and it is,  in turn, the dominant risk factor for noncommunicable diseas -pISSN 1975-8375 eISSN 2233-4521  es (NCDs).",Non-OADS,/arxiv_data1/oa_pdf/97/c4/jpmph-46-173.PMC3740222.pdf
Available from: http://www.jhsph.edu/ bin/g/q/noncommunicable.pdf.,Non-OADS,/arxiv_data1/oa_pdf/97/c4/jpmph-46-173.PMC3740222.pdf
Available from: http://www.bokjiro.go.kr/cmm/  fms/FileDown.do?atchFileId =5951033&fileSn =12872.0 KB  (Korean).,Non-OADS,/arxiv_data1/oa_pdf/97/c4/jpmph-46-173.PMC3740222.pdf
Available from: http://www.mfds.go.kr/index.,Non-OADS,/arxiv_data1/oa_pdf/97/c4/jpmph-46-173.PMC3740222.pdf
"Journal of  Preventive Medicine  & Public Health183 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:183-191   •  http://dx.doi.org/10.3961/jpmph.2013.46.4.183 Drinking Patterns Among Korean Adults: Results of the  2009 Korean Community Health Survey So Yeon Ryu1, Catherine M. Crespi2, Annette E. Maxwell2 1Department of Preventive Medicine, Chosun University Medical School, Gwangju, Korea; 2Fielding School of Public Health and Jonsson   Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USAOriginal Article Objectives: In Korea, the proportion of deaths due to alcohol is estimated at 8.9%, far exceeding the global estimate of 3.8%.",Non-OADS,/arxiv_data1/oa_pdf/e4/b3/jpmph-46-183.PMC3740223.pdf
"Key words:  Alcohol drinking, Epidemiology, High-risk drinking, Risk factors, Republic of Korea Received:  February 25, 2012 Accepted:  May 31, 2012 Corresponding author:  So Yeon Ryu, MD, PhD 309 Pilmun-daero, Dong-gu, Gwangju 501-759, Korea   Tel: +82-62-230-6483, Fax: +82-62-225-8293   E-mail : canrsy@chosun.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Alcohol use has been recognized as one of the major risk  factors worldwide of preventable mortality and morbidity [1].",Non-OADS,/arxiv_data1/oa_pdf/e4/b3/jpmph-46-183.PMC3740223.pdf
Available  from; http://www.who.int/substance_abuse/activities/pub - lic_health_alcohol/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/e4/b3/jpmph-46-183.PMC3740223.pdf
Available from:  http://kosis.kr/ups/ups_01List01.jsp?grp_no =&pubcode =  YD&type =F (Korean).,OADS,/arxiv_data1/oa_pdf/e4/b3/jpmph-46-183.PMC3740223.pdf
"Journal of  Preventive Medicine  & Public Health192 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:192-200   •  http://dx.doi.org/10.3961/jpmph.2013.46.4.192 Behavioural Determinants for Obesity: A Cross-sectional  Study Among Urban Adolescents in India M. Anitha Rani, B.W.C.",Non-OADS,/arxiv_data1/oa_pdf/98/2a/jpmph-46-192.PMC3740224.pdf
"Key words:  Dietary behaviour, Motor activity, Overweight, Obesity, Adolescent Received:  January 2, 2013; Accepted:  June 19, 2013 Corresponding author:  M. Anitha Rani, MD Porur, Chennai 600 116, Tamil Nadu, India Tel: +91-44-4952-3937, Fax: +91-44-2476-8027 E-mail : anithajayaraju@yahoo.co.in This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Obesity is one of the major global problems affecting chil - dren and adolescents.",Non-OADS,/arxiv_data1/oa_pdf/98/2a/jpmph-46-192.PMC3740224.pdf
Available from: http://www.chennai.tn.nic.in/schools.,Non-OADS,/arxiv_data1/oa_pdf/98/2a/jpmph-46-192.PMC3740224.pdf
Available  from: http://www.ipaq.ki.se/questionnaires/IPAQ_S7S_FI - NAL_MAY_01.pdf.,Non-OADS,/arxiv_data1/oa_pdf/98/2a/jpmph-46-192.PMC3740224.pdf
"Journal of  Preventive Medicine  & Public Health201 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:201-209   •  http://dx.doi.org/10.3961/jpmph.2013.46.4.201 Use of Drug-eluting Stents Versus Bare-metal Stents in  Korea: A Cost-minimization Analysis Using Population  Data Hae Sun Suh1,2, Hyun Jin Song1,3, Eun Jin Jang1, Jung-Sun Kim4, Donghoon Choi1,4, Sang Moo Lee1 1National Evidence-based Healthcare Collaborating Agency, Seoul; 2College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei  University, Incheon; 3School of Pharmacy, Sungkyunkwan University, Suwon; 4Division of Cardiology, Severance Cardiovascular Hospital, Yonsei  University College of Medicine, Seoul, KoreaOriginal Article Objectives: The goal of this study was to perform an economic analysis of a primary stenting with drug-eluting stents (DES) compared  with bare-metal stents (BMS) in patients with acute myocardial infarction (AMI) admitted through an emergency room (ER) visit in Korea  using population-based data.",Non-OADS,/arxiv_data1/oa_pdf/94/c6/jpmph-46-201.PMC3740225.pdf
"Key words:  Myocardial infarction, Drug-eluting stents, Costs and cost analysis, Pharmaceutical economics  Received:  May 16, 2013; Accepted:  July 11, 2013 Corresponding author:  Sang Moo Lee, MD, PhD 174 Yulgok-ro, Jongno-gu, Seoul 110-450, Korea Tel: +82-2-2174-2850, Fax: +82-2-741-7060 E-mail : lsmlight@daum.net This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION Primary percutaneous coronary intervention has been es - tablished as the treatment of choice for patients with acute ST- segment elevation myocardial infarction (STEMI) which is a  sub-class of acute myocardial infarction (AMI) and usually re - quires an immediate intervention [1].",Non-OADS,/arxiv_data1/oa_pdf/94/c6/jpmph-46-201.PMC3740225.pdf
Available from:  http://kosis.kr (Korean).,Non-OADS,/arxiv_data1/oa_pdf/94/c6/jpmph-46-201.PMC3740225.pdf
"” J Prev Med Public Health 2013;46:210   •  http://dx.doi.org/10.3961/jpmph.2013.46.4.210Erratum pISSN 1975-8375 eISSN 2233-4521  Corresponding author:  Gun-Chun Ryu, PhD   235 Jinheung-ro, Eunpyeong-gu, Seoul 122-705, Korea   Tel: +82-2-380-8155, Fax: +82-2-380-1674   E-mail : gchryu@kihasa.re.kr",Non-OADS,/arxiv_data1/oa_pdf/58/70/jpmph-46-210.PMC3740226.pdf
"”J Prev Med Public Health 2013;46:211   •  http://dx.doi.org/10.3961/jpmph.2013.46.4.211Erratum pISSN 1975-8375 eISSN 2233-4521  Corresponding author:  Kyung-Duk Zoh, PhD   1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea   Tel: +82-2-880-2737, Fax: +82-2-745-9104   E-mail : zohkd@snu.ac.kr",Non-OADS,/arxiv_data1/oa_pdf/46/63/jpmph-46-211.PMC3740227.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003022).,Non-OADS,/arxiv_data1/oa_pdf/5c/0c/bmjopen-2013-003022.PMC3740244.pdf
Received 9 April 2013 Revised 12 June 2013 Accepted 14 June 2013 This final article is available for use under the terms ofthe Creative Commons Attribution Non-Commercial 3.0 Licence; see http://bmjopen.bmj.com ▸http://dx.doi.org/10.1136/ bmjopen-2013-003056 For numbered affiliations see end of article.,Non-OADS,/arxiv_data1/oa_pdf/5c/0c/bmjopen-2013-003022.PMC3740244.pdf
Supplementary material is also available at http://www.geneticalliance.org.uk/ projects/stratum_docs.htm REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5c/0c/bmjopen-2013-003022.PMC3740244.pdf
2004. http://www.dh.,Non-OADS,/arxiv_data1/oa_pdf/5c/0c/bmjopen-2013-003022.PMC3740244.pdf
Consent exemptions from the Human Tissue Act 2004. http://www.hta.gov.uk/licensingandinspections/consentexemptions.cfm (accessed 26 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/5c/0c/bmjopen-2013-003022.PMC3740244.pdf
https://www.myresearchproject.org.uk/Help/Help% 20Documents/PdfDocuments/researchtissuebank.pdf (accessed 25 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/5c/0c/bmjopen-2013-003022.PMC3740244.pdf
2011 http://www.nuffieldbioethics.org/sites/default/files/Donation_full_report.pdf (accessed 26 Feb 2013).13.,Non-OADS,/arxiv_data1/oa_pdf/5c/0c/bmjopen-2013-003022.PMC3740244.pdf
2010. http://www.hta.gov.uk/_db/_documents/2007-09-10_Ipsos_MORI_general_public_qual_and_quant_report_final_200709101952.pdf (accessed 26 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/5c/0c/bmjopen-2013-003022.PMC3740244.pdf
2010. http://ec.europa.eu/public_ opinion/archives/ebs/ebs_341_en.pdf (accessed 15 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/5c/0c/bmjopen-2013-003022.PMC3740244.pdf
doi:10.1136/bmjopen-2013- 003537 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003537).,Non-OADS,/arxiv_data1/oa_pdf/99/fa/bmjopen-2013-003537.PMC3740245.pdf
2013. http://www.nice.org.uk/nicemedia/live/14183/64124/64124.pdf 9.,Non-OADS,/arxiv_data1/oa_pdf/99/fa/bmjopen-2013-003537.PMC3740245.pdf
2012. http://www.who.int/cancer/palliative/definition/en/ 10.,Non-OADS,/arxiv_data1/oa_pdf/99/fa/bmjopen-2013-003537.PMC3740245.pdf
1997. http://www.who.int/mental_health/media/68.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/99/fa/bmjopen-2013-003537.PMC3740245.pdf
2005. http://www.dh.gov.uk/prod_ consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4122427.pdf 31.,OADS,/arxiv_data1/oa_pdf/99/fa/bmjopen-2013-003537.PMC3740245.pdf
2009. http://cymru.gov.uk/ topics/health/research/word/publications/researchgovernance/?lang=en 32.,Non-OADS,/arxiv_data1/oa_pdf/99/fa/bmjopen-2013-003537.PMC3740245.pdf
2011. http://www.nres.nhs.uk/EasySiteWeb/GatewayLink.aspx?alId=338.,Non-OADS,/arxiv_data1/oa_pdf/99/fa/bmjopen-2013-003537.PMC3740245.pdf
2005. http://www.opsi.,Non-OADS,/arxiv_data1/oa_pdf/99/fa/bmjopen-2013-003537.PMC3740245.pdf
1998. http://www.opsi.,Non-OADS,/arxiv_data1/oa_pdf/99/fa/bmjopen-2013-003537.PMC3740245.pdf
http://www.involvingpeople.org.uk/ 37.,Non-OADS,/arxiv_data1/oa_pdf/99/fa/bmjopen-2013-003537.PMC3740245.pdf
2012. http://www.invo.org.uk/wp-content/uploads/2012/04/INVOLVEpublicinvolvementinclinicaltrialsBriefingnotes2012.pdf 38.,Non-OADS,/arxiv_data1/oa_pdf/99/fa/bmjopen-2013-003537.PMC3740245.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003094).,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/bmjopen-2013-003094.PMC3740246.pdf
26The questionnaire is available online from http://www.45andup.org.au.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/bmjopen-2013-003094.PMC3740246.pdf
2011 http://www.goldcopd.org/.,Non-OADS,/arxiv_data1/oa_pdf/e4/6d/bmjopen-2013-003127.PMC3740247.pdf
10 METHODS We devised two electronic survey questionnaires: one forclinical stroke-prevention services and one for imaging services using the online survey software ‘SurveyMonkey ’ (http://www.surveymonkey.com).,Non-OADS,/arxiv_data1/oa_pdf/fc/f4/bmjopen-2013-003359.PMC3740248.pdf
Data sharing statement Individual and summary responses for both surveys can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.3nc25.,OADS,/arxiv_data1/oa_pdf/fc/f4/bmjopen-2013-003359.PMC3740248.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003511).,Non-OADS,/arxiv_data1/oa_pdf/db/69/bmjopen-2013-003511.PMC3740249.pdf
10Other clinical trials reported similar results with EC-MPS.11–14The Therapeutic Goods Administration of Australia approved EC-MPS-Myfortic(http://www.novartis.com.au/DownloadFile.aspx?t=pf=myf.,Non-OADS,/arxiv_data1/oa_pdf/db/69/bmjopen-2013-003511.PMC3740249.pdf
44. http://www.nss.gov.au/nss/home.nsf/pages/Sample+size+calculator45.,Non-OADS,/arxiv_data1/oa_pdf/db/69/bmjopen-2013-003511.PMC3740249.pdf
Australian code for theconduct of research 2007. http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/e72.pdf.,Non-OADS,/arxiv_data1/oa_pdf/db/69/bmjopen-2013-003511.PMC3740249.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003101).,Non-OADS,/arxiv_data1/oa_pdf/d8/1f/bmjopen-2013-003101.PMC3740252.pdf
"Global Strategy for the Diagnosis, Management and Prevention ofCOPD 2011http://www.goldcopd.org/.Ref Type: Internet Communication 4.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/bmjopen-2013-003101.PMC3740252.pdf
doi:10.1136/bmjopen-2013- 003268 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003268).,Non-OADS,/arxiv_data1/oa_pdf/c8/1d/bmjopen-2013-003268.PMC3740253.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003563).,Non-OADS,/arxiv_data1/oa_pdf/80/f9/bmjopen-2013-003563.PMC3740254.pdf
2010. http://www.cma.ca/multimedia/CMA/Content_Images/ Inside_cma/Advocacy/HCT/HCT-2010report_en.pdf2.,Non-OADS,/arxiv_data1/oa_pdf/80/f9/bmjopen-2013-003563.PMC3740254.pdf
2009. http://www.health.gov.sk.ca/Default.aspx?,Non-OADS,/arxiv_data1/oa_pdf/80/f9/bmjopen-2013-003563.PMC3740254.pdf
http://www.rheumatology.org/practice/clinical/position/multidisciplinaryCare.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/80/f9/bmjopen-2013-003563.PMC3740254.pdf
http://www.clinicaltrials.gov51.,Non-OADS,/arxiv_data1/oa_pdf/80/f9/bmjopen-2013-003563.PMC3740254.pdf
doi:10.1136/bmjopen-2013- 003506 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003506).,Non-OADS,/arxiv_data1/oa_pdf/08/83/bmjopen-2013-003506.PMC3740255.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/08/83/bmjopen-2013-003506.PMC3740255.pdf
"Oslo: Norwegian Institute of Public Health, 2009. http://www.fhi.no/dokumenter/197a20d501.pdf (accessed 22 Dec2012).",Non-OADS,/arxiv_data1/oa_pdf/08/83/bmjopen-2013-003506.PMC3740255.pdf
"Norway: Research Magazine Apollon, University of Oslo, 2010. http://www.apollon.uio.no/artikler/2010/delirium.html(accessed 22 Dec 2012).",Non-OADS,/arxiv_data1/oa_pdf/08/83/bmjopen-2013-003506.PMC3740255.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003056).,Non-OADS,/arxiv_data1/oa_pdf/9e/30/bmjopen-2013-003056.PMC3740256.pdf
"Improved education and more controlledforms of consent for sensitive samples may mitigatesuch concerns.▸http://dx.doi.org/10.1136/ bmjopen-2013-003022ARTICLE SUMMARY Article focus ▪To explore the UK public ’s willingness to donate: residual biosamples following a medical proced-ure, biosamples donated as ‘healthy volunteers ’, additional biosamples during surgery and bio-samples post mortem for medical research.",Non-OADS,/arxiv_data1/oa_pdf/9e/30/bmjopen-2013-003056.PMC3740256.pdf
"51 01 1Greater transparency and education of the public by the research communityabout the role pharmaceutical companies play in research and drug development, (as is currently being conducted through initiatives such as EUPATI; http://www.patientsacademy.eu), will help to highlight the col- laborations that frequently exist between private and public enterprises.",Non-OADS,/arxiv_data1/oa_pdf/9e/30/bmjopen-2013-003056.PMC3740256.pdf
"Data sharing statement Transcripts from the focus groups and full results of the survey are available from CL at celine@geneticalliance.org.uk.Supplementary material is also available at http://www.geneticalliance.org.uk/ projects/stratum_docs.htm Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non- commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.",Non-OADS,/arxiv_data1/oa_pdf/9e/30/bmjopen-2013-003056.PMC3740256.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9e/30/bmjopen-2013-003056.PMC3740256.pdf
2010. http://www.hta.gov.uk/_db/_documents/2007 –09–10_Ipsos_MORI_general_public_qual_and_ quant_report_final_200709101952.pdf (accessed 26 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/9e/30/bmjopen-2013-003056.PMC3740256.pdf
2011. http://www.nuffieldbioethics.org/sites/default/files/Donation_full_report.pdf (accessed 26 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/9e/30/bmjopen-2013-003056.PMC3740256.pdf
36. http://blog.cookcountygov.com/2012/09/12/stroger-hospital-of-cook- county-hosts-komen-cure-tissue-bank-event-september-29th/.,Non-OADS,/arxiv_data1/oa_pdf/9e/30/bmjopen-2013-003056.PMC3740256.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-002749).,Non-OADS,/arxiv_data1/oa_pdf/02/c8/bmjopen-2013-002749.PMC3740257.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fb/89/srep02412.PMC3740276.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2412 | DOI: 10.1038/srep02412 7",Non-OADS,/arxiv_data1/oa_pdf/fb/89/srep02412.PMC3740276.pdf
"Using blood samples from the RCC patients, we sequenced the D-loop, which contains a length of 1122 bps (nucleotide 16024–16569 and 1–576), and referred to mitochondria database http://www.mitomap.org.",OADS,/arxiv_data1/oa_pdf/cb/e0/srep02408.PMC3740277.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2408 | DOI: 10.1038/srep02408 3",Non-OADS,/arxiv_data1/oa_pdf/cb/e0/srep02408.PMC3740277.pdf
http://www.nist.gov/lispix/doc/ fractal/image-java-box-count.htm.,OADS,/arxiv_data1/oa_pdf/8a/20/srep02384.PMC3740278.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8a/20/srep02384.PMC3740278.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2384 | DOI: 10.1038/srep02384 8",Non-OADS,/arxiv_data1/oa_pdf/8a/20/srep02384.PMC3740278.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2405 | DOI: 10.1038/srep02405 6",Non-OADS,/arxiv_data1/oa_pdf/74/10/srep02405.PMC3740279.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/82/20/srep02413.PMC3740280.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2413 | DOI: 10.1038/srep02413 5",Non-OADS,/arxiv_data1/oa_pdf/82/20/srep02413.PMC3740280.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0d/df/srep02410.PMC3740281.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2410 | DOI: 10.1038/srep02410 5",Non-OADS,/arxiv_data1/oa_pdf/0d/df/srep02410.PMC3740281.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/95/4d/srep02414.PMC3740282.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2414 | DOI: 10.1038/srep02414 7",Non-OADS,/arxiv_data1/oa_pdf/95/4d/srep02414.PMC3740282.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/92/42/srep02411.PMC3740283.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2411 | DOI: 10.1038/srep02411 6",Non-OADS,/arxiv_data1/oa_pdf/92/42/srep02411.PMC3740283.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis)YAP1 activation in thyroid cancer SE Lee et al 10 Oncogenesis (2013) 1 – 10 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/d0/2e/oncsis201312a.PMC3740284.pdf
An extensive literature searchwas carried out using PubMed (http://www.ncbi.nlm.nih.gov/ pubmed) to collect original papers.,OADS,/arxiv_data1/oa_pdf/59/22/oncsis201315a.PMC3740285.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis).Targets, pathways and clues for mutant p53 S Garritano et al 7 &2013 Macmillan Publishers Limited Oncogenesis (2013), 1 – 7",Non-OADS,/arxiv_data1/oa_pdf/59/22/oncsis201315a.PMC3740285.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis).MicroRNA-29a regulates DNA damage response in lung cancer cells LR Barkley et al 7 &2013 Macmillan Publishers Limited Oncogenesis (2013), 1 – 7",Non-OADS,/arxiv_data1/oa_pdf/14/83/oncsis201320a.PMC3740286.pdf
"The parent-of-origin-speciﬁc monoallelic expression thatcharacterizes imprinting 11has crucial roles in normal growth anddevelopment.12Genetic and/or epigenetic alterations can activate the normally silenced allele or silence the one that is normally expressed,13and this loss of imprinting (LOI) has been described in several types of cancer.14To date,B80 imprinted human genes have been identiﬁed (http://www.geneimprint.com/), but bioinformatic predictions indicate that the true number is probably higher.11,15Allele-speciﬁc DNA methylation (ASM) of nonimprinted genes also seems to be widespread in the human genome,16and loci of this type are also potential targets of epigenetic changes relevant for tumorigenesis.",Non-OADS,/arxiv_data1/oa_pdf/8a/7f/oncsis201321a.PMC3740287.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis).Silencing of miRNA clusters in colorectal adenomas M Menigatti et al 9 &2013 Macmillan Publishers Limited Oncogenesis (2013), 1 – 9",Non-OADS,/arxiv_data1/oa_pdf/8a/7f/oncsis201321a.PMC3740287.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis)Orphan nuclear receptors in bladder cancer T Okegawa et al 8 Oncogenesis (2013), 1 – 8 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/37/9f/oncsis201325a.PMC3740288.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6a/1b/srep02409.PMC3740289.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2409 | DOI: 10.1038/srep02409 6",Non-OADS,/arxiv_data1/oa_pdf/6a/1b/srep02409.PMC3740289.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4f/36/srep02406.PMC3740290.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2406 | DOI: 10.1038/srep02406 10",Non-OADS,/arxiv_data1/oa_pdf/4f/36/srep02406.PMC3740290.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis).VRK1 in mammary cell proliferation/tumorigenesis TP Molitor and P Traktman 11 &2013 Macmillan Publishers Limited Oncogenesis (2013), 1 – 11",Non-OADS,/arxiv_data1/oa_pdf/51/73/oncsis201311a.PMC3740298.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis).Acid ceramidase activates oncogenic Akt signaling TH Beckham et al 11 &2013 Macmillan Publishers Limited Oncogenesis (2013), 1 – 11",Non-OADS,/arxiv_data1/oa_pdf/62/ae/oncsis201314a.PMC3740300.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis).MUC1 regulates mdr gene expression in PC S Nath et al 9 &2013 Macmillan Publishers Limited Oncogenesis (2013), 1 – 9",Non-OADS,/arxiv_data1/oa_pdf/41/d6/oncsis201316a.PMC3740301.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis).Loss of Erbin induces anoikis resistance YH u et al 12 Oncogenesis (2013), 1 – 12 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/c4/22/oncsis201318a.PMC3740302.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis).Soluble uPAR enhances endothelial cell motility JS Rao et al 10 Oncogenesis (2013), 1 – 10 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/66/72/oncsis201319a.PMC3740303.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)IGH–HTS MRD predicts CLL relapse AC Logan et al 1665 &2013 Macmillan Publishers Limited Leukemia (2013) 1659 – 1665",Non-OADS,/arxiv_data1/oa_pdf/63/68/leu201352a.PMC3740398.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Treatment in essential thrombocythemia A Tefferi and T Barbui 1620 Leukemia (2013) 1617 – 1620 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/65/1f/leu201399a.PMC3740400.pdf
Available at: http://www.worldwidewounds.com/2001/april/wright/Hyperbaricoxygen.html.,Non-OADS,/arxiv_data1/oa_pdf/e0/c1/JOVR-08-119.PMC3740463.pdf
http://cms.revoptom.com/handbook.,Non-OADS,/arxiv_data1/oa_pdf/e1/de/JOVR-08-160.PMC3740468.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comT echnical Note Occipital‑posterior cerebral artery bypass via the occipital  interhemispheric approach Ken Kazumata, Yuka Y okoyama1, Taku Sugiyama1, Katsuyuki Asaoka1 Department of Neurosurgery, Hokkaido University Graduate School of Medicine, 1Department of Neurosurgery, T eine Keijinkai Hospital, Sapporo, Japan E‑mail: *Ken Kazumata  ‑ kazumata@med.hokudai.ac.jp;  Yuka Yokoyama ‑ yukaj77@gmail.com; Taku Sugiyama ‑ taku‑s@yk9.so‑net.ne.jp;   Katsuyuki Asaoka ‑ asaoka@tkeijinkai.gr.jp   *Corresponding author Received: 23 April 13  Accepted: 31 May 13  Published: 12 July 13 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.114975 Quick Response Code: Abstract Background:  The unavailability of the superficial temporal artery (STA) and the  location of lesions pose a more technically demanding challenge when compared  with conventional STA‑superior cerebellar or posterior cerebral artery (PCA) bypass  in vascular reconstruction procedures.",Non-OADS,/arxiv_data1/oa_pdf/4c/03/SNI-4-90.PMC3740606.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/90/114975 Copyright: © 2013 Kazumata K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/4c/03/SNI-4-90.PMC3740606.pdf
"Surgical Neurology International 2013;4:90.  http://www.surgicalneurologyint.com/content/4/1/90MATERIALS AND METHODS Clinical data, radiographic findings, bypass procedures,  and outcomes for the three patients who underwent  OA‑PCA bypass in 2011 are presented in Table 1.",Non-OADS,/arxiv_data1/oa_pdf/4c/03/SNI-4-90.PMC3740606.pdf
Surgical Neurology International 2013;4:90.  http://www.surgicalneurologyint.com/content/4/1/90retraction as well as eliminating the need to sacrificing  cerebral veins to approach posterior interhemispheric  fissure.,Non-OADS,/arxiv_data1/oa_pdf/4c/03/SNI-4-90.PMC3740606.pdf
Surgical Neurology International 2013;4:90.  http://www.surgicalneurologyint.com/content/4/1/90DISCUSSION The present report describes the use of OA‑PCA bypass  as an alternative to conventional STA‑SCA or in the  event that PCA bypasses are unavailable.,Non-OADS,/arxiv_data1/oa_pdf/4c/03/SNI-4-90.PMC3740606.pdf
Surgical Neurology International 2013;4:90.  http://www.surgicalneurologyint.com/content/4/1/90patency of radial artery graft bypass for reconstruction of the internal carotid  artery.,Non-OADS,/arxiv_data1/oa_pdf/4c/03/SNI-4-90.PMC3740606.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Novel devices for intraoperative monitoring of glossopharyngeal  and vagus nerves during skull base surgery Masafumi Fukuda, Tetsuro Takao, Tetsuya Hiraishi, Naoki Yajima, Akihiko Saito, Yukihiko Fujii Department of Neurosurgery, Brain Research Institute, University of Niigata, 1‑757 Asahimachi‑dori, Chuo‑ku, Niigata‑City, Japan E‑mail: *Masafumi Fukuda ‑ mfuku529@bri.niigata‑u.ac.jp; T etsuro Takao ‑ takao@bri.niigata‑u.ac.jp; T etsuya Hiraishi ‑ tetsuya_hiraishi@me.com;   Naoki Yajima ‑ naoki‑ya@bf6.so‑net.ne.jp; Akihiko Saito ‑ akisaito@bri.niigata‑u.ac.jp; Yukihiko Fujii ‑ yfujii@bri.niigata‑u.ac.jp   *Corresponding author Received: 04 April 13  Accepted: 21 May 13  Published: 25 July 13 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.115650 Quick Response Code: Abstract Background:  Swallowing disturbance is among the most burdensome complications  suffered by patients with glossopharyngeal and vagus nerve involvement in lesions  adjacent the jugular foramen.",Non-OADS,/arxiv_data1/oa_pdf/a4/58/SNI-4-97.PMC3740607.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/97/115650 Copyright: © 2013 Fukuda M. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribu ‑ tion, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/a4/58/SNI-4-97.PMC3740607.pdf
"Surgical Neurology International 2013, 4:97  http://www.surgicalneurologyint.com/content/4/1/97been monitored using needle electrodes placed in  the vocal cords or pharyngeal wall, as well as surface  electrodes on an endotracheal tube adhering to the  vocal cords.",Non-OADS,/arxiv_data1/oa_pdf/a4/58/SNI-4-97.PMC3740607.pdf
"Surgical Neurology International 2013, 4:97  http://www.surgicalneurologyint.com/content/4/1/97were attached to the pharyngeal musculature on the side  ipsilateral to the lesion.",Non-OADS,/arxiv_data1/oa_pdf/a4/58/SNI-4-97.PMC3740607.pdf
"Surgical Neurology International 2013, 4:97  http://www.surgicalneurologyint.com/content/4/1/97vagus nerves, especially in patients with nerves severely  distorted by the tumor.",Non-OADS,/arxiv_data1/oa_pdf/a4/58/SNI-4-97.PMC3740607.pdf
"Surgical Neurology International 2013, 4:97  http://www.surgicalneurologyint.com/content/4/1/97of patients in the present data was smaller than that  in the previous data.",OADS,/arxiv_data1/oa_pdf/a4/58/SNI-4-97.PMC3740607.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial It is our moral obligation and the time is now Ronald Pawl Department of Neurosurgery, University of Illinois, Chicago (Retired), USA E‑mail: *Ronald Pawl ‑ ron@pawl.com   *Corresponding author Received: 07 June 13   Accepted: 07 June 13  Published: 18 July 13 The recent outbreaks of violence in the United States  that took lives by gunfire and bombings have stimulated  numerous commentaries and concerns.",Non-OADS,/arxiv_data1/oa_pdf/37/6b/SNI-4-94.PMC3740608.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/94/115238 Access this article online Quick Response Code: Website:    www.surgicalneurologyint.com DOI:    10.4103/2152-7806.115238,Non-OADS,/arxiv_data1/oa_pdf/37/6b/SNI-4-94.PMC3740608.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comHistorical Review Reflections on a career in neurosurgery Robert F .",Non-OADS,/arxiv_data1/oa_pdf/25/23/SNI-4-89.PMC3740609.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/89/114812 Copyright: © 2013 Heimburger RF .,Non-OADS,/arxiv_data1/oa_pdf/25/23/SNI-4-89.PMC3740609.pdf
"Surgical Neurology International 2013, 4:89  http://www.surgicalneurologyint.com/content/4/1/89impending National Institutes of Health grant, to  conduct histopathology and neuropsychology research  with Dr. Percival Bailey on patients undergoing brain  surgery at Illinois Neuropsychiatric Institute .",Non-OADS,/arxiv_data1/oa_pdf/25/23/SNI-4-89.PMC3740609.pdf
"Surgical Neurology International 2013, 4:89  http://www.surgicalneurologyint.com/content/4/1/89cord and nerve roots as the child’s body grew longer.",Non-OADS,/arxiv_data1/oa_pdf/25/23/SNI-4-89.PMC3740609.pdf
"Surgical Neurology International 2013, 4:89  http://www.surgicalneurologyint.com/content/4/1/89small X‑ray units were permanently attached to the  head‑holding device.",Non-OADS,/arxiv_data1/oa_pdf/25/23/SNI-4-89.PMC3740609.pdf
"Surgical Neurology International 2013, 4:89  http://www.surgicalneurologyint.com/content/4/1/89WASHING HAIR AND SCALPS INSTEAD OF  SHAVING FOR CRANIAL SURGERY Shaving patients’ heads, especially women’s, for the small  incisions used in stereotactic surgeries seemed excessive,  so we started washing patients’ hair and scalps with the  soap used for preparing surgeons’ and nurses’ hands for  surgery.",Non-OADS,/arxiv_data1/oa_pdf/25/23/SNI-4-89.PMC3740609.pdf
"Surgical Neurology International 2013, 4:89  http://www.surgicalneurologyint.com/content/4/1/89REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/25/23/SNI-4-89.PMC3740609.pdf
"Surgical Neurology International 2013, 4:89  http://www.surgicalneurologyint.com/content/4/1/89It was his frustration with the current treatment, or better,  lack thereof of involuntary movement disorders and major  behavioral problems that prompted his most significant  and innovative contributions.",Non-OADS,/arxiv_data1/oa_pdf/25/23/SNI-4-89.PMC3740609.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comT echnical Note Techniques for placement of grid and strip electrodes for  intracranial epilepsy surgery monitoring: Pearls and pitfalls Jason M. Voorhies, Aaron Cohen‑Gadol Goodman Campbell Brain and Spine, Department of Neurological Surgery, Indiana University School of Medicine, 355 W .",Non-OADS,/arxiv_data1/oa_pdf/3c/97/SNI-4-98.PMC3740610.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/98/115707 Copyright: © 2013 Voorhies JM.,Non-OADS,/arxiv_data1/oa_pdf/3c/97/SNI-4-98.PMC3740610.pdf
"Surgical Neurology International 2013, 4:98  http://www.surgicalneurologyint.com/content/4/1/98magnetoencephalography (MEG), and long‑term video  electroencephalography (EEG).",Non-OADS,/arxiv_data1/oa_pdf/3c/97/SNI-4-98.PMC3740610.pdf
"Surgical Neurology International 2013, 4:98  http://www.surgicalneurologyint.com/content/4/1/98Large areas of the fontal, temporal, parietal, or  occipital convexities can be covered with appropriately  sized grids and strip electrodes within the subdural  space [Figures 2‑4].",Non-OADS,/arxiv_data1/oa_pdf/3c/97/SNI-4-98.PMC3740610.pdf
"Surgical Neurology International 2013, 4:98  http://www.surgicalneurologyint.com/content/4/1/98In general, before closure of the dura, color photographs  and sketches are prepared to record the location of the  electrodes in relation to the major lobes and fissures/sulci.",Non-OADS,/arxiv_data1/oa_pdf/3c/97/SNI-4-98.PMC3740610.pdf
"Surgical Neurology International 2013, 4:98  http://www.surgicalneurologyint.com/content/4/1/98Anesthesia considerations Benzodiazepines, barbiturates and high‑dose  inhaled halogenated agents interfere with  ECOG.",Non-OADS,/arxiv_data1/oa_pdf/3c/97/SNI-4-98.PMC3740610.pdf
"Surgical Neurology International 2013, 4:98  http://www.surgicalneurologyint.com/content/4/1/9820.",Non-OADS,/arxiv_data1/oa_pdf/3c/97/SNI-4-98.PMC3740610.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article How effective is the local anesthetic infiltration of pin sites prior  to application of head clamps: A  prospective observational  cohort study of hemodynamic response in patients undergoing  elective craniotomy Ayesha Arshad, Muhammad Shahzad Shamim, Muhammad Waqas, Hina Enam,  Syed Ather Enam Department of Surgery, Section of Neurosurgery, Aga Khan University Hospital, Karachi, Pakistan E‑mail:  Ayesha Rashad ‑ ayear@hotmail.com; *Muhammad Shahzad Shamim ‑ shahzad.shamim@aku.edu; Muhammad Waqas ‑ shaiq_waqas@hotmail.com;  Hina Enam ‑ nadeem_matrox@hotmail.com; Syed Ather Enam ‑ ather.enam@aku.edu   *Corresponding author Received: 16 April 13   Accepted: 04 June 13  Published: 18 July 13 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.115237  Quick Response Code: Abstract Background:  Use of Mayfield clamps is associated with potentially hazardous  hemodynamic effects.",Non-OADS,/arxiv_data1/oa_pdf/09/e7/SNI-4-93.PMC3740611.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/93/115237,Non-OADS,/arxiv_data1/oa_pdf/09/e7/SNI-4-93.PMC3740611.pdf
"Surgical Neurology International 2013, 4:93  http://www.surgicalneurologyint.com/content/4/1/93INTRODUCTION Head holders such as the Mayfield head holder, have  become an essential part of neurosurgical procedure,  especially for brain tumors and vascular lesion.",Non-OADS,/arxiv_data1/oa_pdf/09/e7/SNI-4-93.PMC3740611.pdf
"Surgical Neurology International 2013, 4:93  http://www.surgicalneurologyint.com/content/4/1/93pain was measured at 6 hours after extubation, using  the Visual Analogue Scale (VAS) score and compared  between the groups.",Non-OADS,/arxiv_data1/oa_pdf/09/e7/SNI-4-93.PMC3740611.pdf
"Surgical Neurology International 2013, 4:93  http://www.surgicalneurologyint.com/content/4/1/93between the two groups was found to be statistically  significant (P < 0.001) [Table 1].",OADS,/arxiv_data1/oa_pdf/09/e7/SNI-4-93.PMC3740611.pdf
"Surgical Neurology International 2013, 4:93  http://www.surgicalneurologyint.com/content/4/1/93response to pin insertion, with varying success.",Non-OADS,/arxiv_data1/oa_pdf/09/e7/SNI-4-93.PMC3740611.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report A case of large B-cell intravascular lymphoma in the brain Lee Ping Gan1, Wei Seong Ooi2, Hwei Yee Lee3, Wai Hoe Ng1,4 1Departments of Neurosurgery, National Neuroscience Institute, 2Medical Oncology, National Cancer Centre, 3Histopathology, Tan T ock Seng Hospital,   4Duke-NUS Graduate Medical School, Singapore E-mail: *Lee Ping Gan - ganleeping@gmail.com; Wei Seong Ooi - ooi.weiseong@yahoo.com.sg; Hwei  Yee Lee - Hwei_Yee_Lee@ttsh.com.sg;   Wai Hoe Ng - wai_hoe_ng@nni.com.sg   *Corresponding author Received: 03 October 12  Accepted: 29 May 13 Published: 26 July 13 This article may be cited as: Gan LP , Ooi WS, Lee HY, Ng WH.",Non-OADS,/arxiv_data1/oa_pdf/92/cb/SNI-4-99.PMC3740612.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/99/115709 Copyright: © 2013 Gan LP .,Non-OADS,/arxiv_data1/oa_pdf/92/cb/SNI-4-99.PMC3740612.pdf
"Figure 3a: A leptomeningeal vessel showing luminal occlusion by  large pleomorphic lymphoma cells (H&E × 200) S75 Surgical Neurology International 2013, 4:99  http://www.surgicalneurologyint.com/content/4/1/99Four days later the patient suffered another seizure while  sitting at his computer, followed by postictal drowsiness  lasting 2 hours.",Non-OADS,/arxiv_data1/oa_pdf/92/cb/SNI-4-99.PMC3740612.pdf
"S76 Surgical Neurology International 2013, 4:99  http://www.surgicalneurologyint.com/content/4/1/99strong expression of the B lymphocyte marker C20 by  immunoperoxidase staining [Figure 3b].",Non-OADS,/arxiv_data1/oa_pdf/92/cb/SNI-4-99.PMC3740612.pdf
"S77 Surgical Neurology International 2013, 4:99  http://www.surgicalneurologyint.com/content/4/1/99lymphocytosis, although only one of seven patients had  CSF malignant cytopathology.",Non-OADS,/arxiv_data1/oa_pdf/92/cb/SNI-4-99.PMC3740612.pdf
"S78 Surgical Neurology International 2013, 4:99  http://www.surgicalneurologyint.com/content/4/1/99ated with haemophagocytic syndrome.",Non-OADS,/arxiv_data1/oa_pdf/92/cb/SNI-4-99.PMC3740612.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Gamma knife radiosurgery for typical trigeminal neuralgia:  An institutional review of 108 patients Ameer L. Elaimy1,2, Andrew F .",Non-OADS,/arxiv_data1/oa_pdf/21/ec/SNI-4-92.PMC3740613.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/92/115163 Copyright: © 2013 Elaimy AL.,Non-OADS,/arxiv_data1/oa_pdf/21/ec/SNI-4-92.PMC3740613.pdf
"Surgical Neurology International 2013, 4:92  http://www.surgicalneurologyint.com/content/4/1/92INTRODUCTION Trigeminal neuralgia (TN) is a disorder of cranial  nerve (CN) V that affects approximately 4.3 per  100,000 persons per year.",Non-OADS,/arxiv_data1/oa_pdf/21/ec/SNI-4-92.PMC3740613.pdf
"Surgical Neurology International 2013, 4:92  http://www.surgicalneurologyint.com/content/4/1/92placed.",Non-OADS,/arxiv_data1/oa_pdf/21/ec/SNI-4-92.PMC3740613.pdf
"Surgical Neurology International 2013, 4:92  http://www.surgicalneurologyint.com/content/4/1/92RESULTS Pain relief outcomes We performed a total of 127 GKRS procedures on  108 patients with a diagnosis of typical TN between  2002 and 2011.",Non-OADS,/arxiv_data1/oa_pdf/21/ec/SNI-4-92.PMC3740613.pdf
"Surgical Neurology International 2013, 4:92  http://www.surgicalneurologyint.com/content/4/1/92treatment ( P =   0.343), pain laterality (P =   0.375),  previous surgical treatment ( P = 0.196), number of GKRS  procedures ( P =   0.374), and maximum radiosurgery  dose (P = 0.533) did not statistically impact facial pain  relief.",Non-OADS,/arxiv_data1/oa_pdf/21/ec/SNI-4-92.PMC3740613.pdf
"Surgical Neurology International 2013, 4:92  http://www.surgicalneurologyint.com/content/4/1/92with 44 patients treated with a maximum GKRS dose of  85 Gy.",Non-OADS,/arxiv_data1/oa_pdf/21/ec/SNI-4-92.PMC3740613.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Feasibility of the custom‑made titanium cranioplasty  CRANIOTOP® Julius Höhne, Alexander Brawanski, Holger G. Gassner1, Karl‑Michael Schebesch Department of Neurosurgery, University Medical Center, Regensburg, 1Department of Otorhinolaryngology, University Medical Center, Regensburg, Germany E‑mail:  Julius Höhne ‑ julius.hoehne@ukr.de; Alexander Brawanski ‑ alexander.brawanski@ukr.de; Holger G. Gassner ‑ holger.gassner@ukr.de;  *Karl‑Michael Schebesch ‑ karl‑michael.schebesch@ukr.de   *Corresponding author Received: 20 February 13   Accepted: 14 May 13  Published: 09 July 13 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.114811 Quick Response Code: Abstract Background:  With decompressive craniectomy for ischemic stroke, traumatic  brain injury, and skull‑infiltrating tumors, the need for cranioplasty has increased.",Non-OADS,/arxiv_data1/oa_pdf/b4/6f/SNI-4-88.PMC3740614.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/88/114811 Copyright: © 2013 Höhne J .,Non-OADS,/arxiv_data1/oa_pdf/b4/6f/SNI-4-88.PMC3740614.pdf
"Surgical Neurology International 2013, 4:88  http://www.surgicalneurologyint.com/content/4/1/88skull‑penetrating tumors like meningeomas or metastases,  subsequent radiographic assessment must be warranted.",Non-OADS,/arxiv_data1/oa_pdf/b4/6f/SNI-4-88.PMC3740614.pdf
"Surgical Neurology International 2013, 4:88  http://www.surgicalneurologyint.com/content/4/1/88RESULTS The most common indication for craniectomy were  diffuse edema due to traumatic brain injury ( n =  17,  34%) and ischemic stroke of the middle cerebral artery  territory ( n = 12, 24%).",Non-OADS,/arxiv_data1/oa_pdf/b4/6f/SNI-4-88.PMC3740614.pdf
"Surgical Neurology International 2013, 4:88  http://www.surgicalneurologyint.com/content/4/1/88the cranioplasty involves parts of the forehead and of  the viscerocranium.",Non-OADS,/arxiv_data1/oa_pdf/b4/6f/SNI-4-88.PMC3740614.pdf
"Surgical Neurology International 2013, 4:88  http://www.surgicalneurologyint.com/content/4/1/888.",Non-OADS,/arxiv_data1/oa_pdf/b4/6f/SNI-4-88.PMC3740614.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Parasellar arachnoid cyst presenting with a nonpupil sparing  third nerve palsy mimicking a posterior communicating artery  aneurysm in an adult Zachary J. Tempel, Stephen A. Johnson, Paul S. Richard, Robert M. Friedlander, William E. Rothfus1,  Ronald L. Hamilton2 Departments of Neurological Surgery, and 1Radiology, 2Neuropathology, UPMC Presbyterian Hospital, M8709 South T ower, 200 Lothrop Street, Pittsburgh,  PA 15213, USA E‑mail: *Zachary J. T empel ‑ tempelzj@upmc.edu; Stephen A. Johnson ‑ johnsonsa2@upmc.edu; Paul S. Richard ‑ richardps@upmc.edu;   Robert M. Friedlander ‑ friedlanderr@upmc.edu, William E. Rothfus ‑ rothwe@upmc.edu; Ronald L. Hamilton ‑ hamiltonrl@upmc.edu   *Corresponding author Received: 15 February 13  Accepted: 05 June 13  Published: 09 July 13 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.114799 Quick Response Code: Abstract Background:  Arachnoid cysts are congenital lesions that contain fluid identical  to cerebrospinal fluid (CSF).",Non-OADS,/arxiv_data1/oa_pdf/80/53/SNI-4-87.PMC3740615.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/87/114799 Copyright: © 2013 T empel Z J.,Non-OADS,/arxiv_data1/oa_pdf/80/53/SNI-4-87.PMC3740615.pdf
"Surgical Neurology International 2013, 4:87  http://www.surgicalneurologyint.com/content/4/1/87INTRODUCTION Arachnoid cysts are well-described congenital fluid-filled  structures lined with meningothelial cells first reported in  the 16th century by Dutch Anatomist Pieter Paux and first  described by Bright in 1831.",Non-OADS,/arxiv_data1/oa_pdf/80/53/SNI-4-87.PMC3740615.pdf
"Surgical Neurology International 2013, 4:87  http://www.surgicalneurologyint.com/content/4/1/87thrombosed PCommA aneurysm.",Non-OADS,/arxiv_data1/oa_pdf/80/53/SNI-4-87.PMC3740615.pdf
"Surgical Neurology International 2013, 4:87  http://www.surgicalneurologyint.com/content/4/1/87as a consequence of trauma, infection, or hemorrhage;  however, the pathologic components of these cysts are  distinctly different from true congenital arachnoid cysts.",Non-OADS,/arxiv_data1/oa_pdf/80/53/SNI-4-87.PMC3740615.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Dural metastasis of Ewing’s sarcoma Atef Ben Nsir, Mohamed Boughamoura, Mezri Maatouk1, Mohamed Kilani, Nejib Hattab Departments of Neurosurgery, and 1Radiology, Fattouma Bourguiba University Hospital, Monastir, Tunisia E‑mail: *Atef Ben Nsir ‑ atefbn@hotmail.fr; Mohamed Boughamoura ‑ Boughamoura.mohamed@yahoo.fr; Mezri Maatouk ‑ m.mezri@gmail.com;  Mohamed Kilani ‑ kilanineurochirurgien@gmail.com; Nejib Hattab ‑ nejib.hattab@rns.tn   *Corresponding author Received: 11 April 13   Accepted: 07 June 13  Published: 23 July 13  Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.115487 Quick Response Code: Abstract Background: Metastatic Ewing’s sarcoma to the central nervous system is an  uncommon condition and debate concerning the true origin of its metastases is  still up to date.",Non-OADS,/arxiv_data1/oa_pdf/32/e1/SNI-4-96.PMC3740616.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/96/115487,Non-OADS,/arxiv_data1/oa_pdf/32/e1/SNI-4-96.PMC3740616.pdf
"Surgical Neurology International 2013, 4:96  http://www.surgicalneurologyint.com/content/4/1/96CASE REPORT A 24‑year‑old right‑handed female was admitted to our  hospital complaining of a 2‑week history of moderate  headache and weakness in her left leg for the past 2 days.",Non-OADS,/arxiv_data1/oa_pdf/32/e1/SNI-4-96.PMC3740616.pdf
"Surgical Neurology International 2013, 4:96  http://www.surgicalneurologyint.com/content/4/1/96The patient underwent a right frontoparietal craniotomy  with an amazing discovery: The tumor was associated  with a small lobulated epidural extension tightly attached  to the skull [Figure 5].",Non-OADS,/arxiv_data1/oa_pdf/32/e1/SNI-4-96.PMC3740616.pdf
"Surgical Neurology International 2013, 4:96  http://www.surgicalneurologyint.com/content/4/1/96The pathogenesis includes two conceivable possibilities  for meningeal involvement in this type of tumor  presentation: (1) dural metastasis of the pelvic Ewing’s  sarcoma; (2) direct extension of a skull metastasis with  dural breakthrough and massive intradural extension.",Non-OADS,/arxiv_data1/oa_pdf/32/e1/SNI-4-96.PMC3740616.pdf
"Surgical Neurology International 2013, 4:96  http://www.surgicalneurologyint.com/content/4/1/96requires further definition.",Non-OADS,/arxiv_data1/oa_pdf/32/e1/SNI-4-96.PMC3740616.pdf
"Surgical Neurology International 2013, 4:96  http://www.surgicalneurologyint.com/content/4/1/9637.",Non-OADS,/arxiv_data1/oa_pdf/32/e1/SNI-4-96.PMC3740616.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Sphenoid wing en plaque  meningiomas: Surgical results and  recurrence rates Nuno M. Simas, João Paulo Farias Department of Neurosurgery, Santa Maria Hospital, Lisboa, Portugal E‑mail:  *Nuno M. Simas ‑ nunosmas@hotmail.com; João Paulo Farias ‑ jpatlfarias@gmail.com   *Corresponding author Received: 08 January 13   Accepted: 05 May 13  Published: 09 July 13 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.114796 Quick Response Code: Abstract Background:  Sphenoid wing en plaque  meningiomas are a subgroup of  meningiomas defined by its particular sheet‑like dural involvement and its  disproportionately large bone hyperostosis.",Non-OADS,/arxiv_data1/oa_pdf/56/61/SNI-4-86.PMC3740617.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/86/114796 Copyright: © 2013 Simas NM.,Non-OADS,/arxiv_data1/oa_pdf/56/61/SNI-4-86.PMC3740617.pdf
"Surgical Neurology International 2013, 4:86  http://www.surgicalneurologyint.com/content/4/1/86meningiomas, in this particular type of tumor the bone  invasion is much more extensive and is responsible for  the clinical manifestations.",Non-OADS,/arxiv_data1/oa_pdf/56/61/SNI-4-86.PMC3740617.pdf
"Surgical Neurology International 2013, 4:86  http://www.surgicalneurologyint.com/content/4/1/86Surgical treatment The 18 patients were submitted to pterional craniotomy  followed by extradural removal of the invaded bone  using high speed drills, bone rongeurs and kerrison bone  punches.",Non-OADS,/arxiv_data1/oa_pdf/56/61/SNI-4-86.PMC3740617.pdf
"Surgical Neurology International 2013, 4:86  http://www.surgicalneurologyint.com/content/4/1/86follow‑up of 3.5 years, these three patients present  stable lesions, without any evidence of progression.",Non-OADS,/arxiv_data1/oa_pdf/56/61/SNI-4-86.PMC3740617.pdf
"Surgical Neurology International 2013, 4:86  http://www.surgicalneurologyint.com/content/4/1/86•	Group 2) – Six patients presented tumor extension  to the cavernous sinus [Table 3].",Non-OADS,/arxiv_data1/oa_pdf/56/61/SNI-4-86.PMC3740617.pdf
"Surgical Neurology International 2013, 4:86  http://www.surgicalneurologyint.com/content/4/1/86fossa.",Non-OADS,/arxiv_data1/oa_pdf/56/61/SNI-4-86.PMC3740617.pdf
"Surgical Neurology International 2013, 4:86  http://www.surgicalneurologyint.com/content/4/1/8610.",Non-OADS,/arxiv_data1/oa_pdf/56/61/SNI-4-86.PMC3740617.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Facial necrosis after endovascular Onyx‑18 embolization  for epistaxis Ramesh Grandhi, David Panczykowski, Nathan T .",Non-OADS,/arxiv_data1/oa_pdf/fb/77/SNI-4-95.PMC3740618.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/95/115388,Non-OADS,/arxiv_data1/oa_pdf/fb/77/SNI-4-95.PMC3740618.pdf
"Surgical Neurology International 2013, 4:95  http://www.surgicalneurologyint.com/content/4/1/95CASE REPORT A 52‑year‑old African‑American woman with a history of  aortic valve replacement, mitral valve repair, and deep  venous thrombosis on chronic anticoagulation therapy  with warfarin and aspirin presented after developing  epistaxis from her right naris.",Non-OADS,/arxiv_data1/oa_pdf/fb/77/SNI-4-95.PMC3740618.pdf
"Surgical Neurology International 2013, 4:95  http://www.surgicalneurologyint.com/content/4/1/95complication in the form of cerebral infarction or retinal  occlusion during embolization procedures.",Non-OADS,/arxiv_data1/oa_pdf/fb/77/SNI-4-95.PMC3740618.pdf
"Surgical Neurology International 2013, 4:95  http://www.surgicalneurologyint.com/content/4/1/95liquid embolic agent would afford the best chance of  resolving her epistaxis without her having to require  additional blood product transfusions or surgical  procedures.",Non-OADS,/arxiv_data1/oa_pdf/fb/77/SNI-4-95.PMC3740618.pdf
"Surgical Neurology International 2013, 4:95  http://www.surgicalneurologyint.com/content/4/1/95few exceptions) or for epistaxis and we strongly believe that  its use in these situations should be discouraged.",Non-OADS,/arxiv_data1/oa_pdf/fb/77/SNI-4-95.PMC3740618.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Comparison of total versus partial revision of primary  ventriculoperitoneal shunt failures Ishwar Singh, Seema Rohilla1, Manjulata Kumawat2, Manish Goel3 Departments of Neurosurgery, 1Radiodiagnosis, 2Biochemistry, Pt.",Non-OADS,/arxiv_data1/oa_pdf/3a/3f/SNI-4-100.PMC3740619.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/100/115891 Copyright: © 2013 Singh I.,Non-OADS,/arxiv_data1/oa_pdf/3a/3f/SNI-4-100.PMC3740619.pdf
"Surgical Neurology International 2013, 4:100  http://www.surgicalneurologyint.com/content/4/1/100shunt survival.",Non-OADS,/arxiv_data1/oa_pdf/3a/3f/SNI-4-100.PMC3740619.pdf
"Surgical Neurology International 2013, 4:100  http://www.surgicalneurologyint.com/content/4/1/100revision surgeries  [Table  1].",Non-OADS,/arxiv_data1/oa_pdf/3a/3f/SNI-4-100.PMC3740619.pdf
"Surgical Neurology International 2013, 4:100  http://www.surgicalneurologyint.com/content/4/1/100intraventricular hemorrhage  (IVH), and cranial surgeries  because the CSF of these patients contains high  proportion of proteins and debris.",Non-OADS,/arxiv_data1/oa_pdf/3a/3f/SNI-4-100.PMC3740619.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comHistorical Review Violence, mental illness, and the brain  – A  brief history of  psychosurgery: Part  3 – From deep brain stimulation to  amygdalotomy for violent behavior, seizures, and pathological  aggression in humans Miguel A. Faria Clinical Professor of Neurosurgery  (ret.)",Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/91/115162 Copyright: © 2013 Faria MA.,Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
"Surgical Neurology International 2013, 4:91  http://www.surgicalneurologyint.com/content/4/1/91and premonitions of disaster in humans, corresponding  to the intensity of the DBS.",Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
"consult text of “Violence, mental illness, and the brain-A brief history of psychosurgery: Part  1-From trephination to lobotomy”  (http://www.surgicalneurologyint.com/ text.asp?2013/4/1/49/110146 ) and “Violence, mental illness, and the brain-A brief history of psychosurgery: Part  2-From the limbic system and cingulotomy to deep brain  stimulation”  (http://www.surgicalneurologyint.com/text.asp?2013/4/1/49/110146)",Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
"Surgical Neurology International 2013, 4:91  http://www.surgicalneurologyint.com/content/4/1/91to inject and slowly release chemical substances into test  subjects, a forerunner of the implantable reservoirs and catheters used by neurosurgeons today.",Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
"Surgical Neurology International 2013, 4:91  http://www.surgicalneurologyint.com/content/4/1/91Figure  3: Lateral skull X‑ray of a patient with implanted brain  electrodes similar to Julia’s.",Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
"Surgical Neurology International 2013, 4:91  http://www.surgicalneurologyint.com/content/4/1/91Figure  6: Julia’s EEG tracings from three different points deep in her  temporal lobe, simultaneous with remote, high frequency, electrical  stimulation  (ESB) of her brain via the implanted electrodes Figure  7: Julia after DBS  – rage behavior, attacking wall, suddenly  and unexpectedly Figure  8: Julia’s EEG epileptiform recordings from three deep areas  of her temporal lobes simultaneous with her attack on the wall Figure  4: Julia in a pleasant mood before DBS Figure  5:  Julia’s remotely recorded EEG tracing in three channels.",Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
"Surgical Neurology International 2013, 4:91  http://www.surgicalneurologyint.com/content/4/1/91FUNCTIONAL NEUROSURGERY AND THE  TERMINAL MAN When I was a premedical student at the University  of South Carolina  (USC) in Columbia, my minor was  psychology.",Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
"Surgical Neurology International 2013, 4:91  http://www.surgicalneurologyint.com/content/4/1/91Mr.",Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
"consult text of “Violence, mental illness, and the brain-A brief history of psychosurgery: Part  1-From trephination to lobotomy”  (http://www.surgicalneurologyint.com/ text.asp?2013/4/1/49/110146 ) and “Violence, mental illness, and the brain-A brief history of psychosurgery: Part  2-From the limbic system and cingulotomy to deep brain  stimulation”  (http://www.surgicalneurologyint.com/text.asp?2013/4/1/49/110146) Figure  11: Michael Crichton  (1942‑2008), who earned his medical  degree from Harvard, later became a famous and best‑selling author of science and medical fiction books",Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
"Surgical Neurology International 2013, 4:91  http://www.surgicalneurologyint.com/content/4/1/91And so by the time I had completed my undergraduate  studies in Columbia at USC and had ascended the  academic ladder to senior medical student at the  Medical University of South Carolina  (MUSC) in the  charming southern city of Charleston, things had changed  dramatically in the field of psychosurgery  (which had so  much attracted my curiosity and interest).",Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
"Surgical Neurology International 2013, 4:91  http://www.surgicalneurologyint.com/content/4/1/91VIOLENCE AND THE BRAIN IN THE 21ST  CENTURY Numerous studies in the past several decades have  shown that psychopaths and other violent criminals have  abnormal brain structures.",Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
"Surgical Neurology International 2013, 4:91  http://www.surgicalneurologyint.com/content/4/1/91by a small group of persistent criminals.",Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
"Surgical Neurology International 2013, 4:91  http://www.surgicalneurologyint.com/content/4/1/91Veteran’s Administration Hospital, my friend, Dr.  Roy  Bakay, who was in charge of functional neurosurgery and  performed stereotactic surgery exclusively for movement  disorders in the mid‑1980s in Atlanta.",Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
"Read Part  1 of this series: Violence, mental illness, and  the brain  – A brief history of psychosurgery: Part  1 – From  trephination to lobotomy [http://www.surgicalneurologyint.",Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
"com/text.asp?2013/4/1/49/110146] Read Part  2 of this series: Violence, mental illness,  and the brain  – A brief history of psychosurgery:  Part 2 – From the limbic system and cingulotomy to  deep brain stimulation [http://www.surgicalneurologyint.",Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
Available from: http://www.haciendapub.com/medicalsentinel/ tavistock -principles -medical -ethics  [Last accessed on 6  Mar 2013].2.,Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
Available from: http://www.biotele.com/ delgado_%20ebook/chap14.htm  [Last accessed on 2013  Mar 1].,OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
Medical Sentinel 2001; 6:14 -18. http://www.haciendapub.,Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
Available from:  http://www.haciendapub.com/medicalsentinel/transformation -medical -ethi cs-through -time-part-i-medical -ethics -and-statist -control  [Last accessed on  2013 Mar 6].,Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
Available http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC1070820/ [Last accessed on 2013  Mar 6].,Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
Available from: http://www.haciendapub.com/randomnotes/ bioethics -%E2%80%94 -life-and-death -issue [Last accessed on 2013  Mar 6 ].,Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
Available from: http://www.haciendapub.,Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
Available from: http://news.discovery.com/human/ psychology/does -the-brain-have-an-evil-dark-patch -130207  [La st accessed  on 2013  Mar 6].,Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
Available from: http://www.reuters.com/ article/2012/05/07/us -brains -psychopaths -idUSBRE8460ZQ20120507  [Last  accessed on 2013  Mar 6].,Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
Available from: http://sites.duke.,Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
"Surgical Neurology International 2013, 4:91  http://www.surgicalneurologyint.com/content/4/1/91Disclaimer:  The author of this article have no conflicts of interest to disclose,  and have adhered to SNI’s policies regarding human/animal rights, and  informed consent.",Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
Available from: http://www.haciendapub.com/articles/ critique -psychologist-b -f-skinner%E2%80%99s -beyond -freedom -and-digni ty [Last accessed on 2013  Mar 12].,Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
Available  from: http://him.uk.msn.com/in -the-know /weird -science -ideas [L ast accessed  on 2013  Mar 6].,Non-OADS,/arxiv_data1/oa_pdf/f3/ca/SNI-4-91.PMC3740620.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/c6/btt350.PMC3740625.pdf
Available at: http://www.ncbi.nlm.nih.gov/books/NBK7232/.,Non-OADS,/arxiv_data1/oa_pdf/d5/78/JAS-50-658.PMC3741013.pdf
Available at: http://www.lung.org/finding-cures/our- research/trend-reports/asthma-trend-report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d5/78/JAS-50-658.PMC3741013.pdf
Available at: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/d5/78/JAS-50-658.PMC3741013.pdf
Available at: http://www.epa.gov/asthma/pdfs/asth ma_fact_sheet_en.pdf.,OADS,/arxiv_data1/oa_pdf/d5/78/JAS-50-658.PMC3741013.pdf
Available at: http://www.aaaai.org/about-the-aaaai/ newsroom/asthma-statistics.aspx.,Non-OADS,/arxiv_data1/oa_pdf/d5/78/JAS-50-658.PMC3741013.pdf
Available at: http://www.fda.gov/cder/guidance/ index.htm.,Non-OADS,/arxiv_data1/oa_pdf/d5/78/JAS-50-658.PMC3741013.pdf
Available at: http://www.fda.gov/downloads/Drugs/Guidances/ucm070573.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d5/78/JAS-50-658.PMC3741013.pdf
Available at: http://www.nhlbi.nih.gov/ resources/docs/2009_ChartBook.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d5/78/JAS-50-658.PMC3741013.pdf
"http://informahealthcare.com/ids ISSN 0963-8288 print/ISSN 1464-5165 online Disabil Rehabil, 2013; 35(18): 1513–1518 !2013 Informa UK Ltd. DOI: 10.3109/09638288.2012.743602 RESEARCH ARTICLE Conceptualisation and development of the arm activity measure (ArmA) for assessment of activity in the hemiparetic arm Stephen Ashford1,2, Mike Slade3, and Lynne Turner-Stokes1,2 1Regional Rehabilitation Unit, Northwick Park Hospital, London, UK,2Department of Palliative Care, Policy and Rehabilitation, School of Medicine, King’s College London, London, UK, and3Department of Health Service and Population Research, Institute of Psychiatry, King’s College London, London, UK Abstract Purpose: To develop a patient reported outcome measure of active and passive function in the hemiparetic upper limb.",Non-OADS,/arxiv_data1/oa_pdf/1d/4c/DRE-35-1513.PMC3741014.pdf
"The ArmA is freely available to use and can be obtained from the King’s College London, Department ofPalliative Care, Policy and Rehabilitation, web site (http://www.csi.kcl.ac.uk/arma.html).1518 S. Ashford et al.",Non-OADS,/arxiv_data1/oa_pdf/1d/4c/DRE-35-1513.PMC3741014.pdf
"Gene Protein function Tissue expressionDisease associationsDifferential methylation in preeclampsia GRIN2b glutamate receptor, ionotropic, N-methyl- D-aspar- tate 2BExcitatory neurotransmitter receptor in the brain; vol- tage-dependent sensitivity to magnesiumNervous system, cardiovas- cular system, digestive system, and leukocytesCancer Neurologic diseases 6% more methylated in pre- eclampsia ( p50.0001) PCDHB7 protocadherin b7Calcium-dependent cell- adhesion protein withputative importance in establishment and main- tenance of specificWidely expressed including in nervous systemNot well studied Cancer Mental disordersNeurologic disorders6% more methylated in pre- eclampsia ( p50.0001) BEX1 brain expressed X- linked proteinCell cycle progression and neuronal differentiation;implicated as a tumorsuppressor as wellHighly expressed in all areas of brain; low expression:leukocytes, liver, andtestesCancer Cardiovascular dis- ease Neurologic diseasesSpontaneous abortion3% more methylated in pre- eclampsia ( p¼0.0003) GABRA1 gamma-ami- nobutyric acid receptor subunit a-1Component of receptor for major inhibitory neuro- transmitter in the mam-malian brainHighly expressed in all areas of brain; low expression in skeletal muscle; leukocytesCancers Neurological dis- ease –especially seizure disorders Multiple otherdiseases involving manybody systems5% more methylated in pre- eclampsia ( p¼0.0007) Data regarding protein function, tissue expression, and disease association were gathered from expression databases (see http://www.genecards.",Non-OADS,/arxiv_data1/oa_pdf/2f/2f/HIP-32-257.PMC3741019.pdf
org and http://www.nextbio.com).Preeclampsia and widespread altered methylation 265,Non-OADS,/arxiv_data1/oa_pdf/2f/2f/HIP-32-257.PMC3741019.pdf
Methylation data can be found at http://www.ncbi.nlm.nih.gov/geo/ usingGEO submission ID: GSE37722.,OADS,/arxiv_data1/oa_pdf/2f/2f/HIP-32-257.PMC3741019.pdf
"http://informahealthcare.com/jmf ISSN: 1476-7058 (print), 1476-4954 (electronic) J Matern Fetal Neonatal Med, 2013; 26(12): 1180–1185 !2013 Informa UK Ltd. DOI: 10.3109/14767058.2013.770464 Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population Ken Song1, Thomas J. Musci1, and Aaron B. Caughey2 1Ariosa Diagnostics, Inc., San Jose, CA, USA and2Oregon Health & Science University, Portland, OR, USA Abstract Objective : Evaluate the clinical and economic consequences of fetal trisomy 21 (T21) screening with non-invasive prenatal testing (NIPT) in high-risk pregnant women.Methods : Using a decision-analytic model, we estimated the number of T21 cases detected, the number of invasive procedures performed, corresponding euploid fetal losses and total costs for three screening strategies: first trimester combined screening (FTS), integrated screening (INT) or NIPT, whereby NIPT was performed in high-risk patients (women 35 years or olderor women with a positive conventional screening test).",Non-OADS,/arxiv_data1/oa_pdf/d8/c4/JMF-26-1180.PMC3741020.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/19/main.PMC3741157.pdf
Podocyte de-differentiation has been described as a process similar to epithelial to mesenchymal transition (EMT) and has beenshown to occur in response to transforming growth factor-beta (TGF- b)[8].journal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter &2013.,Non-OADS,/arxiv_data1/oa_pdf/5a/19/main.PMC3741157.pdf
This is an open access article under the CC BY-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/19/main.PMC3741157.pdf
http://dx.doi.org/10.1016/j.krcp.2013.01.003 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/5a/19/main.PMC3741157.pdf
"Nat Co mmun 3:735. http://dx.doi.org/ 10.1038/ncomms1734:735, 2012.",OADS,/arxiv_data1/oa_pdf/5a/19/main.PMC3741157.pdf
"However, recent evidence suggests that  Correspondence to: Olivier Binda; Email: olivier.binda@newcastle.ac.uk Submitted: 03/05/13; Revised: 03/24/13; Accepted: 03/26/13http://dx.doi.org/10.4161/epi.24451Lysine methylation of histones and non-histone proteins has  emerged in recent years as a posttranslational modification with wide-ranging cellular implications beyond epigenetic  regulation.",Non-OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Cell  2007; 129:823-37; PMID:17512414; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Curr  Drug Targets 2009; 10:418-31; PMID:19442114;  http://dx.doi.org/10.2174/138945009788185112 5.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Mol Cell  2009; 33:248-56; PMID:19187765; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Nat Rev Mol Cell Biol 2008; 9:815- 20; PMID:18784729; http://dx.doi.org/10.1038/ nrm2502 7.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Cell 2010; 142:682-5; PMID:20813257;  http://dx.doi.org/10.1016/j.cell.2010.08.011 8.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
T rends Genet 2011; 27:389-96; PMID:21764166; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Semin Cell Dev Biol 2010; 21:209-20; PMID:19892027; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
T rends Biochem Sci 2002; 27:396-402; PMID:12151224;  http://dx.doi.org/10.1016/S0968-0004(02)02141-2 11.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Curr Biol 2002; 12:1052-8;  PMID:12123582; http://dx.doi.org/10.1016/S0960- 9822(02)00901-6 14.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Cell  2003; 112:711-23; PMID:12628190; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
J Biol Chem 2011; 286:3359- 69; PMID:21106533; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Mol Cell Proteomics 2011;  10:M110 000976; PMID:20930037; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
PLoS Genet 2013; 9:e1003210; PMID:23349634;  http://dx.doi.org/10.1371/journal.pgen.1003210 18.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Nat Struct Mol Biol 2012; 19:1218- 27; PMID:23211769; http://dx.doi.org/10.1038/ nsmb.2436 19.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Mutat Res 2008; 647:3-12;  PMID:18682256; http://dx.doi.org/10.1016/j.mrfm- mm.2008.07.004 20.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Mol Interv  2009; 9:314-23; PMID:20048137; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Semin Cell Dev Biol  2010; 21:221-30; PMID:19778625; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Mol Cell 2001; 8:1207-17;  PMID:11779497; http://dx.doi.org/10.1016/S1097-2765(01)00405-1 23.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Nat Genet 2007; 39:311-8;  PMID:17277777; http://dx.doi.org/10.1038/ng1966 24.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Nature 2007; 449:933- 7; PMID:17898714; http://dx.doi.org/10.1038/ nature06166 25.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Nature 2007; 449:928-32; PMID:17898715;  http://dx.doi.org/10.1038/nature06160 26.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Cell reports  2012; 1:83-90; PMID:22720264; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Nat Struct Mol Biol 2012; 19:136-44; PMID:22231400; http://dx.doi.org/10.1038/ nsmb.2209 28.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Proc Natl Acad Sci U S A 2009; 106:20198- 203; PMID:19918057; http://dx.doi.org/10.1073/ pnas.0901989106 29.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Mol Cell 2009; 33:181-91;  PMID:19187761; http://dx.doi.org/10.1016/j.mol- cel.2008.12.029 30.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Nature 2004; 432:353- 60; PMID:15525938; http://dx.doi.org/10.1038/ nature03117,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Nature  2005; 438:1176-80; PMID:16222244; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Nature  2001; 410:116-20; PMID:11242053; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Mol Cell  2008; 32:491-502; PMID:19026780; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Science  2002; 298:1039-43; PMID:12351676; http://dx.doi.org/10.1126/science.1076997 61.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Biochemistry 2001; 40:5747-56; PMID:11341840;  http://dx.doi.org/10.1021/bi002631b 62.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Mol  Cell Proteomics 2007; 6:1917-32; PMID:17644761;  http://dx.doi.org/10.1074/mcp.M700070-MCP200 64.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Cell 2010; 142:967- 80; PMID:20850016; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
J Biol Chem 2004; 279:43296-306; PMID:15292170; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Genes Dev  2005; 19:1455-65; PMID:15933070; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Nat Struct Mol Biol 2013; 20:317- 25; PMID:23377543; http://dx.doi.org/10.1038/nsmb.2499 70.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Cell 2006; 127:1361- 73; PMID:17190600; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Epigenetics 2010; 5:767- 75; PMID:21124070; http://dx.doi.org/10.4161/ epi.5.8.13278 45.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Mol Cell 2003; 12:475-87;  PMID:14536086; http://dx.doi.org/10.1016/j.mol-cel.2003.08.007 46.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Nature 2000; 406:593-9; PMID:10949293; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
J Biol Chem 2001; 276:25309- 17; PMID:11316813; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Mol  Cell 2010; 37:46-56; PMID:20129054; http://dx.doi.org/10.1016/j.molcel.2009.12.017 51.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Mol Cell Biol 2008; 28:7337- 44; PMID:18838538; http://dx.doi.org/10.1128/ MCB.00976-08 52.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Genes Dev 2002; 16:479- 89; PMID:11850410; http://dx.doi.org/10.1101/ gad.967202 53.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
PLoS One 2010; 5:e8570;  PMID:20084102; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Mol Cell Biol 2004; 24:9630-45; PMID:15485929;  http://dx.doi.org/10.1128/MCB.24.21.9630- 9645.2004 55.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
J Biol Chem 2008; 283:33585- 90; PMID:18835819; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Nature 2005; 438:1116- 22; PMID:16222246; http://dx.doi.org/10.1038/nature0421931.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Oncogene 2010; 29:2357- 67; PMID:20140018; http://dx.doi.org/10.1038/ onc.2009.511 32.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Nucleic Acids Res 2010; 39; 4:1266-79;  PMID:20959290; http://dx.doi.org/10.193/nar/ gkq861 34.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Nature  2003; 421:652-6; PMID:12540855; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Mol Cell Biol 2007; 27:8466- 79; PMID:17923682; http://dx.doi.org/10.1128/ MCB.00993-07 38.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Cell 2007; 131:58- 69; PMID:17884155; http://dx.doi.org/10.1016/j.cell.2007.08.016 39.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
EMBO J 2010; 29:3967- 78; PMID:20953165; http://dx.doi.org/10.1038/ emboj.2010.261 40.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Genes Dev 2005; 19:472-88; PMID:15681610;  http://dx.doi.org/10.1101/gad.1267105 41.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Oncogene  2012; 31:1408-18; PMID:21804608; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Oncogene  2002; 21:148-52; PMID:11791185; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Genes Dev  2002; 16:919-32; PMID:11959841; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
J Biol Chem 2008; 283:34660- 6; PMID:18840612; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
J Biol Chem  2010; 285:9636-41; PMID:20118233; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Nature 2007; 449:105-8; PMID:17805299;  http://dx.doi.org/10.1038/nature06092 77.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Mol Cell  2007; 27:636-46; PMID:17707234; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
J Biol Chem 2010; 285:37725- 32; PMID:20870725; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Epigenetics 2013; 8:177- 83; PMID:23324626; http://dx.doi.org/10.4161/ epi.23416 73.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
Nature  2006; 444:629-32; PMID:17108971; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
J Biol Chem  2011; 286:38725-37; PMID:21880715; http://dx.doi.org/10.1074/jbc.M111.262410,OADS,/arxiv_data1/oa_pdf/a7/4e/epi-8-457.PMC3741215.pdf
"Epigenetics 8:5, 486–493; May 2013; © 2013 Landes Bioscience BriEf rEport 486 Epigenetics Volume 8 issue 5*Correspondence to: Paul Cairns; Email: Paul.Cairns@fccc.edu Submitted: 03/18/13; Revised: 04/02/13; Accepted: 04/04/13http://dx.doi.org/10.4161/epi.24552Introduction Several tumor suppressor genes predisposing to inherited forms  of renal cell carcinoma (RCC) have been identified1 but, until  recently, with the exception of VHL , few classical tumor sup - pressor genes inactivated by point mutation had been identified in sporadic RCC, which is 96% of the disease.",Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
"www.landesbioscience.com Epigenetics 487 BriEf rEport BriEf rEport annotation (available at ftp://ftp.illumina.com/Methylation/ InfiniumMethylation/HumanMethylation27) used the National Center for Biotechnology Information (NCBI) relaxed definition of 200 bp length, 50% GC content and 0.6 ObsCpG/ExpCpG for identification of CpG islands in genes in the Consensus Coding Sequence (CCDS) database.",OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Fifty fresh-frozen ccRCC and four normal renal paren - chyma from patients with no history of RCC and of similar age (mean 66 y) to the average age of diagnosis of RCC (64 y) from 2005–2009 (http://seer.cancer.gov/statfacts/html/kidrp.html) were obtained from the Fox Chase Cancer Center (FCCC) Biospecimen Repository.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
The localization of the Infinium HumanMethylation27 probe sequence (available at ftp://ftp.illumina.com/Methylation/InfiniumMethylation/HumanMethylation27/) relative to the TSS and bona fide CpG island was examined for each gene in Ensembl (www.ensembl.org).,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Clinicopathological data for the 50 cc rCC ccRCC Stage I Stage II Stage III Stage IV Grade i 3 Grade ii 20 2 Grade iii 4 1 3 8 Grade iV 9examine an area of sequence within 500 bp upstream or down - stream of the TSS predicted by Ensembl in a CpG island that fulfilled the widely used definition criteria of Gardiner-Garden and Frommer 60 as well as the modifications suggested by Takai  and Jones36 using CpG Island Searcher (http://cpgislands.usc.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
The presence of Alu and other repetitive elements was examined by repeatmasker v3.3.0 (http://repeatmasker.org).,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
"We accessed the TCGA  ccRCC raw data available at https://tcga-data.nci.nih.gov/tcga/tcgaCancerDetails.jsp?diseaseType=KIRC&diseaseName=Kid ney%20renal%20clear%20cell%20carcinoma on September 12, 2012.",OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Nat Rev Cancer  2007; 7:531-43; PMID:17585333; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Clin Cancer Res 2009; 15:3938-46; PMID:19509174;  http://dx.doi.org/10.1158/1078-0432.CCR-08-2783.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Epigenomics 2009;  1:177-200; http://dx.doi.org/10.2217/epi.09.14;  PMID:22122642.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Nat Genet  2006; 38:1378-85; PMID:17072317; http://dx.doi.org/10.1038/ng1909.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Hum Mol Genet 1998; 7:737-42; PMID:9499428; http://dx.doi.org/10.1093/ hmg/7.4.737.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Genome Res  2004; 14:1275-84; PMID:15197169; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
J Urol 2002; 167:57-60;  PMID:11743275; http://dx.doi.org/10.1016/S0022- 5347(05)65382-7.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Nat Protoc 2006; 1:2353- 64; PMID:17406479; http://dx.doi.org/10.1038/ nprot.2006.324.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Nucleic Acids Res 1997; 25:4422-6; PMID:9336479; http://dx.doi.org/10.1093/ nar/25.21.4422.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Nucleic Acids Res 2001; 29:E65- 5; PMID:11433041; http://dx.doi.org/10.1093/ nar/29.13.e65.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Hum Mol Genet  2003; 12:1569-78; PMID:12812984; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Nat Rev  Urol 2010; 7:277-85; PMID:20448661; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Nat Rev Cancer  2004; 4:381-93; PMID:15122209; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Nat Genet 2012; 44:17-9;  PMID:22138691; http://dx.doi.org/10.1038/ng.1014.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Nat Genet 2012; 44:751- 9; PMID:22683710; http://dx.doi.org/10.1038/ ng.2323.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Nature 2011; 469:539- 42; PMID:21248752; http://dx.doi.org/10.1038/ nature09639.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Hum Mutat 2012;  33:1059-62; http://dx.doi.org/10.1002/humu.22090;  PMID:22461374.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Science 2010; 330:228-31; PMID:20826764;  http://dx.doi.org/10.1126/science.1196333.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
N Engl J Med  2010; 363:1532-43; http://dx.doi.org/10.1056/ NEJMoa1008433; PMID:20942669.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Nat Genet  2011; 43:875-8; PMID:21822268; http://dx.doi.org/10.1038/ng.907.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Hum Mutat 2012; 33:100-3; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Nat Genet 2009; 41:521-3; PMID:19330029;  http://dx.doi.org/10.1038/ng.349.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Nature 2012; 488:100- 5; PMID:22832583; http://dx.doi.org/10.1038/ nature11284.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Nature 2012; 488:106- 10; PMID:22820256; http://dx.doi.org/10.1038/ nature11329.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Science  2010; 330:1410-3; PMID:21051595; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Nat Genet  2011; 43:668-72; PMID:21642991; http://dx.doi.org/10.1038/ng.855.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Science 2012; 337:1463-4; PMID:22997315; http://dx.doi.org/10.1126/science.1228463.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
N Engl J Med  2008; 358:1148-59; PMID:18337604; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Cell 2007; 128:683-92; PMID:17320506; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Clin  Cancer Res 2008; 14:782-7; PMID:18245539; http://dx.doi.org/10.1158/1078-0432.CCR-07-1753.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Clin Cancer Res 2004; 10:3972-9; PMID:15217927; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
BMC Cancer 2007; 7:133; PMID:17645803;  http://dx.doi.org/10.1186/1471-2407-7-133.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Oncogene 2003; 22:6794-801; PMID:14555992;  http://dx.doi.org/10.1038/sj.onc.1206914.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Cancer Res 2009; 69:4674-81; PMID:19470766; http://dx.doi.org/10.1158/0008- 5472.CAN-09-0146.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Proc Natl Acad Sci U S A 1998; 95:6870- 5; PMID:9618505; http://dx.doi.org/10.1073/ pnas.95.12.6870.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
J Mol Biol 1987; 196:261-82;  PMID:3656447; http://dx.doi.org/10.1016/0022-2836(87)90689-9.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Am J Surg Pathol 1982; 6:655-63; PMID:7180965; http://dx.doi.org/10.1097/00000478-198210000- 00007.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
PLoS Biol 2010; 8:e1000533; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Oncogene 2002; 21:5427-40; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Genes Dev  2009; 23:1327-37; PMID:19487573; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Gastroenterology 2007; 133:647-58;  PMID:17681183; http://dx.doi.org/10.1053/j.gas- tro.2007.05.022.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Proc Natl Acad Sci U S A 2000; 97:10014-9; PMID:10954755; http://dx.doi.org/10.1073/ pnas.180316197.46.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
N Engl J Med 2012; 366:883- 92; http://dx.doi.org/10.1056/NEJMoa1113205;  PMID:22397650.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Cancer Res 2006; 66:5021-8;  PMID:16707423; http://dx.doi.org/10.1158/0008- 5472.CAN-05-3365.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Cancer Prev Res (Phila) 2010; 3:1084-92; PMID:20699414; http://dx.doi.org/10.1158/1940- 6207.CAPR-10-0039.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Oncogene 1999; 18:1313-24; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
Nucleic Acids Res 2012; 40:11490- 8; PMID:23066096; http://dx.doi.org/10.1093/nar/ gks928.,OADS,/arxiv_data1/oa_pdf/29/c3/epi-8-486.PMC3741218.pdf
"Epigenetics 8:5, 494–503; May 2013; © 2013 Landes Bioscience REsEaR ch papER 494 Epigenetics Volume 8 Issue 5 REsEaR ch papER *Correspondence to: Karin Broberg; Email: karin.broberg_palmgren@med.lu.se Submitted: 12/28/12; Revised: 03/05/13; Accepted: 03/21/13http://dx.doi.org/10.4161/epi.24401Introduction The toxic metal cadmium (Cd) is ubiquitous in the environ - ment.",Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
J Environ Sci Health A Tox Hazard Subst  Environ Eng 2010; 45:1468-74; PMID:20694885; http://dx.doi.org/10.1080/10934529.2010.500942 5.,Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
J Epidemiol Community Health 2004; 58:114- 5; PMID:14729887; http://dx.doi.org/10.1136/jech.58.2.114 6.,Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
J Clin Endocrinol Metab 2012; 97:2637-43; PMID:22564668; http://dx.doi.org/10.1210/jc.2012- 1426 7.,Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Environ Health Perspect 2011; 120:284- 9; PMID:21862444; http://dx.doi.org/10.1289/ ehp.1103711 8.,Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Toxicol Lett 2010; 192:162-8;  PMID:19854248; http://dx.doi.org/10.1016/j.tox- let.2009.10.018 10.,OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Biol  T race Elem Res 2005; 108:197-204; PMID:16327072; http://dx.doi.org/10.1385/BTER:108:1-3:197 12.,Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Nature  2007; 447:425-32; PMID:17522676; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Nature 2012; 484:339-44; PMID:22456710; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Toxicology 2008; 244:49- 55; PMID:18077075; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Toxicol  Sci 2011; 120:475-80; PMID:21278052; http://dx.doi.org/10.1093/toxsci/kfr022 18.,OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Environ Health Perspect 2012; 120:879- 84; PMID:22398305; http://dx.doi.org/10.1289/ ehp.1104600 19.,Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Epigenetics  2012; 7:253-60; PMID:22430801; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
PLoS ONE 2012; 7:e44139;  PMID:22957049; http://dx.doi.org/10.1371/journal.pone.0044139 21.,Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Bone  2012; 50:1372-8; PMID:22465267; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Cancer Epidemiol Biomarkers Prev  2012; 21:1756-67; PMID:22879202; http://dx.doi.org/10.1158/1055-9965.EPI-12-030424.,Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
PLoS One 2010; 5:e10028; PMID:20386599; http://dx.doi.org/10.1371/journal.pone.0010028 25.,OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
BMC Bioinformatics 2012; 13:86;  PMID:22568884; http://dx.doi.org/10.1186/1471- 2105-13-86 27.,OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Environ Mol Mutagen 2009; 50:46- 59; PMID:19031421; http://dx.doi.org/10.1002/em.20438 28.,Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Front Biosci  2012; 17:1120-39; PMID:22201794; http://dx.doi.org/10.2741/3977 29.,Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
J Cell Biol  2001; 153:413-28; PMID:11309420; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
PLoS ONE  2012; 7:e30638; PMID:22292003; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
PLoS Genet 2011; 7:e1002291;  PMID:21966279; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
JAMA 2012; 307:2050- 9; PMID:22665104; http://dx.doi.org/10.1001/ jama.2012.4061 35.,Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Environ  Health Perspect 2010; 119:11-9; PMID:20682481;  http://dx.doi.org/10.1289/ehp.100211439.,Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Bull World Health Organ 2007; 85:660- 7; PMID:18026621; http://dx.doi.org/10.2471/ BLT.07.043497 41.,Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Am J Public Health 2011;  101(Suppl 1):S333-8; PMID:21778503; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Toxicol Sci  2012; 129:305-14; PMID:22713597; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
Am J Epidemiol 2008; 169:304- 12; PMID:19037006; http://dx.doi.org/10.1093/aje/ kwn332 38.,Non-OADS,/arxiv_data1/oa_pdf/b3/4a/epi-8-494.PMC3741219.pdf
"Epigenetics 8:5, 512–521; May 2013; © 2013 Landes Bioscience REsEaR ch papER 512 Epigenetics Volume 8 Issue 5*Correspondence to: Silvère M. van der Maarel; Email: S.M.Maarel@lumc.nl Submitted: 01/21/13; Revised: 03/22/13; Accepted: 03/26/13http://dx.doi.org/10.4161/epi.24450Introduction The last decade has provided deeper knowledge on the stabil - ity and maintenance of the repetitive telomeric repeat struc - tures at the ends of human chromosomes in biological processes  such as cellular senescence.",Non-OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Exp Cell Res 1965; 37:614-36;  PMID:14315085; http://dx.doi.org/10.1016/0014- 4827(65)90211-9.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Circ Res 2012; 111:97- 109; PMID:22723221; http://dx.doi.org/10.1161/ CIRCRESAHA.111.247866.3.,Non-OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Nature  1990; 345:458-60; PMID:2342578; http://dx.doi.org/10.1038/345458a0.,Non-OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Exp Gerontol  1996; 31:235-43; PMID:8706793; http://dx.doi.org/10.1016/0531-5565(95)02008-X.5.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Curr Biol 1998; 8:279-82; PMID:9501072; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Annu Rev Genet 2008; 42:301-34; PMID:18680434; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Mol Cell  2012; 47:203-14; PMID:22795131; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Cell 2005; 123:593- 605; PMID:16286008; http://dx.doi.org/10.1016/j.cell.2005.10.025.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Mol Cell 2005; 20:971-8; PMID:16364921; http://dx.doi.org/10.1016/j.mol- cel.2005.11.021.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Cell  2005; 123:581-92; PMID:16286007; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Nat Genet 2003; 33:203-7;  PMID:12539050; http://dx.doi.org/10.1038/ng1084.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
J Cell Sci 2008; 121:4018- 28; PMID:19056671; http://dx.doi.org/10.1242/ jcs.034876.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
J Cell Biol 1996; 135:867-81; PMID:8922373; http://dx.doi.org/10.1083/ jcb.135.4.867.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Nucleic Acids Res 2002; 30:e47; PMID:12000852; http://dx.doi.org/10.1093/ nar/30.10.e47.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Nat Protoc 2006; 1:179-85; PMID:17406230;  http://dx.doi.org/10.1038/nprot.2006.27.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Nucleic Acids Res 2007; 35(Web  Server issue):W71-4; PMID:17485472; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
PLoS One 2012; 7:e37933; PMID:22666415;  http://dx.doi.org/10.1371/journal.pone.0037933.22.,Non-OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Epigenetics 2012; 7:579- 84; PMID:22522912; http://dx.doi.org/10.4161/ epi.20001.,Non-OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
RNA  2009; 15:2186-94; PMID:19850908; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Mol Cell Biol 2009; 29:4519-26; PMID:19528237; http://dx.doi.org/10.1128/MCB.00195-09.,Non-OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
EMBO J  2012; 31:4165-78; PMID:23010778; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Nat Struct  Mol Biol 2012; 19:948-56; PMID:22922742; http://dx.doi.org/10.1038/nsmb.2364.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Nucleic Acids Res 2012; 40:6649-59;  PMID:22553368; http://dx.doi.org/10.1093/nar/ gks358.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
PLoS Genet 2012; 8:1-15; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Genome Res 2011; 21:1426- 37; PMID:21803857; http://dx.doi.org/10.1101/ gr.118091.110.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Nature 2009; 459:802- 7; PMID:19516333; http://dx.doi.org/10.1038/ nature08085.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Aging  Cell 2006; 5:325-30; PMID:16913878; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Am J Epidemiol 2007; 165:14- 21; PMID:17043079; http://dx.doi.org/10.1093/aje/ kwj346.,Non-OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
T ransl  Res 2010; 155:166-9; PMID:20303464; http://dx.doi.org/10.1016/j.trsl.2009.09.012.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Physiol  Rev 2008; 88:557-79; PMID:18391173; http://dx.doi.org/10.1152/physrev.00026.2007.,Non-OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Nat Genet 2007; 39:243-50; PMID:17237781; http://dx.doi.org/10.1038/ng1952.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Nat Rev Genet 2007; 8:299-309;  PMID:17363977; http://dx.doi.org/10.1038/nrg2047.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Nature 2005; 437:94-100; PMID:16136133; http://dx.doi.org/10.1038/ nature04029.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
J Gerontol A Biol Sci Med  Sci 2009; 64:426-34; PMID:19223605; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
J Neurogenet 2012; 26:245-51;  PMID:22364520; http://dx.doi.org/10.3109/0167706 3.2011.651665.,Non-OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
Nat Genet 2003; 35:315-7; PMID:14634647; http://dx.doi.org/10.1038/ng1262.,OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
PLoS Genet 2009; 5:e1000559;  PMID:19593370; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d8/49/epi-8-512.PMC3741221.pdf
"Epigenetics 8:5, 522–533; May 2013; © 2013 Landes Bioscience REsEaR ch papER 522 Epigenetics Volume 8 Issue 5*Correspondence to: Xiaoling Wang; Email: xwang@gru.edu Submitted: 02/22/13; Revised: 03/28/13; Accepted: 04/01/13http://dx.doi.org/10.4161/epi.24506Introduction Recently, it has been reported that increased methylation vari - ability may be an important feature of some malignant human  diseases, such as cancer.1 These increased epigenetic variances  may reflect adaptation to the exposure to environmental risk factors.",Non-OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
Gene ontology analysis was performed using D aVID (http://david.abcc.,OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
**Tumor suppressor genes and oncogenes were selected from the Memorial s loan-Kettering c ancer c enter (M sKcc) cancer database   (http://cbio.mskcc.org/ cancerGenes/ select.action).,OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
Gene ontology analy - sis was performed using DAVID (the Database for annotation visualization and Integrated Discovery v6.7) (http://david.abcc.ncifcrf.gov).,OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
"Genome-wide associated studies (GWAS) genes  for obesity and its related diseases including type 2 diabetes, hypertension, dyslipidemia, breast cancer and colon cancer were identified from publications as well as the GWAS catalog (http://www.genome.gov/gwastudies).",OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
The list of tumor suppressor genes and oncogenes were taken from the Memorial Sloan-Kettering Cancer Center (MSKCC) cancer database (http://cbio.mskcc.org/CancerGenes/Select.action).,OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
Nat Genet 2011; 43:768-75; PMID:21706001;  http://dx.doi.org/10.1038/ng.865.,OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
Genome Med 2012;  4:24; PMID:22453031; http://dx.doi.org/10.1186/ gm323.4.,OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
Bioinformatics 2012; 28:1487-94;  PMID:22492641; http://dx.doi.org/10.1093/bioinfor- matics/bts170.,OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
PLoS Med  2009; 6:e1000058; PMID:19399161; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
J Clin Endocrinol  Metab 2008; 93(Suppl 1):S9-30; PMID:18987276;  http://dx.doi.org/10.1210/jc.2008-1595.7.,Non-OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
Circulation 2006; 113:898-918; PMID:16380542; http://dx.doi.org/10.1161/ CIRCULATIONAHA.106.171016.,Non-OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
Endocrinol Metab Clin North Am 2003; 32:823-54; PMID:14711064; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
"Diabetes Care 2004; 27:2568-9, author reply  2569; PMID:15451946; http://dx.doi.org/10.2337/ diacare.27.10.2568.",Non-OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
Stat Appl Genet Mol Biol 2004; 3:e3;  PMID:16646809; http://dx.doi.org/10.2202/1544- 6115.1027.,OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
Proc Natl Acad Sci U S A  2002; 99:6567-72; PMID:12011421; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
Stat Med 1990;  9:811-8; PMID:2218183; http://dx.doi.org/10.1002/ sim.4780090710.16.,OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
Nat Biotechnol  2013; 31:142-7; PMID:23334450; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
Nature  2012; 490:267-72; PMID:22982992; http://dx.doi.org/10.1038/nature11401.10.,OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
Surgeon 2009;  7:282-5; PMID:19848061; http://dx.doi.org/10.1016/ S1479-666X(09)80005-X.,Non-OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
Cancer Causes Control  2002; 13:741-51; PMID:12420953; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
BMC Med 2010; 8:87;  PMID:21176133; http://dx.doi.org/10.1186/1741- 7015-8-87.,Non-OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
Sci T ransl Med 2010; 2:49ra67;  PMID:20844285; http://dx.doi.org/10.1126/scitrans- lmed.3001262.,OADS,/arxiv_data1/oa_pdf/93/16/epi-8-522.PMC3741222.pdf
"Epigenetics 8:5, 542–547; May 2013; © 2013 Landes Bioscience REsEaR ch papER 542 Epigenetics Volume 8 Issue 5*Correspondence to: Karolina A. Aberg; Email: kaaberg@vcu.edu Submitted: 03/04/13; Revised: 03/25/13; Accepted: 04/01/13http://dx.doi.org/10.4161/epi.24508Introduction Epigenetic modifications to chromatin provide stability and  diversity to the cellular phenotype.",Non-OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
"Except for the isolated CpGs, which were extracted directly from the refer - ence sequence, the features were downloaded from the UCSC genome browser (http://genome.ucsc.edu).",OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Nature 1978; 274:775-80;  PMID:355893; http://dx.doi.org/10.1038/274775a0.,Non-OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Epigenomics 2010; 2:671- 82; PMID:22122050; http://dx.doi.org/10.2217/ epi.10.43.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Am J Hum Genet 2008; 82:696-711;  PMID:18319075; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
T rends Mol Med 2011; 17:714-24; PMID:21885342; http://dx.doi.org/10.1016/j.mol- med.2011.07.005.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Nat Rev Cardiol 2010; 7:510-9; PMID:20603647; http://dx.doi.org/10.1038/nrcar- dio.2010.104.,Non-OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
T rends Genet 2012; 28:118-27; PMID:22226176; http://dx.doi.org/10.1016/j.tig.2011.11.005.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Nature 2007; 447:433- 40; PMID:17522677; http://dx.doi.org/10.1038/nature05919.8.,Non-OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Nature  2010; 465:721-7; PMID:20535201; http://dx.doi.org/10.1038/nature09230.,Non-OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Nucleic Acids Res 1991; 19:5771-5; PMID:1945854;  http://dx.doi.org/10.1093/nar/19.20.5771.,Non-OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Nat  Biotechnol 2010; 28:1097-105; PMID:20852635;  http://dx.doi.org/10.1038/nbt.1682.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Genome Res 2012; 22:1407-18; PMID:22684279; http://dx.doi.org/10.1101/ gr.132878.111.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
PLoS One 2011; 6:e22226;  PMID:21779396; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Methods  2010; 52:203-12; PMID:20430099; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Epigenetics 2011; 6:34-44; PMID:20818161; http://dx.doi.org/10.4161/epi.6.1.13313.,Non-OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Nucleic Acids Res 2010; 38:391- 9; PMID:19906696; http://dx.doi.org/10.1093/nar/ gkp992.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Nat Methods 2009;  6(Suppl):S22-32; PMID:19844228; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Genome Biol 2008; 9:R137;  PMID:18798982; http://dx.doi.org/10.1186/gb-2008- 9-9-r137.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
BMC Bioinformatics 2013; 14:50; PMID:23398781;  http://dx.doi.org/10.1186/1471-2105-14-50.25.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Forensic Sci Int  Genet 2012; 6:306-9; PMID:21737370; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Genome Res 2012; 22:2138- 45; PMID:22919074; http://dx.doi.org/10.1101/ gr.134304.111.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Mol Genet Metab 2013; 108:225-31;  PMID:23422032; http://dx.doi.org/10.1016/j.ymgme.2013.01.016.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
BMC Genet 2011; 12:58;  PMID:21726430; http://dx.doi.org/10.1186/1471- 2156-12-58.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
BMC Med Genet 2011; 12:22; PMID:21306642;  http://dx.doi.org/10.1186/1471-2350-12-22.,Non-OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Electrophoresis 2009; 30:2532-5; PMID:19639574;  http://dx.doi.org/10.1002/elps.200800655.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Epigenomics 2012; 4:605-21; PMID:23244307; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Arch Gen Psychiatry  1996; 53:1129-36; PMID:8956679; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Am J Phys Anthropol 1997;  104:1-21; PMID:9331450; http://dx.doi.org/10.1002/ (SICI)1096-8644(199709)104:1<1::AID- AJPA1>3.0.CO;2-V.11.,Non-OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Ann N Y Acad Sci 2003;  983:151-60; PMID:12724220; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Epigenetics 2012;  7:20-8; PMID:22207355; http://dx.doi.org/10.4161/ epi.7.1.18688.,Non-OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
FASEB J 2012; 26:2712-8;  PMID:22426120; http://dx.doi.org/10.1096/fj.11-202069.,Non-OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Nat Genet 2000; 24:88-91; PMID:10615135; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Nat Rev Genet 2010; 11:191-203; PMID:20125086; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Nat Rev Genet 2011; 12:529-41;  PMID:21747404; http://dx.doi.org/10.1038/nrg3000.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Epigenomics 2009; 1:177- 200; PMID:22122642; http://dx.doi.org/10.2217/ epi.09.14.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Science 2008; 322:881-8; PMID:18988837; http://dx.doi.org/10.1126/sci- ence.1156409.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Nat Rev Genet 2009; 10:241-51; PMID:19293820;  http://dx.doi.org/10.1038/nrg2554.,Non-OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Science  2006; 312:279-83; PMID:16614226; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
Science  2005; 308:385-9; PMID:15761122; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
BMC Res  Notes 2012; 5:503; PMID:22974252; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/8f/epi-8-542.PMC3741224.pdf
"ReviewISSN 1738-5997(Print) • ISSN 2092-9935(Online) Electrolyte Blood Press 11:1-8, 2013  http://dx.doi.org/10.5049/EBP.2013.11.1.1 Copyright © 2013 The Korean Society of Electrolyte MetabolismeThe Role of V2 Receptor Antagonists in the  Treatment of Hyponatremia Biff F. Palmer, M.D.",Non-OADS,/arxiv_data1/oa_pdf/24/39/ebp-11-1.PMC3741437.pdf
"Electrolyte Blood Press 11:1-8, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.1.1 3 Copyright © 2013 The Korean Society of Electrolyte MetabolismeTable 1.",Non-OADS,/arxiv_data1/oa_pdf/24/39/ebp-11-1.PMC3741437.pdf
"Electrolyte Blood Press 11:1-8, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.1.1 5 Copyright © 2013 The Korean Society of Electrolyte Metabolismereceptor blockade has the potential to increase the degree  of arterial vasodilation in the splanchnic arteriolar bed.",Non-OADS,/arxiv_data1/oa_pdf/24/39/ebp-11-1.PMC3741437.pdf
"Electrolyte Blood Press 11:1-8, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.1.1 7 Copyright © 2013 The Korean Society of Electrolyte Metabolismecause of increased AVP is deemed to be chronic and irre- versible then therapy can be extended into the outpatient setting.",Non-OADS,/arxiv_data1/oa_pdf/24/39/ebp-11-1.PMC3741437.pdf
"ReviewISSN 1738-5997(Print) • ISSN 2092-9935(Online) Electrolyte Blood Press 11:17-23, 2013  http://dx.doi.org/10.5049/EBP.2013.11.1.17 Copyright © 2013 The Korean Society of Electrolyte MetabolismPharmacologic Management of the Cardio-renal  Syndrome Chang Seong Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/d0/7d/ebp-11-17.PMC3741438.pdf
"Electrolyte Blood Press 11:17-23, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.1.17 19 Copyright © 2013 The Korean Society of Electrolyte Metabolismheart failure and renal dysfunction frequently require high-  dose diuretic treatment, the administered dose must be carefully calculated to improve fluid balance and relieve symptoms without stimulating adverse physiologic effects.",Non-OADS,/arxiv_data1/oa_pdf/d0/7d/ebp-11-17.PMC3741438.pdf
"Electrolyte Blood Press 11:17-23, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.1.17 21 Copyright © 2013 The Korean Society of Electrolyte Metabolismiron over 1 year led to improvements in cardiac function,  left ventricular remodeling, and B-type natriuretic pep-tide levels compared with oral iron therapy alone 36).",Non-OADS,/arxiv_data1/oa_pdf/d0/7d/ebp-11-17.PMC3741438.pdf
"Electrolyte Blood Press 11:17-23, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.1.17 23 Copyright © 2013 The Korean Society of Electrolyte MetabolismMS, Gallotta M, et al.",Non-OADS,/arxiv_data1/oa_pdf/d0/7d/ebp-11-17.PMC3741438.pdf
"ReviewISSN 1738-5997(Print) • ISSN 2092-9935(Online) Electrolyte Blood Press 11:24-28, 2013  http://dx.doi.org/10.5049/EBP.2013.11.1.24 Copyright © 2013 The Korean Society of Electrolyte MetabolismAdrenergic Genetic Mechanisms in Hypertension  and Hypertensive Kidney Disease Sun Woo Kang, M.D.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/ebp-11-24.PMC3741439.pdf
"Electrolyte Blood Press 11:24-28, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.1.24 25 Copyright © 2013 The Korean Society of Electrolyte Metabolism Fig.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/ebp-11-24.PMC3741439.pdf
"Electrolyte Blood Press 11:24-28, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.1.24 27 Copyright © 2013 The Korean Society of Electrolyte Metabolism Fig.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/ebp-11-24.PMC3741439.pdf
"Case ReportISSN 1738-5997(Print) • ISSN 2092-9935(Online) Electrolyte Blood Press 11:29-32, 2013  http://dx.doi.org/10.5049/EBP.2013.11.1.29 Copyright © 2013 The Korean Society of Electrolyte MetabolismParanoid Adipsia-induced Severe Hypernatremia  and Uremia treated with Hemodialysis Jae-Hyun Choi, M.D., Hee Seung Lee, M.D., Sun Moon Kim, M.D., Hye-young Kim, M.D, Soon Kil Kwon, M.D.We describe a patient with severe hypernatremia and uremia caused by paranoid  adipsia who was treated successfully with hydration and hemodialysis.",Non-OADS,/arxiv_data1/oa_pdf/ee/1e/ebp-11-29.PMC3741440.pdf
"Electrolyte Blood Press 11:29-32, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.1.29 31 Copyright © 2013 The Korean Society of Electrolyte Metabolismcreate severe dehydration or uremic pre-renal acute kid- ney injury.",Non-OADS,/arxiv_data1/oa_pdf/ee/1e/ebp-11-29.PMC3741440.pdf
"ReviewISSN 1738-5997(Print) • ISSN 2092-9935(Online) Electrolyte Blood Press 11:9-16, 2013  http://dx.doi.org/10.5049/EBP.2013.11.1.9 Copyright © 2013 The Korean Society of Electrolyte MetabolismPotassium Balances in Maintenance Hemodialysis Hoon Young Choi, M.D., Sung Kyu Ha, M.D.Potassium is abundant in the ICF compartment in the body and its excretion  primarily depends on renal (about 90%), and to a lesser extent (about 10%) on  colonic excretion.",Non-OADS,/arxiv_data1/oa_pdf/6e/73/ebp-11-9.PMC3741441.pdf
"Electrolyte Blood Press 11:9-16, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.1.9 11 Copyright © 2013 The Korean Society of Electrolyte Metabolismsible for [K] excretion in healthy adults, it is not surpris- ing that patients with ESRD are at a high risk population for developing hyperkalemia.",Non-OADS,/arxiv_data1/oa_pdf/6e/73/ebp-11-9.PMC3741441.pdf
"Electrolyte Blood Press 11:9-16, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.1.9 13 Copyright © 2013 The Korean Society of Electrolyte Metabolisminto the intracellular compartment, and (3) removal of [K]  from the body.",Non-OADS,/arxiv_data1/oa_pdf/6e/73/ebp-11-9.PMC3741441.pdf
"Electrolyte Blood Press 11:9-16, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.1.9 15 Copyright © 2013 The Korean Society of Electrolyte MetabolismConflicts of Interest The authors have nothing to disclose.",Non-OADS,/arxiv_data1/oa_pdf/6e/73/ebp-11-9.PMC3741441.pdf
"Among them, ten articles that provided notable and interest - ing results for the management of sepsis, ARDS, and mechani -REVIEW http://dx.doi.org/10.4046/trd.2013.75.1.1 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:1-8 1Address for correspondence: Hye Sook Choi, M.D., Ph.D.  Department of Internal Medicine, Dongguk University Gyeongju  Hospital, Dongguk University College of Medicine, 87 Dongdae-ro,  Gyeongju 780-350, Korea Phone:  82-54-770-8586, Fax: 82-54-770-8378 E-mail: maxymus72@hanmail.net Received:  May 11, 2013 Revised:  May 16, 2013 Accepted:  May 21, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/89/32/trd-75-1.PMC3741468.pdf
"Review of critical care 2013 http://dx.doi.org/10.4046/trd.2013.75.1.1  3 www.e-trd.orgtress Syndrome Clinical Trials Network Fluid and Catheter  Treatment Trial, we assessed neuropsychological function at 2  and 12 months post-hospital discharge.",Non-OADS,/arxiv_data1/oa_pdf/89/32/trd-75-1.PMC3741468.pdf
"Review of critical care 2013 http://dx.doi.org/10.4046/trd.2013.75.1.1  5 www.e-trd.orgResults  Of 316 patients, 4 were withdrawn and not included  in analysis.",Non-OADS,/arxiv_data1/oa_pdf/89/32/trd-75-1.PMC3741468.pdf
Review of critical care 2013 http://dx.doi.org/10.4046/trd.2013.75.1.1  7 www.e-trd.orgity of ICU care is unknown.,Non-OADS,/arxiv_data1/oa_pdf/89/32/trd-75-1.PMC3741468.pdf
"All rights reserved.Kyung-Wook Jo, M.D.1, Yoonki Hong, M.D.1, Jae Seuk Park, M.D.2, In-Gyu Bae, M.D.3, Joong Sik  Eom, M.D.4, Sang-Rok Lee, M.D.5, Oh-Hyun Cho, M.D.3, Eun Ju Choo, M.D.6, Jung Yeon Heo, M.D.7,  Jun Hee Woo, M.D.8 and Tae Sun Shim, M.D.1 1Division of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul,  2Department of Internal Medicine, Dankook University College of Medicine, Seoul, 3Department of Internal Medicine,  Gyeongsang National University School of Medicine, Jinju, 4Division of Infectious Diseases, Department of Internal Medicine,  Kandong Sacred Heart Hospital College of Medicine, Hallym University College of Medicine, Seoul, 5Department of Internal  Medicine, Division of Allergy and Infectious Diseases, Cheongju St. Mary’s Hospital, Cheonju, 6Division of Infectious Diseases,  Department of Internal Medicine, Soon Chun Hyang University Bucheon Hospital, Soon Chun Hyang University College of  Medicine, Bucheon, 7Department of Internal Medicine, Armed Forces Capital Hospital, Seoul, 8Division of Infectious Diseases,  Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2013.75.1.18 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:18-24 18Address for correspondence: Tae Sun Shim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/35/05/trd-75-18.PMC3741469.pdf
"1, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/35/05/trd-75-18.PMC3741469.pdf
Prevalence of LTBI in Korean HCWs http://dx.doi.org/10.4046/trd.2013.75.1.18  19 www.e-trd.orgIntroduction It has long been thought that health care workers (HCWs)  are at an increased risk for Mycobacterium tuberculosis infec - tion as a result of occupational exposure to patients infected  with M. tuberculosis1.,Non-OADS,/arxiv_data1/oa_pdf/35/05/trd-75-18.PMC3741469.pdf
Prevalence of LTBI in Korean HCWs http://dx.doi.org/10.4046/trd.2013.75.1.18  21 www.e-trd.orgTable 3.,Non-OADS,/arxiv_data1/oa_pdf/35/05/trd-75-18.PMC3741469.pdf
Prevalence of LTBI in Korean HCWs http://dx.doi.org/10.4046/trd.2013.75.1.18  23 www.e-trd.orgTwo tests generally showed poor agreement.,Non-OADS,/arxiv_data1/oa_pdf/35/05/trd-75-18.PMC3741469.pdf
"Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan  University School of Medicine, Seoul, KoreaCASE REPORThttp://dx.doi.org/10.4046/trd.2013.75.1.25 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:25-27 25Address for correspondence: Won-Jung Koh, M.D.",Non-OADS,/arxiv_data1/oa_pdf/74/42/trd-75-25.PMC3741470.pdf
"Received:  Oct. 4, 2012 Revised:  Oct. 23, 2012 Accepted:  Jan. 3, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/74/42/trd-75-25.PMC3741470.pdf
"Normalization of increased CA 19-9 in Mycobacterium abscessus  lung disease http://dx.doi.org/10.4046/trd.2013.75.1.25  27 www.e-trd.orgDiscussion Although CA 19-9 is a well-known tumor marker for pan - creatic cancer, increased levels of CA 19-9 can also be detect - ed in several benign conditions.",Non-OADS,/arxiv_data1/oa_pdf/74/42/trd-75-25.PMC3741470.pdf
"All rights reserved.Jin Sun Park, M.D.1, Eul Sik Jung, M.D.1, Woosuk Choi, M.D.1, Soo Yong Park, M.D.1, Min Young  Rim, M.D.1, Inku Yu, M.D.1, Hyeonsu Park, M.D.1, Sang Min Lee, M.D.1, Jeong-Woong Park, M.D.,  Ph.D.1, Sung Hwan Jeong, M.D., Ph.D.1, Sang Pyo Lee, M.D., Ph.D.1 and Sanghui Park, M.D., Ph.D.2 1Department of Internal Medicine, Gachon University Gil Hospital, Gachon University Medicine and Science, Incheon,  2Department of Pathology, Ewha Womans University School of Medicine, Seoul, Korea Introduction During the past decades, methotrexate (MTX) was re - garded as a disease-modifying anti-rheumatic drug due to its CASE REPORThttp://dx.doi.org/10.4046/trd.2013.75.1.28 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:28-31 28Address for correspondence: Sang Pyo Lee, M.D., Ph.D. Department of Internal Medicine, Gachon University Gil Hospital, 21  Namdong-daero 774beon-gil, Namdong-gu, Incheon 405-760, Korea Phone:  82-32-460-3864, Fax: 82-32-460-3073  E-mail: allergy21@hotmail.com Address for Co-correspondence: Sanghui Park, M.D., Ph.D. Department of Pathology, Ewha Womans University School of Medicine,  1071 Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, Korea Phone:  82-2-2650-5731, Fax: 82-2-2650-2879 E-mail: americandoc@hanmail.net Received:  Jan. 21, 2012 Revised:  Feb. 6, 2012 Accepted:  Mar.",Non-OADS,/arxiv_data1/oa_pdf/4f/4a/trd-75-28.PMC3741471.pdf
"7, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/4f/4a/trd-75-28.PMC3741471.pdf
"Actively caseating endobronchial NTM disease http://dx.doi.org/10.4046/trd.2013.75.1.28  29 www.e-trd.orgCase Report A 58-year old woman was admitted to our hospital with a  two month history of a worsening productive cough, fatigue  and fever.",Non-OADS,/arxiv_data1/oa_pdf/4f/4a/trd-75-28.PMC3741471.pdf
"Actively caseating endobronchial NTM disease http://dx.doi.org/10.4046/trd.2013.75.1.28  31 www.e-trd.orgcaseating endobronchial M. intracellulare  disease with a pul - monary infiltration in a patient with RA, and the patient de - veloped this infection while receiving MTX.",Non-OADS,/arxiv_data1/oa_pdf/4f/4a/trd-75-28.PMC3741471.pdf
"While there have been sporadic case CASE REPORThttp://dx.doi.org/10.4046/trd.2013.75.1.32 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:32-35 32Address for correspondence: Hae-Seong Nam, M.D.",Non-OADS,/arxiv_data1/oa_pdf/02/78/trd-75-32.PMC3741472.pdf
"Received:  Dec. 5, 2012 Revised:  Jan. 14, 2013 Accepted:  Jan. 17, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/02/78/trd-75-32.PMC3741472.pdf
"Late-onset distant metastatic UUT-UC http://dx.doi.org/10.4046/trd.2013.75.1.32  33 www.e-trd.orgthe urology clinic for 10 years, and no additional tumors were  identified.",Non-OADS,/arxiv_data1/oa_pdf/02/78/trd-75-32.PMC3741472.pdf
Late-onset distant metastatic UUT-UC http://dx.doi.org/10.4046/trd.2013.75.1.32  35 www.e-trd.orgadenocarcinoma of lung have been reported that TTF-1 is  a more sensitive marker than p6313.,Non-OADS,/arxiv_data1/oa_pdf/02/78/trd-75-32.PMC3741472.pdf
"We report a case of isolated endobronchial capillary  hemangioma in adult, which was diagnosed with pathologic  examination of the forcep biopsied specimen.CASE REPORThttp://dx.doi.org/10.4046/trd.2013.75.1.36 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:36-39 36Address for correspondence: Choon-Sik Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/3b/31/trd-75-36.PMC3741473.pdf
"Department of Internal Medicine, Soonchunhyang University Bucheon  Hospital, 170 Jomaru-ro, Wonmi-gu, Bucheon 420-767, Korea Phone:  82-32-621-5105, Fax: 82-32-621-5023 E-mail: mdcspark@daum.net Received:  Nov. 8, 2012 Revised:  Nov. 19, 2012 Accepted:  Dec. 14, 2012 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/3b/31/trd-75-36.PMC3741473.pdf
Isolated endobronchial capillary hemangioma http://dx.doi.org/10.4046/trd.2013.75.1.36  37 www.e-trd.orgment in both lungs and irregular linear and nodular opacities  with distortion of surrounding architecture in right upper lobe.,Non-OADS,/arxiv_data1/oa_pdf/3b/31/trd-75-36.PMC3741473.pdf
Isolated endobronchial capillary hemangioma http://dx.doi.org/10.4046/trd.2013.75.1.36  39 www.e-trd.orghistopathologic findings.,Non-OADS,/arxiv_data1/oa_pdf/3b/31/trd-75-36.PMC3741473.pdf
"Division of Pulmonology, Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, KoreaORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2013.75.1.9 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:9-17 9Copyright © 2013 The Korean Academy of Tuberculosis and Respiratory Diseases.",Non-OADS,/arxiv_data1/oa_pdf/ff/f6/trd-75-9.PMC3741474.pdf
"16, 2013 Accepted:  May 6, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/ff/f6/trd-75-9.PMC3741474.pdf
"Monensin enhances rapamycin- or erlotinib-induced cell cycle arrest and apoptosis http://dx.doi.org/10.4046/trd.2013.75.1.9  11 www.e-trd.orgwas performed; briefly, the treated cells were stained with AO  (1 µg/mL in serum-free RPMI 1640 media) in the dark at 37oC  for 15 minutes, and then washed with serum-free RPMI 1640  media.",Non-OADS,/arxiv_data1/oa_pdf/ff/f6/trd-75-9.PMC3741474.pdf
Monensin enhances rapamycin- or erlotinib-induced cell cycle arrest and apoptosis http://dx.doi.org/10.4046/trd.2013.75.1.9  13 www.e-trd.orgFigure 2.,Non-OADS,/arxiv_data1/oa_pdf/ff/f6/trd-75-9.PMC3741474.pdf
Monensin enhances rapamycin- or erlotinib-induced cell cycle arrest and apoptosis http://dx.doi.org/10.4046/trd.2013.75.1.9  15 www.e-trd.org3.,Non-OADS,/arxiv_data1/oa_pdf/ff/f6/trd-75-9.PMC3741474.pdf
Monensin enhances rapamycin- or erlotinib-induced cell cycle arrest and apoptosis http://dx.doi.org/10.4046/trd.2013.75.1.9  17 www.e-trd.organtibiotics on gram-positive bacteria.,Non-OADS,/arxiv_data1/oa_pdf/ff/f6/trd-75-9.PMC3741474.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/cf/ket185.PMC3741479.pdf
"253Korean J Physiol Pharmacol Vol 17: 253 －257, August, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.4.253 ABBREVIATIONS: ANS, 1-anilinonaphthalene-8-sulfonic acid;  BSA,  bovine serum albumin; PBS, phosphate-buffered saline; Py-3-Py,  1,3-di(1-pyrenyl)propane; RET, radiationless energy transfer;  SPMV,  synaptosomal plasma membrane vesicles isolated from bovine cerebral cortex; SPMVTL, liposome of total lipids extracted from  SPMV; SPMVPL, liposome of phospholipids extracted from SPMV.",Non-OADS,/arxiv_data1/oa_pdf/e2/6d/kjpp-17-253.PMC3741480.pdf
"259Korean J Physiol Pharmacol Vol 17: 259 －265, August, 2013 http://dx.doi.org/ 10.4196/kjpp.2013.17.4.259 Received January 20, 2013, Revised May 2, 2013,  Accepted May 16, 2013  Corresponding to: May Al-Maghrebi, Department of Biochemistry,  Faculty of Medicine, Kuwait University, P.O.",Non-OADS,/arxiv_data1/oa_pdf/24/e5/kjpp-17-259.PMC3741481.pdf
"267Korean J Physiol Pharmacol Vol 17: 267 －274, August, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.4.267 ABBREVIATIONS: TGF-β1, transforming growth factor- β1; TNF- α, tumor necrosis factor- α; CTGF, connective tissue growth factor;  NF-κB, nuclear factor-kappa B; COX-2, cyclooxygenase-2.",Non-OADS,/arxiv_data1/oa_pdf/ce/66/kjpp-17-267.PMC3741482.pdf
"275Korean J Physiol Pharmacol Vol 17: 275 －281, August, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.4.275 ABBREVIATIONS: LDH, Lactic dehydrogenase; MTT, 3-(4,5-Dime- thylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; GFAP, glial fibril- lary acidic protein.",Non-OADS,/arxiv_data1/oa_pdf/4a/b7/kjpp-17-275.PMC3741483.pdf
"283Korean J Physiol Pharmacol Vol 17: 283 －289, August, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.4.283 ABBREVIATIONS: KRG, Korean red ginseng; I/R, ischemia and  reperfusion; MI, myocardial infarction; N/C, normal control; AF,  aortic flow; CF, coronary flow; CO, cardiac output; LVSP, left vent-ricular systolic pressure; ＋dP/dt max, the maximal rate of contraction;  −dP/dt max, the maximal rate of relaxation; ECG, electrocardio- graphy; LDH, lactate dehydrogenase; CK-MB, creatine kinase; cTnI, troponin I; MDA, malondialdehyde; GSH, glutathione; S.E, standard  error of means.",Non-OADS,/arxiv_data1/oa_pdf/6b/ae/kjpp-17-283.PMC3741484.pdf
"291Korean J Physiol Pharmacol Vol 17: 291 －297, August, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.4.291 ABBREVIATIONS: ChIP, chromatin immunoprecipitation; EMSA,  electrophoretic mobility shift assay; NICD, Notch1 intracellular  domain; siRNA, small interfering RNA; TUNEL, terminal deoxy-nucleotidyl transferase dUTP nick end labeling; RT-PCR, reverse  transcription polymerase chain reaction.",OADS,/arxiv_data1/oa_pdf/6c/59/kjpp-17-291.PMC3741485.pdf
SUPPLEMENTARY MATERIALS   Supplementary data includ ing one figure can be found  with this article online at http://pdf.medrang.co.kr/paper/  pdf/Kjpp/Kjpp017-04-06-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6c/59/kjpp-17-291.PMC3741485.pdf
"299Korean J Physiol Pharmacol Vol 17: 299 －306, August, 2013 http://dx.doi.org/ 10.4196/kjpp.2013.17.4.299 ABBREVIATIONS: PD, Parkinson’s disease; DBS, deep brain  stimulation; STN, subthalamic nucleus; GP, globus pallidus.",Non-OADS,/arxiv_data1/oa_pdf/4a/b3/kjpp-17-299.PMC3741486.pdf
"307Korean J Physiol Pharmacol Vol 17: 307 －314, August, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.4.307 ABBREVIATIONS: CTGF, connective tissue growth factor; ECM,  extracelluar matrix; VSMC, vascular smooth muscle cell; TGF β,  transforming growth factor β; Egr-1, early growth response-1;  ERK1/2, extracellular signal regulated kinase 1/2; MAPK, mitogen activated protein kinase; FBS, fetal bovine serum; ECL, electro- chemiluminescence; MTT, 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl- tetrazolidium bromide; DMEM, Dulbecco’s modified eagle’s medium; SDS, sodium dodecyl sulfate; PBS, phosphate buffered saline;  DMSO, dimethyl sulfoxide; PVDF, polyvinylidene difluoride.",Non-OADS,/arxiv_data1/oa_pdf/bd/6e/kjpp-17-307.PMC3741487.pdf
"315Korean J Physiol Pharmacol Vol 17: 315 －320, August, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.4.315 ABBREVIATIONS: iNOS, inducible nitric oxide synthase; IFN- γ,  interferon- γ; TNF-α, tumor necrosis factor- α; IL-1β, interleukin-1 β.",Non-OADS,/arxiv_data1/oa_pdf/97/f2/kjpp-17-315.PMC3741488.pdf
"321Korean J Physiol Pharmacol Vol 17: 321 －329, August, 2013 http://dx.doi.org/ 10.4196/kjpp.2013.17.4.321 ABBREVIATIONS: FST, forced swimming test; DMI, desipramine;  CIT, citalopram; PrL, prelimbic cortex; NAc core, nucleus accumbens  core; NAc shell, nucleus accumbens shell; LSv, ventral lateral septal  nucleus; dlBNST, dorsolateral bed nucleus of the stria terminalis; vBNST, ventral bed nucleus of the stria terminalis; PVN, hy- pothalamic paraventricular nucleus; CeA, central nucleus of the  amygdala; PVT, paraventricular thalamic nucleus; LHb, lateral habenula; PAG, periaqueductal gray; DR, dorsal raphe; LC, locus  ceruleus.",Non-OADS,/arxiv_data1/oa_pdf/ff/22/kjpp-17-321.PMC3741489.pdf
"331Korean J Physiol Pharmacol Vol 17: 331 －338, August, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.4.331 ABBREVIATIONS: AMPK, AMP-activated protein kinase; AChE,  acetylcholinesterase; Ad-AMPK-WT, AMPK wild type subunit; Ad-  AMPK-DN, AMPK dominant negative form; FACS, flow cytometry; BDNF, brain-derived neurotrophic factor; CNS, central nervous  system; AD, Alzheimer’s disease.",Non-OADS,/arxiv_data1/oa_pdf/02/01/kjpp-17-331.PMC3741490.pdf
"339Korean J Physiol Pharmacol Vol 17: 339 －345, August, 2013 http://dx.doi.org/ 10.4196/kjpp.2013.17.4.339 ABBREVIATIONS: L-NAME, NG-nitro-L-arginine methyl ester hydro- chloride; MAP, mean arterial pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; NOS, nitric oxide synthase; GSH,  glutathione; ROS, reactive oxygen species; MDA, malondialdehyde.",Non-OADS,/arxiv_data1/oa_pdf/33/f6/kjpp-17-339.PMC3741491.pdf
"347Korean J Physiol Pharmacol Vol 17: 347 －357, August, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.4.347 ABBREVIATIONS: ARF, acute renal failure; ESRD, end stage renal  disease; UTI, urinary tract infection; AT1b, angiotensin II type 1b; NO, nitric oxide; GEC, glomerular epithelial cell; Hbs, sickle  haemoglobin; FSGS, focal and segmental glomerulosclerosis; MPGN,  membrano proliferative Glomerulo nephritis; ET-1, endothelin-1; AIN, acute interstitial nephritis; HPTEC, human proximal tubular  epithelial cell; BE, benzoylecgonine; EME, ecgonine methyl ester;  NCOC, norcocaine; ROS, reactive oxygen species; KTZ, ketoconazole; SHR, spontaneously hypertensive rats; TGF- β, transforming growth  factor-β; α-SMA, α-smooth muscle actin; MCP-1, monocyte chemo- tactic protein; nAChR, nicotinic acetylcholine receptor; SHHF, spon-taneously hypertensive heart failure ; RVR, renal vascular resistance;  ADPKD, autosomal dominant polycystic kidney disease; p1rIMCD,  passage-1 rat renal inner medullary collecting duct cells; PAN, puromycin amino nucleoside; CrCl, creatinine clearance; ADH,  antidiuretic hormone.",Non-OADS,/arxiv_data1/oa_pdf/21/1c/kjpp-17-347.PMC3741492.pdf
"359Korean J Physiol Pharmacol Vol 17: 359 －365, August, 2013 http://dx.doi.org/ 10.4196/kjpp.2013.17.4.359 ABBREVIATIONS: TEA, tetraethylammonium; 4-AP, 4-aminopyri- dine; OXT, oxytocin; RMP, resting membrane potential; K Ca channel,  Ca2＋-activated K＋ channel; K V channel, voltage-activated K＋ chan- nel; K 2P channels, two-pore domain weak inwardly rectifying K＋ channel; TASK, two-pore domain weak inwardly rectifying K＋ channel (TWIK)-related acid-sensing K＋ channels; TREK, stretch-  dependent K 2P channels; KRB, Krebs-Ringer bicarbonate; MES,  2-N-morpholinoethanesulphonic acid; pH o, extracellular pH; TTX,  tetrodotoxin; ATR, atropine; NIOK, non ‐inactivating outward K＋ current; VDCCL, voltage-dependent L-type Ca2＋ channel.",Non-OADS,/arxiv_data1/oa_pdf/9d/58/kjpp-17-359.PMC3741493.pdf
"367Korean J Physiol Pharmacol Vol 17: 367 －373, August, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.4.367 ABBREVIATIONS: BL, bilateral labyrinthectomy; PE, phenyle- phrine; RVLM, rostral ventrolateral medulla; SAD, sinoaortic dener- vation; SNP, sodium nitroprusside.",Non-OADS,/arxiv_data1/oa_pdf/52/9a/kjpp-17-367.PMC3741494.pdf
Available from: http://www.mushroomexpert.com/ microscope_sections.html.,Non-OADS,/arxiv_data1/oa_pdf/57/18/mb-38-249.PMC3741517.pdf
Available from: http://www.mushroomexpert.com/lacrymaria_velutina.html.,Non-OADS,/arxiv_data1/oa_pdf/57/18/mb-38-249.PMC3741517.pdf
Available from: http://www.rogers-mushrooms.com.,Non-OADS,/arxiv_data1/oa_pdf/57/18/mb-38-249.PMC3741517.pdf
Available from: http://www.mycobank.org.,Non-OADS,/arxiv_data1/oa_pdf/38/e8/mb-38-321.PMC3741526.pdf
Available from: http://nt.ars-grin.gov/ fungaldatabases.,OADS,/arxiv_data1/oa_pdf/15/f6/mb-38-339.PMC3741531.pdf
"All synonyms were adopted from the Index Fungorum online database (http://www.index- fungorum.org/) and were revised by the authors, and themost significant were chosen.",Non-OADS,/arxiv_data1/oa_pdf/c7/5e/mb-38-159.PMC3741539.pdf
were used to perform a preliminary phylogenetic analysis; 16 ITS sequences were obtained from the GenBank database (http://www.ncbi.nlm.nih.gov/) (Table 2).,OADS,/arxiv_data1/oa_pdf/05/05/mb-38-166.PMC3741540.pdf
"Materials and Methods Three LFF, including Nephromopsis ornata  (041359, fastgrowing), Myelochroa irrugans  (040608, moderately growing), and Usnea longissima  (CH050154, slow grow- ing) were obtained from the Korean Lichen and AlliedBioresource Bank (http://www.lichen.re.kr).",OADS,/arxiv_data1/oa_pdf/0e/ed/mb-38-176.PMC3741542.pdf
grubii serotype A genome database (http://www.broad.mit.edu/annotation/ genome/cryptococcus_neoformans).,OADS,/arxiv_data1/oa_pdf/fc/85/mb-38-215.PMC3741550.pdf
"Species identification of each fungal isolate was conducted by sequencing of inter-nal transcribed spacer (ITS) regions, including the 5.8S rDNA region, and comparison of the obtained sequences with the GenBank database at the National Center for Biotechnol-ogy Information (NCBI; http://www.ncbi.nlm.nih.gov).",OADS,/arxiv_data1/oa_pdf/d6/df/mb-38-225.PMC3741553.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/ea/thnov03p0532.PMC3741603.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/48/1e/thnov03p0544.PMC3741604.pdf
[Internet]  http://en.wikipedia.org/wiki/Fluorescence.,Non-OADS,/arxiv_data1/oa_pdf/48/1e/thnov03p0544.PMC3741604.pdf
[Internet ] http://www.distrilabparticles.com/filters/pdf/Bul120'A'%   20FluorPoly.pdf.,Non-OADS,/arxiv_data1/oa_pdf/48/1e/thnov03p0544.PMC3741604.pdf
[Internet ] http://www.si gmaaldrich.com/life -science/biochemicals/  biochemicalproducts.html?TablePage=15933819   40.,Non-OADS,/arxiv_data1/oa_pdf/48/1e/thnov03p0544.PMC3741604.pdf
[Internet ] http://www.hybridsilica.com/c.spec -basics.html.,Non-OADS,/arxiv_data1/oa_pdf/48/1e/thnov03p0544.PMC3741604.pdf
[Internet] http://stemcells.nih.gov/info/basics/basics2.asp .,Non-OADS,/arxiv_data1/oa_pdf/48/1e/thnov03p0544.PMC3741604.pdf
[Internet] http://www.clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/48/1e/thnov03p0544.PMC3741604.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/36/33/thnov03p0561.PMC3741605.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/3e/thnov03p0573.PMC3741606.pdf
"More and  more stem cell therapies are being devised and en-tering trials: the public EU clinical trials database (https://www.clinicaltrialsregister.eu/index.html) lists over 400 studies currently in stages II -IV clinical  trials, and globally the number of studies runs into the thousands [3].",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/thnov03p0573.PMC3741606.pdf
The New York Blood Center markets Hemacord [6] for use  in hematopoietic stem cell replacement with the source of the stem cells being umbilical cord blood rather than bone marrow; several other institutions such as Clinimmune Labs at the University of Chicago also offer similar stem cell th erapies from this source   (http://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/   ucm305600.htm).,Non-OADS,/arxiv_data1/oa_pdf/bf/3e/thnov03p0573.PMC3741606.pdf
Email: weianz@uci.edu ; Webpage: http://faculty.sites.uci.edu/zhaolab/   © Ivyspring International Publisher.,Non-OADS,/arxiv_data1/oa_pdf/32/10/thnov03p0583.PMC3741607.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/32/10/thnov03p0583.PMC3741607.pdf
This is an open- access a rticle distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/5a/86/thnov03p0595.PMC3741608.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/4c/thnov03p0616.PMC3741609.pdf
"    Journal of Epidemiology and  Global Health    ISSN (Online): 2210 -6014  ISSN (Print): 2210 -6006   Journal Home Page:  https://www.atlantis -press.com/journals/jegh      Impact of the Family Health Program on gastroenteritis in children  in Bahia, Northeast Brazil: An analysis of primary care -sensitive  conditions   Laura J. Monahan, Gregory S. Calip, Patricia M. Novo, Mark Sherstinsky, Mildred  Casian o, Eduardo Mota, Inês Dourado   To cite this article : Laura J. Monahan, Gregory S. Calip, Patricia M. Novo, Mark  Sherstinsky, Mildred Casian o, Eduardo Mota, Inês Dourado  (2013 ) Impact of the Family  Health Program on gastroenteritis in children in Bahia, Northeast Brazil: An analysis of  primary care -sensitive conditions , Journal of Epidemiology and Global Health  3:3, 175– 185, DOI: https://doi.org/10.1016/j.jegh.2013.03.002  To link to this article : https://doi.org/ 10.1016/j.jegh.2013.03.002    Published online: 23  April 2019",Non-OADS,/arxiv_data1/oa_pdf/e0/27/JEGH-3-3-175.PMC3741617.pdf
http://dx.doi.org/10.1016/j.jegh.2013.03.002*Corresponding author.,OADS,/arxiv_data1/oa_pdf/e0/27/JEGH-3-3-175.PMC3741617.pdf
Available from: < http://dtr2004.sau- de.gov.br/dab/abnumeros.php> - numeros; 2007 [accessed 24.11.09.],OADS,/arxiv_data1/oa_pdf/e0/27/JEGH-3-3-175.PMC3741617.pdf
Available from: < http://www.ibge.- gov.br/home/estatistica/populacao/projecao_da_popula- cao/2008/default.shtm>; 2008 [accessed 10.11.10].,OADS,/arxiv_data1/oa_pdf/e0/27/JEGH-3-3-175.PMC3741617.pdf
Available from: < http://dtr2004.saude.gov.br/ dab>; 2006 [accessed 10.11.10].,OADS,/arxiv_data1/oa_pdf/e0/27/JEGH-3-3-175.PMC3741617.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2429 | DOI: 10.1038/srep02429 7",Non-OADS,/arxiv_data1/oa_pdf/80/d8/srep02429.PMC3741620.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/42/e6/srep02420.PMC3741621.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2420 | DOI: 10.1038/srep02420 6",Non-OADS,/arxiv_data1/oa_pdf/42/e6/srep02420.PMC3741621.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2424 | DOI: 10.1038/srep02424 5",Non-OADS,/arxiv_data1/oa_pdf/2f/11/srep02424.PMC3741622.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/70/a5/srep02430.PMC3741623.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2430 | DOI: 10.1038/srep02430 6",Non-OADS,/arxiv_data1/oa_pdf/70/a5/srep02430.PMC3741623.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d6/e2/srep02419.PMC3741625.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2419 | DOI: 10.1038/srep02419 7",Non-OADS,/arxiv_data1/oa_pdf/d6/e2/srep02419.PMC3741625.pdf
"29–31, 2008, available at: http://www.htspeerreview.com/2008/pdfs/ presentations/wednesday/2G/5_2g_ornl_superpower.pdf (Accessed on March06, 2009).",Non-OADS,/arxiv_data1/oa_pdf/8c/b3/srep02310.PMC3741626.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2310 | DOI: 10.1038/srep02310 9",Non-OADS,/arxiv_data1/oa_pdf/8c/b3/srep02310.PMC3741626.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/18/6b/srep02427.PMC3741627.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2427 | DOI: 10.1038/srep02427 6",Non-OADS,/arxiv_data1/oa_pdf/18/6b/srep02427.PMC3741627.pdf
All authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9a/15/srep02422.PMC3741628.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2422 | DOI: 10.1038/srep02422 8",Non-OADS,/arxiv_data1/oa_pdf/9a/15/srep02422.PMC3741628.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/srep02423.PMC3741629.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2423 | DOI: 10.1038/srep02423 7",Non-OADS,/arxiv_data1/oa_pdf/9a/8e/srep02423.PMC3741629.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/72/f2/srep02421.PMC3741630.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2421 | DOI: 10.1038/srep02421 13",Non-OADS,/arxiv_data1/oa_pdf/72/f2/srep02421.PMC3741630.pdf
"Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Vik, E. S. et al.",Non-OADS,/arxiv_data1/oa_pdf/0a/ed/ncomms3271.PMC3741635.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3271 ARTICLE NATURE COMMUNICATIONS | 4:2271 | DOI: 10.1038/ncomms3271 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/0a/ed/ncomms3271.PMC3741635.pdf
"Reprint and permissions information is available at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Barkauskaite, E. et al.",Non-OADS,/arxiv_data1/oa_pdf/09/5b/ncomms3164.PMC3741636.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3164 8 NATURE COMMUNICATIONS | 4:2164 | DOI: 10.1038/ncomms3164 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/09/5b/ncomms3164.PMC3741636.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Adami, C. & Hintze, A.",Non-OADS,/arxiv_data1/oa_pdf/f8/4f/ncomms3193.PMC3741637.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3193 ARTICLE NATURE COMMUNICATIONS | 4:2193 | DOI: 10.1038/ncomms3193 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f8/4f/ncomms3193.PMC3741637.pdf
"Methods Interaction data .Human, yeast, worm and A. thaliana PPI data sets were down- loaded from the Center for Cancer Systems Biology (CCSB) (http://ccsb.dfci.- harvard.edu): CCSB-YI1 (ref.",OADS,/arxiv_data1/oa_pdf/6a/b0/ncomms3241.PMC3741638.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/6a/b0/ncomms3241.PMC3741638.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Tran, N. H. et al.",Non-OADS,/arxiv_data1/oa_pdf/6a/b0/ncomms3241.PMC3741638.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3241 8 NATURE COMMUNICATIONS | 4:2241 | DOI: 10.1038/ncomms3241 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/6a/b0/ncomms3241.PMC3741638.pdf
"Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Liu, G.-Q.",Non-OADS,/arxiv_data1/oa_pdf/37/22/ncomms3254.PMC3741639.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3254 ARTICLE NATURE COMMUNICATIONS | 4:2254 | DOI: 10.1038/ncomms3254 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/37/22/ncomms3254.PMC3741639.pdf
"Among the palmcrops, the top three out of the ﬁve major domesticated palm species in the world are African oil palm ( Elaeis guineensis ), coconut ( Cocos nucifera ) and date palm ( Phoenix dactylifera )— the other two are peach palm ( Bactris gasipaes ) and betel palm (Areca catechu ) (FAO, http://www.fao.org).",Non-OADS,/arxiv_data1/oa_pdf/f7/f2/ncomms3274.PMC3741641.pdf
LEA gene identiﬁcation .We searched LEA domains (Pfam with Evaluer1e-5) against the predicted P. dactylifera gene models and other sequenced plant genes/ genomes using HMMER v3.0 and validated the candidate LEA genes using Blastp against plant LEA protein sequences of UniProt (http://www.uniprot.org/).,OADS,/arxiv_data1/oa_pdf/f7/f2/ncomms3274.PMC3741641.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/f7/f2/ncomms3274.PMC3741641.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Al-Mssallem, I. S. et al.",Non-OADS,/arxiv_data1/oa_pdf/f7/f2/ncomms3274.PMC3741641.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3274 ARTICLE NATURE COMMUNICATIONS | 4:2274 | DOI: 10.1038/ncomms3274 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f7/f2/ncomms3274.PMC3741641.pdf
"    Journal of Epidemiology and  Global Health    ISSN (Online): 2210 -6014  ISSN (Print): 2210 -6006   Journal Home Page:  https://www.atlantis -press.com/journals/jegh      Prevalence of modifiable cardiovascular ris k factors among tea  garden and general population in Dibrugarh, Assam, India   Tulika G. Mahanta, Rajnish Joshi, Bhupendra N. Mahanta, Denis Xavier   To cite this article : Tulika G. Mahanta, Rajnish Joshi, Bhupendra N. Mahanta, Denis  Xavier  (2013 ) Prevalence of modifiable cardiovascular ris k factors among tea garden and  general population in Dibrugarh, Assam, India , Journal of Epidemiology and Global  Health 3:3, 147– 156, DOI: https://doi.org/10.1016/j.jegh.2013.04.001  To link to this article : https://doi.org/10.1016/j.jegh.2013.04.001    Published online: 23  April 2019",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/JEGH-3-3-147.PMC3741672.pdf
http://dx.doi.org/10.1016/j.jegh.2013.04.001*Corresponding author.,OADS,/arxiv_data1/oa_pdf/dd/b9/JEGH-3-3-147.PMC3741672.pdf
[20] < http://www.nhlbi.nih.gov/new/press/17-1998.htm >.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/JEGH-3-3-147.PMC3741672.pdf
"Associ- ation of high C-reactive protein with established cardio- vascular risk factors in the Indian population; Nutr Metabol, 2011; < http://www.nutritionandmetabolism.com >.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/JEGH-3-3-147.PMC3741672.pdf
"2915–2927, 2013 doi:10.1093/jxb/ert133  Advance Access publication 16 May, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.© The Author(2) [2013].Resea Rch pape R A wheat PI4K gene whose product possesses threonine  autophophorylation activity confers tolerance to drought and  salt in Arabidopsis Pei Liu, Zhao-Shi Xu *,  Pan-Pan Lu, Di Hu, Ming Chen, Lian-Cheng Li and You-Zhi Ma * Institute of Crop Science, Chinese Academy of Agricultural Sciences (CAAS)/National Key Facility for Crop Gene Resources and Genetic  Improvement, Key Laboratory of Biology and Genetic Improvement of Triticeae Crops, Ministry of Agriculture, Beijing 100081, China * To whom correspondence should be addressed.",Non-OADS,/arxiv_data1/oa_pdf/e0/b0/ert133.PMC3741686.pdf
The amino acid sequences of TaPI4KII γ homologous proteins  were obtained from the NCBI using Blastp ( http://blast.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/e0/b0/ert133.PMC3741686.pdf
"2805–2815, 2013 doi:10.1093/jxb/ert131  Advance Access publication 13 May, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.© The Author(2) [2013].Resea Rch pape R Enhanced drought and heat stress tolerance of tobacco  plants with ectopically enhanced cytokinin oxidase/ dehydrogenase gene expression Hana Macková1, Marie Hronková2, Jana Dobrá1, Veronika Ture čková3, Ond řej Novák3, Zuzana Lubovská1,  Václav Motyka1, Daniel Haisel1, Tomáš Hájek4, Ilja Tom Prášil5, Alena Gaudinová1, Helena Štorchová1, Eva Ge1,  Tomáš Werner6, Thomas Schmülling6 and Radomíra Vanková1,* 1 Institute of Experimental Botany AS CR, Rozvojová 263, 16502 Prague 6, Czech Republic 2 Institute of Plant Molecular Biology, Biology Centre AS CR, Branišovská 31/1160, 37005 České Bud ějovice, Czech Republic 3 Laboratory of Growth Regulators, Faculty of Science, Palacký University and Institute of Experimental Botany AS CR, Šlechtitel ů 11,  78371 Olomouc, Czech Republic 4 Institute of Botany AS CR, Dukelska 135, 37982 T řebon, Czech Republic 5 Crop Research Institute, Drnovská 507/73, 16106 Prague 6, Czech Republic 6 Freie Universität Berlin, Dahlem Centre of Plant Sciences/Applied Genetics, Albrecht-Thaer-Weg 6, D-14195 Berlin, Germany *To whom correspondence should be addressed.",Non-OADS,/arxiv_data1/oa_pdf/65/e2/ert131.PMC3741687.pdf
"3045–3060, 2013 doi:10.1093/jxb/ert149  Advance Access publication 6 June, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.© The Author(2) [2013].Resea Rch pape R Roles of NIA/NR/NOA1-dependent nitric oxide production  and HY1 expression in the modulation of Arabidopsis  salt  tolerance Yanjie Xie1,*, Yu Mao1,*, Diwen Lai1, Wei Zhang1, Tianqing Zheng2 and Wenbiao Shen1,† 1  College of Life Sciences, Co.",Non-OADS,/arxiv_data1/oa_pdf/71/83/ert149.PMC3741688.pdf
"2859–2869, 2013 doi:10.1093/jxb/ert129  Advance Access publication 13 May, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.© The Author(2) [2013].Resea Rch pape R Is floret primordia death triggered by floret development in  durum wheat?",Non-OADS,/arxiv_data1/oa_pdf/5f/61/ert129.PMC3741689.pdf
"2997–3008, 2013 doi:10.1093/jxb/ert144  Advance Access publication 22 May, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.© The Author(2) [2013].Resea Rch pape R Graft union formation in grapevine induces transcriptional  changes related to cell wall modification, wounding,  hormone signalling, and secondary metabolism Sarah Jane Cookson1,*, Maria José  Clemente Moreno1, Cyril Hevin1, Larissa Zita Nyamba Mendome1,  Serge Delrot2, Claudine Trossat-Magnin2 and Nathalie Ollat1 1  INRA, ISVV, EGFV, UMR 1287, F-33140 Villenave d’Ornon, France 2  Université de Bordeaux, ISVV, EGFV, UMR 1287, F-33140 Villenave d’Ornon, France *To whom correspondence should be addressed.",Non-OADS,/arxiv_data1/oa_pdf/cf/ea/ert144.PMC3741690.pdf
", 2007 ) using the grapevine V1 gene model pre - diction from Centro Ricerche Interdipartimentale Biotecnologie  Innovative, Italy ( http://genomes.cribi.unipd.it/ ).",Non-OADS,/arxiv_data1/oa_pdf/cf/ea/ert144.PMC3741690.pdf
The probe design  is available online at the following address: http://ddlab.sci.univr.it/ FunctionalGenomics/ .,OADS,/arxiv_data1/oa_pdf/cf/ea/ert144.PMC3741690.pdf
"The microarray data were analysed using the statistical package  R, version 2.14.0 (R Development Core Team, 2005) with various  Bioconductor packages ( http://www.bioconductor.org , Gentleman  et al.",OADS,/arxiv_data1/oa_pdf/cf/ea/ert144.PMC3741690.pdf
The raw and normalized microarray data are  available on http://www.ebi.ac.uk/arrayexpress ; the accession num - ber is E-MEXP-3803.,OADS,/arxiv_data1/oa_pdf/cf/ea/ert144.PMC3741690.pdf
Enrichments of functional cat - egories of the MapMan annotation in the significantly differentially  expressed genes were tested for significance by applying Fisher tests  with a Bonferroni correction for multiple tests using Mefisto Version  0.23beta ( http://www.usadellab.org ).,OADS,/arxiv_data1/oa_pdf/cf/ea/ert144.PMC3741690.pdf
"Enrichment of Gene Ontology  (GO) terms in significantly differentially expressed genes was evalu - ated using analysis tool from AgriGO ( http://bioinfo.cau.edu.cn/ agriGO/ , Du et al.",OADS,/arxiv_data1/oa_pdf/cf/ea/ert144.PMC3741690.pdf
"2899–2914, 2013 doi:10.1093/jxb/ert143  Advance Access publication 22 May, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.© The Author(2) [2013].Abbreviations: RING, really interesting new gene; ABA, abscisic acid; BiFC, bimolecular fluorescence complementation; PEG, polyethylene glycol; DDO/X/A,  synthetic defined medium lacking Leu and Trp supplemented with 40  μg ml–1 X-α-Gal and 70  ng ml–1 aureobasidin A (AbA); QDO/X/A, SD medium lacking Ade, His,  Leu, and Trp with 40  μg ml–1 X-α-Gal and 70  ng ml–1 AbA.Resea Rch pape R The rice RING finger E3 ligase, OsHCI1, drives nuclear  export of multiple substrate proteins and its heterogeneous  overexpression enhances acquired thermotolerance Sung Don Lim, Hyun Yong Cho, Yong Chan Park, Deok Jae Ham, Ju Kyong Lee and Cheol Seong Jang * Department of Applied Plant Sciences, Kangwon National University, Chuncheon 200–713, Korea * To whom correspondence should be addressed.",Non-OADS,/arxiv_data1/oa_pdf/68/6b/ert143.PMC3741691.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/0d/e0/JCN-1-184.PMC3742017.pdf
"Commun Integr Biol 2013; 6: e24474; http://dx.doi.org/10.4161/cib.24474*Correspondence to: Aparna Lakkaraju;   Email: lakkaraju@wisc.eduIn non-polarized cells, calcium- induced exocytosis of “conventional”  lysosomes is important in diverse pro - cesses like membrane repair after exposure to pore-forming toxins and clearance of cellular debris.",Non-OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Nat Immunol 2009;  10:899-906; PMID:19561612; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Mol Genet Metab  2006; 89:339-48; PMID:16914343; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Biochem Biophys Res Commun 2005; 327:663- 7; PMID:15649398; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
J Biol Chem 2004; 279:20471-9; PMID:14993220; http://dx.doi.org/10.1074/jbc.M400798200 16.,OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Mol Biol Cell 2011; 22:2068-82; PMID:21525240; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Cell  1988; 55:157-65; PMID:3139302; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
EMBO J  2002; 21:1289-300; PMID:11889035; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
EMBO  J 2010; 29:3607-20; PMID:20871593; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Cell Host Microbe 2011; 9:147- 57; PMID:21320697; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Am J Physiol  Renal Physiol 2011; 301:F622-33; PMID:21677144;  http://dx.doi.org/10.1152/ajprenal.00134.2011 25.,Non-OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
J Clin Invest 1989; 83:30-9; PMID:2910913; http://dx.doi.org/10.1172/ JCI113873Disclosure of Potential Conflicts of Interest No potential conflicts of interest were  disclosed.,OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Nat Cell  Biol 2005; 7:847-9; PMID:16136179; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Nat Rev Mol Cell Biol 2009; 10:623- 35; PMID:19672277; http://dx.doi.org/10.1038/ nrm2745 3.,Non-OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Nat Rev Mol Cell Biol 2007; 8:622- 32; PMID:17637737; http://dx.doi.org/10.1038/ nrm2217 4.,OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Proc Natl Acad Sci USA  2004; 101:9745-50; PMID:15192144; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Science 2004; 305:55-9; PMID:15232098; http://dx.doi.org/10.1126/science.1095291 8.,OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
J Cell Biol 2002; 159:625-35; PMID:12438417;  http://dx.doi.org/10.1083/jcb.200208154 9.,OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
J Cell Biol 1997; 137:93-104; PMID:9105039; http://dx.doi.org/10.1083/jcb.137.1.93 10.,OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
J Cell Biol 1996; 134:349- 62; PMID:8707821; http://dx.doi.org/10.1083/ jcb.134.2.349 11.,Non-OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Nat  Rev Microbiol 2005; 3:819-23; PMID:16175174;  http://dx.doi.org/10.1038/nrmicro1249protein in spatially restricting lysosome  fusion with the basolateral membrane.,OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Diabetes 2011; 60:3034-43; PMID:21940783; http://dx.doi.org/10.2337/db11- 0851 33.,Non-OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Mol Biol Cell 2009; 20:4932-40; PMID:19812252; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Ophthalmic Res 2006; 38:83-8; PMID:16352920; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Eye (Lond) 2011; 25:1074-82;  PMID:21597483; http://dx.doi.org/10.1038/ eye.2011.10926.,Non-OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Kidney Int 2010; 78:382- 8; PMID:20531453; http://dx.doi.org/10.1038/ ki.2010.166 27.,Non-OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Proc Natl Acad Sci USA 2007; 104:11026- 31; PMID:17578916; http://dx.doi.org/10.1073/ pnas.0702504104 28.,OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
J Clin Invest 2010; 120:3033- 41; PMID:20811159; http://dx.doi.org/10.1172/ JCI42437 29.,Non-OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
Ophthalmic Res 1985; 17:148-53; PMID:4011128; http://dx.doi.org/10.1159/000265366,Non-OADS,/arxiv_data1/oa_pdf/cf/d1/cib-6-e24474.PMC3742055.pdf
"Dev Cell 2012; 23:1189–202; pm ID:23201120;  http://dx.doi.org/10.1016/j.devcel.2012.10.027Keywords:  resting microglia, neuronal  activity, microglia-neuron contact,   pannexin-1 hemichannel, optic tectum, glutamate uncaging, in vivo two-photon imaging, calcium imaging, in vivo whole-cell recording, zebrafish Submitted: 03/14/13Revised: 03/28/13Accepted: 03/28/13 Citation: Li Y, Du X-F, Du J-L.",OADS,/arxiv_data1/oa_pdf/29/cb/cib-6-e24493.PMC3742056.pdf
Commun Integr Biol 2013; 6: e24493;  http://dx.doi.org/10.4161/cib.24493*Correspondence to: Jiu-lin Du;  Email: forestdu@ion.ac.cnMicroglia are the primary immune  cells in the brain.,Non-OADS,/arxiv_data1/oa_pdf/29/cb/cib-6-e24493.PMC3742056.pdf
Cell 2011; 145:1012-22; PMID:21703446; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/29/cb/cib-6-e24493.PMC3742056.pdf
Nature 2002; 420:414-8; PMID:12459783; http://dx.doi.org/10.1038/nature012427.,OADS,/arxiv_data1/oa_pdf/29/cb/cib-6-e24493.PMC3742056.pdf
J  Neurophysiol 2008; 99:2026-32; PMID:18256162;  http://dx.doi.org/10.1152/jn.01210.2007 8.,Non-OADS,/arxiv_data1/oa_pdf/29/cb/cib-6-e24493.PMC3742056.pdf
Mol Pain 2010; 6:19;  PMID:20380706; http://dx.doi.org/10.1186/1744- 8069-6-19 9.,Non-OADS,/arxiv_data1/oa_pdf/29/cb/cib-6-e24493.PMC3742056.pdf
Eur J Neurosci 2009; 29:1108-18; PMID:19302147;  http://dx.doi.org/10.1111/j.1460-9568.2009.06659.x 10.,Non-OADS,/arxiv_data1/oa_pdf/29/cb/cib-6-e24493.PMC3742056.pdf
Trends Neurosci  2010; 33:93-102; PMID:20022389; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/29/cb/cib-6-e24493.PMC3742056.pdf
Eur J Neurosci 2005; 21:3277-90; PMID:16026466; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/29/cb/cib-6-e24493.PMC3742056.pdf
Brain Res Mol Brain Res 2005; 141:113- 20; PMID:16143426; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/29/cb/cib-6-e24493.PMC3742056.pdf
Am J Respir Cell Mol Biol  2009; 41:525-34; PMID:19213873; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/29/cb/cib-6-e24493.PMC3742056.pdf
Nat Neurosci  2005; 8:752-8; PMID:15895084; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/29/cb/cib-6-e24493.PMC3742056.pdf
Science 2005; 308:1314- 8; PMID:15831717; http://dx.doi.org/10.1126/sci - ence.1110647 3.,OADS,/arxiv_data1/oa_pdf/29/cb/cib-6-e24493.PMC3742056.pdf
Dev Cell 2012; 23:1189- 202; PMID:23201120; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/29/cb/cib-6-e24493.PMC3742056.pdf
PLoS Biol 2010; 8:e1000527;  PMID:21072242; http://dx.doi.org/10.1371/jour - nal.pbio.1000527 5.,Non-OADS,/arxiv_data1/oa_pdf/29/cb/cib-6-e24493.PMC3742056.pdf
J Neurosci 2009; 29:3974-80; PMID:19339593; http://dx.doi.org/10.1523/ JNEUROSCI.4363-08.2009 6.,Non-OADS,/arxiv_data1/oa_pdf/29/cb/cib-6-e24493.PMC3742056.pdf
Neuron 2009; 61:247-58; PMID:19186167;  http://dx.doi.org/10.1016/j.neuron.2008.10.054,OADS,/arxiv_data1/oa_pdf/29/cb/cib-6-e24493.PMC3742056.pdf
Commun Integr Biol 2013; 6: e24560; http://dx.doi.org/10.4161/cib.24560Photosymbiosis is common and widely distributed in plankton  and is considered to be beneficial for both partners (mutualism).,OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
Am J Bot 2004; 91:1481- 93; PMID:21652304; http://dx.doi.org/10.3732/ ajb.91.10.1481 2.,Non-OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
Aquat  Microb Ecol 2009; 57:279-310; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
Plant Cell Environ 2008; 31:679-94;  PMID:18315536; http://dx.doi.org/10.1111/j.1365- 3040.2008.01802.x 6.,OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
J Phycol 2001; 37:866-80; http://dx.doi.org/10.1046/j.1529-8817.2001.01031.x 7.,Non-OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
Science 2006; 312:857- 8; PMID:16690848; http://dx.doi.org/10.1126/sci-ence.1123701 8.,OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
Hydrobiologia 2001; 461:1-7; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
Mar Ecol Prog Ser 2006; 325:59-71; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
J Plankton  Res 1995; 17:131-63; http://dx.doi.org/10.1093/ plankt/17.1.131 11.,Non-OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
Proc Natl Acad Sci USA  2012; 109:18000-5; PMID:23071304; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
Symbiosis 2012;  58:233-44; http://dx.doi.org/10.1007/s13199-012- 0195-x 15.,Non-OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
Proc Natl Acad Sci USA 2009; 106:12803- 8; PMID:19622724; http://dx.doi.org/10.1073/ pnas.0905841106 16.,OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
Aquat Microb Ecol 2007; 50:75-89; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
Nat Rev Microbiol  2004; 2:632-42; PMID:15263898; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
J Sea  Res 2005; 53:43-66; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
J Phycol 2006; 42:243-50; http://dx.doi.org/10.1111/j.1529- 8817.2006.00185.x 23.,Non-OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
Symbiosis 2012; In  press; http://dx.doi.org/10.1007/s13199-012-0174-224.,Non-OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
T rends Ecol  Evol 2011; 26:202-9; PMID:21371775; http://dx.doi.org/10.1016/j.tree.2011.01.010 25.,OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
T rends Ecol  Evol 2000; 15:321-6; PMID:10884696; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
T rends Ecol Evol  1999; 14:49-53; PMID:10234251; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
Q Rev Biol 2004; 79:135-60;  PMID:15232949; http://dx.doi.org/10.1086/383541 30.,Non-OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
J Phycol 2005; 41:880-6; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
T rends Ecol Evol 1989; 4:350-2; PMID:21227377;  http://dx.doi.org/10.1016/0169-5347(89)90090-6 34.,OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
Bioessays  2010; 32:615-25; PMID:20517874; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
Am J Bot 2009; 96:1409- 18; PMID:21628288; http://dx.doi.org/10.3732/ajb.0800258,Non-OADS,/arxiv_data1/oa_pdf/3a/88/cib-6-e24560.PMC3742057.pdf
"PLoS ONE 2013; 8:e55938; PMID:23418480; http://dx.doi.org/10.1371/journal.pone.0055938Keywords:  mimicry, visual signals, adap - tive coloration, conspicuousness, camou - flage, anti-predator strategies, eyespots,  fish, deceptive behaviors, reliability Submitted: 04/02/13Accepted: 04/02/13 Citation: Depczynski M, Gagliano M. Natural-born  con artists and counterfeiters: Who is being de - ceived here?",Non-OADS,/arxiv_data1/oa_pdf/63/b9/cib-6-e24586.PMC3742058.pdf
Commun Integr Biol 2013; 6: e24586; http://dx.doi.org/10.4161/cib.24586*Correspondence to: Martial Depczynski;   Email: m.depczynski@aims.gov.auDeception is ubiquitous in plant and  animal kingdoms and is widely  thought to provide selective advantages to the individual and evolutionary suc - cess to the species.,Non-OADS,/arxiv_data1/oa_pdf/63/b9/cib-6-e24586.PMC3742058.pdf
Discourse Process 2012; 49:79-106; http://dx.doi.org/10.1080/0163853X.2011.633331 2.,Non-OADS,/arxiv_data1/oa_pdf/63/b9/cib-6-e24586.PMC3742058.pdf
Neuroscientist 2011; 17:560-74; PMID:21454323; http://dx.doi.org/10.1177/10738584103933593.,Non-OADS,/arxiv_data1/oa_pdf/63/b9/cib-6-e24586.PMC3742058.pdf
Proc R Soc Lond B Biol Sci 1979; 205:489-511; PMID:42057; http://dx.doi.org/10.1098/rspb.1979.0081 5.,Non-OADS,/arxiv_data1/oa_pdf/63/b9/cib-6-e24586.PMC3742058.pdf
Behav Processes 1986; 13:159-76; http://dx.doi.org/10.1016/0376-6357(86)90023-9 6.,OADS,/arxiv_data1/oa_pdf/63/b9/cib-6-e24586.PMC3742058.pdf
Biol Rev Camb Philos Soc 2005; 80:573-88; PMID:16221330; http://dx.doi.org/10.1017/S1464793105006810 7.,Non-OADS,/arxiv_data1/oa_pdf/63/b9/cib-6-e24586.PMC3742058.pdf
Behav Ecol 2011; 22:1264-71; http://dx.doi.org/10.1093/beheco/arr123 8.,Non-OADS,/arxiv_data1/oa_pdf/63/b9/cib-6-e24586.PMC3742058.pdf
Entomol Exp Appl 2012; 143:231-44; http://dx.doi.org/10.1111/j.1570-7458.2012.01260.x9.,OADS,/arxiv_data1/oa_pdf/63/b9/cib-6-e24586.PMC3742058.pdf
Environ Biol Fishes 1989; 25:143-57; http://dx.doi.org/10.1007/BF00002208 11.,Non-OADS,/arxiv_data1/oa_pdf/63/b9/cib-6-e24586.PMC3742058.pdf
Copeia 1993; 235-40; http://dx.doi.org/10.2307/1446319 12.,Non-OADS,/arxiv_data1/oa_pdf/63/b9/cib-6-e24586.PMC3742058.pdf
Behav Ecol 2008; 19:733-9; http://dx.doi.org/10.1093/beheco/arn013 13.,Non-OADS,/arxiv_data1/oa_pdf/63/b9/cib-6-e24586.PMC3742058.pdf
PLoS ONE 2013; 8:e55938; PMID:23418480; http://dx.doi.org/10.1371/journal.pone.0055938 14.,Non-OADS,/arxiv_data1/oa_pdf/63/b9/cib-6-e24586.PMC3742058.pdf
PLoS ONE  2013; 8:e55602; PMID:23405176; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
"Commun Integr Biol 2013; 6: e24787;    http://dx.doi.org/10.4161/cib.24787 *Correspondence to: Daniel J. Ballhorn;   Email: ballhorn@pdx.eduOlfactometer experiments, in which  arthropods are given the choice  between two or more odor sources to  test behavioral preferences, are com - monly used in chemical ecology research.",Non-OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
J Chem Ecol 2013; 39:413- 7; PMID:23417653; http://dx.doi.org/10.1007/ s10886-013-0255-6 21.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
J Chem Ecol 2007; 33:2195-208;  PMID:17987336; http://dx.doi.org/10.1007/ s10886-007-9380-4 22.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
Entomol Exp Appl 2010; 134:245-59;  http://dx.doi.org/10.1111/j.1570-7458.2009.00961.x 23.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
Plant  Soil 2011; 341:209-19; http://dx.doi.org/10.1007/ s11104-010-0635-4 24.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
J  Chem Ecol 2008; 34:1298-301; PMID:18758862;  http://dx.doi.org/10.1007/s10886-008-9540-1 25.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
PLoS ONE  2009; 4:e5450; PMID:19424497; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
J Chem Ecol 1988; 14:2213-7; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
Proc Biol Sci 2011; 278:718-24;  PMID:20843847; http://dx.doi.org/10.1098/ rspb.2010.1593 28.,OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
Trends Plant Sci 2010; 15:167-75;  PMID:20047849; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
Oecologia 2000; 125:504-11;  http://dx.doi.org/10.1007/s004420000482 12.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
Chem Senses 2003; 28:231-6; PMID:12714445;  http://dx.doi.org/10.1093/chemse/28.3.231 13.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
Ecol Entomol  2011; 36:117-24; http://dx.doi.org/10.1111/j.1365- 2311.2010.01248.x 14.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
Theor Popul Biol 1978; 14:350- 6; PMID:751265; http://dx.doi.org/10.1016/0040- 5809(78)90012-6 15.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
Ecol Entomol 2006; 31:395-401; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
Chemoecology 2002;  12:23-8; http://dx.doi.org/10.1007/s00049-002- 8323-3 17.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
J Ecol  2011; 99:313-26; http://dx.doi.org/10.1111/j.1365- 2745.2010.01747.x 18.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
J Chem Ecol 2005; 31:1445- 73; PMID:16222786; http://dx.doi.org/10.1007/ s10886-005-5791-2 19.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
Trends Plant Sci  2005; 10:269-74; PMID:15949760; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
J Chem Ecol  2004; 30:1289-95; PMID:15303330; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
Can J Zool-Rev Can Zool  2010; 88:628-67; http://dx.doi.org/10.1139/Z10- 032 6.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
Plant Cell Environ  2009; 32:542-52; PMID:19183286; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
PLoS ONE 2013; 8:e55602; PMID:23405176;  http://dx.doi.org/10.1371/journal.pone.0055602 9.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
Anim Behav  2005; 69:869-79; http://dx.doi.org/10.1016/j.anbe - hav.2004.07.010,OADS,/arxiv_data1/oa_pdf/4d/7d/cib-6-e24787.PMC3742059.pdf
"Proc Natl Acad Sci USA 2013; 110:E1524–32;  PMID:23576737; http://dx.doi.org/10.1073/ pnas.1220179110.Keywords:  neural progenitors, networks,  calcium signaling, stem cells, gap junc - tions Submitted: 04/19/13 Accepted: 04/23/13 Citation: Malmersjö S, Rebellato P , Smedler E, Uhlén  P. Small-world networks of spontaneous Ca2+ activ - ity; Commun Integr Biol; 6: e24788;   http://dx.doi.org/10.4161/cib.24788 *Correspondence to: Per Uhlén;   Email: per.uhlen@ki.seSynchronized network activity among  groups of interconnected cells is  essential for diverse functions in the  brain.",OADS,/arxiv_data1/oa_pdf/5b/8f/cib-6-e24788.PMC3742060.pdf
Nat Rev Mol Cell Biol 2003; 4:517-29;  PMID:12838335; http://dx.doi.org/10.1038/ nrm1155 2.,OADS,/arxiv_data1/oa_pdf/5b/8f/cib-6-e24788.PMC3742060.pdf
Neuron 2004; 43:647-61;  PMID:15339647; http://dx.doi.org/10.1016/j.neu - ron.2004.08.015 3.,OADS,/arxiv_data1/oa_pdf/5b/8f/cib-6-e24788.PMC3742060.pdf
J Neurosci 2010; 30:4197-209;  PMID:20335455; http://dx.doi.org/10.1523/ JNEUROSCI.4187-09.2010 4.,Non-OADS,/arxiv_data1/oa_pdf/5b/8f/cib-6-e24788.PMC3742060.pdf
Nat Rev Neurosci 2010; 11:18- 29; PMID:19953103; http://dx.doi.org/10.1038/ nrn2759 5.,Non-OADS,/arxiv_data1/oa_pdf/5b/8f/cib-6-e24788.PMC3742060.pdf
Nature 2006; 444:707-12; PMID:17151658;  http://dx.doi.org/10.1038/nature05300 6.,Non-OADS,/arxiv_data1/oa_pdf/5b/8f/cib-6-e24788.PMC3742060.pdf
Proc Natl Acad Sci USA 2013; 110:E1524- 32; PMID:23576737; http://dx.doi.org/10.1073/ pnas.1220179110 9.,OADS,/arxiv_data1/oa_pdf/5b/8f/cib-6-e24788.PMC3742060.pdf
Physiol Rev  2012; 92:1359-92; PMID:22811430; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/8f/cib-6-e24788.PMC3742060.pdf
Stem Cells 2006;  24:1654-67; PMID:16574755; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/8f/cib-6-e24788.PMC3742060.pdf
Stem Cells Dev 2010; 19:1355-64;  PMID:20043754; http://dx.doi.org/10.1089/ scd.2009.0436 12.,Non-OADS,/arxiv_data1/oa_pdf/5b/8f/cib-6-e24788.PMC3742060.pdf
Proc Natl Acad Sci USA 2005; 102:7794- 9; PMID:15911778; http://dx.doi.org/10.1073/ pnas.0407994102 13.,OADS,/arxiv_data1/oa_pdf/5b/8f/cib-6-e24788.PMC3742060.pdf
"Nature 2011; 473:167-73;  PMID:21562557; http://dx.doi.org/10.1038/ nature10011scale-free small-world network has a good  tolerance for random deletion of nodes,  but low tolerance for a directed attack to a  hub.",Non-OADS,/arxiv_data1/oa_pdf/5b/8f/cib-6-e24788.PMC3742060.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/00/8b/hiv-5-163.PMC3742296.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpHIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/00/8b/hiv-5-163.PMC3742296.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/00/8b/hiv-5-163.PMC3742296.pdf
DOI: http://dx.doi.org/10.1177/101053951244149 1.,Non-OADS,/arxiv_data1/oa_pdf/00/8b/hiv-5-163.PMC3742296.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8d/a9/ceg-6-139.PMC3742342.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical and Experimental Gastroenterology 2013:6 139–148Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  139OriG inal rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S4568 5Platelet aggregation measurement for assessment  of hemostasis failure mechanisms in patients   with gastroduodenal ulcer bleeding Edward Barinov1 Oksana sulaieva1 Yuriy lyakch2 Vitaliy Guryanov2 Petr Kondratenko3 Yevgeniy radenko3 1Department of histology, Cytology,  and Embryology, 2Department of  Medical, Biological Physics, Medical  informatics, and Biostatistics,  3Department of surgery and  Endoscopy, M Gorky Donetsk  national Medical University,   Donetsk, Ukraine Correspondence: Oksana sulaieva   Department of histology, Cytology,   and Embryology, M Gorky Donetsk  national Medical University,   illicha ave 16, Donetsk, Ukraine 83003   Tel +38 09 9380 9417   Email oksana.sulaeva@dsmu.edu.u aBackground:  The purpose of this study was to identify factors associated with the risk of  unsustainable hemostasis in patients with gastric and duodenal ulcer bleeding by in vitro assess - ment of platelet reactivity using artificial neural networks.",Non-OADS,/arxiv_data1/oa_pdf/8d/a9/ceg-6-139.PMC3742342.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/8d/a9/ceg-6-139.PMC3742342.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/a9/ceg-6-139.PMC3742342.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9a/5e/ijgm-6-657.PMC3742343.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2013:6 657–664International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  657RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S4588 0Potential role of gabapentin and extended-   release gabapentin in the management   of menopausal hot flashes Manisha Yadav Judith volkar Center for Specialized women’s  Health, Cleveland Clinic Foundation,   Cleveland, Ohio, USA Correspondence: Manisha Yadav   Palo Alto Medical Foundation,   2734 el Camino Real, Santa Clara,   CA-95051, USA   Tel +1 408 431 4708   Fax +1 408 524 5733   email yadav.manisha@gmail.co mAbstract:  About 80% of postmenopausal women experience vasomotor symptoms, such as  hot flashes and night sweats – symptoms that are associated with sleep disruption and can lead  to fatigue and mood changes.",Non-OADS,/arxiv_data1/oa_pdf/9a/5e/ijgm-6-657.PMC3742343.pdf
"Available from:  http://journals.lww.com/menopausejournal/Citation/2010/17060/21st_ Annual_Meeting_of_The_North_American.26.asp x. Accessed  January 5, 2012.",Non-OADS,/arxiv_data1/oa_pdf/9a/5e/ijgm-6-657.PMC3742343.pdf
"Baron M, Utian W , Portman D, Koltun W , Cowles V , Sathyanarayana R,  Sweeney M. Available at http://phx.corporate-ir.net/External.File?ite m=  UGFyZW50SUQ9NjU5MDB8Q2hpbGRJRD0tMXxUeXBlPTM =&  t=1.",Non-OADS,/arxiv_data1/oa_pdf/9a/5e/ijgm-6-657.PMC3742343.pdf
Available from: http://www.internalmedicinenews.com/ single-view/gabapentin-extended-release-effective-for-moderate-to- severe-hot-flashes-in-postmenopausal-women/c7a8f2d553.html?tx_ ttnews[sViewPointe r]=1.,Non-OADS,/arxiv_data1/oa_pdf/9a/5e/ijgm-6-657.PMC3742343.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT0077702 3.,Non-OADS,/arxiv_data1/oa_pdf/9a/5e/ijgm-6-657.PMC3742343.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT00755417.,Non-OADS,/arxiv_data1/oa_pdf/9a/5e/ijgm-6-657.PMC3742343.pdf
Available from  http://investor.depomedinc.com/phoenix.zhtml?,Non-OADS,/arxiv_data1/oa_pdf/9a/5e/ijgm-6-657.PMC3742343.pdf
"Available from:  http://www.prnewswire.com/news-releases/breeze-3-data-for-serada- presented-at-2012-north-american-menopause-society-annual-meet - ing-172446971.html#13600742071654&req =rpuCloseM e. Accessed  February 20, 2013.",Non-OADS,/arxiv_data1/oa_pdf/9a/5e/ijgm-6-657.PMC3742343.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/9a/5e/ijgm-6-657.PMC3742343.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/5e/ijgm-6-657.PMC3742343.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/92/1e/ndt-9-1077.PMC3742344.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1077–1086Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1077Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S4986 8intermittent hypoxia from obstructive sleep   apnea may cause neuronal impairment   and dysfunction in central nervous system:   the potential roles played by microglia Qingchan Yang1,* Yan wang2,* Jing Feng2 Jie Cao2 Baoyuan Chen2 1Graduate School of Tianjin Medical  University, 2Respiratory Department,  Tianjin Medical University General  Hospital, Tianjin, People’s Republic   of China *These authors contributed equally   to this work Correspondence: Jing Feng   Respiratory Department, Tianjin   Medical University General   Hospital, 154 Anshan Road,   Heping, Tianjin 300052,   People’s Republic of China   Tel +86 139 2050 0251   Fax +86 22 6036 1632   email zyyhxkfj@126.co mAbstract:  Obstructive sleep apnea (OSA) is a common condition characterized by repetitive  episodes of complete (apnea) or partial (hypopnea) obstruction of the upper airway during  sleep, resulting in oxygen desaturation and arousal from sleep.",Non-OADS,/arxiv_data1/oa_pdf/92/1e/ndt-9-1077.PMC3742344.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/92/1e/ndt-9-1077.PMC3742344.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/92/1e/ndt-9-1077.PMC3742344.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/49/a3/ndt-9-1113.PMC3742345.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1113–1120Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1113OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4757 1T obacco smoking in treatment-resistant  schizophrenia patients is associated   with impaired cognitive functioning, more severe  negative symptoms, and poorer social adjustment Felice iasevoli raffaele Balletta Valentina gilardi sara giordano andrea de Bartolomeis Unit on Treatment resistance  in Psychiatry and laboratory of  Molecular and Translational Psychiatry,   section of Psychiatry, Department of  Neuroscience, reproductive sciences  and Odontostomatology, University  school of Medicine ‘Federico ii’,   Naples, italy correspondence: andrea de Bartolomeis   chief Outpatient Unit on Treatment   resistance in Psychiatry and   laboratory of Molecular Psychiatry   and Psychopharmacotherapy, section   of Psychiatry, Department   of Neuroscience, reproductive sciences  and Odontostomatology, University  school of Medicine ‘Federico ii’,   Edificio 18, Via Pansini 5,   80131 Naples, Italy   Tel +39 081 746 3673   Fax +39 081 746 2378   email adebarto@unina.itAbstract:  Tobacco smoking is common in schizophrenia patients.",Non-OADS,/arxiv_data1/oa_pdf/49/a3/ndt-9-1113.PMC3742345.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/49/a3/ndt-9-1113.PMC3742345.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/49/a3/ndt-9-1113.PMC3742345.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/53/ndt-9-1045.PMC3742346.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1045–1052Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1045ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S4902 1Shared decision making in psychiatric practice   and the primary care setting is unique,   as measured using a 9-item Shared Decision  Making Questionnaire (SDM-Q-9) Carlos De las Cuevas1,2 Wenceslao Peñate3 Lilisbeth Perestelo-Pérez2,4 Pedro Serrano-Aguilar2,4 1Department of Psychiatry, University  of La Laguna, T enerife, Spain; 2Health  Services Research Network for  Chronic Diseases (REDISSEC),   T enerife, Spain; 3Department  of Personality, Assessment and  Psychological Treatments, University  of La Laguna, T enerife, Spain;   4Evaluation Unit, Canary Island Health  Service, Santa Cruz de T enerife, Spain Correspondence: Carlos De las Cuevas   Department of Psychiatry, University   of La Laguna, School of Medicine,   Campus de Ofra s/n, 38071 San Cristóbal  de La Laguna, Canary Islands, Spain   Tel +34 60 952 1405   Fax +34 92 231 9353   Email cdelascuevas@gmail.co mBackground:  To measure and compare the extent to which shared a decision making (SDM)  process is implemented both in psychiatric outpatient clinical encounters and in the primary  care setting from the patient’ s perspective.",Non-OADS,/arxiv_data1/oa_pdf/d0/53/ndt-9-1045.PMC3742346.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/d0/53/ndt-9-1045.PMC3742346.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/53/ndt-9-1045.PMC3742346.pdf
"Available from:  http://www.who.int/classifications/icd/en/bluebook.pd f. Accessed  September 1, 2012.",OADS,/arxiv_data1/oa_pdf/d0/53/ndt-9-1045.PMC3742346.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/d3/ndt-9-1095.PMC3742348.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1095–1099Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1095Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4729 3Clinical features and imaging findings in a case   of Capgras syndrome Maria Luca1 andrea Bordone1 antonina Luca2 andrea patti1 Giuseppe sortino3 Carmela Calandra1 1Department of Medical and  surgery specialties, psychiatry Unit,   2Department GF Ingrassia, section  of Neuroscience, 3Department of  Diagnostic Imaging, Radiology Unit,   University Hospital policlinico- Vittorio emanuele, Catania, sicily, Italy Correspondence: Carmela Calandra   Department of Medical and surgery  specialties, psychiatry Unit of the  University Hospital policlinico-Vittorio  Emanuele, Via S Sofia 78, Catania,   sicily 95100, Italy   Tel +39 09 5378 2636   Fax +39 09 5378 2636   email c.calandra@unict.i tAbstract:  Capgras syndrome consists of the delusional belief that a person or persons have been  replaced by doubles or impostors.",Non-OADS,/arxiv_data1/oa_pdf/6e/d3/ndt-9-1095.PMC3742348.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/6e/d3/ndt-9-1095.PMC3742348.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/d3/ndt-9-1095.PMC3742348.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ba/d2/ndt-9-1035.PMC3742349.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment  2013:9 1035–1043Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1035Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S4945 4Efficacy and tolerability of pramipexole   for the treatment of primary restless leg  syndrome: a meta-analysis of randomized   placebo-controlled trials wei Zhang Ye wang Shu Yan Cong Jian Fei Nao Juan Feng Guo Rong Bi Neurology Department, Shengjing  Hospital of China Medical University,  Shenyang, People’s Republic of China Correspondence: Guo Rong Bi   Neurology Department, Shengjing  Hospital of China Medical University,   No 36 Sanhao St, Shenyang,   Liaoning 110004,   People’s Republic of China   Tel +86 24 9661 528 111   Fax +86 24 6239 8906   email biguorong@163.co mAbstract:  Primary restless leg syndrome (RLS) is a common sensory-motor disorder  that is characterized by an irresistible urge to move the limbs and unpleasant sensations in  the legs, which affects 1.9%–4.6% adults.",Non-OADS,/arxiv_data1/oa_pdf/ba/d2/ndt-9-1035.PMC3742349.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ba/d2/ndt-9-1035.PMC3742349.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/d2/ndt-9-1035.PMC3742349.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/11/b9/ndt-9-1029.PMC3742350.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1029–1033Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1029OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4668 9Influence of rs1080985 single nucleotide  polymorphism of the CYP2D6 gene on response  to treatment with donepezil in patients   with alzheimer’s disease aleksandra Klimkowicz- Mrowiec1 Pawel Wolkow2 Malgorzata Sado3 anna Dziubek3 Joanna Pera1 T omasz Dziedzic1 andrzej szczudlik1 Agnieszka Slowik1 1Department of Neurology,   Jagiellonian University, School of  Medicine, Botaniczna, 2Department   of Pharmacology, Jagiellonian   University, School of Medicine,    Grzegórzecka, 3Department of   Neurology, University Hospital,    Botaniczna, Krakow, Poland correspondence: aleksandra  Klimkowicz-Mrowiec   Department of Neurology, University   Hospital, Jagiellonian University,   School of Medicine, 31-503 Cracow,   Botaniczna 3, Poland   Tel +481 2424 8600   Fax +481 2424 8626   email a leksandra.",Non-OADS,/arxiv_data1/oa_pdf/11/b9/ndt-9-1029.PMC3742350.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/11/b9/ndt-9-1029.PMC3742350.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/b9/ndt-9-1029.PMC3742350.pdf
Available from: http://www.cypalleles.ki.se /.,Non-OADS,/arxiv_data1/oa_pdf/11/b9/ndt-9-1029.PMC3742350.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/6a/ndt-9-1067.PMC3742351.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1067–1069Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1067Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4845 5a case of early onset parkinson’s disease   after major stress Ke Zou1 Wanjun Guo2 Gongshun Tang3 Bo Zheng4 Zhong Zheng1 1Neurobiological Laboratory,    2Mental Health Center, 3Department   of Nuclear Medicine, West China  Hospital of sichuan University,   Chengdu, people’s republic of China;   4Huaxi Clinical College, sichuan  University, Chengdu, people’s republic  of China Correspondence: Zhong Zheng   Neurobiological Laboratory, West China  Hospital of sichuan University, 28 south  Dianxin road, Chengdu, sichuan 610041,  people’s republic of China   T el +86 28 8542 2783   Fax +86 28 8542 2733   email zhengzhong19638t@gmail.co mAbstract:  A 38-year-old woman experienced sudden onset of rest tremor in the left forearm  1 week after learning that her deeply loved husband was involved in an affair.",Non-OADS,/arxiv_data1/oa_pdf/29/6a/ndt-9-1067.PMC3742351.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/29/6a/ndt-9-1067.PMC3742351.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/6a/ndt-9-1067.PMC3742351.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/51/6c/ndt-9-1061.PMC3742352.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1061–1066Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1061OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4936 4self-concept evaluation and migraine   without aura in childhood Maria esposito1 Beatrice gallai2 lucia Parisi3 laura castaldo1 rosa Marotta4 serena Marianna lavano4 giovanni Mazzotta5 Michele roccella3 Marco carotenuto1 1center for childhood headache,   clinic of child and adolescent  Neuropsychiatry, Department of  Mental health, Physical and Preventive  Medicine, second University of  Naples, Naples, italy; 2Unit of child  and adolescent Neuropsychiatry,   University of Perugia, Perugia, italy;   3child Neuropsychiatry, Department  of Psychology, University of  Palermo, Palermo, italy; 4Department  of Psychiatry, “Magna graecia”  University of catanzaro, catanzaro,   italy; 5Unit of child and adolescent  Neuropsychiatry, aUsl Umbria 2,   T erni, italy correspondence: Michele roccella   Department of Psychology,   University of Palermo, Viale delle   scienze ed 15, 90128 Palermo, italy   Tel +39 091 2389 7756   Fax +39 091 651 3825   email michele.roccella@unipa.i tIntroduction:  Self-esteem is related to the broadly understood concept of self-schemas and is  a crucial mechanism for a correct psychological development in children and adolescents.",Non-OADS,/arxiv_data1/oa_pdf/51/6c/ndt-9-1061.PMC3742352.pdf
The sample size was calculated using online  software ( http://www.dssresearch.com/toolkit/sscalc/ size_a2.as p).,OADS,/arxiv_data1/oa_pdf/51/6c/ndt-9-1061.PMC3742352.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/51/6c/ndt-9-1061.PMC3742352.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/51/6c/ndt-9-1061.PMC3742352.pdf
Available from:  http://www.wma.net/en/30publications/10policies/b3 /.,Non-OADS,/arxiv_data1/oa_pdf/51/6c/ndt-9-1061.PMC3742352.pdf
"Retrieved Feb 1, 2011, from http://www.praat.org Bradbury JW, Vehrencamp SL (2011) Principles of animal communication, Second Edition.",Non-OADS,/arxiv_data1/oa_pdf/6b/33/265_2013_Article_1489.PMC3742427.pdf
"http://solomoncoder.com/ Peters RA, Evans CS (2003) Design of the Jacky dragon visual display: signal and noise characteristics in a complex moving environment.",Non-OADS,/arxiv_data1/oa_pdf/6b/33/265_2013_Article_1489.PMC3742427.pdf
"www.landesbioscience.com Cancer Biology & Therapy 597Cancer Biology & Therapy 14:7, 597–605; July 2013; © 2013 Landes Bioscience ReseaRCh papeR ReseaRCh papeR *Correspondence to: Jin-Hyoung Kang; Email: jinkang@catholic.ac.kr Submitted: 12/21/12; Revised: 03/28/13; Accepted: 04/07/13http://dx.doi.org/10.4161/cbt.24592Introduction Mutations in the KRAS oncogene have been implicated in  the development of various malignancies including non-small cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Int J Med Sci 2008; 5:209-17; PMID:18645621; http://dx.doi.org/10.7150/ijms.5.209 4.,OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Clin Cancer Res  2007; 13:2890-6; PMID:17504988; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Biochim Biophys Acta  2007; 1773:1263-84; PMID:17126425; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Cancer Lett 2012; 322:213-22; PMID:22433711;  http://dx.doi.org/10.1016/j.canlet.2012.03.01510.,OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
"Cancer Res 2012; 72:3048-59;  PMID:22511580; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3649 11. van Krieken JH, Jung A, Kirchner T, Carneiro F , Seruca R, Bosman FT, et al.",Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Virchows Arch 2008; 453:417-31;  PMID:18802721; http://dx.doi.org/10.1007/s00428- 008-0665-y 12.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Biochem J 2000; 351:289-305; PMID:11023813;  http://dx.doi.org/10.1042/0264-6021:3510289 13.,OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Curr Biol  2006; 16:1171-82; PMID:16782007; http://dx.doi.org/10.1016/j.cub.2006.04.044 14.,OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Proc Natl Acad Sci U S A 1998; 95:1091- 6; PMID:9448290; http://dx.doi.org/10.1073/ pnas.95.3.1091 15.,OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Nature 1993; 366:704-7;  PMID:8259215; http://dx.doi.org/10.1038/366704a0 16.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Genes Chromosomes  Cancer 1998; 22:232-40; PMID:9624535;  http://dx.doi.org/10.1002/(SICI)1098- 2264(199807)22:3<232::AID-GCC9>3.0.CO;2-X 17.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Science  1995; 267:249-52; PMID:7809631; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Gastroenterology 1999; 116:1063-71;  PMID:10220498; http://dx.doi.org/10.1016/S0016-5085(99)70009-020.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Nat Med 2002; 8:1105-14; PMID:12357246; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Cancer  Cell 2010; 18:63-73; PMID:20609353; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Br J Cancer  2011; 104:1862-8; PMID:21610706; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Clin Cancer Res 2011; 17:1591-602; PMID:21278246; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
J  Natl Cancer Inst 1993; 85:388-94; PMID:8094467;  http://dx.doi.org/10.1093/jnci/85.5.388 26.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
J  Natl Cancer Inst 1993; 85:384-8; PMID:8094466;  http://dx.doi.org/10.1093/jnci/85.5.384 27.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Cell 2004; 118:493-504; PMID:15315761;  http://dx.doi.org/10.1016/j.cell.2004.08.002,OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Cancer Res  2010; 70:3537-46; PMID:20406971; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Curr Med Chem Anticancer Agents  2003; 3:291-306; PMID:12769774; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Oncogene 2001; 20:3806- 13; PMID:11439344; http://dx.doi.org/10.1038/sj.onc.1204487 48.,OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
J Natl Cancer Inst  1990; 82:1107-12; PMID:2359136; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Adv Enzyme Regul 1984; 22:27- 55; PMID:6382953; http://dx.doi.org/10.1016/0065- 2571(84)90007-438.,OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Lung Cancer 2003;  41(Suppl 1):S155-61; PMID:12867074; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Cancer Res 2004; 64:8109-15;  PMID:15520223; http://dx.doi.org/10.1158/0008- 5472.CAN-03-3938 40.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Cancer Res 2007; 67:1660- 9; PMID:17308107; http://dx.doi.org/10.1158/0008-5472.CAN-06-103830.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
J Natl Cancer Inst 2001; 93:436- 46; PMID:11259469; http://dx.doi.org/10.1093/ jnci/93.6.436 31.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
T rends Cell  Biol 2009; 19:89-98; PMID:19168356; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
J Cell Sci 2008; 121:3853- 7; PMID:19020303; http://dx.doi.org/10.1242/ jcs.039131 33.,OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Mol Biol Cell 2007; 18:1457-63;  PMID:17314399; http://dx.doi.org/10.1091/mbc.E06-10-0908 35.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Nature 2004; 432:316-23; PMID:15549093;  http://dx.doi.org/10.1038/nature03097 36.,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Oncogene 2002; 21:2108-13; PMID:11960384; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
Curr Cancer Drug Targets 2001; 1:1-32; PMID:12188889;  http://dx.doi.org/10.2174/1568009013334296,Non-OADS,/arxiv_data1/oa_pdf/79/8b/cbt-14-597.PMC3742489.pdf
"Cancer Biology & Therapy 14:7, 638–647; July 2013; © 2013 Landes Bioscience ReseaRCh papeR 638 Cancer Biology & Therapy Volume 14 Issue 7*Correspondence to: Menghang Xia; Email: mxia@mail.nih.gov Submitted: 01/20/13; Revised: 03/29/13; Accepted: 04/07/13http://dx.doi.org/10.4161/cbt.24596Introduction Chordoma is a rare, slow growing malignant tumor arising from  remnants of the fetal notochord, an embyological structure that guides the growth of the bony skull and spine.",Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Cancer Chemother Pharmacol 2012; 69:1117-26;  PMID:22205203; http://dx.doi.org/10.1007/s00280- 011-1808-4 24.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Ann Oncol 2012; 23:1555-61; PMID:22012966;  http://dx.doi.org/10.1093/annonc/mdr450 25.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Curr Med Chem 2008;  15:422-32; PMID:18288997; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Mol Cancer Ther 2008; 7:1851-63; PMID:18606717;  http://dx.doi.org/10.1158/1535-7163.MCT-08-0017 27.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
J Chem Biol 2008; 1:27-36;  PMID:19568796; http://dx.doi.org/10.1007/s12154- 008-0003-5 28.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Environ  Health Perspect 2008; 116:284-91; PMID:18335092; http://dx.doi.org/10.1289/ehp.10727 29.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
J Mol Cell Cardiol 1998; 30:495-507; PMID:9515027;  http://dx.doi.org/10.1006/jmcc.1997.0614 30.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Chem Res Toxicol  2008; 21:659-67; PMID:18281954; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Oncogene  2009; 28:3949-59; PMID:19718046; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Oncogene 2008; 27:6207- 15; PMID:18931688; http://dx.doi.org/10.1038/ onc.2008.298 13.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
J Pathol 2006; 209:157-65; PMID:16538613;  http://dx.doi.org/10.1002/path.1969 14.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Curr Cancer  Drug Targets 2011; 11:239-53; PMID:21247388;  http://dx.doi.org/10.2174/156800911794519752 15.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Expert Opin Pharmacother  2009; 10:909-16; PMID:19351237; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Cancer Res 2005; 65:6282-93; PMID:16024630; http://dx.doi.org/10.1158/0008-5472.CAN-05-0676 17.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Science 2000; 288:1053-8;  PMID:10807576; http://dx.doi.org/10.1126/sci- ence.288.5468.1053 18.,OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Lancet 2003; 361:2235-42; PMID:12842380; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Expert Rev  Anticancer Ther 2008; 8:819-31; PMID:18471053;  http://dx.doi.org/10.1586/14737140.8.5.819 21.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Curr Cancer Drug Targets  2002; 2:103-23; PMID:12188913; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Biochem Pharmacol 1999; 57:727-41;  PMID:10075079; http://dx.doi.org/10.1016/S0006- 2952(98)00307-4References 1.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Australas Radiol  2001; 45:427-34; PMID:11903173; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Oncologist 2007; 12:1344-50;  PMID:18055855; http://dx.doi.org/10.1634/theon- cologist.12-11-1344 3.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Curr Opin Oncol 2007; 19:367- 70; PMID:17545801; http://dx.doi.org/10.1097/ CCO.0b013e3281214448 5.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Neurosurg Rev  2009; 32:403-16; PMID:19319583; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
"Neurosurgery 2011; 68:231-40, discussion  240-1; PMID:21099719; http://dx.doi.org/10.1227/ NEU.0b013e3181fd2ac5 7.",Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Biochem Pharmacol  2010; 79:1272-80; PMID:20067776; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Genes Chromosomes Cancer 2001; 32:203-11; PMID:11579460; http://dx.doi.org/10.1002/ gcc.1184 10.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
Sarcoma 2010;  2010:630129; PMID:21253487; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
J Biomol Screen 1999; 4:67-73; PMID:10838414; http://dx.doi.org/10.1177/108705719900400206,OADS,/arxiv_data1/oa_pdf/10/bc/cbt-14-638.PMC3742493.pdf
"Do not distribute.Cancer Biology & Therapy 14:7, 658–671; July 2013; © 2013 Landes Bioscience ReseaRCh papeR 658 Cancer Biology & Therapy Volume 14 Issue 7*Correspondence to: Martin Tenniswood; Email: mtenniswood@albany.edu Submitted: 02/07/13; Revised: 05/12/13; Accepted: 05/19/13http://dx.doi.org/10.4161/cbt/25088Introduction Inflammatory breast cancer (IBC) accounts for less than 2% of  all breast cancer casess.",Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Semin Oncol 2008; 35:11-6;  PMID:18308141; http://dx.doi.org/10.1053/j.semi - noncol.2007.11.018 2.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
CA  Cancer J Clin 2010; 60:351-75; PMID:20959401;  http://dx.doi.org/10.3322/caac.20082 3.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
J Natl Cancer Inst 2005; 97:966- 75; PMID:15998949; http://dx.doi.org/10.1093/jnci/ dji172 4.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Cancer Causes Control 2004; 15:321-8;  PMID:15090727; http://dx.doi.org/10.1023/ B:CACO.0000024222.61114.185.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Breast Cancer Res T reat 2010; 121:53-64; PMID:19593635; http://dx.doi.org/10.1007/s10549- 009-0460-8 7.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Brief Funct Genomic Proteomic  2006; 5:190-208; PMID:16980317; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Clin Cancer  Res 2007; 13:18-26; PMID:17200334; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Br J Cancer 2012; 106:116-25; PMID:22158273;  http://dx.doi.org/10.1038/bjc.2011.532 11.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Mol Cancer Ther 2007; 6:51-60;  PMID:17218635; http://dx.doi.org/10.1158/1535- 7163.MCT-06-0144 13.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Cell Death Differ 2005; 12:482- 91; PMID:15746940; http://dx.doi.org/10.1038/ sj.cdd.4401581U6 snRNA as the endogenous control.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Images were imported into ImageJ software (http://rsb.info.nih.gov/ij/) and converted to binary images.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Biochem Pharmacol  2004; 68:753-60; PMID:15276083; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Cell 1997; 90:595-606; PMID:9288740;  http://dx.doi.org/10.1016/S0092-8674(00)80521-8 16.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Cell 2008; 133:612- 26; PMID:18485870; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
J Biol Chem  2001; 276:18375-83; PMID:11279135; http://dx.doi.org/10.1074/jbc.M100800200 20.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Nutr Metab (Lond) 2011; 8:12; PMID:21371315; http://dx.doi.org/10.1186/1743- 7075-8-12 21.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Nat Protoc 2009; 4:44- 57; PMID:19131956; http://dx.doi.org/10.1038/ nprot.2008.211 23.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Nucleic Acids  Res 2009; 37:1-13; PMID:19033363; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Cell Mol Life Sci  2010; 67:1255-64; PMID:20082207; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Cancer Lett 2009; 280:125-33; PMID:19359091;  http://dx.doi.org/10.1016/j.canlet.2009.02.042 26.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
J Biomed Biotechnol 2011;  2011:856985; PMID:21188173; http://dx.doi.org/10.1155/2011/85698527.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Mol Cancer  Res 2008; 6:1908-19; PMID:19074835; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Cancer 2010;  116(Suppl):2760-7; PMID:20503408; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Cell Death Differ 2012; 19:107-20; PMID:21760595;  http://dx.doi.org/10.1038/cdd.2011.96 31.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Mol Cancer Ther 2008; 7:1931-9; PMID:18645003; http://dx.doi.org/10.1158/1535-7163.MCT-07-2353 32.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
T rends Mol Med  2010; 16:528-36; PMID:20932800; http://dx.doi.org/10.1016/j.molmed.2010.09.002 33.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Steroids 2007; 72:221-30; PMID:17291555; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
T rends Cell Biol 2009; 19:606-16; PMID:19733077; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Semin Cell Dev Biol 2010; 21:899- 908; PMID:20732438; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Curr Biol  2011; 21:815-24; PMID:21565503; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Mol Biol Cell  2011; 22:3584-94; PMID:21832156; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Nature 2002; 417:455-8;  PMID:12024216; http://dx.doi.org/10.1038/417455a40.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
EMBO J 2002; 21:6820-31;  PMID:12486003; http://dx.doi.org/10.1093/emboj/ cdf682 41.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
FASEB J 2012; 26:4057-67;  PMID:22751009; http://dx.doi.org/10.1096/fj.12- 206656 42.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Mol Cancer 2011; 10:58;  PMID:21592394; http://dx.doi.org/10.1186/1476-4598-10-58 44.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Breast Cancer  Res 2006; 8:R23; PMID:16626501; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Nucleic Acids Res 2007; 35(Database issue):D805-9;  PMID:17068075; http://dx.doi.org/10.1093/nar/ gkl767 47.,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Mol Biol Cell 2005; 16:3187-99; PMID:15843429;  http://dx.doi.org/10.1091/mbc.E05-02-0167 48.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Chromosoma  2001; 110:322-34; PMID:11685532; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
Proc Natl Acad Sci U S A 2006; 103:17402- 7; PMID:17090670; http://dx.doi.org/10.1073/ pnas.0608396103,OADS,/arxiv_data1/oa_pdf/53/30/cbt-14-658.PMC3742495.pdf
"Do not distribute.www.landesbioscience.com Cancer Biology & Therapy 679Cancer Biology & Therapy 14:7, 679–691; July 2013; © 2013 Landes Bioscience ReseaRCh papeR ReseaRCh papeR *Correspondence to: Ravi Salgia; Email: rsalgia@medicine.bsd.uchicago.edu Submitted: 03/15/13; Revised: 05/14/13; Accepted: 05/19/13http://dx.doi.org/10.4161/cbt.25091Introduction Lung cancer is a devastating illness with over 220 000 patients  diagnosed and more than 160 000 patients dying in the United  States this year alone.1 Lung cancer is typically divided into  small cell lung cancer (SCLC) and non-small cell lung cancer  (NSCLC), with histologies including adenocarcinoma, bron - choalveolar carcinoma, and squamous cell carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Cell Calcium 2000; 28:285- 96; PMID:11115368; http://dx.doi.org/10.1054/ ceca.2000.0168 26.,OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
FEBS Lett 2004; 567:96- 102; PMID:15165900; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
J Cell Biol 2003; 160:189- 200; PMID:12527753; http://dx.doi.org/10.1083/ jcb.200211046 28.,OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
EMBO  J 2009; 28:1589-600; PMID:19360003; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Nature 2006; 443:658-62; PMID:17035996;  http://dx.doi.org/10.1038/nature05111 30.,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
J Cell Biol 2004; 164:493- 9; PMID:14769861; http://dx.doi.org/10.1083/ jcb.200309082 31.,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Mol Cell Biochem 2004;  256-257:341-58; PMID:14977193; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Gene  1999; 238:211-30; PMID:10570998; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Annu Rev Genet 2005; 39:359- 407; PMID:16285865; http://dx.doi.org/10.1146/ annurev.genet.39.110304.09575112.,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Nat Rev Cancer 2004; 4:891-9;  PMID:15516961; http://dx.doi.org/10.1038/nrc1478 13.,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
FASEB  J 2012; 26:2175-86; PMID:22321727; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Cytokine Growth Factor  Rev 2002; 13:41-59; PMID:11750879; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Cancer Res 2005; 65:1479-88;  PMID:15735036; http://dx.doi.org/10.1158/0008-5472.CAN-04-2650 16.,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Ann N Y Acad Sci 2008; 1147:283-92; PMID:19076450; http://dx.doi.org/10.1196/ annals.1427.030 17.,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
J Drug Deliv 2012;  2012:581363; PMID:21904682; http://dx.doi.org/10.1155/2012/581363 19.,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
J Nucl Med 2008; 49(Suppl 2):43S-63S;  PMID:18523065; http://dx.doi.org/10.2967/ jnumed.107.045930 21.,OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
T rends Endocrinol  Metab 2002; 13:75-8; PMID:11854022; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Nature  2001; 414:807-12; PMID:11742413; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Mitochondrion 2007;  7:359-66; PMID:17822963; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
CA Cancer J Clin 2012; 62:10-29;  PMID:22237781; http://dx.doi.org/10.3322/ caac.20138 2.,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
J Hematol Oncol 2011; 4:16; PMID:21504625;  http://dx.doi.org/10.1186/1756-8722-4-16 3.,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
J  Clin Pathol 2011; 64:16-24; PMID:21045234; http://dx.doi.org/10.1136/jcp.2010.075853 5.,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Cancer  Res 2008; 68:132-42; PMID:18172305; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Oncogene 1998; 16:43-52; PMID:9467941; http://dx.doi.org/10.1038/ sj.onc.1201504 9.,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
J Cell  Sci 2008; 121:2435-44; PMID:18650496; http://dx.doi.org/10.1242/jcs.018044 11.,OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Cell Adh Migr 2012; 6:302-6; PMID:22983197; http://dx.doi.org/10.4161/cam.20488,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Br J Cancer 1987; 55:513-6; PMID:3038157;  http://dx.doi.org/10.1038/bjc.1987.104 39.,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Neurotoxicology 2013; 34:51-60; PMID:23103224;  http://dx.doi.org/10.1016/j.neuro.2012.10.01134.,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Mol Cell  2006; 21:761-73; PMID:16543146; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
J Biol Chem 1995; 270:5039- 47; PMID:7534286; http://dx.doi.org/10.1074/ jbc.270.10.5039 36.,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Semin Cancer Biol 2009; 19:50- 6; PMID:19138741; http://dx.doi.org/10.1016/j.sem- cancer.2008.12.001,Non-OADS,/arxiv_data1/oa_pdf/cd/27/cbt-14-679.PMC3742497.pdf
Mobile Genetic Elements 2013; 3:e25167; http://dx.doi.org/10.4161/mge.25167transposons are mobile genetic elements that are capable of self-directed excision and subsequent reintegration within  the host genome.,OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
Science 1999; 284:1180- 3; PMID:10325231; http://dx.doi.org/10.1126/sci- ence.284.5417.1180 3.,OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
Reprod Nutr Dev  2001; 41:465-85;  PMID:12126294 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
Science  2002; 295:868-72; PMID:11786607 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
Curr Gene  Ther 2005; 5:367-73; PMID:16101511; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
Physiol Genomics 2007; 31:159-73;  PMID:17684037; http://dx.doi.org/10.1152/physiol- genomics.00069.2007 7.,Non-OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
Cell 2005; 122:473- 83; PMID:16096065; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
Proc Natl Acad Sci U S A  2012; 109:19184-9; PMID:23093669; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
Science  2010; 330:1104-7; PMID:20947725 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
Stem Cells Int  2011; 2011:717069; PMID:21977042; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
Biol Reprod  2003; 68:1903-10; PMID:12606337 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
J Androl 2012; 33:229-38; PMID:21546611;  http://dx.doi.org/10.2164/jandrol.111.013532 15.,Non-OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
Cell 1997; 91:501-10; PMID:9390559; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
T ransl Res 2013; 161:265- 83; PMID:23313630; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
BMC Biotechnol 2007; 7:5;  PMID:17233894; http://dx.doi.org/10.1186/1472- 6750-7-5 19.,Non-OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
Hum Gene Ther 2007; 18:1193-204; PMID:17988194; http://dx.doi.org/10.1089/ hum.2007.099 20.,OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
Nucleic Acids Res 2011; 39:e148;  PMID:21948799; http://dx.doi.org/10.1093/nar/ gkr764 22.,OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
Methods Cell Biol  2004; 74:219-42; PMID:15575609 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
Genome Biol  2007; 8(Suppl 1):S12; PMID:18047689; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
Proc Natl Acad Sci U S  A 2008; 105:9290-5; PMID:18579772; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/53/mge-3-e25167.PMC3742596.pdf
First report on class 1 integrons and trimethoprim-resistance genes from dfrA  group in uropathogenic E. coli   (UPEC) from the aleppo area in syria; Mobile Genetic Elements 2013; 3:25204; http://dx.doi.org/10.4161/mge.25204Introduction Urinary tract infections (UTIs) are among the most preva - lent bacterial infections in humans.,Non-OADS,/arxiv_data1/oa_pdf/ed/1f/mge-3-e25204.PMC3742597.pdf
J Urol 2005; 173:1281-7;  PMID:15758783; http://dx.doi.org/10.1097/01.,OADS,/arxiv_data1/oa_pdf/ed/1f/mge-3-e25204.PMC3742597.pdf
"Eur Urol 2001; 40:439-44,  discussion 445; PMID:11713400; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ed/1f/mge-3-e25204.PMC3742597.pdf
Clin Microbiol Infect 2004; 10:272-88;  PMID:15059115; http://dx.doi.org/10.1111/j.1198- 743X.2004.00858.x 4.,OADS,/arxiv_data1/oa_pdf/ed/1f/mge-3-e25204.PMC3742597.pdf
J Infect Dis 2003; 187:251-9;  PMID:12552449; http://dx.doi.org/10.1086/345880 5.,OADS,/arxiv_data1/oa_pdf/ed/1f/mge-3-e25204.PMC3742597.pdf
Vet Res 2001; 32:261-73; PMID:11432417;  http://dx.doi.org/10.1051/vetres:2001123 6.,Non-OADS,/arxiv_data1/oa_pdf/ed/1f/mge-3-e25204.PMC3742597.pdf
Front Microbiol 2011;  2:203; PMID:22046172; http://dx.doi.org/10.3389/ fmicb.2011.00203 8.,Non-OADS,/arxiv_data1/oa_pdf/ed/1f/mge-3-e25204.PMC3742597.pdf
J Antimicrob Chemother  2006; 57:666-72; PMID:16464890; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/1f/mge-3-e25204.PMC3742597.pdf
J Antimicrob Chemother  2004; 53:445-50; PMID:14963060; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/1f/mge-3-e25204.PMC3742597.pdf
Lett Appl Microbiol 2010; 51:456-61;  PMID:20840552; http://dx.doi.org/10.1111/j.1472- 765X.2010.02926.x 11.,OADS,/arxiv_data1/oa_pdf/ed/1f/mge-3-e25204.PMC3742597.pdf
Microbiol Immunol 2010; 54:164- 9; PMID:20236427; http://dx.doi.org/10.1111/ j.1348-0421.2010.00197.x 12.,Non-OADS,/arxiv_data1/oa_pdf/ed/1f/mge-3-e25204.PMC3742597.pdf
Microb Drug Resist 2012; 18:546-9; PMID:22816551;  http://dx.doi.org/10.1089/mdr.2012.0073 14.,Non-OADS,/arxiv_data1/oa_pdf/ed/1f/mge-3-e25204.PMC3742597.pdf
Antimicrob Agents Chemother 2001; 45:2658- 61; PMID:11502548; http://dx.doi.org/10.1128/ AAC.45.9.2658-2661.200115.,Non-OADS,/arxiv_data1/oa_pdf/ed/1f/mge-3-e25204.PMC3742597.pdf
Clin Microbiol Infect  2005; 11:185-92; PMID:15715715; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/1f/mge-3-e25204.PMC3742597.pdf
Kaohsiung J Med  Sci 2007; 23:273-80; PMID:17525011; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/1f/mge-3-e25204.PMC3742597.pdf
FEMS Microbiol Lett 2000;  182:265-9; PMID:10620677; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/1f/mge-3-e25204.PMC3742597.pdf
Clin Microbiol Infect  2007; 13:1112-8; PMID:17725650; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/1f/mge-3-e25204.PMC3742597.pdf
Mobile Genetic Elements 2013; 3:e25255; http://dx.doi.org/10.4161/mge.25255 *Correspondence to: Pietro E. Varaldo;   Email: pe.varaldo@univpm.itThe unprecedented wealth of data - bases that have become available in  the era of next-generation sequencing has  considerably increased our knowledge of bacterial genetic elements (GEs).,Non-OADS,/arxiv_data1/oa_pdf/48/63/mge-3-e25255.PMC3742598.pdf
Antimicrob Agents Chemother 2013; 57:2440–1; PMID:23580584; http://dx.doi.org/10.1128/AAC.02548-12,Non-OADS,/arxiv_data1/oa_pdf/48/63/mge-3-e25255.PMC3742598.pdf
Microbiol  Mol Biol Rev 2004; 68:538-59; PMID:15353569;  http://dx.doi.org/10.1128/MMBR.68.3.538- 559.2004 2.,Non-OADS,/arxiv_data1/oa_pdf/48/63/mge-3-e25255.PMC3742598.pdf
Curr Biol 2013; 23:R118- 9; PMID:23391387; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/48/63/mge-3-e25255.PMC3742598.pdf
Antimicrob Agents Chemother  2010; 54:221-9; PMID:19858262; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/63/mge-3-e25255.PMC3742598.pdf
Antimicrob Agents Chemother  2003; 47:2844-9; PMID:12936983; http://dx.doi.org/10.1128/AAC.47.9.2844-2849.2003 5.,Non-OADS,/arxiv_data1/oa_pdf/48/63/mge-3-e25255.PMC3742598.pdf
J Antimicrob Chemother 2004; 54:991-8; PMID:15563518; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/63/mge-3-e25255.PMC3742598.pdf
FEMS Microbiol Lett 2005; 245:195- 203; PMID:15837373; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/48/63/mge-3-e25255.PMC3742598.pdf
Antimicrob Agents Chemother  2009; 53:343-53; PMID:19001115; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/63/mge-3-e25255.PMC3742598.pdf
Antimicrob Agents Chemother 2012; 56:591- 4; PMID:21986826; http://dx.doi.org/10.1128/ A AC.05352-11 9.,Non-OADS,/arxiv_data1/oa_pdf/48/63/mge-3-e25255.PMC3742598.pdf
Antimicrob Agents  Chemother 2013; 57:2440-1; PMID:23580584;  http://dx.doi.org/10.1128/AAC.02548-1210.,Non-OADS,/arxiv_data1/oa_pdf/48/63/mge-3-e25255.PMC3742598.pdf
Antimicrob Agents Chemother 2012; 56:4697-702; PMID:22710115; http://dx.doi.org/10.1128/AAC.00629-12 11.,Non-OADS,/arxiv_data1/oa_pdf/48/63/mge-3-e25255.PMC3742598.pdf
J Antimicrob Chemother 2007; 60:127-31; PMID:17483548;  http://dx.doi.org/10.1093/jac/dkm120 12.,Non-OADS,/arxiv_data1/oa_pdf/48/63/mge-3-e25255.PMC3742598.pdf
Antimicrob Agents  Chemother 2008; 52:1285-90; PMID:18285489; http://dx.doi.org/10.1128/AAC.01457-07 13.,Non-OADS,/arxiv_data1/oa_pdf/48/63/mge-3-e25255.PMC3742598.pdf
Antimicrob Agents Chemother 2012; 56:5994-7; PMID:22890760;  http://dx.doi.org/10.1128/AAC.01487-12,Non-OADS,/arxiv_data1/oa_pdf/48/63/mge-3-e25255.PMC3742598.pdf
"Mobile Genetic Elements 2013; 3:e25640; http://dx.doi.org/10.4161/mge.25640Introduction Aeromonas salmonicida  subsp salmonicida  (A. salmonicida ) is the  Gram-negative bacterium responsible for furunculosis, a disease  that mainly affects fish in the salmonid family.1,2 A. salmonicida  strains usually contain many plasmids.",Non-OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
Dis Aquat Organ 1998;  32:49-69; PMID:9696626; http://dx.doi.org/10.3354/ dao032049 2.,Non-OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
Plasmid 2003; 50:131-44;  PMID:12932739; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
Microbiology 2006; 152:2809- 18; PMID:16946275; http://dx.doi.org/10.1099/ mic.0.28889-0 6.,Non-OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
J Bacteriol 2012; 194:722-3; PMID:22247525;  http://dx.doi.org/10.1128/JB.06276-117.,Non-OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
PLoS  One 2012; 7:e33725; PMID:22432045; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
Vet Microbiol 2011; 152:353-60; PMID:21621930;  http://dx.doi.org/10.1016/j.vetmic.2011.04.034 9.,Non-OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
"BMC Genomics 2008; 9:427;  PMID:18801193; http://dx.doi.org/10.1186/1471- 2164-9-427The DNA was sent to the genome analysis plat - form (IBIS, Université Laval, Quebec City, QC,  Canada) for sequencing.",OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
Plasmid  2009; 61:176-81;  PMID:19195484 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
Antimicrob Agents Chemother 2003; 47:1285- 90; PMID:12654659; http://dx.doi.org/10.1128/ AAC.47.4.1285-1290.2003 15.,Non-OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
Mobile Genet Elements  2013; 3:1-4; http://dx.doi.org/10.4161/mge.23498 16.,OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
J Mol Biol 1994; 237:452-63;  PMID:8151705 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
Proc Natl Acad Sci U S  A 1995; 92:5754-8; PMID:7777581; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
Vet Immunol  Immunopathol 2006; 110:27-36; PMID:16263179; http://dx.doi.org/10.1016/j.vetimm.2005.09.008 20.,Non-OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
Microbiology 2006; 152:1847- 56; PMID:16735747; http://dx.doi.org/10.1099/ mic.0.28768-0 22.,Non-OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
Cell Mol Life  Sci 2001; 58:403-19; PMID:11315188; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
J Clin Microbiol 2003; 41:3854-6; PMID:12904401; http://dx.doi.org/10.1128/ JCM.41.8.3854-3856.2003 24.,Non-OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
Microbiol Mol Biol Rev 2007; 71:121- 57; PMID:17347521; http://dx.doi.org/10.1128/ MMBR.00031-0625.,Non-OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
Antimicrob Agents  Chemother 2006; 50:1156-63; PMID:16569824; http://dx.doi.org/10.1128/AAC.50.4.1156-1163.2006 26.,Non-OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
J Bacteriol 2004; 186:6077-92; PMID:15342577;  http://dx.doi.org/10.1128/JB.186.18.6077-6092.2004 27.,Non-OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
Microbiology 2003; 149:1297-310; PMID:12724391;  http://dx.doi.org/10.1099/mic.0.26121-0 28.,Non-OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
Antimicrob Agents Chemother  2010; 54:4978-84; PMID:20921317 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
Microbiology 2006; 152:1275-86; PMID:16622045;  http://dx.doi.org/10.1099/mic.0.28485-0 31.,Non-OADS,/arxiv_data1/oa_pdf/19/38/mge-3-e25640.PMC3742599.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 491 Korean J Urol 2013;54:491www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.8.491 Editorial The Era of Robotic and Minimally Invasive Surgery  This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativeco mmons.org/licenses/by-nc/3.",Non-OADS,/arxiv_data1/oa_pdf/b7/06/kju-54-491.PMC3742898.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 492 Korean J Urol 2013;54:492-498www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.8.492 Review Article Current Evaluation and Treatment of Nocturia Hyoung Keun Park, Hyeong Gon Kim Department of Urology, Konkuk University School of Medicine, Seoul, Korea Nocturia is usually considered to be just one of the symptoms included with lower  urinary tract symptoms (LUTS) and is treated with therapy based on LUTS.",Non-OADS,/arxiv_data1/oa_pdf/9c/d4/kju-54-492.PMC3742899.pdf
"Keywords:  Epidemiology; Evaluation; Noctur ia; Pathophysiology; Treatment This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 30 April, 2013 accepted 5 June, 2013 Corresponding Author: Hyeong Gon KimDepartment of Urology, Konkuk  University School of Medicine,  263 Achasan-ro, Gwangjin-gu, Seoul 143-701, Korea TEL: +82-2-2030-7672 FAX: +82-2-2030-7748E-mail: khgsjh@kuh.ac.kr INTRODUCTION Nocturia has usually been consid ered to be just one of the  symptoms that constitute lower urinary tract symptoms (LUTS).",Non-OADS,/arxiv_data1/oa_pdf/9c/d4/kju-54-492.PMC3742899.pdf
Available from: http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/9c/d4/kju-54-492.PMC3742899.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 499 Korean J Urol 2013;54:499-503www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.8.499 Urological Oncology Effect of Type 2 Diabetes Mellitus on Prognosis of Nonmetastatic  Renal Cell Cancer Evren Süer, Erdem Öztürk, Ömer Gülp ınar, Aytaç Kay ış, Sümer Baltac ı Department of Urology, Ankara University School of Medicine, Ankara, Turkey Purpose:  We evaluated the prognostic value of ty pe 2 diabetes mellitus (DM) in patients  treated surgically for localiz ed renal cell carcinoma (RCC).",Non-OADS,/arxiv_data1/oa_pdf/c1/f9/kju-54-499.PMC3742900.pdf
"Keywords:  Prognosis; Renal cell carcinoma; Type 2 diabetes mellitus This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 11 March, 2013 accepted 17 April, 2013 Corresponding Author: Erdem Öztürk Department of Urology, Ankara  University School of Medicine, Adnan Saygun Caddesi, Alt ındağ,  Ankara, Turkey TEL: +90-3125082258FAX: +90-3123112167 E-mail: drerdemoz@gmail.com INTRODUCTION Renal cell carcinoma (RCC) forms 2% to 3% of all cancers,  with the highest incidence in Western Europe and the United States [1,2].",Non-OADS,/arxiv_data1/oa_pdf/c1/f9/kju-54-499.PMC3742900.pdf
Available from: http://www.cdc.gov/diabetes/statistics/prev/  national/figpersons.htm.,Non-OADS,/arxiv_data1/oa_pdf/c1/f9/kju-54-499.PMC3742900.pdf
http://dx.doi.org/10.1016/j.urolonc.2011.12.013.,OADS,/arxiv_data1/oa_pdf/c1/f9/kju-54-499.PMC3742900.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 504 Korean J Urol 2013;54:504-509www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.8.504 Urological Oncology Usefulness of the Ice-Cream Cone Pattern in Computed  Tomography for Prediction of Angiomyolipoma in Patients With a Small Renal Mass Kwang Ho Kim, Bu Hyeon Yun, Seung Il Jung, In Sang Hwang, Eu Chang Hwang, Taek Won Kang,  Dong Deuk Kwon, Kwangsung Park, Jin Woong Kim1  Departments of Urology and 1Diagnostic Radiology, Chonnam National University Medical School, Gwangju, Korea Purpose:  A morphologic contour method for assessing an exophytic renal mass as be- nign versus malignant on the basis of the shape of the interface with the renal paren- chyma was recently developed.",Non-OADS,/arxiv_data1/oa_pdf/5e/fd/kju-54-504.PMC3742901.pdf
"Keywords:  Angiomyolipoma; Diagnostic imagin g; Kidney; Nephrectomy; Renal cell  carcinoma This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 2 May, 2013 accepted 11 June, 2013 Corresponding Author: Seung Il Jung Department of Urology, Chonnam National University  Hwasun Hospital, Chonnam  National University Medical School, 322 Seoyang-ro, Hwasun  519-763, Korea TEL: +82-61-379-8160FAX: +82-61-379-7750 E-mail: drjsi@yahoo.co.kr INTRODUCTION Small renal masses (SRMs) ar e defined as solid renal tu- mors that are enhanced on computed tomographic (CT) scan and magnetic resonanc e imaging and that are sus- pected as renal cell carcinomas (RCCs).",Non-OADS,/arxiv_data1/oa_pdf/5e/fd/kju-54-504.PMC3742901.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 510 Korean J Urol 2013;54:510-515www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.8.510 Urological Oncology Do Positive Surgical Margins Predict Biochemical Recurrence in All  Patients Without Adjuvant Therapy After Radical Prostatectomy?",Non-OADS,/arxiv_data1/oa_pdf/da/5b/kju-54-510.PMC3742902.pdf
"Keywords:  Prostatectomy; Prostatic neoplasms; Recurrence This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 7 May, 2013 accepted 14 June, 2013 Corresponding Author: Tae Young Jung Department of Urology, Veterans Health Service Medical Center,  53 Jinhwangdo-ro 61-gil,  Gangdong-gu, Seoul 134-791, Korea TEL: +82-2-2225-1739 FAX: +82-2-484-4604E-mail: urodoct@hotmail.com INTRODUCTION In Korea, prostate cancer (P Ca) is the fifth most common  malignancy in men and the inci dence has been rising stead- ily [1].",Non-OADS,/arxiv_data1/oa_pdf/da/5b/kju-54-510.PMC3742902.pdf
http://dx.doi.org/10.1016/j.urolonc.2012.11.021.,OADS,/arxiv_data1/oa_pdf/da/5b/kju-54-510.PMC3742902.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 516 Korean J Urol 2013;54:516-521www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.8.516 Laparoscopy/Robotics Single-Surgeon Experience With Robot-Assisted  Ureteroneocystostomy for Distal Ureteral Pathologies in Adults Ziho Lee, Shailen Sehgal, Elton Llukani1, Christopher Reilly1, Leo Doumanian1, Jack Mydlo1,  David Inkoo Lee, Daniel Dong-In Eun1 Division of Urology, University of Pennsylvania School of Medicine, Philadelphia, PA, 1Department of Urology, Temple University School  of Medicine, Philadelphia, PA, USA Purpose:  To demonstrate our technical approa ch for robot-assisted ureteroneocy- stostomy (R-UNC) for benign and malig nant distal ureteral pathologies.",Non-OADS,/arxiv_data1/oa_pdf/0c/c2/kju-54-516.PMC3742903.pdf
"Keywords:  Minimally invasive surgical procedures;  Reconstructive surgical procedures;  Ureter This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 8 May, 2013 accepted 31 May, 2013 Corresponding Author: Daniel Dong-In EunDepartment of Urology, Temple  University School of Medicine,  255 S 17th Street, Suite #2101Philadelphia, PA 19103, USA TEL: +1-215-470-2530 FAX: +1-215-875-9714E-mail: Daniel.Eun@tuhs.",Non-OADS,/arxiv_data1/oa_pdf/0c/c2/kju-54-516.PMC3742903.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 522 Korean J Urol 2013;54:522-526www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.8.522 Laparoscopy/Robotics Experience With Robot-Assisted Laparoscopic Radical Prostatec- tomy at a Secondary Training Hospital: Operation Time, Treatment Outcomes, and Complications With the Accumulation of Experience  Do Young Seo, Hee Ju Cho, Jeong Man Cho, Jung Yoon Kang, Tag Keun Yoo Department of Urology, Eulji General Hospital, Eulji University School of Medicine, Seoul, Korea Purpose:  To investigate the learning curve and outcomes of robot-assisted laparoscopic  radical prostatectomy (RALP) performed by a relatively lower volu me surgeon at a sec- ondary training hospital.",Non-OADS,/arxiv_data1/oa_pdf/4f/73/kju-54-522.PMC3742904.pdf
"Keywords:  Learning curve; Prostatectomy; Prostatic neoplasms; Robotics This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 6 May, 2013 accepted 18 June, 2013 Corresponding Author: Tag Keun Yoo Department of Urology, Eulji General Hospital, Eulji  University School of Medicine, 68  Hangeulbiseok-ro, Nowon-gu, Seoul 139-711, Korea TEL: +82-2-970-8305 FAX: +82-2-970-8349E-mail: ytk5202@eulji.ac.kr INTRODUCTION The increasing availability of  the prostate-specific antigen  (PSA) screening test has led to earlier diagnosis of prostate  cancer as well as to the promotion of more active treatment.",Non-OADS,/arxiv_data1/oa_pdf/4f/73/kju-54-522.PMC3742904.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 527 Korean J Urol 2013;54:527-530www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.8.527 Endourology/Urolithiasis A Prospective Randomized Controlled Trial of the Efficacy of  Tamsulosin After Extracorporeal Shock Wave Lithotripsy for a Single Proximal Ureteral Stone Yong Hyun Park, Hahn Ey Lee, Jae Young Park1, Seung Bae Lee2, Hyeon Hoe Kim Department of Urology, Seoul National University College of Medicine, Seoul, 1Department of Urology, Korea University Ansan Hospital,  Korea University College of Medicine, Ansan, 2Department of Urology, SMG-SNU Bo ramae Medical Center, Seoul, Korea Purpose:  The objective of this study was to evaluate the efficacy of tamsulosin on stone  clearance after extracorporeal shock wave lithotripsy (ESWL) in patients with a single  proximal ureteral stone.Materials and Methods:  This prospective randomized controlled trial was performed  on 88 patients with a single proximal ureter al stone.",Non-OADS,/arxiv_data1/oa_pdf/03/76/kju-54-527.PMC3742905.pdf
"Keywords:  Lithotripsy; Tamsulosin; Urolithiasis This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 27 February, 2013 accepted 18 June, 2013 Corresponding Author: Hyeon Hoe Kim Department of Urology, Seoul  National University Hospital, Seoul National University  College of Medicine, 101  Daehak-ro, Jongno-gu, Seoul 110-744, Korea TEL: +82-2-2072-2425 FAX: +82-2-742-4665E-mail: hhkim@snu.ac.kr INTRODUCTION The lifetime prevalence of urinary stones is estimated to  be 1% to 15%, with the probability of having a stone varying according to age, gender, race, and body mass index (BMI) [1].",Non-OADS,/arxiv_data1/oa_pdf/03/76/kju-54-527.PMC3742905.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 531 Korean J Urol 2013;54:531-535www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.8.531 Endourology/Urolithiasis Relationship Between Patient Position and Pain Severity During  Shock Wave Lithotripsy for Renal Stones With the MODULITH SLX-F2 Lithotripter: A Matched Case-Control Study Jung Hun Kang, Sin Woo Lee, Sung Ho Moon, Hyun Hwan Sung, Seol Ho Choo, Deok Hyun Han Department of Urology, Samsung Medical Center, Sung kyunkwan University School of Medicine, Seoul, Korea Purpose:  We evaluated the association between shock wave lithotripsy (SWL)-related  pain and patient positioning during SWL.",Non-OADS,/arxiv_data1/oa_pdf/03/0a/kju-54-531.PMC3742906.pdf
"Keywords:  Extracorporeal shockwave lithotripsy; Kidney calculi; Pa tient positioning This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 18 April, 2013 accepted 21 June, 2013 Corresponding Author: Deok Hyun Han Department of Urology, Samsung  Medical Center, Sungkyunkwan University School of Medicine, 81  Irwon-ro, Gangnam-gu, Seoul  135-710, Korea TEL: +82-2-3410-6431 FAX: +82-2-3410-3027 E-mail: deokhyun.han@samsung.com INTRODUCTION  After the first reported shock wave lithotripsy (SWL) of re- nal calculi in 1980 by Schmie dt and Chaussy [1], SWL has  been improved and has gained acceptance as a first-line treatment option for small urinary stones.",Non-OADS,/arxiv_data1/oa_pdf/03/0a/kju-54-531.PMC3742906.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 536 Korean J Urol 2013;54:536-540www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.8.536 Male Infertility Success Rate of Microsurgical Multiple Testicular Sperm  Extraction and Sperm Presence in the Ejaculate in Korean Men With Y Chromosome Microdeletions  Se Hwan Park, Hyo Serk Lee, Jin Ho Choe, Joong Shik Lee, Ju Tae Seo Department of Urology, Cheil General Hospital & Women's Healthca re Center, Kwandong University College of Medicine, Seoul, Kore a Purpose:  We assessed the frequency of azoos permia factor a (AZFa), AZFb, and AZFc  deletions and examined correla tions between the deletion sites and the success rates  of sperm presence within the ejaculate and surgical sperm retrieval in Korean men.",Non-OADS,/arxiv_data1/oa_pdf/fa/a5/kju-54-536.PMC3742907.pdf
"Keywords:  Azoospermia; Infertility; Male; Y chromosome This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 3 April, 2013 accepted 7 June, 2013 Corresponding Author: Ju Tae Seo Department of Urology, Cheil General Hospit al & Women's  Healthcare Center, Kwandong  University College of Medicine, 17 Seoae-ro 1-gil, Jung-gu, Seoul  100-380, Korea TEL: +82-2-2000-7585FAX: +82-2-2000-7787 E-mail: jtandro@cgh.co.kr INTRODUCTION  Approximately 15% of couples attempting to conceive over  the course of a year are infertile, and approximately half of these cases of infertility are attributable to a male factor [1,2].",Non-OADS,/arxiv_data1/oa_pdf/fa/a5/kju-54-536.PMC3742907.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 541 Korean J Urol 2013;54:541-546www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.8.541 Pediatric Urology Laparoendoscopic Single-Site Urologic Surgery in Children Less  Than 5 Years of Age Arvind Ganpule, Chetan Sheladiya, Shashikant Mishra, Ravindra Sabnis, Mahesh Desai Department of Urology, Muljibhai Patel Urological Hospital, Gujarat, India Purpose:  We report our experience with laparoendoscopic single-site (LESS) urological  procedures in children less than 5 years of age.",Non-OADS,/arxiv_data1/oa_pdf/e8/65/kju-54-541.PMC3742908.pdf
"Keywords:  Laproscopy; Nephrectomy; Pyeloplasty This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 7 December, 2012 accepted 4 March, 2013 Corresponding Author: Mahesh Desai Department of Urology, Muljibhai Patel Urological Hospital, Dr  Virendra Desai Road, Gujarat  387001, IndiaTEL: +912682520323 FAX: +912682520248 E-mail: mrdesai@mpuh.org INTRODUCTION Laparoendoscopic single-site surgery (LESS) in urology  was first described by Rane et al.",Non-OADS,/arxiv_data1/oa_pdf/e8/65/kju-54-541.PMC3742908.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 547 Korean J Urol 2013;54:547-554www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.8.547 Basic and Translational Research Possible Role of Sonic Hedgehog and Epithelial-Mesenchymal  Transition in Renal Cell Cancer Progression  Hosny M. Behnsawy1,2, Katsumi Shigemura1, Fatma Y. Meligy2,3, Fukashi Yamamichi1,  Masuo Yamashita4, Wen-Chin Haung5, Xiangyan Li5, Hideaki Miyake1, Kazushi Tanaka1,  Masato Kawabata3, Toshiro Shirakawa1,3, Masato Fujisawa1 1Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan, 2Faculty of Medicine, Assiut University, Assiut, Egypt,  3Infectious Center, Kobe University Graduate School of Medicine, Kobe, 4Department of Urology, Shinko Hospital, Kobe, Japan,  5Department of Medicine, Samuel Oschin Comprehensive Cancer In stitute, Cedars-Sinai Medical Center, Los Angeles, CA, USA  Purpose:  Sonic hedgehog (Shh) signaling an d epithelial-mesenchymal transition  (EMT) are both known to relate to cancer progression.",Non-OADS,/arxiv_data1/oa_pdf/b6/16/kju-54-547.PMC3742909.pdf
"Keywords:  Epithelial-mesenchymal transition ; Hedgehogs; Renal cell carcinoma This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 8 January, 2013 accepted 6 March, 2013 Corresponding Author: Katsumi Shigemura Department of Urology, Kobe  University Graduate School of Medicine, 7-5-1 Kusunoki-cho,  Chuo-ku, Kobe 650-0017, Japan TEL: +81-78-382-6155FAX: +81-78-382-6169 E-mail: yutoshunta@hotmail.co.jp INTRODUCTION Renal cell carcinoma (RCC) shows less response to chemo- therapy than other urological cancers.",Non-OADS,/arxiv_data1/oa_pdf/b6/16/kju-54-547.PMC3742909.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 555 Korean J Urol 2013;54:555-557www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.8.555 Case Report Squamous Cell Carcinoma in Exstrophy of the Bladder Pramod Kumar Sharma, Praveen Kumar Pandey, Mukesh Kumar Vijay, Malay Kumar Bera,  Jitendra Pratap Singh, Kaushik Saha1 Departments of Urology and 1Pathology, Institute of Post Graduate Medi cal Education and Research, Kolkata, India Exstrophy of the bladder is a rare congenital  anomaly with an incidence of about 1 per  50,000 newborns.",Non-OADS,/arxiv_data1/oa_pdf/75/ee/kju-54-555.PMC3742910.pdf
"Keywords:  Bladder exstrophy; Squamous cell carcinoma; Urinary bladder neoplasms This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 21 November, 2011 accepted 8 December, 2011 Corresponding Author: Pramod Kumar Sharma Department of Urology, Institute of Post Graduate Medical  Education and Research, Room  No.",Non-OADS,/arxiv_data1/oa_pdf/75/ee/kju-54-555.PMC3742910.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 558 Korean J Urol 2013;54:558-560www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.8.558 Case Report Corticosteroid Therapy Improves the Outcome of Semen Analysis  in an Oligozoospermic Patient With Epididymal Sarcoidosis Onder Canguven, Muhsin Balaban, Ahmet Selimoglu, Selami Albayrak Urology II Clinics, Kartal Teaching and Research Hospital, Istanbul, Turkey Sarcoidosis is a multisystem, inflammatory disorder characterized by the presence of  noncaseating epithelioid granulomas.",Non-OADS,/arxiv_data1/oa_pdf/74/45/kju-54-558.PMC3742911.pdf
"Keywords:  Infertility; Testicul ar diseases; Sperm count; Spermatogenesis This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 23 November, 2011 accepted 26 December, 2011 Corresponding Author: Muhsin Balaban Urology II Clinics, Kartal  Teaching and Research Hospital, Yeni mah., Pegagaz Sok.",Non-OADS,/arxiv_data1/oa_pdf/74/45/kju-54-558.PMC3742911.pdf
KEGG pathway analysis was performed through the KEGG database ( http://www.genome.jp/kegg/ ).,OADS,/arxiv_data1/oa_pdf/88/97/436_2013_Article_3495.PMC3742962.pdf
"After removal of adapters, these short-insert Illumina reads were de novo assembled by the CLC bio software (http://www.clcbio.com/index.php?id=1109 ).",Non-OADS,/arxiv_data1/oa_pdf/88/97/436_2013_Article_3495.PMC3742962.pdf
Available from: http://www.zimmer.com/z/ctl/op/global/action/1/id/9214/template/MP/prcat/M7/prod/y 11.,OADS,/arxiv_data1/oa_pdf/9c/3a/IJSS-7-52.PMC3743031.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/97/7e/IJSS-7-59.PMC3743032.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/5d/4f/IJSS-7-79.PMC3743035.pdf
"3.1a) and Fiji (http://fiji.sc/), respectively.",Non-OADS,/arxiv_data1/oa_pdf/dd/63/srep02436.PMC3743053.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: N.N.,Non-OADS,/arxiv_data1/oa_pdf/dd/63/srep02436.PMC3743053.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2436 | DOI: 10.1038/srep02436 7",Non-OADS,/arxiv_data1/oa_pdf/dd/63/srep02436.PMC3743053.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a6/74/srep02431.PMC3743054.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2431 | DOI: 10.1038/srep02431 7",Non-OADS,/arxiv_data1/oa_pdf/a6/74/srep02431.PMC3743054.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2440 | DOI: 10.1038/srep02440 7",Non-OADS,/arxiv_data1/oa_pdf/da/9d/srep02440.PMC3743055.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c4/c9/srep02439.PMC3743056.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2439 | DOI: 10.1038/srep02439 8",Non-OADS,/arxiv_data1/oa_pdf/c4/c9/srep02439.PMC3743056.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/20/13/srep02434.PMC3743057.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2434 | DOI: 10.1038/srep02434 5",Non-OADS,/arxiv_data1/oa_pdf/20/13/srep02434.PMC3743057.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a2/28/srep02433.PMC3743058.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2433 | DOI: 10.1038/srep02433 6",Non-OADS,/arxiv_data1/oa_pdf/a2/28/srep02433.PMC3743058.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4a/60/srep02442.PMC3743059.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2442 | DOI: 10.1038/srep02442 6",Non-OADS,/arxiv_data1/oa_pdf/4a/60/srep02442.PMC3743059.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2438 | DOI: 10.1038/srep02438 13",Non-OADS,/arxiv_data1/oa_pdf/99/0b/srep02438.PMC3743060.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/95/9d/srep02435.PMC3743062.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2435 | DOI: 10.1038/srep02435 8",Non-OADS,/arxiv_data1/oa_pdf/95/9d/srep02435.PMC3743062.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/71/02/srep01763.PMC3743064.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Sugimoto, N. et al.",Non-OADS,/arxiv_data1/oa_pdf/71/02/srep01763.PMC3743064.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial use, distribution, and reproduction in any medium, provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced o r disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.",Non-OADS,/arxiv_data1/oa_pdf/2e/f8/eht083.PMC3743068.pdf
"This is anOpenAccessarticledistributed underthe termsof theCreative Commons AttributionLicense(http://creativecommons.org/licenses/by- nc/3.0/),whichpermitsnon-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/47/eht149.PMC3743069.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/31/eht187.PMC3743070.pdf
"Remarks at the Oxford China Business Forum, Beijing, available at http://www.bankofengland.co.uk/publications/speeches/ 2010/speech445.pdf (2010).",Non-OADS,/arxiv_data1/oa_pdf/f4/dd/srep02110.PMC3743071.pdf
"Financial Times, available at http://www.ft.com/cms/s/0/b2373a36-b6c2-11df-b3dd- 00144feabdc0.html (2010).",Non-OADS,/arxiv_data1/oa_pdf/f4/dd/srep02110.PMC3743071.pdf
"The Wall Street Journal (October 2, 2010) , http://online.wsj.com (2010).",Non-OADS,/arxiv_data1/oa_pdf/f4/dd/srep02110.PMC3743071.pdf
"Reuters (August, 2012) , http://www.reuters.com/ (2012).",Non-OADS,/arxiv_data1/oa_pdf/f4/dd/srep02110.PMC3743071.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f4/dd/srep02110.PMC3743071.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2110 | DOI: 10.1038/srep02110 8",Non-OADS,/arxiv_data1/oa_pdf/f4/dd/srep02110.PMC3743071.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/8a/2b/JCN-1-91.PMC3743138.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.,Non-OADS,/arxiv_data1/oa_pdf/8a/2b/JCN-1-91.PMC3743138.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/d3/4b/JCN-1-72.PMC3743139.pdf
Available from: http://www.merck.com.,Non-OADS,/arxiv_data1/oa_pdf/38/e1/JCN-1-96.PMC3743144.pdf
Available from: http://inomax.com/assets/pdf/INOmax-PI-web-0909.pdf [Last cited on 2012 Feb 24].,OADS,/arxiv_data1/oa_pdf/6a/8e/JCN-1-59.PMC3743146.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/6a/8e/JCN-1-59.PMC3743146.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/d8/2a/JCN-1-70.PMC3743147.pdf
Available from: http://www.sswahs.nsw.gov.au/ rpa/neonatal/html/docs/hypothermia.pdf [Last accessed on 2011  Mar 14].,Non-OADS,/arxiv_data1/oa_pdf/50/70/JCN-1-101.PMC3743149.pdf
Available from: http://www.clinicalguidelines.scot.nhs.How to cite this article: Mosalli R. Whole body cooling for infants with hypoxic-ischemic encephalopathy.,Non-OADS,/arxiv_data1/oa_pdf/50/70/JCN-1-101.PMC3743149.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1285Case Reporthttp://dx.doi.org/10.3349/ymj.2013.54.5.1285 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1285-1288, 2013 IgG4-Related Sclerosing Disease Involving the Superior   Vena Cava and the Atrial Septum of the Heart  Changho Song,1 Myoung Ju Koh,2 Yong-Nam Yoon,3 Boyoung Joung,1 and Se Hoon Kim2 1Division of Cardiology, Department of Internal Medicine, Departments of 2Pathology and 3Cardiothoracic Surgery,  Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d7/fc/ymj-54-1285.PMC3743176.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.A 55-year-old woman presented with frequent episodes of syncope due to sinus  pauses.",Non-OADS,/arxiv_data1/oa_pdf/d7/fc/ymj-54-1285.PMC3743176.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1286ry Holter monitoring, frequent episodes of sinus pauses and  atrial fibrillation were observed.",Non-OADS,/arxiv_data1/oa_pdf/d7/fc/ymj-54-1285.PMC3743176.pdf
"IgG4-Related Sclerosing Disease Involving the Heart Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1287ever, to our knowledge, involvement of the cardiac conduc - tion system has not been reported.",Non-OADS,/arxiv_data1/oa_pdf/d7/fc/ymj-54-1285.PMC3743176.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1288fibrosclerosis and IgG4-related disease involving the cardiovascu - lar system.,Non-OADS,/arxiv_data1/oa_pdf/d7/fc/ymj-54-1285.PMC3743176.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1178Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1178 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1178-1185, 2013 Feasibility of Sorafenib Combined with Local Radiotherapy   in Advanced Hepatocellular Carcinoma Jihye Cha,1 Jinsil Seong,1,2 Ik Jae Lee,1 Jun Won Kim,1 and Kwang-Hyub Han2 1Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul;  2Yonsei Liver Cancer Special Clinic, Yonsei University Health System, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/fd/7f/ymj-54-1178.PMC3743177.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Sorafenib is an effective systemic agent for advanced hepatocellular car - cinoma.",Non-OADS,/arxiv_data1/oa_pdf/fd/7f/ymj-54-1178.PMC3743177.pdf
Sorafenib with RT in Advanced HCC Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1179studies of these patients were retrospectively reviewed.,Non-OADS,/arxiv_data1/oa_pdf/fd/7f/ymj-54-1178.PMC3743177.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1180cc of the duodenum was limited to 45 Gy.,Non-OADS,/arxiv_data1/oa_pdf/fd/7f/ymj-54-1178.PMC3743177.pdf
Sorafenib with RT in Advanced HCC Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1181of size reduction rate for in-field target lesions was 61%.,Non-OADS,/arxiv_data1/oa_pdf/fd/7f/ymj-54-1178.PMC3743177.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1182rates of the primary group and the measurable metastasis  group were 35% and 60%, respectively.",Non-OADS,/arxiv_data1/oa_pdf/fd/7f/ymj-54-1178.PMC3743177.pdf
Sorafenib with RT in Advanced HCC Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1183apy before undergoing the combined treatment.,Non-OADS,/arxiv_data1/oa_pdf/fd/7f/ymj-54-1178.PMC3743177.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1184well as another study in a sequential manner (ClinicalTri - als.gov number, NCT00999843).",Non-OADS,/arxiv_data1/oa_pdf/fd/7f/ymj-54-1178.PMC3743177.pdf
Sorafenib with RT in Advanced HCC Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1185oxyuridine and conformal radiation therapy for patients with pri - mary hepatobiliary cancers or colorectal liver metastases.,Non-OADS,/arxiv_data1/oa_pdf/fd/7f/ymj-54-1178.PMC3743177.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1143Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1143 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1143-1148, 2013 Late-Presenting Congenital Diaphragmatic Hernia in Children:  The Experience of Single Institution in Korea Dong Jin Kim and Jae Hee Chung Department of Pediatric Surgery, Yeouido St. Mary’ s Hospital, The Catholic University of Korea, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/55/b1/ymj-54-1143.PMC3743178.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Late-presenting congenital diaphragmatic hernia (CDH) beyond the neo - natal period is rare and often misdiagnosed, with delayed treatment.",Non-OADS,/arxiv_data1/oa_pdf/55/b1/ymj-54-1143.PMC3743178.pdf
Dong Jin Kim and Jae Hee Chung Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1144×10 cm.,Non-OADS,/arxiv_data1/oa_pdf/55/b1/ymj-54-1143.PMC3743178.pdf
Late-Presenting CDH in Children Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1145eral defect of the left diaphragm.,Non-OADS,/arxiv_data1/oa_pdf/55/b1/ymj-54-1143.PMC3743178.pdf
"Dong Jin Kim and Jae Hee Chung Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1146In our opinion, type 3 could be divided into two groups:  the early-presenting group and late-presenting group (those  having symptoms beyond neonatal period).",Non-OADS,/arxiv_data1/oa_pdf/55/b1/ymj-54-1143.PMC3743178.pdf
Late-Presenting CDH in Children Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1147duce the distension of the stomach into the abdomen.,Non-OADS,/arxiv_data1/oa_pdf/55/b1/ymj-54-1143.PMC3743178.pdf
Dong Jin Kim and Jae Hee Chung Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 11482004;71:948.,Non-OADS,/arxiv_data1/oa_pdf/55/b1/ymj-54-1143.PMC3743178.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1149Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1149 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1149-1157, 2013 Sendai F/HN Viroplexes for Efficient Transfection   of Leukemic T Cells Jung Seok Kim,1 Yeon Kyung Lee,1 Hwa Yeon Jeong,1 Seong Jae Kang,1 Min Woo Kim,1  Seung Hyun Ryu,1 Hong Sung Kim,2 Keun Sik Kim,3 Dong-Eun Kim,4 and Yong Serk Park1 1Department of Biomedical Laboratory Science, Yonsei University, Wonju;  2Department of Biomedical Laboratory Science, Korea Nazarene University, Cheonan;  3Department of Biomedical Laboratory Science, Konyang University, Daejeon;  4Department of Bioscience and Biotechnology, Konkuk University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/54/7b/ymj-54-1149.PMC3743179.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Most chemical transfection reagents are ineffective for the transfection  of cells in suspension, such as leukemic cell and stem cell lineages.",Non-OADS,/arxiv_data1/oa_pdf/54/7b/ymj-54-1149.PMC3743179.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1150mL penicillin and 100 μg/mL streptomycin at 37°C under  5% CO 2.,Non-OADS,/arxiv_data1/oa_pdf/54/7b/ymj-54-1149.PMC3743179.pdf
"Transfection of Leukemic T Cells Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1151Malvern, UK).",Non-OADS,/arxiv_data1/oa_pdf/54/7b/ymj-54-1149.PMC3743179.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1152cDNAs were sequentially amplified with 2.5 units of a G- Taq kit (Cosmogenetech, Seoul) and 10 pmol of each primer  in a PTC-200 thermocycler (Bio-RAD) with the following  program: 25 cycles (22 cycles for β-actin) of denaturation  (94°C for 5 sec), annealing (55°C for 20 sec), and extension  (72°C for 7 min).",OADS,/arxiv_data1/oa_pdf/54/7b/ymj-54-1149.PMC3743179.pdf
Transfection of Leukemic T Cells Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1153cording to the in vitro  transfection data using Jurkat and  CEM cells (Fig.,Non-OADS,/arxiv_data1/oa_pdf/54/7b/ymj-54-1149.PMC3743179.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1154mediated by the viroplexes, siRNA molecules of vimentin,  a member of the intermediate filament structure, were uti - lized for transfection.",Non-OADS,/arxiv_data1/oa_pdf/54/7b/ymj-54-1149.PMC3743179.pdf
Transfection of Leukemic T Cells Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1155ic or quantitative reports of transfection of suspension leu - kemic T cells mediated by chemical vector systems.,OADS,/arxiv_data1/oa_pdf/54/7b/ymj-54-1149.PMC3743179.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1156Jurkat and CEM cells than the other formulations tested.,Non-OADS,/arxiv_data1/oa_pdf/54/7b/ymj-54-1149.PMC3743179.pdf
Transfection of Leukemic T Cells Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1157209:701-7.,Non-OADS,/arxiv_data1/oa_pdf/54/7b/ymj-54-1149.PMC3743179.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1282Brief Communicationhttp://dx.doi.org/10.3349/ymj.2013.54.5.1282 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1282-1284, 2013 Detection of Methicillin-Resistant Staphylococcus aureus  in  Healthcare Workers Using Real-Time Polymerase Chain Reaction Myeong Hee Kim, Woo In Lee, and So Young Kang Department of Laboratory Medicine, School of Medicine, Kyung Hee University and    Kyung Hee University Hospital at Gangdong, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/09/f8/ymj-54-1282.PMC3743180.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Healthcare-associated infections caused by methicillin-resistant Staphylococcus  aureus  (MRSA) have recently become an important issue for healthcare facilities  due to high rates of infection, mortality, and high treatment costs.",Non-OADS,/arxiv_data1/oa_pdf/09/f8/ymj-54-1282.PMC3743180.pdf
"Detection of MRSA Using Real-Time PCR Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1283A TCC33591, a methicillin-resistant strain.",Non-OADS,/arxiv_data1/oa_pdf/09/f8/ymj-54-1282.PMC3743180.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1284ACKNOWLEDGEMENTS This work was supported by a grant from the Kyung Hee  University in 2011 (KHU-20110666).,Non-OADS,/arxiv_data1/oa_pdf/09/f8/ymj-54-1282.PMC3743180.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1253Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1253 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1253-1258, 2013 Efficacy of Combination of Meloxicam and Pregabalin   for Pain in Knee Osteoarthritis Seiji Ohtori, Gen Inoue, Sumihisa Orita, Masashi Takaso, Yawara Eguchi, Nobuyasu Ochiai,   Shunji Kishida, Kazuki Kuniyoshi, Yasuchika Aoki, Tetsuhiro Ishikawa, Masayuki Miyagi,   Hiroto Kamoda, Miyako Suzkuki, Junichi Nakamura, Gou Kubota, Yoshihiro Sakuma, Yasuhiro Oikawa,  Tomoaki Toyone, Kazuhide Inage, Takeshi Sainoh, Kazuyo Yamauchi, and Kazuhisa Takahashi Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.",Non-OADS,/arxiv_data1/oa_pdf/94/c2/ymj-54-1253.PMC3743181.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Osteoarthritic pain is largely considered to be inflammatory pain.",Non-OADS,/arxiv_data1/oa_pdf/94/c2/ymj-54-1253.PMC3743181.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1254col for the human procedures used in this study.,Non-OADS,/arxiv_data1/oa_pdf/94/c2/ymj-54-1253.PMC3743181.pdf
Pregabalin for OA Pain Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1255demographic characteristics for patients.,Non-OADS,/arxiv_data1/oa_pdf/94/c2/ymj-54-1253.PMC3743181.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1256that OA pain is a combination of inflammatory and neuro - pathic pain components.,Non-OADS,/arxiv_data1/oa_pdf/94/c2/ymj-54-1253.PMC3743181.pdf
Pregabalin for OA Pain Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1257flammatory and neuropathic pain components.,Non-OADS,/arxiv_data1/oa_pdf/94/c2/ymj-54-1253.PMC3743181.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1258Joint Surg Am 2004;86-A:963-74.,Non-OADS,/arxiv_data1/oa_pdf/94/c2/ymj-54-1253.PMC3743181.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1214Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1214 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1214-1219, 2013 Evaluation of Quality of Life with the Chronic Obstructive  Pulmonary Disease Assessment Test in Chronic Obstructive  Pulmonary Disease and the Effect of Dyspnea on   Disease-Specific Quality of Life in These Patients Oguzhan Okutan, Dilaver Tas, Ersin Demirer, and Zafer Kartaloglu GATA Haydarpasa Training Hospital, Department of Pulmonary Diseases, Istanbul, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/5c/35/ymj-54-1214.PMC3743182.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  The chronic obstructive pulmonary disease (COPD) assessment test  (CA T) was recently introduced for use in assessing disease-specific quality of life  and follow-up of patients with COPD.",Non-OADS,/arxiv_data1/oa_pdf/5c/35/ymj-54-1214.PMC3743182.pdf
Evaluation of QoL with CA T in COPD and Dyspnea Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1215as follows: 1) a known post-bronchodilator forced expirato - ry volume in 1 s/forced vital capacity (FEV1/FVC) ratio of  <70% and an FEV1 <80% (except GOLD I patients) of the  predicted value for all measurements made over the prior  six months; 2) a smoking history of  >10 packet-years; 3) no  history suggestive of bronchial asthma; 4) no exacerbations  of the airflow limitation over the preceding six weeks; and  5) no changes in treatment regimen over the preceding four  weeks.,Non-OADS,/arxiv_data1/oa_pdf/5c/35/ymj-54-1214.PMC3743182.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1216patients were GOLD III, and 2 patients were GOLD IV .",Non-OADS,/arxiv_data1/oa_pdf/5c/35/ymj-54-1214.PMC3743182.pdf
Evaluation of QoL with CA T in COPD and Dyspnea Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1217pnea score obtained from MRC was correlated with spiro - metric measurement (FEV1).,Non-OADS,/arxiv_data1/oa_pdf/5c/35/ymj-54-1214.PMC3743182.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1218status impairment between patients in GOLD stage I and II  can be seen with the CA T. In present study, we discerned  that no difference in health status impairment among GOLD  II, III and IV stage patients can be seen with the CA T. In  contrast, there was significant difference between patients of  GOLD stages I and II according to CA T. Also, Jones, et al.",Non-OADS,/arxiv_data1/oa_pdf/5c/35/ymj-54-1214.PMC3743182.pdf
Evaluation of QoL with CA T in COPD and Dyspnea Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 121926:319-38.,Non-OADS,/arxiv_data1/oa_pdf/5c/35/ymj-54-1214.PMC3743182.pdf
Available at: http://www.catestonline.org/english/index_ Turkey.htm.,Non-OADS,/arxiv_data1/oa_pdf/5c/35/ymj-54-1214.PMC3743182.pdf
Available at: http://www.catestonline.org/images/ UserGuides/CA THCPUser%20guideEn.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5c/35/ymj-54-1214.PMC3743182.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1168Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1168 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1168-1177, 2013 Prognostic Factors for Patients with Bone-Only Metastasis   in Breast Cancer Sung Gwe Ahn,1 Hak Min Lee,1 Sang-Hoon Cho,2 Seung Ah Lee,1 Seung Hyun Hwang,1  Joon Jeong,1 and Hy-De Lee1 1Department of Surgery, Yonsei University Medical College, Seoul; 2Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d0/d4/ymj-54-1168.PMC3743183.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Bone is the most frequent site of metastasis among breast cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d0/d4/ymj-54-1168.PMC3743183.pdf
Prognostic Factors for Bone Metastasis Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1169ment.,Non-OADS,/arxiv_data1/oa_pdf/d0/d4/ymj-54-1168.PMC3743183.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1170treatement was subsequently changed to zoledronic acid.,Non-OADS,/arxiv_data1/oa_pdf/d0/d4/ymj-54-1168.PMC3743183.pdf
"All statistical analyses were per - formed using the Statistical Software Package for the Social  Sciences (SPSS version 18.0 for Windows; SPSS Inc., Chi - cago, IL, USA) and the R software (http://www.r-projet.org).",OADS,/arxiv_data1/oa_pdf/d0/d4/ymj-54-1168.PMC3743183.pdf
Prognostic Factors for Bone Metastasis Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1171patients with other types of distant metastasis.7-9 This favor - able survival outcome of the patients with bone-only me - tastasis motivated us to conduct this investigation and facil - itated the attempt to seek a treatment strategy best suited to  these patients.,Non-OADS,/arxiv_data1/oa_pdf/d0/d4/ymj-54-1168.PMC3743183.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1172of life for patients with hormone receptor (HR)-positive and  human epidermal receptor-2-negative patients with bone- only metastases.9,18 However, endocrine therapy did not  provide a statistically significant therapeutic effect in our  study.",Non-OADS,/arxiv_data1/oa_pdf/d0/d4/ymj-54-1168.PMC3743183.pdf
"Prognostic Factors for Bone Metastasis Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1173that the administration of bisphosphonates including zole - dronic acid and pamidronate may provide a survival benefit  in patients with metastatic breast cancer with HR-negative  tumors, whereas it did not enhance survival in a recent study  on the antitumor effect of zoledronic acid in breast cancer  patients with bone-only metastasis.14 In our results, bisphosphonate treatment was the most  significant prognostic factor of OS after bone-only metasta - sis.",Non-OADS,/arxiv_data1/oa_pdf/d0/d4/ymj-54-1168.PMC3743183.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1174Table 4.,Non-OADS,/arxiv_data1/oa_pdf/d0/d4/ymj-54-1168.PMC3743183.pdf
"Prognostic Factors for Bone Metastasis Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1175its retrospective and single-institution design, possibly lead - ing to selection and referral bias.",Non-OADS,/arxiv_data1/oa_pdf/d0/d4/ymj-54-1168.PMC3743183.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1176et al.,Non-OADS,/arxiv_data1/oa_pdf/d0/d4/ymj-54-1168.PMC3743183.pdf
Prognostic Factors for Bone Metastasis Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1177low-up of a randomized controlled trial of adjuvant clodronate  treatment in node-positive breast cancer patients.,Non-OADS,/arxiv_data1/oa_pdf/d0/d4/ymj-54-1168.PMC3743183.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1158Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1158 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1158-1167, 2013 NAD(P)H: Quinone Oxidoreductase 1 and NRH:Quinone  Oxidoreductase 2 Polymorphisms in Papillary Thyroid  Microcarcinoma: Correlation with Phenotype Junguee Lee,1* Koon Soon Kim,2* Min Ho Lee,3* Yeon Soo Kim,4 Min Hee Lee,5 Seong Eun Lee,5  Yong Kyung Kim,5 Min Jeong Ryu,5 Soung Jung Kim,5 Min Jeong Choi,5 and Young Suk Jo2 1Department of Pathology, Daejeon St. Mary’ s Hospital, College of Medicine, The Catholic University of Korea, Daejeon; 2Research Center for Endocrine and Metabolic Diseases, Chungnam National University Hospital, Daejeon; 3College of Biological Sciences and Biotechnology, Department of Bioscience, Chungnam National University, Daejeon; 4Cheong Shim International Academy, Gapyeong; 5Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/69/96/ymj-54-1158.PMC3743184.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  NAD(P)H:Quinone Oxidoreductase 1 (NQO1) C609T missense variant  (NQO1*2) and 29 basepair (bp)-insertion/deletion (I29/D) polymorphism of the  NRH:Quinone Oxidoreductase 2 (NQO2) gene promoter have been proposed as  predictive and prognostic factors for cancer development and progression.",Non-OADS,/arxiv_data1/oa_pdf/69/96/ymj-54-1158.PMC3743184.pdf
NQO1 and NQO2 Polymorphism in PTMC Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1159the NQO1*2 polymorphism modified cancer risk and was  significantly associated with the K- ras codon 12 mutation.18  There is another presumptive evidence for a protective  role of NQO1 and NQO2 in thyroid carcinogenesis; these  proteins can stabilize and increase p53 levels.,Non-OADS,/arxiv_data1/oa_pdf/69/96/ymj-54-1158.PMC3743184.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1160Abcam plc, Cambridge, UK) primary antibody for 60 min at  room temperature, after which they were treated sequential - ly with biotinylated anti-mouse immunoglobulin for 30 min,  peroxidase-labeled streptavidin for 30 min, and diamino - benzidine in the presence of hydrogen peroxide.",Non-OADS,/arxiv_data1/oa_pdf/69/96/ymj-54-1158.PMC3743184.pdf
NQO1 and NQO2 Polymorphism in PTMC Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1161was 58.3% (28/48) and 56.8% (71/125) in PTMC.,OADS,/arxiv_data1/oa_pdf/69/96/ymj-54-1158.PMC3743184.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1162ality, lymph node metastasis and the presence of BRAFV600E  mutation were similar in the presence and absence of  NQO1*2 polymorphism.",Non-OADS,/arxiv_data1/oa_pdf/69/96/ymj-54-1158.PMC3743184.pdf
NQO1 and NQO2 Polymorphism in PTMC Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1163(Table 4).,Non-OADS,/arxiv_data1/oa_pdf/69/96/ymj-54-1158.PMC3743184.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1164analysis of the frequency of NQO2 promoter polymor - phisms in PTMC and NH also revealed no significant dif - ferences in the frequency of the I29/D polymorphisms.,OADS,/arxiv_data1/oa_pdf/69/96/ymj-54-1158.PMC3743184.pdf
NQO1 and NQO2 Polymorphism in PTMC Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1165showed that patients with the I29/I29 genotype were at  higher risk of lymph node metastasis.,Non-OADS,/arxiv_data1/oa_pdf/69/96/ymj-54-1158.PMC3743184.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 116617.,Non-OADS,/arxiv_data1/oa_pdf/69/96/ymj-54-1158.PMC3743184.pdf
NQO1 and NQO2 Polymorphism in PTMC Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1167cells.,Non-OADS,/arxiv_data1/oa_pdf/69/96/ymj-54-1158.PMC3743184.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1186Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1186 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1186-1193, 2013 Growth Inhibition of Hepatocellular Carcinoma Huh7 Cells   by Lactobacillus casei  Extract Dae Jong Han,1,3 Jong Bin Kim,2 Seo Young Park,1 Man Gil Yang,1 and Hyuncheol Kim3,4 1Biomedical Research Institute, Seoul National University Hospital, Seoul;  2Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul; 3Interdisciplinary Program of Integrated Biotechnology, Sogang University, Seoul; 4Department of Chemical and Biomolecular Engineering, Sogang University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/09/86/ymj-54-1186.PMC3743185.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Lactobacillus casei  (L. casei ) is known to exert anti-proliferation effects on  many types of cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/09/86/ymj-54-1186.PMC3743185.pdf
"Lactobacillus  casei Extract Inhibits the Growth of Huh7 Cells Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1187tract, 20 g of glucose, 1 g of sorbitan monooleate complex  (Tween 80), 5 g of ammonium acetate, 5 g of sodium acetate,  2 g of K 2HPO 4, 0.2 g of MgSO 4-7H 2O, and 0.2 g of Mn - SO 4-4H 2O.",Non-OADS,/arxiv_data1/oa_pdf/09/86/ymj-54-1186.PMC3743185.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1188CA, USA).",Non-OADS,/arxiv_data1/oa_pdf/09/86/ymj-54-1186.PMC3743185.pdf
Lactobacillus  casei Extract Inhibits the Growth of Huh7 Cells Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1189controls.,Non-OADS,/arxiv_data1/oa_pdf/09/86/ymj-54-1186.PMC3743185.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1190found to be increased by 6% in the treated group, compared  to the control group (Fig.",Non-OADS,/arxiv_data1/oa_pdf/09/86/ymj-54-1186.PMC3743185.pdf
"Lactobacillus  casei Extract Inhibits the Growth of Huh7 Cells Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1191cellular extracts of Lactobacillus  strains was found to inhib - it cancer cell proliferation.19 Taken together, we concluded  that the cell wall components of L. casei  exhibit anti-tumor  activities.",Non-OADS,/arxiv_data1/oa_pdf/09/86/ymj-54-1186.PMC3743185.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1192REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/09/86/ymj-54-1186.PMC3743185.pdf
Lactobacillus  casei Extract Inhibits the Growth of Huh7 Cells Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 119317.,Non-OADS,/arxiv_data1/oa_pdf/09/86/ymj-54-1186.PMC3743185.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1194Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1194 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1194-1201, 2013 Proteinuria as a Risk Factor for Mortality in Patients   with Colorectal Cancer Min Jee Kim,1 Yong Un Kang,1 Chang Seong Kim,1 Joon Seok Choi,1 Eun Hui Bae,1  Seong Kwon Ma,1 Sun-Seog Kweon,2,3 and Soo Wan Kim1 Departments of 1Internal Medicine and 2Preventive Medicine, Chonnam National University Medical School, Gwangju;  3Jeonnam Regional Cancer Center, Chonnam National University Hwasun Hospital, Hwasun, Korea.",Non-OADS,/arxiv_data1/oa_pdf/af/9e/ymj-54-1194.PMC3743186.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  We investigated the effects of proteinuria and renal insufficiency on all- cause mortality in patients with colorectal cancer, with special emphasis on cancer  staging and cancer-related deaths.",Non-OADS,/arxiv_data1/oa_pdf/af/9e/ymj-54-1194.PMC3743186.pdf
"Proteinuria and Colorectal Cancer Mortality Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1195ity of cancer and proteinuria: group 1, patients without pro - teinuria and with operable stage (early stage) cancer (colorec - tal cancer stage ≤3); group 2, patients with proteinuria and  early stage cancer; group 3, patients without proteinuria and  with advanced stage cancer (colorectal cancer stage 4); and  group 4, patients with proteinuria and advanced stage cancer.",Non-OADS,/arxiv_data1/oa_pdf/af/9e/ymj-54-1194.PMC3743186.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1196diabetes mellitus was observed in 558 patients (16.5%).,Non-OADS,/arxiv_data1/oa_pdf/af/9e/ymj-54-1194.PMC3743186.pdf
Proteinuria and Colorectal Cancer Mortality Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1197vanced cancer stage (Fig.,Non-OADS,/arxiv_data1/oa_pdf/af/9e/ymj-54-1194.PMC3743186.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1198DISCUSSION Our study demonstrated that proteinuria is a strong, inde - pendent prognostic factor for mortality in patients with  colorectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/af/9e/ymj-54-1194.PMC3743186.pdf
"Proteinuria and Colorectal Cancer Mortality Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1199discrepancies between previous studies and ours may be  due to differences in study cases (e.g., combined different  cancer types, including hepatic, renal, and urinary tract can - cers versus single-entity colorectal cancer in this study).",Non-OADS,/arxiv_data1/oa_pdf/af/9e/ymj-54-1194.PMC3743186.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1200Cancer-specific mortality in chronic kidney disease: longitudinal  follow-up of a large cohort.,Non-OADS,/arxiv_data1/oa_pdf/af/9e/ymj-54-1194.PMC3743186.pdf
Proteinuria and Colorectal Cancer Mortality Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1201immune complex deposits in cancer patients.,Non-OADS,/arxiv_data1/oa_pdf/af/9e/ymj-54-1194.PMC3743186.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1259Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1259 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1259-1265, 2013 Comparison of Preoperative and Postoperative Ocular Biometry  in Eyes with Phakic Intraocular Lens Implantations Joo Youn Shin,1 Jae Bum Lee,2 Kyoung Yul Seo,1 Eung Kweon Kim,1 and Tae-im Kim1 1The Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul; 2Yonsei Plus Eye Center, Seongnam, Korea.",Non-OADS,/arxiv_data1/oa_pdf/08/ef/ymj-54-1259.PMC3743187.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  To compare preoperative and postoperative ocular biometry in patients  with iris-fixated phakic intraocular lens (pIOLs): Artisan and Artiflex.",Non-OADS,/arxiv_data1/oa_pdf/08/ef/ymj-54-1259.PMC3743187.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1260stitutional Review Board approval was obtained.,Non-OADS,/arxiv_data1/oa_pdf/08/ef/ymj-54-1259.PMC3743187.pdf
Ocular Biometry in Eyes with Phakic IOLs Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1261Statistical analysis    A paired t-test was used to compare the difference between  preoperative and postoperative anterior chamber depth and  axial length measurements.,Non-OADS,/arxiv_data1/oa_pdf/08/ef/ymj-54-1259.PMC3743187.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1262p=0.028) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/08/ef/ymj-54-1259.PMC3743187.pdf
Ocular Biometry in Eyes with Phakic IOLs Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1263that influenced IOLMaster ACD measurements.,Non-OADS,/arxiv_data1/oa_pdf/08/ef/ymj-54-1259.PMC3743187.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1264ACKNOWLEDGEMENTS This study was supported by grant MEST (2010-0022006)  from the National Research Foundation of Korea and the  Converging Research Center Program funded by the Minis - try of Education, Science and Technology (2012K001354).",Non-OADS,/arxiv_data1/oa_pdf/08/ef/ymj-54-1259.PMC3743187.pdf
"Ocular Biometry in Eyes with Phakic IOLs Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1265liability of RTVue, Visante, and slit-lamp adapted ultrasonic  pachymetry for central corneal thickness measurement.",Non-OADS,/arxiv_data1/oa_pdf/08/ef/ymj-54-1259.PMC3743187.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1084Review Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1084 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1084-1090, 2013 Outcome Predictors for Intestinal Behçet’s Disease Jae Jun Park,1 Won Ho Kim,2 and Jae Hee Cheon2 1Department of Internal Medicine and Institute of Gastroenterology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul; 2Department of Internal Medicine and Institute of Gastroenterology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.",OADS,/arxiv_data1/oa_pdf/54/07/ymj-54-1084.PMC3743188.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Behçet’s disease (BD) is a multisystem inflammatory disorder that presents as re - current oral and genital ulcers in conjunction with other dermatological and ocular  manifestations.",Non-OADS,/arxiv_data1/oa_pdf/54/07/ymj-54-1084.PMC3743188.pdf
Outcome Predictors for Intestinal Behçet’s Disease Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1085tation of tailored treatment and individualized monitoring  strategies.,Non-OADS,/arxiv_data1/oa_pdf/54/07/ymj-54-1084.PMC3743188.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1086To date, there is limited data regarding specific serologic  markers for intestinal BD.",Non-OADS,/arxiv_data1/oa_pdf/54/07/ymj-54-1084.PMC3743188.pdf
"Outcome Predictors for Intestinal Behçet’s Disease Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1087remission were 5.8%, 43.7%, and 51.7%, respectively.30  Y ounger age (<25 years) at the time of diagnosis (HR, 7.20;  95% CI, 1.64-31.53) and a lower hemoglobin level (<11 g/ dL) (HR, 14.77; 95% CI, 2.94-74.19) at the time of remis - sion were independent predictive factors for relapse in this  population.30  Predictors during biologic agent therapy Although corticosteroids and immunosuppressants are ef - fective treatments for intestinal BD, patients who are refrac - tory to these conventional therapies will eventually require  ileocecal resection.",Non-OADS,/arxiv_data1/oa_pdf/54/07/ymj-54-1084.PMC3743188.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1088quent surgery during follow-up.,Non-OADS,/arxiv_data1/oa_pdf/54/07/ymj-54-1084.PMC3743188.pdf
Outcome Predictors for Intestinal Behçet’s Disease Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 10895.,Non-OADS,/arxiv_data1/oa_pdf/54/07/ymj-54-1084.PMC3743188.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1090118-21.,Non-OADS,/arxiv_data1/oa_pdf/54/07/ymj-54-1084.PMC3743188.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1104Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1104 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1104-1109, 2013 Outcome of Transcatheter Closure of Oval Shaped Atrial Septal  Defect with Amplatzer Septal Occluder Jinyoung Song,1 Sang Yoon Lee,2 Jae Sook Baek,2 Woo Seub Shim,2 and Eun Young Choi3 1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; 2Department of Pediatrics, Sejong General Hospital, Sejong Heart Institute, Bucheon; 3Department of Pediatrics, Seoul National University Bundang Hosiptal, Seongnam, Korea.",Non-OADS,/arxiv_data1/oa_pdf/de/c9/ymj-54-1104.PMC3743189.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  For the successful completion of transcatheter closure of atrial septal de - fects with the Amplatzer septal occluder, shape of the defects should be considered  prior to selecting the device.",Non-OADS,/arxiv_data1/oa_pdf/de/c9/ymj-54-1104.PMC3743189.pdf
Device Closure of Oval Shaped ASD Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1105We decided the device size based on the measured data  from various echocardiographic images and images from  cardiac computed tomography.,OADS,/arxiv_data1/oa_pdf/de/c9/ymj-54-1104.PMC3743189.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1106(Table 1).,Non-OADS,/arxiv_data1/oa_pdf/de/c9/ymj-54-1104.PMC3743189.pdf
"Device Closure of Oval Shaped ASD Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1107For a successful device closure of ASD, a trans-esopha - geal echocardiogram can assess the size, anatomy, and suit - ability of the lesion for closure.",Non-OADS,/arxiv_data1/oa_pdf/de/c9/ymj-54-1104.PMC3743189.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1108vice was much larger than 45 mm and no residual leak was  detected by trans-thoracic echocardiogram immediately as  well as 6 months later.,Non-OADS,/arxiv_data1/oa_pdf/de/c9/ymj-54-1104.PMC3743189.pdf
Device Closure of Oval Shaped ASD Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1109al.,Non-OADS,/arxiv_data1/oa_pdf/de/c9/ymj-54-1104.PMC3743189.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1234Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1234 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1234-1240, 2013 Posaconazole Treatment in Korea: Single-Center   Experience Over 5 Years  Hyo-Jin Lee,1 Jae-Cheol Kwon,2 Si-Hyun Kim,3 Su-Mi Choi,1 Dong-Gun Lee,1,4 Sun-Hee Park,1  Jung-Hyun Choi,1 Jin-Hong Yoo,1 Byung-Sik Cho,4 Seok Lee,4 Hee-Je Kim,4 Chang-Ki Min,4  Jong-Wook Lee,4 and Woo-Sung Min4 1Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul;  2Division of Infectious Diseases, Department of Internal Medicine, National Health Insurance Corporation Ilsan Hospital, Goyang;  3Department of Life Sciences, Pohang University of Science and Technology, Pohang;  4Catholic Blood and Marrow Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d9/9e/ymj-54-1234.PMC3743190.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Posaconazole is a second-generation triazole with a broad spectrum.",Non-OADS,/arxiv_data1/oa_pdf/d9/9e/ymj-54-1234.PMC3743190.pdf
"Current Experience of Posaconazole Treatment Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1235a refractory IFI (disease progression, or failure to improve  clinically after at least 7-day use of other licensed antifun - gal agents); 2) history of intolerance of standard antifungal  therapy due to toxicity; 3) preexisting organ dysfunction  that prevented the administration of other licensed antifun - gal therapies; or 4) need for long-term maintenance treat - ment of IFI with posaconazole after treatment with any oth - er antifungal agent.1  Clinical responses were evaluated at the end of treat - ment using both clinical and radiological data.",Non-OADS,/arxiv_data1/oa_pdf/d9/9e/ymj-54-1234.PMC3743190.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1236   Table 1.,Non-OADS,/arxiv_data1/oa_pdf/d9/9e/ymj-54-1234.PMC3743190.pdf
Current Experience of Posaconazole Treatment Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1237tion of posaconazole.,Non-OADS,/arxiv_data1/oa_pdf/d9/9e/ymj-54-1234.PMC3743190.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1238abscesses in the right peribronchial area and subpleural por - tion of the right lower lobe (RLL) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/d9/9e/ymj-54-1234.PMC3743190.pdf
Current Experience of Posaconazole Treatment Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1239than that of posaconazole.,Non-OADS,/arxiv_data1/oa_pdf/d9/9e/ymj-54-1234.PMC3743190.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 12402010;79:587-91.,Non-OADS,/arxiv_data1/oa_pdf/d9/9e/ymj-54-1234.PMC3743190.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1273Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1273 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1273-1281, 2013 Risk Assessment of Postoperative Nausea and Vomiting in the  Intravenous Patient-Controlled Analgesia Environment:  Predictive Values of the Apfel’s Simplified Risk Score   for Identification of High-Risk Patients Shin Hyung Kim, Yang-Sik Shin, Young Jun Oh, Jeong Rim Lee,   Sung Chan Chung, and Yong Seon Choi Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4a/b5/ymj-54-1273.PMC3743191.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Opioid-based intravenous patient-controlled analgesia (IV PCA) is pop - ular method of postoperative pain control, but many patients suffer from IV PCA- related postoperative nausea and vomiting (PONV).",Non-OADS,/arxiv_data1/oa_pdf/4a/b5/ymj-54-1273.PMC3743191.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1274audit and outcome assessment (more than 20000 cases at  present).,Non-OADS,/arxiv_data1/oa_pdf/4a/b5/ymj-54-1273.PMC3743191.pdf
"Postoperative Nausea and V omiting with Intravenous Patient-Controlled Analgesia Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1275Additionally, a receiver operating characteristics (ROC)  curve was drawn.",Non-OADS,/arxiv_data1/oa_pdf/4a/b5/ymj-54-1273.PMC3743191.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1276p=0.669).,Non-OADS,/arxiv_data1/oa_pdf/4a/b5/ymj-54-1273.PMC3743191.pdf
Postoperative Nausea and V omiting with Intravenous Patient-Controlled Analgesia Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1277the study period (1-6 hr: 5% vs. 38%; 6-24 hr: 4% vs. 34%;  24-48 hr: 1% vs. 19%; p<0.001).,Non-OADS,/arxiv_data1/oa_pdf/4a/b5/ymj-54-1273.PMC3743191.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1278dict the risk of PONV with more favorable discrimination  and calibration properties than other PONV scoring sys - tems.14,17,22 In our multivariate analysis, the Apfel’s simpli - fied risk score was the strongest predictive factor for IV  PCA-related intractable PONV among the numerous pa - tients, anesthetics and surgical parameters that we assessed.",Non-OADS,/arxiv_data1/oa_pdf/4a/b5/ymj-54-1273.PMC3743191.pdf
Postoperative Nausea and V omiting with Intravenous Patient-Controlled Analgesia Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1279to intractable PONV in our study.,Non-OADS,/arxiv_data1/oa_pdf/4a/b5/ymj-54-1273.PMC3743191.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1280strong predictors might need careful attention in the selec - tion of intraoperative anesthetic technique, dose of fentanyl  used in IV PCA, and prophylactic antiemetic strategies.",Non-OADS,/arxiv_data1/oa_pdf/4a/b5/ymj-54-1273.PMC3743191.pdf
Postoperative Nausea and V omiting with Intravenous Patient-Controlled Analgesia Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1281Anesth Analg 2006;102:1884-98.,Non-OADS,/arxiv_data1/oa_pdf/4a/b5/ymj-54-1273.PMC3743191.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1207Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1207 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1207-1213, 2013 Outcomes of Gleason Score ≤8 among High Risk Prostate  Cancer Treated with 125I Low Dose Rate Brachytherapy  Based Multimodal Therapy Dong Soo Park,1 In Hyuck Gong,1 Don Kyung Choi,1 Jin Ho Hwang,1 Hyun Soo Shin,2 and Jong Jin Oh1,3 Departments of 1Urology and 2Radiation Oncology, CHA Bundang Medical Center, CHA University, Seongnam; 3CHA Cancer Research Center, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c3/aa/ymj-54-1207.PMC3743192.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  To investigate the role of low dose rate (LDR) brachytherapy-based mul - timodal therapy in high-risk prostate cancer (PCa) and analyze its optimal indica - tions.",Non-OADS,/arxiv_data1/oa_pdf/c3/aa/ymj-54-1207.PMC3743192.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1208Treatment Permanent 125I seeds were implanted into the prostate.,Non-OADS,/arxiv_data1/oa_pdf/c3/aa/ymj-54-1207.PMC3743192.pdf
Brachytherapy in High Risk Prostate Cancer  Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1209ard regression analysis.,Non-OADS,/arxiv_data1/oa_pdf/c3/aa/ymj-54-1207.PMC3743192.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1210had BCR.,Non-OADS,/arxiv_data1/oa_pdf/c3/aa/ymj-54-1207.PMC3743192.pdf
"Brachytherapy in High Risk Prostate Cancer  Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1211concluded that high-risk PCa, as defined by the D’Amico  classification, did not lead to the creation of a homogenous  group; in particular, patients with higher Gleason scores rep - resented a “very-high-risk” group within the “high-risk”  group.",Non-OADS,/arxiv_data1/oa_pdf/c3/aa/ymj-54-1207.PMC3743192.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1212Reed JL, et al.",OADS,/arxiv_data1/oa_pdf/c3/aa/ymj-54-1207.PMC3743192.pdf
Brachytherapy in High Risk Prostate Cancer  Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1213dine-125 seed brachytherapy.,Non-OADS,/arxiv_data1/oa_pdf/c3/aa/ymj-54-1207.PMC3743192.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1227Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1227 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1227-1233, 2013 Treatment Response and Adverse Reactions in Older  Tuberculosis Patients with Immunocompromising Comorbidities Seo Yun Kim, Sang-Min Lee, Jae-Joon Yim, Chul-Gyu Yoo, Young Whan Kim,   Sung Koo Han, and Seok-Chul Yang Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center,   Seoul National University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/31/f3/ymj-54-1227.PMC3743193.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  The aim of this study was to elucidate the effects of immunocompromis - ing comorbidities on treatment response and adverse reactions in older tuberculo - sis (TB) patients.",Non-OADS,/arxiv_data1/oa_pdf/31/f3/ymj-54-1227.PMC3743193.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1228steroid therapy, chemotherapy), malnutrition, and HIV in - fection including HIV infection, advanced HIV disease and  AIDS.",Non-OADS,/arxiv_data1/oa_pdf/31/f3/ymj-54-1227.PMC3743193.pdf
"Older Tuberculosis Patients with Comorbidities Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1229nutrition and 16 patients were receiving immunosuppressive  therapy (e.g., corticosteroids, chemotherapy).",Non-OADS,/arxiv_data1/oa_pdf/31/f3/ymj-54-1227.PMC3743193.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1230The mean durations of treatment were 9.9±3.3 months in  the comorbidity group and 9.3±3.2 months in the non-co - morbidity group ( p=0.21).,Non-OADS,/arxiv_data1/oa_pdf/31/f3/ymj-54-1227.PMC3743193.pdf
Older Tuberculosis Patients with Comorbidities Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1231in the elderly population.,Non-OADS,/arxiv_data1/oa_pdf/31/f3/ymj-54-1227.PMC3743193.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1232dysfunction in older people may explain the lower rate of  use of pyrazinamide for treating TB in the older patients in  this study.,Non-OADS,/arxiv_data1/oa_pdf/31/f3/ymj-54-1227.PMC3743193.pdf
Older Tuberculosis Patients with Comorbidities Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1233prospective comparison study.,Non-OADS,/arxiv_data1/oa_pdf/31/f3/ymj-54-1227.PMC3743193.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1098Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1098 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1098-1103, 2013 Prevalence and Geographic Distribution of Herniated  Intervertebral Disc in Korean 19-Year-Old Male from 2008   to 2009: A Study Based on Korean Conscription   -National and Geographic Prevalence of Herniated Intervertebral   Disc in Korean 19YO Male- Sang Hun Lee,1 Chang Hyun Oh,2,3 Seung Hwan Yoon,1 Hyeong-chun Park,1 and Chong Oon Park1 1Department of Neurosurgery, Inha University Hospital, College of Medicine, Inha University, Incheon;  2Seoul Regional Military Manpower Administration, Seoul; 3Department of Neurosurgery, Guro Teun Teun Hospital, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/35/51/ymj-54-1098.PMC3743194.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  This study was to determine the prevalence of herniated intervertebral  disc (HIVD) among Korean 19-year-old male in a large national sample and to  compare the prevalence across geographic regions based on the data of conscrip - tion.",Non-OADS,/arxiv_data1/oa_pdf/35/51/ymj-54-1098.PMC3743194.pdf
"Prevalence of HIVD in Korean 19YO Male Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1099The spinal fusion cases by HIVD were excluded from the  study, although the cases were very few.",Non-OADS,/arxiv_data1/oa_pdf/35/51/ymj-54-1098.PMC3743194.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1100presence of bias by checking the difference of a regional  HIVD proportion.,Non-OADS,/arxiv_data1/oa_pdf/35/51/ymj-54-1098.PMC3743194.pdf
Prevalence of HIVD in Korean 19YO Male Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1101other regions did not show statistical differences.,Non-OADS,/arxiv_data1/oa_pdf/35/51/ymj-54-1098.PMC3743194.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1102differences are seen among the regions; the reasons for the  differences could be social economic status, motivation for  hospitalization, trauma rate, number of hospitals and etc.",Non-OADS,/arxiv_data1/oa_pdf/35/51/ymj-54-1098.PMC3743194.pdf
Prevalence of HIVD in Korean 19YO Male Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 110317.,Non-OADS,/arxiv_data1/oa_pdf/35/51/ymj-54-1098.PMC3743194.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1220Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1220 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1220-1226, 2013 A Simple and Efficient Multiplex PCR Assay for the  Identification of Mycobacterium  Genus and Mycobacterium tuberculosis   Complex to the Species Level Yeun Kim,1 Yeonim Choi,1 Bo-Young Jeon,1 Hyunwoo Jin,1,2 Sang-Nae Cho,3 and Hyeyoung Lee1 1Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University, Wonju;  2Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan, Busan; 3Department of Microbiology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/41/e0/ymj-54-1220.PMC3743195.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  The Mycobacterium tuberculosis  complex comprises M. tuberculosis ,  M. bovis , M. bovis  bacillus Calmette-Guérin (BCG) and M. africanum , and causes  tuberculosis in humans and animals.",Non-OADS,/arxiv_data1/oa_pdf/41/e0/ymj-54-1220.PMC3743195.pdf
"Multiplex PCR for Mycobacterium  Genus and M. tuberculosis  Complex Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1221berculosis  and M. bovis , but is absent in M. bovis  BCG, al - lowing for M. tuberculosis and M. bovis  to be differentiated  from M. bovis  BCG.11,12 Additionally, a novel RD8 is pres - ent in M. tuberculosis  and M. africanum  that is deleted in  M. bovis  and M. bovis  BCG and absent in M. microti  and  nontuberculous mycobacteria.14 In this study, we developed a rapid and efficient multi - plex PCR assay that enables not only the identification of  the genus Mycobacterium  using the rpoB sequence con - served in all mycobacteria, but also the identification of the  M. tuberculosis  complex to the species level, using RD1  and RD8 sequences.",Non-OADS,/arxiv_data1/oa_pdf/41/e0/ymj-54-1220.PMC3743195.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 12221.5 units of Taq DNA polymerase (Bioneer, Daejeon, Ko - rea), and 20 ng of genomic DNA as the template.",OADS,/arxiv_data1/oa_pdf/41/e0/ymj-54-1220.PMC3743195.pdf
Multiplex PCR on reference strains and clinical isolates PCR products using the four sets of primer pairs were per -analysis of the appropriate genomic regions using Primer 3  software (http://frodo.wi.mit.edu/) (Fig.,OADS,/arxiv_data1/oa_pdf/41/e0/ymj-54-1220.PMC3743195.pdf
Multiplex PCR for Mycobacterium  Genus and M. tuberculosis  Complex Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1223results identical to M. tuberculosis (Fig.,Non-OADS,/arxiv_data1/oa_pdf/41/e0/ymj-54-1220.PMC3743195.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1224DISCUSSION We developed a simple and effective multiplex PCR assay  that enabled the differentiation of Mycobacteria  spp.,Non-OADS,/arxiv_data1/oa_pdf/41/e0/ymj-54-1220.PMC3743195.pdf
Multiplex PCR for Mycobacterium  Genus and M. tuberculosis  Complex Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1225not used routinely in clinical microbiology laboratories as  they are time consuming and costly.,Non-OADS,/arxiv_data1/oa_pdf/41/e0/ymj-54-1220.PMC3743195.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1226Mycobacterium tuberculosis complex in clinical specimens.,Non-OADS,/arxiv_data1/oa_pdf/41/e0/ymj-54-1220.PMC3743195.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1137Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1137 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1137-1142, 2013 Effect of 45° Reclining Sitting Posture on Swallowing   in Patients with Dysphagia Byung-Hyun Park, Jeong-Hwan Seo, Myoung-Hwan Ko, and Sung-Hee Park Department of Physical Medicine and Rehabilitation, Institute for Medical Sciences, Chonbuk National University Medical School and   Research Institute of Clinical Medicine, Chonbuk National University Hospital, Jeonju, Korea.",Non-OADS,/arxiv_data1/oa_pdf/49/60/ymj-54-1137.PMC3743196.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  To determine the effect of a 45° reclining sitting posture on swallowing  in patients with dysphagia.",Non-OADS,/arxiv_data1/oa_pdf/49/60/ymj-54-1137.PMC3743196.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1138the VFSS test.,Non-OADS,/arxiv_data1/oa_pdf/49/60/ymj-54-1137.PMC3743196.pdf
45° Reclining Sitting Posture on Swallowing Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1139Grades of residue Grades of residue in valleculae decreased significantly in  all diets at 45° reclined sitting than at 90° upright sitting  (p<0.05) (Table 6).,Non-OADS,/arxiv_data1/oa_pdf/49/60/ymj-54-1137.PMC3743196.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1140show changes in grades of residue in pyriform sinuses, ex - cept the cases of thick liquid and yogurt in which there were  significant increases at 45° reclined sitting ( p<0.05) (Table  7, Fig.",Non-OADS,/arxiv_data1/oa_pdf/49/60/ymj-54-1137.PMC3743196.pdf
"45° Reclining Sitting Posture on Swallowing Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1141clining position is an effective compensation technique in  case of increased residue in the valleculae, but not in the  case of increased residue in the pyriform.",Non-OADS,/arxiv_data1/oa_pdf/49/60/ymj-54-1137.PMC3743196.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1142Research Institute, Chonbuk National University Hospital.",Non-OADS,/arxiv_data1/oa_pdf/49/60/ymj-54-1137.PMC3743196.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1266Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1266 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1266-1272, 2013 Kidney Function in Living Donors Undergoing Nephrectomy   by Sevoflurane or Desflurane Anesthesia Min-Soo Kim,1 Jeong-Rim Lee,1 Myoung-Soo Kim,2 Sung-Yeon Ham,1 and Seung-Ho Choi1 1Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul; 2Department of Surgery, The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e8/a8/ymj-54-1266.PMC3743197.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Although there is no clinical evidence of nephrotoxicity with the volatile  anesthetics currently used in general anesthesia, a better agent should be needed in  terms of preserving postoperative renal function in living kidney donors who have  only single remaining kidney.",Non-OADS,/arxiv_data1/oa_pdf/e8/a8/ymj-54-1266.PMC3743197.pdf
V olatile Anesthetics for Kidney Donor Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1267ing video-assisted minilaparotomy surgery (V AMS).21 The  patients were managed intraoperatively using the standard  anesthesia protocol for our institution.,Non-OADS,/arxiv_data1/oa_pdf/e8/a8/ymj-54-1266.PMC3743197.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1268cago, IL, USA).",Non-OADS,/arxiv_data1/oa_pdf/e8/a8/ymj-54-1266.PMC3743197.pdf
"V olatile Anesthetics for Kidney Donor Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1269Sevoflurane has many advantages such as pleasant odor,  no pungency, and bronchodilating effect, while desflurane  does not have these qualities.10 However, the concern about  the nephrotoxicity of sevoflurane exists still.19 The issues of  nephrotoxicity related to sevoflurane use are based not only  on its fluoride metabolite but also on compound A.10,23 Early  reports of fluoride-associated nephrotoxicity from the metab - olism of volatile anesthetics focused on methoxyflurane and  enflurane, and the toxic threshold of inorganic fluoride asso - ciated with nephrotoxicity was found to be 50 µmol/L.24,25  Previous investigations of sevoflurane metabolism demon - strated that a fluoride ion concentration greater than 50 µmol/ L could be observed even though sevoflurane was used dur - ing operations of average duration.",Non-OADS,/arxiv_data1/oa_pdf/e8/a8/ymj-54-1266.PMC3743197.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1270Intrarenal metabolism of methoxyflurane and subsequent in - trarenal production of fluoride ion are considered to be a sig - nificant cause of the nephrotoxic effects of methoxyflurane.,Non-OADS,/arxiv_data1/oa_pdf/e8/a8/ymj-54-1266.PMC3743197.pdf
V olatile Anesthetics for Kidney Donor Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1271et al.,Non-OADS,/arxiv_data1/oa_pdf/e8/a8/ymj-54-1266.PMC3743197.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1272anesthesia and low-flow isoflurane anesthesia.,Non-OADS,/arxiv_data1/oa_pdf/e8/a8/ymj-54-1266.PMC3743197.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1110Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1110 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1110-1118, 2013 Standardized Approaches to Syncope Evaluation for Reducing  Hospital Admissions and Costs in Overcrowded   Emergency Departments  Tae Gun Shin,1 June Soo Kim,2 Hyoung Gon Song,3 Ik Joon Jo,1 Min Seob Sim,1 and Seung-Jung Park2 1Department of Emergency Medicine, 2Division of Cardiology, Department of Medicine , Cardiac and Vascular Center,  Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; 3Executive Board Member of Public Relations, Korean Medical Association, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/63/ad/ymj-54-1110.PMC3743198.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License  (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  The evaluation of syncope is often disorganized and ineffective.",Non-OADS,/arxiv_data1/oa_pdf/63/ad/ymj-54-1110.PMC3743198.pdf
"Standardized Approaches to Syncope Evaluation Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1111consent, previous enrollment in other studies, and non-syn - copal episodes such as lightheadedness, vertigo, hypogly - cemia, seizure or stroke.",Non-OADS,/arxiv_data1/oa_pdf/63/ad/ymj-54-1110.PMC3743198.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1112the protocol for evaluation of syncope.,Non-OADS,/arxiv_data1/oa_pdf/63/ad/ymj-54-1110.PMC3743198.pdf
Standardized Approaches to Syncope Evaluation Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1113vention group).,Non-OADS,/arxiv_data1/oa_pdf/63/ad/ymj-54-1110.PMC3743198.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1114cies of other diagnostic tests were not significantly different  between the two groups (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/63/ad/ymj-54-1110.PMC3743198.pdf
Standardized Approaches to Syncope Evaluation Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1115they were deaths due to malignancies.,Non-OADS,/arxiv_data1/oa_pdf/63/ad/ymj-54-1110.PMC3743198.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1116fact, increase costs.2,15,18,25-27 However, risk stratification  may be useful if clinical evaluation is appropriately per - formed, depending on risk.",Non-OADS,/arxiv_data1/oa_pdf/63/ad/ymj-54-1110.PMC3743198.pdf
Standardized Approaches to Syncope Evaluation Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1117sis and management of syncope (version 2009).,Non-OADS,/arxiv_data1/oa_pdf/63/ad/ymj-54-1110.PMC3743198.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1118evaluation of an educational programme for physicians involved  in the management of syncope.,Non-OADS,/arxiv_data1/oa_pdf/63/ad/ymj-54-1110.PMC3743198.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1202Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1202 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1202-1206, 2013 Role of Prostate Volume in the Early Detection of Prostate  Cancer in a Cohort with Slowly Increasing   Prostate Specific Antigen Young Min Kim,1 Sungchan Park,2 June Kim,2 Seonghun Park,3 Ji Ho Lee,4  Dong Soo Ryu,5 Seong Hoon Choi,6 and Sang Hyeon Cheon2 Departments of 1Pathology, 2Urology, 4Occupational and Environmental Medicine, and 6Radiology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan; 3School of Mechanical Engineering, Pusan National University, Busan; 5Department of Urology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ab/5b/ymj-54-1202.PMC3743199.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  To investigate the relationship between prostate volume and the increased  risk for being diagnosed with prostate cancer (PCa) in men with slowly increasing  prostate specific antigen (PSA).",Non-OADS,/arxiv_data1/oa_pdf/ab/5b/ymj-54-1202.PMC3743199.pdf
"Role of Prostate V olume in Prostate Cancer Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1203ing a standard sextant, which was originally described by  Hodge, et al.9 and three core biopsies was used in case of hy - poechoic lesions on TRUS.",Non-OADS,/arxiv_data1/oa_pdf/ab/5b/ymj-54-1202.PMC3743199.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1204prostate volume was 0.724 (Fig.,OADS,/arxiv_data1/oa_pdf/ab/5b/ymj-54-1202.PMC3743199.pdf
"Role of Prostate V olume in Prostate Cancer Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1205reduce the number of patients undergoing prostate biopsy  without significantly compromising the cancer detection.23,24  The usefulness of PSAD for PCa detection is widely ac - cepted in the PSA range of 4.0-10.0 ng/mL; however, this  has been controversial and it’s advantages have not been  fully accepted.25,26 Prospective multi-center studies with a  larger number of patients are needed to firmly establish the  usefulness of PSAD.",Non-OADS,/arxiv_data1/oa_pdf/ab/5b/ymj-54-1202.PMC3743199.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1206PSA, age, prostate volume, and race in predicting positive prostate  biopsy findings.",Non-OADS,/arxiv_data1/oa_pdf/ab/5b/ymj-54-1202.PMC3743199.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1241Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1241 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1241-1247, 2013 Clinical Significance of Serum CA-125 in Korean   Females with Ascites So Young Bae, Jun Haeng Lee, Jun Young Park, Da-min Kim, Byung-Hoon Min,   Poong-Lyul Rhee, and Jae J. Kim Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/61/44/ymj-54-1241.PMC3743200.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Mycobacterium tuberculosis  is endemic in Korea.",Non-OADS,/arxiv_data1/oa_pdf/61/44/ymj-54-1241.PMC3743200.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1242initial diagnosis.,Non-OADS,/arxiv_data1/oa_pdf/61/44/ymj-54-1241.PMC3743200.pdf
Serum CA-125 for Female with Ascites Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1243Table 1.,Non-OADS,/arxiv_data1/oa_pdf/61/44/ymj-54-1241.PMC3743200.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1244was significantly higher than that in the tuberculous perito - nitis group ( p≤0.01, Mann-Whitney test).",Non-OADS,/arxiv_data1/oa_pdf/61/44/ymj-54-1241.PMC3743200.pdf
Serum CA-125 for Female with Ascites Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1245tuberculous peritonitis may depend on the prevalence of tu - berculosis in a particular society.,Non-OADS,/arxiv_data1/oa_pdf/61/44/ymj-54-1241.PMC3743200.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1246surgery, as serum CA-125 level rapidly returned to normal  when anti- Mycobacterium  medication was given.21,22 In conclusion, the possibility of tuberculous peritonitis  should be considered in the differential diagnosis of patients  with ascites and high serum CA-125 level.",Non-OADS,/arxiv_data1/oa_pdf/61/44/ymj-54-1241.PMC3743200.pdf
Serum CA-125 for Female with Ascites Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1247cer and endometriosis.,Non-OADS,/arxiv_data1/oa_pdf/61/44/ymj-54-1241.PMC3743200.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1248Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1248 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1248-1252, 2013 Modified Mandibulotomy Technique to Reduce Postoperative  Complications: 5-Year Results Hye-Young Na,1 Eun-Joo Choi,1 Eun-Chang Choi,2 Hyung Jun Kim,1 In-Ho Cha,1 and Woong Nam1 1Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University, Seoul; 2Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b0/78/ymj-54-1248.PMC3743201.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  To review the 5-year outcomes of our modified mandibulotomy tech - nique.",Non-OADS,/arxiv_data1/oa_pdf/b0/78/ymj-54-1248.PMC3743201.pdf
Modified Mandibulotomy without Complications Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1249critical in preventing postoperative malocclusion.,Non-OADS,/arxiv_data1/oa_pdf/b0/78/ymj-54-1248.PMC3743201.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1250molar pad, and base of tongue when there are no clinical or  radiological findings of bony invasion, can provide a clear  surgical view of the primary lesion and facilitate an en-bloc  resection.1-3 In this study, 70% of patients had tumors in the  posterior oral cavity and oropharynx.",Non-OADS,/arxiv_data1/oa_pdf/b0/78/ymj-54-1248.PMC3743201.pdf
Modified Mandibulotomy without Complications Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1251REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b0/78/ymj-54-1248.PMC3743201.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1252101:e65-70.,Non-OADS,/arxiv_data1/oa_pdf/b0/78/ymj-54-1248.PMC3743201.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1127Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1127 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1127-1136, 2013 Reduced Food Intake is the Major Contributor to the Protective  Effect of Rimonabant on Islet in Established   Obesity-Associated Type 2 Diabetes Sang-Man Jin,1 Bae Jun Oh,2 Suel Lee,2 Jung Mook Choi,3 Soo Jin Yang,4 Sung Woo Park,5  Kwang-Won Kim,1 Jae Hyeon Kim,1 and Cheol-Young Park5 1Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; 2Samsung Biomedical Research Institute, Seoul; 3Diabetes Research Institute, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul; 4Department of Food and Nutrition, Chonnam National University, Gwangju; 5Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital,  Sungkyunkwan University School of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/1b/84/ymj-54-1127.PMC3743202.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Although the presence of cannabinoid type 1 (CB1) receptor in islets has  been reported, the major contributor to the protective effect of rimonabant on islet  morphology is unknown.",Non-OADS,/arxiv_data1/oa_pdf/1b/84/ymj-54-1127.PMC3743202.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1128more, if the effect is reproducible, we planned to determine  whether the protective effect of rimonabant is independent  of reduced food intake.",Non-OADS,/arxiv_data1/oa_pdf/1b/84/ymj-54-1127.PMC3743202.pdf
"Rimonabant in Established Diabetes Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1129were determined by an ELISA kit (Crystal Chem, Downers  Grove, IL, USA).",Non-OADS,/arxiv_data1/oa_pdf/1b/84/ymj-54-1127.PMC3743202.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 11300.05 for both time and interaction by repeated measures  ANOV A) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/1b/84/ymj-54-1127.PMC3743202.pdf
Rimonabant in Established Diabetes Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1131 Control    Rimonabant    Pair-feeding    Rosiglitazone      Control    Rimonabant    Pair-feeding    Rosiglitazone      Control    Rimonabant    Pair-feeding    Rosiglitazone     Control    Rimonabant    Pair-feeding    Rosiglitazone      Control    Rimonabant    Pair-feeding    Rosiglitazone      Control    Rimonabant    Pair-feeding    Rosiglitazone     Fig.,Non-OADS,/arxiv_data1/oa_pdf/1b/84/ymj-54-1127.PMC3743202.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1132 0.00.51.01.5Beta cell area/pancreas area (%) Control Rimonabant Pair-fed Rosiglitazone†* LETO     OLETF Control group Pair-fed control group Rimonabant group Rosiglitazone groupLETO OLETF A B Fig.,Non-OADS,/arxiv_data1/oa_pdf/1b/84/ymj-54-1127.PMC3743202.pdf
Rimonabant in Established Diabetes Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1133mass than that of control group.,Non-OADS,/arxiv_data1/oa_pdf/1b/84/ymj-54-1127.PMC3743202.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1134were comparable to that of rosiglitazone group, could ex - plain the reduced islet fibrosis.",Non-OADS,/arxiv_data1/oa_pdf/1b/84/ymj-54-1127.PMC3743202.pdf
Rimonabant in Established Diabetes Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 113511.,Non-OADS,/arxiv_data1/oa_pdf/1b/84/ymj-54-1127.PMC3743202.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 113628.,Non-OADS,/arxiv_data1/oa_pdf/1b/84/ymj-54-1127.PMC3743202.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1091Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1091 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1091-1097, 2013 Comparison of Drainage Volume of Chronic Subdural  Hematoma According to Drainage Catheter Type Gun-Young Lee,1 Chang Hyun Oh,2 Yu Shik Shim,1 Seung Hwan Yoon,1  Hyeong-Chun Park,1 Chong Oon Park,1 and Dongkeun Hyun1 1Department of Neurosurgery, School of Medicine, Inha University, Incheon; 2Department of Neurosurgery, Guro Teun Teun Hospital, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ab/94/ymj-54-1091.PMC3743203.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  To assess the therapeutic value of two different drainage catheters in  treating chronic subdural hematoma (CSDH).",Non-OADS,/arxiv_data1/oa_pdf/ab/94/ymj-54-1091.PMC3743203.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1092text of the current literature.,Non-OADS,/arxiv_data1/oa_pdf/ab/94/ymj-54-1091.PMC3743203.pdf
"Drainage of CSDH Based on Catheter Type Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1093pared with each other in total drainage volume, initial drain - age volume within 2 days, percentage of initial drainage vol - ume per total drainage volume, duration of catheter insertion,  and reoperation rate.",Non-OADS,/arxiv_data1/oa_pdf/ab/94/ymj-54-1091.PMC3743203.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1094ference was statistically significant ( p=0.034).,OADS,/arxiv_data1/oa_pdf/ab/94/ymj-54-1091.PMC3743203.pdf
"Drainage of CSDH Based on Catheter Type Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1095sion after surgery has also been suggested to contribute to  the recurrence of CSDH.11,19 Interestingly, the literature in - dicates that the rate of recurrence is not significantly differ - ent for different surgical methods.",Non-OADS,/arxiv_data1/oa_pdf/ab/94/ymj-54-1091.PMC3743203.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1096chronic subdural hematoma.,Non-OADS,/arxiv_data1/oa_pdf/ab/94/ymj-54-1091.PMC3743203.pdf
Drainage of CSDH Based on Catheter Type Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 109753:512-5.,Non-OADS,/arxiv_data1/oa_pdf/ab/94/ymj-54-1091.PMC3743203.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1293Case Reporthttp://dx.doi.org/10.3349/ymj.2013.54.5.1293 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1293-1296, 2013 Familial Occurrence of Pulmonary Embolism after Intravenous,  Adipose Tissue-Derived Stem Cell Therapy Jae Woo Jung, Minsuk Kwon, Jae Chol Choi, Jong Wook Shin, In Won Park,   Byoung Whui Choi, and Jae Yeol Kim  Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4b/62/ymj-54-1293.PMC3743204.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.The therapeutic potential of human multipotent mesenchymal stromal cells, especial - ly human adipose tissue-derived stem cells (hASC), is promising.",Non-OADS,/arxiv_data1/oa_pdf/4b/62/ymj-54-1293.PMC3743204.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1294had not recently taken airplane for a long period.,Non-OADS,/arxiv_data1/oa_pdf/4b/62/ymj-54-1293.PMC3743204.pdf
Pulmonary Embolism after Stem Cell Therapy Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1295injected hASC provoked coagulation pathway and resulted  in multiple pulmonary embolism in our three cases.,Non-OADS,/arxiv_data1/oa_pdf/4b/62/ymj-54-1293.PMC3743204.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1296H, et al.",Non-OADS,/arxiv_data1/oa_pdf/4b/62/ymj-54-1293.PMC3743204.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1119Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1119 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1119-1126, 2013 Optimal Anticoagulation during Off Pump Coronary Artery  Bypass in Patients Recently Exposed to Clopidogrel Young Song,1,2 Jong Wook Song,1,2 Jae Kwang Shim,1,2 and Young Lan Kwak1,2,3 1Department of Anesthesiology and Pain Medicine, 2Anesthesia and Pain Research Institute,  and 3Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/21/51/ymj-54-1119.PMC3743205.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  The aim of this study was to find an optimal range of activated clotting  time (ACT) during off-pump coronary artery bypass surgery (OPCAB) yielding  ischemic protection without the risk of hemorrhagic complications in patients with  recent exposure to dual antiplatelet therapy.",Non-OADS,/arxiv_data1/oa_pdf/21/51/ymj-54-1119.PMC3743205.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1120emergent conversion to on-pump coronary artery bypass  grafting (CABG), or excessive postoperative bleeding due  to any obvious surgical bleeder.",Non-OADS,/arxiv_data1/oa_pdf/21/51/ymj-54-1119.PMC3743205.pdf
Optimal Anticoagulation during OPCAB Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1121n=time interval number;  N=total number of time intervals;  c=ACT measured at each end of time interval (sec)  Endpoints The primary end point of the current study was to compare  combined hemorrhagic and ischemic outcomes in relation  to the tertile distribution of TW A ACT.,Non-OADS,/arxiv_data1/oa_pdf/21/51/ymj-54-1119.PMC3743205.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1122levels (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/21/51/ymj-54-1119.PMC3743205.pdf
"Optimal Anticoagulation during OPCAB Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1123246 patients (90%, 76%, and 75% in each tertile, respec - tively).",Non-OADS,/arxiv_data1/oa_pdf/21/51/ymj-54-1119.PMC3743205.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1124tions is of critical importance.,Non-OADS,/arxiv_data1/oa_pdf/21/51/ymj-54-1119.PMC3743205.pdf
"Optimal Anticoagulation during OPCAB Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1125As cumulating evidence supports its beneficial role in the  PCI setting, further clinical experience and research regard - ing the optimal intraoperative anticoagulation management  in patients treated by ticagrelor are warranted.",Non-OADS,/arxiv_data1/oa_pdf/21/51/ymj-54-1119.PMC3743205.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1126coronary artery bypass grafting: comparison between on-pump  and off-pump techniques.,Non-OADS,/arxiv_data1/oa_pdf/21/51/ymj-54-1119.PMC3743205.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1289Case Reporthttp://dx.doi.org/10.3349/ymj.2013.54.5.1289 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1289-1292, 2013 Spurious Elevation of Glucose Concentration during  Administration of High Dose of Ascorbic Acid in a Patient   with Type 2 Diabetes on Hemodialysis Soo Kyoung Kim,1,2 Jong Ryeal Hahm,1,2 Ho-Su Kim,1 Sungsu Kim,1 Tae Sik Jung,1,2  Jung Hwa Jung,1 Hye Ryun Lee,3 and Deok Ryong Kim4 Departments of 1Internal Medicine, 3Laboratory Medicine, 4Biochemistry, and 2Institute of Health Sciences,  Gyeongsang National University School of Medicine, Jinju, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c2/f5/ymj-54-1289.PMC3743206.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.We describe herein a case of life-threatening hypoglycemia due to spurious eleva - tion of glucose concentration during the administration of ascorbic acid in a type 2  diabetic patient.",Non-OADS,/arxiv_data1/oa_pdf/c2/f5/ymj-54-1289.PMC3743206.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1290reading in SMBG device could be interfered by ascorbic  acid, the high dose ascorbic acid treatment was stopped im - mediately.",Non-OADS,/arxiv_data1/oa_pdf/c2/f5/ymj-54-1289.PMC3743206.pdf
"Spurious Hypoglycemia and Ascorbic Acid Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1291that her glucose concentration was too high to cause the de - velop hypoglycemia before the present event, and she did  not take high dose of ascorbic acid.",Non-OADS,/arxiv_data1/oa_pdf/c2/f5/ymj-54-1289.PMC3743206.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 129210.,Non-OADS,/arxiv_data1/oa_pdf/c2/f5/ymj-54-1289.PMC3743206.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1297Letter to the Editorhttp://dx.doi.org/10.3349/ymj.2013.54.5.1297 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1297-1298, 2013 Human Infection of Salmonella  Matadi in Korea Deog-Yong Lee and Yeonho Kang   Division of Enteric Diseases, Korean Centers for Disease Control and Prevention, Cheongwon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/26/39/ymj-54-1297.PMC3743207.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.To the Editor: Salmonella  Matadi ( S. Matadi) was firstly isolated in 19541 from Mata - di, the regional capital of Belgian Congo which was the former name of Democratic  Republic of the Congo.",Non-OADS,/arxiv_data1/oa_pdf/26/39/ymj-54-1297.PMC3743207.pdf
Deog-Y ong Lee and Y eonho Kang Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1298ed salmonellosis in New Y ork State.,Non-OADS,/arxiv_data1/oa_pdf/26/39/ymj-54-1297.PMC3743207.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1075Review Articlehttp://dx.doi.org/10.3349/ymj.2013.54.5.1075 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(5):1075-1083, 2013 Stent Evaluation with Optical Coherence Tomography Seung-Yul Lee1 and Myeong-Ki Hong1,2 1Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul; 2Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/dc/f4/ymj-54-1075.PMC3743208.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Optical coherence tomography (OCT) has been recently applied to investigate cor - onary artery disease in interventional cardiology.",Non-OADS,/arxiv_data1/oa_pdf/dc/f4/ymj-54-1075.PMC3743208.pdf
"Seung-Y ul Lee and Myeong-Ki Hong Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1076min vs. 11.2±2.5 min, p<0.01) and a higher acquisition rate  of clear images (99.4% vs. 80.8%, p<0.01) than time-do - main OCT.11 Additionally, frequency-domain OCT was not  related to any adverse cardiac events.11 Frequency-domain  OCT showed better detection of incomplete stent apposi - tion (malapposition) or uncovered strut, compared with  IVUS.12,13 STENT STRUT APPOSITION In IVUS study, incomplete stent apposition is defined as a  separation of at least one stent strut from the intimal surface  of the arterial wall that is not overlapping a side branch and  has evidence of blood flow behind the strut.14 OCT enables  one to observe apposition of a stent strut more accurately  compared to IVUS; malapposed stent struts on OCT are de - fined as a distance between the strut marker and lumen con - tour greater than the strut thickness plus the axial resolution  of OCT.15 Accordingly, definitions of malapposed struts dif - fer according to type of coronary stent because the thick - ness of struts and applied polymer vary.",OADS,/arxiv_data1/oa_pdf/dc/f4/ymj-54-1075.PMC3743208.pdf
Stent Evaluation with OCT Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1077delayed neointimal coverage of a DES is somewhat to be  expected.,Non-OADS,/arxiv_data1/oa_pdf/dc/f4/ymj-54-1075.PMC3743208.pdf
Seung-Y ul Lee and Myeong-Ki Hong Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1078over time.,Non-OADS,/arxiv_data1/oa_pdf/dc/f4/ymj-54-1075.PMC3743208.pdf
"Stent Evaluation with OCT Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1079ered patterns of neointima were more frequently observed  in ISR lesions than in non-ISR lesions.40 However, to clari - fy the clinical implications of different neointimal features,  further investigations are needed.",Non-OADS,/arxiv_data1/oa_pdf/dc/f4/ymj-54-1075.PMC3743208.pdf
Seung-Y ul Lee and Myeong-Ki Hong Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1080penetration depth of about 2 mm and is not able to visualize  structures behind severely attenuated components such as  lipid-laden neointima or thrombus.,Non-OADS,/arxiv_data1/oa_pdf/dc/f4/ymj-54-1075.PMC3743208.pdf
"Stent Evaluation with OCT Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1081A V , et al.",Non-OADS,/arxiv_data1/oa_pdf/dc/f4/ymj-54-1075.PMC3743208.pdf
Seung-Y ul Lee and Myeong-Ki Hong Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1082patterns of stent restenosis.,Non-OADS,/arxiv_data1/oa_pdf/dc/f4/ymj-54-1075.PMC3743208.pdf
Stent Evaluation with OCT Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1083polymer-coated zotarolimus-eluting stent vs. a fluoropolymer- coated everolimus-eluting stent at 13-month follow-up: an optical  coherence tomography substudy from the RESOLUTE All Com - ers trial.,Non-OADS,/arxiv_data1/oa_pdf/dc/f4/ymj-54-1075.PMC3743208.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/45/elt008.PMC3743258.pdf
"Phage genes can be identified by similarity to known homologs in a relevant database of viral pro- teins, such as Phantome (http://www.phantome.",Non-OADS,/arxiv_data1/oa_pdf/42/45/elt008.PMC3743258.pdf
http://dx.doi.org/10.1016/j.nicl.2013.04.011 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/4b/b2/main.PMC3743264.pdf
"Access to this data and its analysis canThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://www.cpc.unc.edu/measure/publications/sr-08-43/at_download/document, accessed September 2010.",Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://www.cpc .unc.edu/measure/publications/pdf/ms-09-34.pdf, accessed August2010.",Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://www.bt.cdc.gov/disasters/surveillance/, accessed 31 August 2010.",Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://www.alnap.org/pool/files/needs-assessment-final-report.pdf, accessed 6September 2012.",Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://www.who.int/healthmetrics/documents/hmn_framework200803.pdf, accessed 1 June 2010.",OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://www.unhcr.org/refworld/ docid/460a8ccc2.html, accessed 6 September 2012.",Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://www.alnap.org/pool/files/ocha.pdf, accessed 6 September 2012.",OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
Online at: http://www.humanitarianinfo.org/iasc/downloaddoc.aspx?docID ¼4709& type¼pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
Online at: http://www.irinnews.org/pdf/HEALTH INFORMATION SYSTEMS FOR DISASTER SITUATIONS 505,Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://themimu.info/ 3W/index.php, accessed November 2011.",Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://themimu.info/Pcodes/index.php, accessed November 2011.",Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://ochaonline.un .org/roap/WhatWeDo/InformationManagement/tabid/4490/Default .aspx, accessed November 2011.",Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://www.pacificdisaster.net/pdnadmin/data/original/AsiaPac_OCHA_ CommonOperationalDatasets_v1.pdf, accessed 31 August 2010.OCHA.",OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://ochaonline.un.org/roap/ MapCentre/HazardMaps/tabid/3725/language/en-US/Default.aspx, accessed 31 January 2011.",Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://www.gppi.net/fileadmin/gppi/GPPi- URD_Cluster_II_Evaluation_SYNTHESIS_REPORT_e.pdf, accessed6 September 2012.",OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
Online at: http://www.ausaid.gov.au/publications/documents/ pakistan_eval.pdf.506 HEALTH POLICY AND PLANNING,Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
Online at: http://unic.un.org/imucms/userfiles/ yangon/file/post-nargis_joint_assessment_all_pages.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
Online at: http://ochaonline.un.org/OchaLinkClick.aspx?link ¼ ocha&docId ¼1128739.,Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://www.whomyanmar.org/LinkFiles/Publications_EWAR_NARGIS_SOP.doc,accessed November 2011.",Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://hdr.undp.org/en/media/ HDR_2011_EN_Table1.pdf, accessed 6 September 2012.",Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://www.rhrc.org/resources/rhrkit.pdf, accessed 31 August 2010.",Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://www.drugdonations.org/mrhealthkit.pdf, accessed 31 August2010.",Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://www.who.int/ healthinfo/statistics/toolkit_hss/EN_PDF_Toolkit_HSS_InformationSystems.pdf, accessed 1 June 2010. WHO.",OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://www.whoindia.org/LinkFiles/Sustainable_Develop ment_Part_IV.pdf, accessed August 2010. WHO Myanmar.",Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"Online at: http://www.themimu.info/ docs/P-CODE.zip, accessed November 2011.",Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
Online at: http://membres.multimania.fr/dloquercio/know-how/Ressources/radio/Communication%20in%20disasters.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/c9/czs081.PMC3743306.pdf
"/C15Global health policy may face a conflict between maximizing distributive justice and ensuring procedural justice with regards to health systems improvement.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/d2/czs094.PMC3743307.pdf
"Online at: http://data.worldbank.org/data-catalog/world-development-indicators, accessed 23 November 2010.",Non-OADS,/arxiv_data1/oa_pdf/4e/d2/czs094.PMC3743307.pdf
"Keywords Immunization, health equity, reaching every district, reaching every communityThis is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/fa/czs096.PMC3743308.pdf
"Online at: http://www.gavialliance.org/resources/Evaluation_of_ISS_Funding_Aug04.pdf, accessed January 2010.",Non-OADS,/arxiv_data1/oa_pdf/cf/fa/czs096.PMC3743308.pdf
"Online at: http://www.adb.org/sites/default/files/pub/2002/indigenous_cam.pdf, accessed 30 March2012.",Non-OADS,/arxiv_data1/oa_pdf/cf/fa/czs096.PMC3743308.pdf
"Online at: http://www.gavialliance.org/performance/country_results/index.php?countID ¼11, accessed January 2010.",OADS,/arxiv_data1/oa_pdf/cf/fa/czs096.PMC3743308.pdf
"Online at: http://www.statcompiler.com/index.cfm, accessed December2011.",OADS,/arxiv_data1/oa_pdf/cf/fa/czs096.PMC3743308.pdf
"Online at: http://www.unicef.org/eapro/Health_ Service_Access_Among_Poor_Communities_Phnom_Penh_Low.pdf, accessed January 2010.",Non-OADS,/arxiv_data1/oa_pdf/cf/fa/czs096.PMC3743308.pdf
Online at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/cf/fa/czs096.PMC3743308.pdf
"Online at: http://apps.who.int/ghodata/, accessed January 2010. WHO, UNICEF.",Non-OADS,/arxiv_data1/oa_pdf/cf/fa/czs096.PMC3743308.pdf
Online at: http://www.who .int/vaccines-documents/DocsPDF05/GIVS_Final_EN.pdf (Accessed January 2010).REACHING EVERY COMMUNITY 535,Non-OADS,/arxiv_data1/oa_pdf/cf/fa/czs096.PMC3743308.pdf
Available from: http://www.who.int/ mediacentre/factsheets/fs277/en/.,Non-OADS,/arxiv_data1/oa_pdf/57/12/JRMS-18-66.PMC3743325.pdf
Available  from: http://en.wikipedia.org/wiki/Metabolic_syndrome.,Non-OADS,/arxiv_data1/oa_pdf/13/d4/IJEM-17-545.PMC3743352.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/13/d4/IJEM-17-545.PMC3743352.pdf
Available from: http://www.idf.org/diabetesatlas/5e/the-global-burden [Last accessed on 2013 Feb 1].,Non-OADS,/arxiv_data1/oa_pdf/68/ef/IJEM-17-548.PMC3743353.pdf
Available at: http://www.who.int/mediacentre/factsheets/fs312/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/68/ef/IJEM-17-548.PMC3743353.pdf
Available on Pakistan  social and living standards measurement survey (2005-2006) http://web.worldbank.org.,Non-OADS,/arxiv_data1/oa_pdf/68/ef/IJEM-17-548.PMC3743353.pdf
Available from: http://wdronline.worldbank.org.,Non-OADS,/arxiv_data1/oa_pdf/68/ef/IJEM-17-548.PMC3743353.pdf
Available  from: http://www.idf.org/women-and-diabetes.,Non-OADS,/arxiv_data1/oa_pdf/68/ef/IJEM-17-548.PMC3743353.pdf
Available from: http://www.cdc.gov/Diabetesandwomen\Plan\CDC groupsespeciallyaffected.htm [Last accessed on 2013 Feb 1].,Non-OADS,/arxiv_data1/oa_pdf/68/ef/IJEM-17-548.PMC3743353.pdf
Available from: http://www.idf.org/sites/default/files/Global_Diabetes_Plan_Final.pdf [Last accessed on 2013 Nov 26].,Non-OADS,/arxiv_data1/oa_pdf/68/ef/IJEM-17-548.PMC3743353.pdf
Available from: http://www.rcn.org.uk/data/assets/pdf_file/0011/78572/002011.pdf [Last accessed on 2012 Nov 26].,OADS,/arxiv_data1/oa_pdf/68/ef/IJEM-17-548.PMC3743353.pdf
Available from: http://www.idf.org/diabetes-atlas-update-2012.,Non-OADS,/arxiv_data1/oa_pdf/68/ef/IJEM-17-548.PMC3743353.pdf
Available from: http://www.uis.unesco.org/Education/Documents/unesco-world-atlas-gender-education-2012.pdf [Last accessed on 2012 Apr 12].,Non-OADS,/arxiv_data1/oa_pdf/68/ef/IJEM-17-548.PMC3743353.pdf
Available from: http://www.idf.org/sites/default/files/Policy_Briefing_ GlobalHealth.pdf [Last accessed on 2012 Nov 22].,Non-OADS,/arxiv_data1/oa_pdf/68/ef/IJEM-17-548.PMC3743353.pdf
Available from: http://www.worlddiabetesfoundation.org/sites/default/files/Diabetes%20Women%20and%20Development_Expert%20Meeting%202008.pdf.,Non-OADS,/arxiv_data1/oa_pdf/68/ef/IJEM-17-548.PMC3743353.pdf
A vailable from: http://www.cdc.gov/diabetes/pubs/women/index.,Non-OADS,/arxiv_data1/oa_pdf/68/ef/IJEM-17-548.PMC3743353.pdf
A vailable from: http://www.idf.org/diabetesatlas/5e/ diabetes-and-the-millennium-development-goals.,Non-OADS,/arxiv_data1/oa_pdf/68/ef/IJEM-17-548.PMC3743353.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/5d/19/IJEM-17-563.PMC3743354.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/ae/a4/IJEM-17-568.PMC3743355.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3y sr3me for the free  applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/ae/a4/IJEM-17-568.PMC3743355.pdf
Available from: http://www.who.int/topics/alcohol_drinking/en/[Last accessed on 2012 Sep 24].,Non-OADS,/arxiv_data1/oa_pdf/41/37/IJEM-17-580.PMC3743356.pdf
Available from:  http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/41/37/IJEM-17-580.PMC3743356.pdf
Available from: http://www.unodc.org/india/national_Survey.html [Last accessed on 2012 Aug 2].,OADS,/arxiv_data1/oa_pdf/41/37/IJEM-17-580.PMC3743356.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22730517 [Last accessed on 2012 Aug 2].,OADS,/arxiv_data1/oa_pdf/41/37/IJEM-17-580.PMC3743356.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22802427 [Last accessed on 2012 Jul 25].,OADS,/arxiv_data1/oa_pdf/41/37/IJEM-17-580.PMC3743356.pdf
Available from: http://www.idf.org/ diabetesatlas/5e/the-global-burden.,Non-OADS,/arxiv_data1/oa_pdf/37/a4/IJEM-17-594.PMC3743358.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/d3/dc/IJEM-17-602.PMC3743359.pdf
Available at http://clinicaltrials.gov/ct2/show/NCT01409239.,Non-OADS,/arxiv_data1/oa_pdf/a9/12/IJEM-17-611.PMC3743360.pdf
Available from: http://www.nhlbi.nih.gov/about/ ncep/ncep_pd.htm.,OADS,/arxiv_data1/oa_pdf/e4/06/IJEM-17-628.PMC3743362.pdf
Available from: http://www.nhlbi.,Non-OADS,/arxiv_data1/oa_pdf/e4/06/IJEM-17-628.PMC3743362.pdf
Available from: http://www.nhlbi.nih.gov/guidelines/cholesterol/ atp4/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/e4/06/IJEM-17-628.PMC3743362.pdf
Available from: http://www.acli.com/Events/Documents/ Tue22812%20‑%20Lipidology%20‑%20Pamela%20Morris.,Non-OADS,/arxiv_data1/oa_pdf/e4/06/IJEM-17-628.PMC3743362.pdf
[http://www.fda.gov/Drugs/DrugSafety].,Non-OADS,/arxiv_data1/oa_pdf/6e/70/IJEM-17-636.PMC3743363.pdf
Available from: http://www.seen.es/pdf/IDD%20NL%20email%20May%202011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/15/f8/IJEM-17-647.PMC3743364.pdf
Available from:  http://www.idf.org/diabetesatlas/.,Non-OADS,/arxiv_data1/oa_pdf/d0/b9/IJEM-17-653.PMC3743365.pdf
Available from: http://www.idf.org/diabetes-education-modules.,Non-OADS,/arxiv_data1/oa_pdf/d0/b9/IJEM-17-653.PMC3743365.pdf
Internet: Available from: http://www.glycemicindex.com [Last accessed on 2012 May 10].,Non-OADS,/arxiv_data1/oa_pdf/ac/de/IJEM-17-689.PMC3743371.pdf
Available from: http://www.emea.eu.int.,Non-OADS,/arxiv_data1/oa_pdf/58/a0/IJEM-17-709.PMC3743375.pdf
Available from: http://www.fda.gov/cder/foi/nda/99/021073A Actos.htm.,Non-OADS,/arxiv_data1/oa_pdf/58/a0/IJEM-17-709.PMC3743375.pdf
"Statistical analysis Online Graphpad Quickcalcs software (Graphpad  Software Inc, La Jolla, CA, USA, available at http://www.graphpad.com/quickcalcs/index.cfm) was used for statistical calculations.",OADS,/arxiv_data1/oa_pdf/78/db/IJEM-17-716.PMC3743376.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/85/f3/vhrm-9-457.PMC3743512.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2013:9 457–464Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  457ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S4970 2Vacuum-venipuncture skills: time required   and importance of tube order chieko Fujii Faculty of nursing and Medical care,   Keio University, Fujisawa, Japan correspondence: chieko Fujii   Faculty of nursing and Medical care,   Keio University, 4411 endo, Fujisawa,   Kanagawa 252-0883, Japan   Tel +81 466 49 6218   Fax +81 466 49 6218   email chieko@sfc.keio.ac.j pBackground:  The purpose of this study was to assess specific vacuum-venipuncture skills and  the influence of the time involved in skin puncture and blood collection.",Non-OADS,/arxiv_data1/oa_pdf/85/f3/vhrm-9-457.PMC3743512.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/85/f3/vhrm-9-457.PMC3743512.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/f3/vhrm-9-457.PMC3743512.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided theoriginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/3d/dkt155.PMC3743513.pdf
"http://www.who.int/mediacentre/ factsheets/fs104/en/index.html (10 April 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/a5/3d/dkt155.PMC3743513.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/36/8b/ppa-7-741.PMC3743518.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:7 741–749Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  741OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S4651 7Facilitators and barriers to hypertension   self-management in urban African Americans:  perspectives of patients and family members sarah J Flynn1,2 Jessica M Ameling1,2 Felicia hill-Briggs1–3 Jennifer l Wolff4,5 lee r Bone1,3 David M levine1,4 Debra l roter3 laPricia lewis-Boyer1,2 Annette r Fisher6 leon Purnell6 Patti l ephraim2,7 Jeffrey Barbers1,2 stephanie l Fitzpatrick1,2 Michael c Albert1,8 lisa A cooper1,2 Peter J Fagan9,10 Destiny Martin1 hema c ramamurthi1,2 l ebony Boulware1,2,7 1Department of Medicine, Johns hopkins  University school of Medicine, Baltimore, MD,   UsA; 2Welch center for Prevention, epidemiology,   and clinical research, Johns hopkins Medical  institutions, Baltimore, MD, UsA; 3Department  of health, Behavior, and society, Johns hopkins  Bloomberg school of Public health, Baltimore,   MD, UsA; 4Department of health Policy and  Management, Johns hopkins Bloomberg school  of Public health, Baltimore, MD, UsA; 5Division  of geriatric Medicine and gerontology, Johns  hopkins University school of Medicine, Baltimore,   MD, UsA; 6community and Provider Advisory  Board, Johns hopkins center to eliminate  cardiovascular health Disparities, Baltimore, MD,   UsA; 7Department of epidemiology, Johns hopkins  Bloomberg school of Public health, Baltimore,   MD, UsA; 8Johns hopkins community Physicians,   Johns hopkins Medical institutions, Baltimore, MD,   UsA; 9Department of Psychiatry and Behavioral  sciences, Johns hopkins University school of  Medicine, Baltimore, MD, UsA; 10Johns hopkins  healthcare llc, glen Burnie, MD, UsA correspondence: l ebony Boulware   Division of general internal Medicine and Welch  center for Prevention, epidemiology and clinical  research, 2024 e Monument street, suite 2-600,   Johns hopkins school of Medicine,   Baltimore, MD 21205, UsA   Tel +1 443 287 4388   Fax +1 410 955 0476   email lboulwa@jhmi.ed uIntroduction:  We aimed to inform the design of behavioral interventions by identifying  patients’ and their family members’ perceived facilitators and barriers to hypertension self- management.",Non-OADS,/arxiv_data1/oa_pdf/36/8b/ppa-7-741.PMC3743518.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/36/8b/ppa-7-741.PMC3743518.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/8b/ppa-7-741.PMC3743518.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/82/9a/idr-6-079.PMC3743519.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2013:6 79–81Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  79Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IDR.S4969 0streptococcus group C meningitis with cavernous  sinus thrombosis Mattew Clarke1 Hilary enuh1 Jessie saverimuttu2 Jay Nfonoyim3 1Department of Medicine, 2Division of  Infectious Disease, 3Critical Care Unit,   Richmond University Medical Center,   staten Island, NY, Usa Correspondence: Jessie saverimuttu   Division of Infectious Disease,  Department of Medicine, Richmond  University Medical Center, staten Island  NY 10310, Usa   email j saverimuttu@rumcsi.or gAbstract:  Group C Streptococcus (GCS) is a rare cause of bacteremia in humans.",Non-OADS,/arxiv_data1/oa_pdf/82/9a/idr-6-079.PMC3743519.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/82/9a/idr-6-079.PMC3743519.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/9a/idr-6-079.PMC3743519.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/42/ce/opth-7-1587.PMC3743520.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 1587–1590Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1587Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S4949 6Color vision abnormality as an initial presentation  of the complete type of congenital stationary  night blindness Xue tan aya aoki Yasuo Yanagi Department of Ophthalmology,   University of tokyo school of  Medicine, Hongo, Bunkyo-ku, tokyo,   Japan Correspondence: Yasuo Yanagi   Department of Ophthalmology,   University of tokyo school of   Medicine, 7-3-1 Hongo, Bunkyo-ku,   tokyo 113-8655, Japan   tel +81 3 5800 8660   Fax +81 3 3817 0798   email yanagi-tky@umin .ac.jpAbstract:  Patients with the complete form of congenital stationary night blindness (CSNB)  often have reduced visual acuity, myopia, impaired night vision, and sometimes nystagmus and  strabismus, however, they seldom complain of color vision abnormality.",Non-OADS,/arxiv_data1/oa_pdf/42/ce/opth-7-1587.PMC3743520.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/42/ce/opth-7-1587.PMC3743520.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/42/ce/opth-7-1587.PMC3743520.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9e/87/opth-7-1581.PMC3743521.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 1581–1585Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1581Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S4928 1Obvious optic disc swelling in a patient   with cryopyrin-associated periodic syndrome Mariko Kawai1 tadanobu Y oshikawa1 ryuta Nishikomori2 toshio Heike2 Kanji takahashi1 1Department of Ophthalmology,  Kansai Medical University, Osaka,  2Department of pediatrics, Graduate  school of Medicine, Kyoto University,  Kyoto, Japan Correspondence: tadanobu Yoshikawa   Kansai Medical University, Department  of Ophthalmology, 2-5-1 shinmachi,  Hirakata, Osaka, Japan   tel +81 072 804 0101   Fax +81 072 804 2039   email yoshikat@takii.kmu.ac.j pAbstract:  Cryopyrin-associated periodic syndrome (CAPS) is a group of rare hereditary  autoinflammatory diseases caused by mutations of the NLRP3  gene, and leads to excessive  production of the proinflammatory cytokine, interleukin-l β.",Non-OADS,/arxiv_data1/oa_pdf/9e/87/opth-7-1581.PMC3743521.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/9e/87/opth-7-1581.PMC3743521.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/87/opth-7-1581.PMC3743521.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c7/83/cia-8-1051.PMC3743522.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1051–1054Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1051OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S4712 1Pacemaker implantation complication rates   in elderly and young patients Kazım Serhan Özcan Damirbek Osmonov servet Altay Cevdet Dönmez Ersin Yıldırım Ceyhan Türkkan Barış Güngör Ahmet Ekmekçi Ahmet Taha Alper Kadir Gürkan I.zzet erdinler Department of Cardiology, siyami  Ersek Cardiovascular and Thoracic  surgery Center, Istanbul, T urkey Correspondence: Kazım Serhan Özcan   Barbaros Mahallesi, Bekir Sıtkı   Sezgin Sokak, Özlem Sitesi,   B blok, Daire: 9 Üsküdar,   Koşuyolu-I ˙stanbul, 34087, Turkey   Tel +90 532 674 2429;   +90 216 545 4736   Fax +90 216 337 9719   email serhandr@gmail.co m;   serhan_oz@yahoo.co mAims:  To evaluate the complication rate differences between elderly and younger patients who  receive a permanent pacemaker implantation.",Non-OADS,/arxiv_data1/oa_pdf/c7/83/cia-8-1051.PMC3743522.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/c7/83/cia-8-1051.PMC3743522.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/83/cia-8-1051.PMC3743522.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/46/e3/opth-7-1591.PMC3743523.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 1591–1595Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1591Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5063 4Intravitreal aflibercept for polypoidal   choroidal vasculopathy after developing   ranibizumab tachyphylaxis Masahiro Miura1,2 Takuya iwasaki1,2 hiroshi goto2 1Department of Ophthalmology,  Tokyo Medical University, Ibaraki  Medical Center, Ami, Ibaraki, Japan;  2Department of Ophthalmology,  Tokyo Medical University,  Nishi-Shinjuku, Tokyo, Japan Correspondence: Masahiro Miura   Department of Ophthalmology,   Tokyo Medical University,   Ibaraki Medical Center, 3-20-1 Chuo,  Ami, Inashiki, Ibaraki 300395, Japan   Tel +81 298 87 1161   Fax +81 298 87 7656   email m-miura@tokyo-med.ac.j pPurpose:  To evaluate the effect of aflibercept treatment after developing ranibizumab   tachyphylaxis for the treatment of polypoidal choroidal vasculopathy (PCV).",Non-OADS,/arxiv_data1/oa_pdf/46/e3/opth-7-1591.PMC3743523.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/46/e3/opth-7-1591.PMC3743523.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/e3/opth-7-1591.PMC3743523.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/61/5b/jaa-6-109.PMC3743524.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Asthma and Allergy 2013:6 109–116Journal of Asthma and Allergy Dove press submit your manuscript | www.dovepress.co m Dove press  109OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S4882 7effects of two inhaled corticosteroid/long-acting  beta-agonist combinations on small-airway  dysfunction in mild asthmatics measured   by impulse oscillometry Bill Diong1 Kshitiz singh2 rogelio Menendez3 1school of engineering, southern  Polytechnic state University, Marietta,   gA, UsA; 2college of science  and engineering, Texas christian  University, Fort Worth, TX, UsA;   3Allergy and Asthma research center  of el Paso, el Paso, TX, UsA correspondence: Bill Diong   school of engineering, southern  Polytechnic state University,   1100 south Marietta Parkway,   Marietta, gA 30060, UsA   Tel +1 678 915 5574   Fax +1 678 915 5527   email bdiong@spsu.ed uBackground:  We previously showed that the long-acting beta agonist (LABA) salmeterol  as inhalation powder or metered-dose inhaler improves lung-function parameters assessed by  impulse oscillometry (IOS) in 2- to 5-year-old children with reversible-airway disease within  15 minutes.",Non-OADS,/arxiv_data1/oa_pdf/61/5b/jaa-6-109.PMC3743524.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/61/5b/jaa-6-109.PMC3743524.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/5b/jaa-6-109.PMC3743524.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2a/36/cia-8-1015.PMC3743526.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1015–1021Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1015OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5023 8Pharmacodynamics of vancomycin in elderly  patients aged 75 years or older with methicillin- resistant Staphylococcus aureus  hospital-acquired  pneumonia Fumihiro Mizokami1 Masataka shibasaki2 Yasunori Y oshizue1 Takeshi noro1 T omohiro Mizuno3 Katsunori Furuta4 1Department of Pharmacy, 2Department  of respiratory Medicine, national  Center for geriatrics and gerontology,  Obu, 3Department of Analytical  Pharmacology, Meijo University  graduate school of Pharmacy, n agoya,  4Department of Clinical research and  Development, national Center for  geriatrics and gerontology, Obu, Japan Correspondence: Fumihiro Mizokami   Department of Pharmacy,   national Center for geriatrics   and gerontology, 35 gengo,   Morioka, Obu, Aichi 474-8511, Japan   Tel +815 6246 2311   Fax +815 6248 8895   email mizokami@ncgg.go.j pBackground:  Methicillin-resistant Staphylococcus aureus  (MRSA) infections are associated  with significant mortality and health care costs.",Non-OADS,/arxiv_data1/oa_pdf/2a/36/cia-8-1015.PMC3743526.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/2a/36/cia-8-1015.PMC3743526.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/36/cia-8-1015.PMC3743526.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3a/93/cia-8-1047.PMC3743527.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1047–1050Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1047OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S4969 8Trend of the incidence of lumbar disc herniation:  decreasing with aging in the elderly Daoyou Ma1 Yunbiao liang1 Daoming Wang1 Zejiang liu1 Wei Zhang1 Tantan Ma1 liang Zhang1 Xingjun lu1 Zhiyou Cai2 1Department of rehabilitation,   the lu’an Affiliated hospital of  Anhui Medical University, lu’an  People’s hospital, lu’an, Anhui  Province, People’s republic of China;   2Department of n eurology, the lu’an  Affiliated hospital of Anhui Medical  University, lu’an People’s hospital,   lu’an, Anhui Province, People’s  republic of China Correspondence: Zhiyou Cai   Department of neurology, the   Lu’an Affiliated Hospital of Anhui   Medical University, lu’an People’s  hospital, no 21 Wanxi West road,   lu’an, Anhui Province, People’s   republic of China, 237005   Tel +86 564 333 8520   Fax +86 564 333 8520   email c0909@hotmail.co mBackground:  Compelling evidence has shown that the incidence of lumbar disc herniation  (LDH) increases with age.",Non-OADS,/arxiv_data1/oa_pdf/3a/93/cia-8-1047.PMC3743527.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/3a/93/cia-8-1047.PMC3743527.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/93/cia-8-1047.PMC3743527.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/cb/ott-6-1041.PMC3743528.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1041–1045OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1041Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S4959 7single nucleotide polymorphisms in the  mitochondrial displacement loop and age   at onset of non-hodgkin lymphoma haiyan Fan1 cuiju Wang2 Zhanjun guo1 1Department of gastroenterology  and hepatology, 2Department of  gynaecology Ultrasound, The Fourth  hospital of hebei Medical University,   shijiazhuang, People’s republic of  china correspondence: Zhanjun guo   Department of gastroenterology and  hepatology, The Fourth hospital of  hebei Medical University, 12 Jiankang  road, shijiazhuang 050011, People’s  republic of china   Tel +86 311 8609 534   email zjguo5886@aliyun.co mObjective:  Single nucleotide polymorphisms (SNPs) accumulated frequently in the mitochon - drial displacement loop (D-loop) in many cancers.",Non-OADS,/arxiv_data1/oa_pdf/29/cb/ott-6-1041.PMC3743528.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/29/cb/ott-6-1041.PMC3743528.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/cb/ott-6-1041.PMC3743528.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/77/jbm-4-101.PMC3743529.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd.  Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Blood Medicine 2013:4 101–110Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  101Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S3547 8Deferasirox: appraisal of safety and efficacy   in long-term therapy Preeti Chaudhary vinod Pullarkat Jane Ann Nohl Division of  Hematology, University of Southern  California Keck School of Medicine,  Los Angeles, CA, USA Correspondence: vinod Pullarkat   Jane Ann Nohl Division of   Hematology, University of   Southern California Keck   School of Medicine, 1441 eastlake   Avenue, MC 9172, NOR 3461,   Los Angeles, CA 90033, USA   Tel +1 323 865 3848   Fax +1 323 865 0060   email vinod.pullarkat@med.usc.ed uAbstract:  Deferasirox is a once-daily, oral iron chelator that is widely used in the management  of patients with transfusional hemosiderosis.",Non-OADS,/arxiv_data1/oa_pdf/bf/77/jbm-4-101.PMC3743529.pdf
Available from: http://www.fda.gov/Safety/ MedWatch / SafetyInformation /SafetyAlertsforHumanMedicalProducts/ucm200850.,Non-OADS,/arxiv_data1/oa_pdf/bf/77/jbm-4-101.PMC3743529.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/bf/77/jbm-4-101.PMC3743529.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/77/jbm-4-101.PMC3743529.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3e/89/dddt-7-729.PMC3743609.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 729–745Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  729Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S1546 7Developing therapeutic approaches   for metachromatic leukodystrophy Shilpa A Patil1 Gustavo HB Maegawa1,2 1McKusick-Nathans institute   of Genetic Medicine, 2Department   of Pediatrics, The Johns Hopkins   School of Medicine, Baltimore,    MD, USA Correspondence: Gustavo HB Maegawa   McKusick-Nathans institute of Genetic   Medicine, Department of Pediatrics,   The Johns Hopkins School of   Medicine, Baltimore, MD 21205, USA   Tel +1 443 287 3505   Fax +1 410 502 5677   email gmaegaw1@jhmi.ed uAbstract:  Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal dis - order caused by the deficiency of arylsulfatase A (ASA), resulting in impaired degradation of  sulfatide, an essential sphingolipid of myelin.",Non-OADS,/arxiv_data1/oa_pdf/3e/89/dddt-7-729.PMC3743609.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/3e/89/dddt-7-729.PMC3743609.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/89/dddt-7-729.PMC3743609.pdf
Available from http://clinicaltrials.gov/ct2/show/NCT00633139?ter m =NCT00633139&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/3e/89/dddt-7-729.PMC3743609.pdf
Available from  http://clinicaltrials.gov/ct2/show/NCT01510028?ter m=NCT015100 28&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/3e/89/dddt-7-729.PMC3743609.pdf
Available at http://clinicaltrials.gov/ct2/show/NCT00681811?ter m= NCT00681811&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/3e/89/dddt-7-729.PMC3743609.pdf
Available  from http://clinicaltrials.gov/ct2/show/NCT00418561?ter m=NC T00418561&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/3e/89/dddt-7-729.PMC3743609.pdf
Available from http://clinicaltrials.gov/ct2/show/ NCT01560182?ter m=NCT01560182&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/3e/89/dddt-7-729.PMC3743609.pdf
Available at http://clinicaltrials.gov/ ct2/show/NCT00683189?ter m=NCT00683189&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/3e/89/dddt-7-729.PMC3743609.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/78/imcrj-6-037.PMC3743637.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Medical Case Reports Journal 2013:6 37–39International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  37 Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S4776 9Resolution of exudative retinal detachment   and regression of retinal macrocyst post-laser   in Coats disease Yusoff Munira1 embong Zunaina1,2 Yaakub azhany1,2 1Department of ophthalmology,   school of Medical sciences, Health  Campus, Universiti sains Malaysia,   Kubang Kerian, Kelantan, Malaysia;   2Hospital Universiti sains Malaysia,   Jalan Raja perempuan Zainab II,   Kubang Kerian, Kelantan, Malaysia Correspondence: embong Zunaina   Department of ophthalmology, school  of Medical sciences, Universiti sains  Malaysia, 16150 Kubang Kerian,   Kelantan, Malaysia   tel +60 9767 6362   Fax +60 9767 3370   email zunaina@kb.usm.m yAbstract:  A 15-year-old boy presented with painless progressive blurring of vision in the right  eye for 1 year in duration.",Non-OADS,/arxiv_data1/oa_pdf/c2/78/imcrj-6-037.PMC3743637.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/c2/78/imcrj-6-037.PMC3743637.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/78/imcrj-6-037.PMC3743637.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/dd/tcrm-9-319.PMC3743638.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2013:9 319–328Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  319Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S3513 7A new generation of antipsychotics:   pharmacology and clinical utility   of cariprazine in schizophrenia Silvio Caccia Roberto william invernizzi Alessandro Nobili Luca Pasina iRCCS- istituto di Ricerche  Farmacologiche Mario Negri,    Milan, italy Correspondence: Silvio Caccia and  Roberto w invernizzi   iRCCS-istituto di Ricerche  Farmacologiche Mario Negri,   via La Masa 19, 20156 Milan, italy   Tel +39 02 3901 4556   Fax +39 02 3900 1916   email silvio.caccia@marionegri.i t;   rinvernizzi@marionegri.i tAbstract:  Cariprazine is a potential antipsychotic awaiting approval from the US Food and  Drug Administration.",Non-OADS,/arxiv_data1/oa_pdf/29/dd/tcrm-9-319.PMC3743638.pdf
http://dx.doi.org/10.1017/S146114570800946 2.,Non-OADS,/arxiv_data1/oa_pdf/29/dd/tcrm-9-319.PMC3743638.pdf
http://embase.com/search/results?subaction=viewrecord&rid=5 &page=1&L7090956 6.,OADS,/arxiv_data1/oa_pdf/29/dd/tcrm-9-319.PMC3743638.pdf
Available from:  https://www.evidence.nhs.uk/document?ci=http%3A%2F%2Fwww.,OADS,/arxiv_data1/oa_pdf/29/dd/tcrm-9-319.PMC3743638.pdf
"Available  from: http://news.frx.com/press-release/rd-news/forest-laboratories-inc- and-gedeon-richter-plc-announce-results-two-positive- p. Accessed July  9, 2013.",Non-OADS,/arxiv_data1/oa_pdf/29/dd/tcrm-9-319.PMC3743638.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/29/dd/tcrm-9-319.PMC3743638.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/dd/tcrm-9-319.PMC3743638.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/73/a4/ijwh-5-465.PMC3743641.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:5 465–475International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  465RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S3945 5Management of osteoporosis and menopausal  symptoms: focus on bazedoxifene/conjugated  estrogen combination Sebastian Mirkin1 James H Pickar2 1Pfizer Inc, Collegeville, PA,   2Department of Obstetrics and  Gynecology, Columbia University  Medical Center, New Y ork, NY, USA Correspondence: Sebastian Mirkin   Pfizer Inc, 500 Arcola Rd, Collegeville,   PA 19426, USA   Tel +1 484 865 4121   Fax +1 484 865 4321   email sebastian.mirkin@pfizer.co mAbstract:  Loss of estrogen production in women during menopause results in a state of estrogen  deficiency which has been associated with multiple problems, including vasomotor symptoms,  symptoms of vulvovaginal atrophy, bone loss, and difficulties with sleep, mood, memory, and  sexual activity.",Non-OADS,/arxiv_data1/oa_pdf/73/a4/ijwh-5-465.PMC3743641.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/73/a4/ijwh-5-465.PMC3743641.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/a4/ijwh-5-465.PMC3743641.pdf
Available from:  http://labeling.pfizer.com/showlabeling.aspx?id =133.,Non-OADS,/arxiv_data1/oa_pdf/73/a4/ijwh-5-465.PMC3743641.pdf
Available  from: http://labeling.pfizer.com/showlabeling.aspx?id =131.,Non-OADS,/arxiv_data1/oa_pdf/73/a4/ijwh-5-465.PMC3743641.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b2/cb/ijn-8-2917.PMC3743642.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 2917–2926International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2917OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4751 0self-microemulsifying drug delivery system   for improved oral bioavailability of oleanolic   acid: design and evaluation rui Yang1 Xin huang1 Jinfeng Dou2 guangxi Zhai2 lequn su1 1Pharmacy Department, shandong  Provincial Qianfoshan hospital,  shandong University, Jinan, People’s  republic of china; 2Department of  Pharmaceutics, college of Pharmacy,  shandong University, Jinan, People’s  republic of china correspondence: lequn su   Pharmacy Department, shandong   Provincial Qianfoshan hospital,   66 Jingshi road, Jinan 250014,   People’s republic of china   email professorslq@126.co mAbstract:  Oleanolic acid is a poorly water-soluble drug with low oral bioavailability.",Non-OADS,/arxiv_data1/oa_pdf/b2/cb/ijn-8-2917.PMC3743642.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b2/cb/ijn-8-2917.PMC3743642.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/cb/ijn-8-2917.PMC3743642.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1121–1135Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1121Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S4878 2Mental health system in Saudi Arabia: an overview Naseem Akhtar Qureshi1 Abdulhameed Abdullah  Al-Habeeb2 Harold G Koenig3 1General Administration for Research  and Studies, 2Mental Health and  Social Services, Ministry of Health,   Riyadh, Saudi Arabia; 3Department of  Psychiatry and Behavioral Sciences,   Duke University Medical Center,   Durham, NC, USA Correspondence: Naseem Akhtar Qureshi   General Administration for Research   and Studies, Sulaimania Medical Complex,  Ministry of Health, Riyadh 11176,   Saudi Arabia   Tel +966 1 473 5038   Fax +966 1 473 5039   email qureshinaseem@live.co mBackground:  There is evidence that mapping mental health systems (MHSs) helps in   planning and developing mental health care services for users, families, and other caregivers.",Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
The  final Saudi country report was published on the WHO EMRO  website ( http://www.emro.who.in t; a copy of this report is  available upon request from AAAH).,OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
Available  from: http://www.who.int/mental_health/evidence/AIMS_WHO_2_2.,Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Available  from: http://www.who.int/mental_health/resources/en/Financing.pd f.  Accessed April 12 , 2013.",Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Available from: http://www.bls.gov/ooh/community- and-social-service/mental-health-counselors-and-marriage-and-family- therapists.ht m. Accessed April 12 , 2013.",Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Available from: http://www.kff.org/medicaid/upload/8182.pd f.  Accessed April 17 , 2013.",Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
Available from: http://www.oecd.,Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Available from:  http://strategy.mentalhealthcommission.ca/pdf/strategy-text-en.pd f.   Accessed April 23 , 2013.",Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
Available from: http://healthland.time.,Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
Available from: http://myweb.polyu.edu.,Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Available from: http://www.who.int/mental_health/resources/en/ Legislation.pd f. Accessed July 12 , 2013.",Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Available from:  http://www.who.int/features/qa/43/e n. Accessed April 27 , 2013.",OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Available from: http://www.who.int/mental_health/ policy/e n. Accessed March 2 , 2013.",Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Available from: http://www.who.int/mental_health/media/en/242.pd f.  Accessed July 12 , 2013.",Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Available  from: http://www.mentalhealthcare.org.uk/forensic_mental_health_  service s. Accessed May 5 , 2013.",Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
Available from: http://www.urban.org/health_policy  / url.cfm?,Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Available from: http://www.nmhccf.org.au/documents/MHCA%20 CareWF%20Layout%2016-9.pd f. Accessed May 6, 2013.",OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Available from: http://www.euro.who.int/__data/ assets/pdf_file/0020/113834/E93430.pd f. Accessed May 18, 2013.",OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Available from: http://psychcentral.com/blog/archives/2012/04/09/ help-is-available-when-mental-illness-prevents-workin g. Accessed May  17, 2013.",Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Available from: http://www.who.int/mental_health/policy/ mnh_info_sys.pd f. Accessed May 6, 2013.",OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Available from: http://www.timeshighereducation.co.uk/news/research/ research-intelligence-help-make-the-desert-bloom/411532.articl e.  Accessed July 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Available  from: http://www.nimh.nih.gov/index.shtm l. Accessed March 12,  2013.",OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
"Available from: http://www.who.int/mental_health/policy/ services/4_organisation%20services_WEB_07.pd f. Accessed July 12,  2013.",Non-OADS,/arxiv_data1/oa_pdf/dd/e5/ndt-9-1121.PMC3743653.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/73/ad/ijn-8-2835.PMC3743654.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 2835–2845International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2835OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4836 7cisplatin-incorporated nanoparticles   of poly(acrylic acid- co-methyl methacrylate)  copolymer Kyung Dong lee1,* Y oung-Il Jeong2,* Da hye Kim3,4 gyun-Taek lim2 Ki-choon choi5 1Department of Oriental Medicine  Materials, Dongshin University, Naju,  south Korea; 2Department of Polymer  engineering, chonnam National  University, gwangju, south Korea;  3Faculty of life and environmental  science, shimane University,  Matsue, Japan; 4United graduate  school of agricultural sciences,  Tottori University, Tottori, Japan;  5grassland and Forages Division,  National Institute of animal science,  rural Development administration,  cheonan, south Korea *These authors contributed equally   to this work correspondence: Ki-choon choi   grassland and Forages Division,   National Institute of animal science,  rural Development administration,   9 eoryong-ri, seonghwan-eup, cheonan,  chungnam 331-808, south Korea   Tel +82 41 580 6752   Fax +82 41 580 6779   email choiwh@rda.go.k rBackground:  Although cisplatin is extensively used in the clinical field, its intrinsic toxicity  limits its clinical use.",Non-OADS,/arxiv_data1/oa_pdf/73/ad/ijn-8-2835.PMC3743654.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/73/ad/ijn-8-2835.PMC3743654.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/ad/ijn-8-2835.PMC3743654.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/09/ndt-9-1137.PMC3743655.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1137–1144Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1137OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4652 5Facial expression in patients with bipolar disorder  and schizophrenia in response to emotional  stimuli: a partially shared cognitive and social  deficit of the two disorders giuseppe Bersani1 elisa Polli1 giuseppe Valeriani1 Daiana Zullo1 claudia Melcore1 enrico capra2 adele Quartini1 Pietropaolo Marino1 amedeo Minichino2 laura Bernabei2 Maddalena robiony1 Francesco saverio Bersani1,2 Damien liberati1 1Department of Medico-Surgical  sciences and Biotechnologies,   Sapienza University of Rome, Rome,   italy; 2Department of Neurology   and Psychiatry, sapienza University   of Rome, Rome, Italy correspondence: Francesco saverio  Bersani,   Department of Neurology and Psychiatry,  Sapienza University of Rome, Rome, Italy   T el +39 34 0516 5865   Fax +39 06 4991 4728   email bersani.fs@gmail.co m Introduction:  It has recently been highlighted that patients affected by schizophrenia (SCZ)  and those affected by bipolar disorder (BD) undergo gradual chronic worsening of cognitive  and social functioning.",Non-OADS,/arxiv_data1/oa_pdf/93/09/ndt-9-1137.PMC3743655.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/93/09/ndt-9-1137.PMC3743655.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/09/ndt-9-1137.PMC3743655.pdf
9Corresponding author E-mail lboulang@princeton.eduArticle is online at http://www.learnmem.org/cgi/doi/10.,Non-OADS,/arxiv_data1/oa_pdf/64/33/NelsonLM031351.PMC3744042.pdf
"The ability of Golgi cells to ﬁre repetitive low-threshold bursts at physiological snifﬁng frequencies suggests that these in-terneurons may effect rapid inhibition of GABAergic GCs during 2Present address: Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA 3Corresponding author E-mail bens@case.eduArticle is online at http://www.learnmem.org/cgi/doi/10.",Non-OADS,/arxiv_data1/oa_pdf/99/6b/PresslerLM031856.PMC3744043.pdf
"Donahue, M. & Porter, D. G. OOMMF Users guide, Version 1.0, Interagency Report NISTIR 6376 (NIST, Gaithersburg, 1999) at http://math.nist.gov/oommf/.",Non-OADS,/arxiv_data1/oa_pdf/4f/22/srep02444.PMC3744080.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2444 | DOI: 10.1038/srep02444 8",Non-OADS,/arxiv_data1/oa_pdf/4f/22/srep02444.PMC3744080.pdf
"Codon optimization was performed using an online tool, OPTIMIZER (http://gen-omes.urv.es/OPTIMIZER/), based on E. coli codon usage.",OADS,/arxiv_data1/oa_pdf/4e/fc/srep02445.PMC3744081.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4e/fc/srep02445.PMC3744081.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2445 | DOI: 10.1038/srep02445 7",Non-OADS,/arxiv_data1/oa_pdf/4e/fc/srep02445.PMC3744081.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/07/a6/srep02446.PMC3744082.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2446 | DOI: 10.1038/srep02446 8",Non-OADS,/arxiv_data1/oa_pdf/07/a6/srep02446.PMC3744082.pdf
http://dx.doi.org/10.1016/j.ijplas.2013.07.002.,OADS,/arxiv_data1/oa_pdf/2e/d9/srep02448.PMC3744083.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2e/d9/srep02448.PMC3744083.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2448 | DOI: 10.1038/srep02448 7",Non-OADS,/arxiv_data1/oa_pdf/2e/d9/srep02448.PMC3744083.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0c/7d/srep02426.PMC3744084.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2426 | DOI: 10.1038/srep02426 6",Non-OADS,/arxiv_data1/oa_pdf/0c/7d/srep02426.PMC3744084.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/42/73/srep02447.PMC3744087.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2447 | DOI: 10.1038/srep02447 11",Non-OADS,/arxiv_data1/oa_pdf/42/73/srep02447.PMC3744087.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fc/e5/srep02403.PMC3744199.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2403 | DOI: 10.1038/srep02403 5",Non-OADS,/arxiv_data1/oa_pdf/fc/e5/srep02403.PMC3744199.pdf
"FAO, FAOSTAT http://faostat.fao.org/ (13 November 2012).",Non-OADS,/arxiv_data1/oa_pdf/c7/0a/srep02418.PMC3744200.pdf
"Statistics of Agriculture, Forestry and Fisheries http://www.maff.go.jp/j/tokei/kouhyou/sakumotu/ sakkyou_kazyu/index.html (31 October 2012).",OADS,/arxiv_data1/oa_pdf/c7/0a/srep02418.PMC3744200.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c7/0a/srep02418.PMC3744200.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2418 | DOI: 10.1038/srep02418 7",Non-OADS,/arxiv_data1/oa_pdf/c7/0a/srep02418.PMC3744200.pdf
"6, Jun 2013 , pp.543-551                                                          Original Article   543   Available at:    http://ijph.tums.ac.ir        Chronic Obstructive Pulmonary Diseases Related Health Re - sources Allocation in Hunan Province of China     Chengli BEI  1, Anmei HU  1, Huayun LIU  1, Ping CHEN  1, Xiujie JIA  1, Guisheng ZHOU  2,  *Shan CAI  1    1.",Non-OADS,/arxiv_data1/oa_pdf/37/c6/ijph-42-543.PMC3744250.pdf
": Chronic Obstructive Pulmonary Diseases  …    Available at:    http://ijph.tums.ac.ir   544 anticholi nergics and methylxanthines, are the  mains tay of management in symptoms and im - provement in lung function and health status for  COPD (11, 12).",Non-OADS,/arxiv_data1/oa_pdf/37/c6/ijph-42-543.PMC3744250.pdf
"543-551  545   Available at:    http://ijph.tums.ac.ir  gree of medicine, median educational levels mean  Bachelor degree of medicine, low educational le - vels indicated someone just finished junior medi - cal college or medical  school , even bared -foot  doctors and did  not study further.",Non-OADS,/arxiv_data1/oa_pdf/37/c6/ijph-42-543.PMC3744250.pdf
: Chronic Obstructive Pulmonary Diseases  …    Available at:    http://ijph.tums.ac.ir   546 consistency of each question with the questions’  set: 93.57% for the first and 92.56% for the  second.,Non-OADS,/arxiv_data1/oa_pdf/37/c6/ijph-42-543.PMC3744250.pdf
"543-551  547   Available at:    http://ijph.tums.ac.ir  low PPs’ educational levels in 192 PPs was  38.02%, 60.94% and 1.04%.",Non-OADS,/arxiv_data1/oa_pdf/37/c6/ijph-42-543.PMC3744250.pdf
": Chronic Obstructive Pulmonary Diseases  …    Available at:    http://ijph.tums.ac.ir   548 and 2011 (24) , however, enormous barriers to the  understanding and implementing COPD guide - lines for PHs and PPs is still living in central south  China.",Non-OADS,/arxiv_data1/oa_pdf/37/c6/ijph-42-543.PMC3744250.pdf
"543-551  549   Available at:    http://ijph.tums.ac.ir  3rd levels, neglected its importance and didn’t car- ried out it.",Non-OADS,/arxiv_data1/oa_pdf/37/c6/ijph-42-543.PMC3744250.pdf
: Chronic Obstructive Pulmonary Diseases  …    Available at:    http://ijph.tums.ac.ir   550 development in China.,Non-OADS,/arxiv_data1/oa_pdf/37/c6/ijph-42-543.PMC3744250.pdf
http://www.who.int/whosis/whostat/EN_ WHS08_Full.pdf (accessed Oct 20 2011).,OADS,/arxiv_data1/oa_pdf/37/c6/ijph-42-543.PMC3744250.pdf
"Global strategy  for the  diagnosis, management, and prevention of  COPD: updated 2010.   http://www.goldcopd.org/uploads/users/file s/GOLDReport_April112011.pdf (accessed  Oct 20 2011).",OADS,/arxiv_data1/oa_pdf/37/c6/ijph-42-543.PMC3744250.pdf
"543-551  551   Available at:    http://ijph.tums.ac.ir  Comor bidities, patient knowledge, and dis - ease management in a national sample of pa - tients with COPD.",Non-OADS,/arxiv_data1/oa_pdf/37/c6/ijph-42-543.PMC3744250.pdf
"6, Jun 2013 , pp.552-558                                                        Original Article   552   Available at:    http://ijph.tums.ac.ir        Cost Effectiveness of Adopted Quality Requirements in Hospital  Laboratories     Alneil HAMZA  1, * Eltayib AHMED -ABAKUR  2, Elsir ABUGROUN  3, Siham BAKHIT  2,  Mohamed HOLI 2    1.",Non-OADS,/arxiv_data1/oa_pdf/b9/17/ijph-42-552.PMC3744251.pdf
: Cost Effectiveness of Adopted Quality Requirements  …    Available at:    http://ijph.tums.ac.ir                                                                                                                              553 progressively accepted as optimal approach to assur - ing quality in medical testing (1).,Non-OADS,/arxiv_data1/oa_pdf/b9/17/ijph-42-552.PMC3744251.pdf
552-558    554                                                                                                  Available at:    http://ijph.tums.ac.ir  laboratories [2] marks means the requirement  adopted and documented [1] mark means in com- plete adoption or documentation and (zero) mark  means the item is neither adopted nor docu - mented.,Non-OADS,/arxiv_data1/oa_pdf/b9/17/ijph-42-552.PMC3744251.pdf
": Cost Effectiveness of Adopted Quality Requirements  …    Available at:    http://ijph.tums.ac.ir                                                                                                                              555   Table 2:  Compliance of the study group and control group to ISO 15189 in pre and post intervention phases     Study phases  Pre – intervention (2008)  Post – intervention (2009)   Laboratories  Study  Control  P-value  Study  Control  P-value   % % % %  LAB1  53 57  82 60   LAB2  47 39  82 49   LAB3  51 47  82 56   LAB4  47 44  79 56   LAB5  49 46  79 51   LAB6  45 48  75 55   Average compliance %  49 47 0.48*  79 54 0.00    Table 3:  Size effect of quality management activities of study group and control group in pre and post intervention  phases     The pre - intervention results showed that the an - nual average total costs per -test of the study group  was 1.8 ± 0.25 Sudanese pound (SDG) it was  equal to 0.33 USA dollar and control group was  1.97 ± 0.39 SDG, with insignificant effect ( P=  0.39) (Table 4), whereas t he post -intervention re - sults showed that the annual average total costs  per-test for study and control groups was 1.57 ±  0.23 and 2.08 ± 0.38 SDG, respectively with si g- nificant effect ( P= 0.019) Table 4.",Non-OADS,/arxiv_data1/oa_pdf/b9/17/ijph-42-552.PMC3744251.pdf
"552-558    556                                                                                                  Available at:    http://ijph.tums.ac.ir  Table 4:  Annual average cost per -test of pre and post intervention phases     Study phases  Pre – intervention (2008)  Post – intervention (2009   Laboratories  Study  Control  P-value  Study  Control  P-value  cost/ test  cost/ test  cost/ test  cost/ test   LAB1  1.52 1.87  1.48 1.92   LAB2  1.61 1.85  1.5 1.98   LAB3  2.21 1.42  1.49 1.49   LAB4  1.82 2.03  1.77 2.26   LAB5  1.7 2.02  1.29 2.2   LAB6  1.93 2.62  1.92 2.62   Mean (± SD)  1.80 ± 0.25  1.97± 0.39  0.39*  1.57 ± 0.23  2.08 ± 0.38  0.019   Table 5:  Cost efficiency and cost -effectiveness ratios of study and control groups in pre - intervention phase     Study groups  Study group  Control group  Efficiency  ratio  Cost effec - tiveness ratio   Laboratories  QMS  cost/  test Cost effec - tiveness %  QMS  cost/  test Cost effective - ness %     Compl - iance %  Compl - iance %     LAB1  53 1.52 2.87 57 1.87 3.28    LAB2  47 1.61 3.43 39 1.85 4.74    LAB3  51 2.21 4.33 47 1.42 3.02    LAB4  47 1.83 3.87 44 2.03 4.61    LAB5  49 1.7 3.47 46 2.02 4.39    LAB6  45 1.93 4.29 48 2.62 5.46    Average  49 1.8 3.71 47 1.97 4.25 0.91 0.88    Table 6:  Cost efficiency and cost -effectiveness ratios of study and control groups in post - intervention phase       Discussion     ISO 15189 being an important template for a s- sessing and recognizing the competence of medi - cal laboratories in their technical capacity and the  effective quality management of a professional  service and its staff (5, 8).",Non-OADS,/arxiv_data1/oa_pdf/b9/17/ijph-42-552.PMC3744251.pdf
": Cost Effectiveness of Adopted Quality Requirements  …    Available at:    http://ijph.tums.ac.ir                                                                                                                              557 tion of laboratory operations across inter national  borders (12, 13).",Non-OADS,/arxiv_data1/oa_pdf/b9/17/ijph-42-552.PMC3744251.pdf
"552-558    558                                                                                                  Available at:    http://ijph.tums.ac.ir  Ethical considerations     Ethical issues (Including plagiarism, Informed  Consent, misconduct, data fabrication and/or  falsification, double publication and/or submi s- sion, redundancy, etc) have been completely o b- served by the authors.",Non-OADS,/arxiv_data1/oa_pdf/b9/17/ijph-42-552.PMC3744251.pdf
"559-569                                                              Original Article   559   Available at:    http://ijph.tums.ac.ir         Depression, Prevalence and Some Risk Factors in Elderly  Nursing Homes in Tehran, Iran     Lyly NAZEMI 1, 2 ,3, Ingmar SKOOG 4, Ingvar KARLSSON 4, Saeed HOSSEINI 1,2,  *Mostafa HOSSEINI 5, Mohammad Javad HOSSEINZADEH 1,2, Mohammad Reza MO - HAMMADI 6, Zahra POURANSARI 7, Maryam CHAMARI 1,2, Masoud BAIKPOUR 8    1.",Non-OADS,/arxiv_data1/oa_pdf/8c/62/ijph-42-559.PMC3744252.pdf
": Depression, Prevalence and Some Risk  Factors …    Available at:    http://ijph.tums.ac.ir   560 Older people are prone to psychiatric disorders  through vicissitudes of life such as social isolation,  malnutrition, economic problems and emotional  depression.",Non-OADS,/arxiv_data1/oa_pdf/8c/62/ijph-42-559.PMC3744252.pdf
"559-569  561   Available at:    http://ijph.tums.ac.ir  from the nursing homes was generally cluster  sampling, we used 1.2 as design effect and the fi - nal size of sample was computed as 192.",OADS,/arxiv_data1/oa_pdf/8c/62/ijph-42-559.PMC3744252.pdf
": Depression, Prevalence and Some Risk  Factors …    Available at:    http://ijph.tums.ac.ir   562 Table 1:  Demographic character istics of the study population according to depression status     P* Total   n (%)  Depression   Demographic characteristics  Severe   n (%)  Moderate   n (%)  Mild   n (%)  Not  n (%)   0.80 114 (46.7)  10 (8.8)  33 (29.0)  64 (56.1)  7 (6.1)  Male  Sex 130 (53.3)  16 (12.3)  39 (30.0)  58 (44.7)  17 (13.1)  Female   0.62 112 (45.9)  11 (9.8)  36 (32.2)  55 (49.1)  10 (8.9)  60_74 yr   Age groups  88 (36.1)  8 (9.1)  25 (28.4)  44 (50.0)  11 (12.5)  75_84 yr   44 (18.0)  7 (15.9)  11 (25.0)  23 (52.3)  3 (6.8)  ≥85 yr   0.07 166 (68.0)  20 (12.1)  50 (30.1)  77 (46.4)  19 (11.4)  Married   Marital status  42 (17.2)  1 (2.48)  13 (31.0)  23 (54.8)  5 (11.9)  Single   36 (14.8)  5 (13.9)  9 (25.0)  22 (61.1)  0 (0) Divorced   0.49 106 (43.4)  14 (13.2)  32 (31.2)  50 (47.2)  10 (9.4)  Illiterate   Education  73 (29.9)  7 (9.6)  23 (31.5)  37 (50.7)  6 (8.2)  Primary or high  school   65 (26.7)  5 (7.7)  17 (26.2)  35 (53.8)  8 (12.3)  Diploma or uni - versity   0.04 4 (3.7)  0 (0) 3 (75.0)  1 (25.0)  0 (0) Worker   Male      Job 30 (28.4)  1 (3.3)  7 (23.3)  17 (56.7)  5 (16.7)  Employee   64 (58.7)  7 (10.9)  18 (28.1)  37 (57.8)  2 (3.1)  Self-employed   10 (9.2)  1 (10.0)  2 (20.0)  7 (70.0)  0 (0) Other   0.57 95 (74.2)  12 (12.6)  25 (26.3)  45 (47.4)  13 (13.7)  House wife  Female  33 (25.8)  4 (12.1)  12 (36.4)  13 (39.4)  4 (12.1)  Employed   0.55 141 (57.8)  12 (9.9)  40 (28.4)  72 (51.1)  15 (10.6)  0-2 No of children  103 (42.2)  12 (11.7)  32 (31.1)  50 (48.5)  9 (8.7)  ≥3  0.65 194 (80.2)  21 (10.8)  60 (30.9)  93 (47.9)  20 (10.3)  Non-smoker  Smoking   (pack -year) 32 (13.2)  4 (12.5)  7 (21.9)  17 (53.1)  4 (12.5)  0-19  16 (6.6)  1 (6.2)  4 (25.0)  11 (68.8)  0 (0) ≥20  244 (100.0)  26 (10.7)  72 (29.5)  122 (50.0)  24 (9.8)  Total  * SVY ordinal regression     Of these cases, 16.0% had diabetes, 23.1 %  hypertension , 3.8%  renal disease,  5% digestive  problems.",Non-OADS,/arxiv_data1/oa_pdf/8c/62/ijph-42-559.PMC3744252.pdf
"559-569  563   Available at:    http://ijph.tums.ac.ir  Table 2:  Free time activity, satisfaction from the personnel and  food quality, and sun light  exposure of the  study population according to depression status     P* Total   n (%)  Depression   Characteris tics Severe   n (%)  Moderate   n (%)  Mild   n (%)  Not  n (%)   <0.0001  235 (97.1)  26 (11.0)  71 (30.2)  116 (49.4)  22 (9.4)  No Studied in their free  time 7 (2.9)  0 (0) 0 (0) 5 (71.4)  2 (28.6)  Yes  0.17 71 (29.3)  9 (12.7)  22 (31.0)  37 (52.1)  3 (4.2)  No Watched TV  171 (70.7)  17 (9.9)  49 (28.7)  84 (49.1)  21 (12.3)  Yes  0.30 49 (20.3)  7 (14.3)  14 (28.6)  26 (53.1)  2 (4.1)  No Spoke with others  193 (79.7)  19 (9.9)  57 (29.5)  95 (49.2)  22 (11.4)  Yes  0.67 110 (45.5)  17 (15.4)  29 (26.4)  50 (45.5)  14 (12.7)  No Prayed  132 (54.5)  9 (6.8)  42 (31.8)  71 (53.8)  10 (7.6)  Yes  0.08 94 (38.8)  7 (7.4)  23 (24.5)  53 (56.4)  11 (11.7)  No Rested  148 (61.2)  19 (12.8)  48 (32.4)  68 (46.0)  13 (8.8)  Yes  0.13 221 (91.3)  24 (10.9)  61 (27.6)  113 (51.1)  23 (10.4)  No Helped the others  21 (8.7)  2 (9.5)  10 (47.6)  8 (38.1)  1 (4.8)  Yes  0.03 131 (54.1)  13 (9.9)  33 (25.2)  67 (51.2)  18 (37)  No Walked  111 (45.9)  13 (11.7)  38 (34.2)  54 (48.7)  6 (5.4)  Yes  0.002  217 (88.9)  19 (8.8)  61 (28.1)  115 (53.0)  22 (10.1)  No Satisfied with food  quality  27 (11.1)  7 (25.9)  11 (40.8)  7 (25.9)  2 (7.4)  Yes  0.0008  15 (6.1)  4 (26.7)  7 (46.7)  3 (20.0)  1 (6.6)  No Satisfied with the  personnel  229 (93.9)  22 (9.6)  65 (28.4)  119 (52.0)  23 (10.0)  Yes  0.11 108 (44.3)  17 (15.7)  32 (29.6)  50 (46.3)  9 (8.3)  0  Sun light exposure  109 (44.7)  9 (8.3)  33 (30.3)  53 (48.6)  14 (12.8)  0.1-2 hr  23 (9.4)  0 (0) 7 (30.4)  15 (65.2)  1 (4.4)  2.1-4 hr  4 (1.6)  0 (0) 0 (0) 4 (100)  0 (0) 4.1-7.5 hr   * SVY ordinal regression     A negative correlation (Spearman's rho= -0.13)  between sunlight exposure and the severity of de - pression was observed, which meant the elderly  who had more sunlight exposure in their free  times, were less depressed, but the correlation was  not significant ( P=0.11).",Non-OADS,/arxiv_data1/oa_pdf/8c/62/ijph-42-559.PMC3744252.pdf
": Depression, Prevalence and Some Risk  Factors …    Available at:    http://ijph.tums.ac.ir   564 and 1.98 (1.24 -3.18), respectively).",Non-OADS,/arxiv_data1/oa_pdf/8c/62/ijph-42-559.PMC3744252.pdf
559-569  565   Available at:    http://ijph.tums.ac.ir  therefore higher than in  the study by Doumit and  Nasser (22).,Non-OADS,/arxiv_data1/oa_pdf/8c/62/ijph-42-559.PMC3744252.pdf
": Depression, Prevalence and Some Risk  Factors …    Available at:    http://ijph.tums.ac.ir   566 Several studies in Iran investigated the maximum  current prevalence of MDD (Major or severe  depres sive disorder).",Non-OADS,/arxiv_data1/oa_pdf/8c/62/ijph-42-559.PMC3744252.pdf
559-569  567   Available at:    http://ijph.tums.ac.ir  5.,Non-OADS,/arxiv_data1/oa_pdf/8c/62/ijph-42-559.PMC3744252.pdf
": Depression, Prevalence and Some Risk  Factors …    Available at:    http://ijph.tums.ac.ir   568 25.",Non-OADS,/arxiv_data1/oa_pdf/8c/62/ijph-42-559.PMC3744252.pdf
559-569  569   Available at:    http://ijph.tums.ac.ir  Nigerian Survey of Mental Health and Well - Being.,Non-OADS,/arxiv_data1/oa_pdf/8c/62/ijph-42-559.PMC3744252.pdf
"570-580                                                        Original Article   570   Available at:    http://ijph.tums.ac.ir        The Interrelations among the Perception of Parental Styles and  Psychological Well -Being in Adolescence: A Longitudinal Study     *Farnaz SHAHIMI 1, Patrick HEAVEN  2, Joseph CIARROCHI 2    1.",Non-OADS,/arxiv_data1/oa_pdf/54/b0/ijph-42-570.PMC3744253.pdf
": The Interrelations among the Perception of Parental Styles …    Available at:    http://ijph.tums.ac.ir                                                                                                                               571 Related research  around the effects of different  parenting styles showed that authoritarian par ent- ing style is associated with children's passive atti - tudes (9 -10), lower self -esteem (11),  internalizing  and externalizing problems (12 -14), and lower  self-esteem and hope (2) compared to other pa r- enting styles, yet, higher marks in school adjus t- ment and lower rates of school misbehavior and  drug abuse in comparison with adolescents of n e- glectful fami lies (15).",Non-OADS,/arxiv_data1/oa_pdf/54/b0/ijph-42-570.PMC3744253.pdf
570-580  572                                                                                                        Available at:    http://ijph.tums.ac.i r years (SD = 0.49) and the same group was surveyed  every 12 months .,OADS,/arxiv_data1/oa_pdf/54/b0/ijph-42-570.PMC3744253.pdf
: The Interrelations among the Perception of Parental Styles …    Available at:    http://ijph.tums.ac.ir                                                                                                                               573 time in all the participants.,Non-OADS,/arxiv_data1/oa_pdf/54/b0/ijph-42-570.PMC3744253.pdf
570-580  574                                                                                                        Available at:    http://ijph.tums.ac.i r Results are shown in Table 1  for all the partici - pants in each parental style and Table 2for the top     Correlations   Pearson Correlation was conducted between three  parental styles as shown  in Table  2.,OADS,/arxiv_data1/oa_pdf/54/b0/ijph-42-570.PMC3744253.pdf
": The Interrelations among the Perception of Parental Styles …    Available at:    http://ijph.tums.ac.ir                                                                                                                               575 Post-hoc tests (Tukey and Scheffe) showed statisti - cally significant differences between all groups  (P<0.05) hence, no significant differences were  observed between the mean score of  permissive  with authorita rian in hope  in all grades and with  authoritative group in grades 10, permis sive with  authoritarian and authoritative in self -esteem in  grades 8 and 10 and with authoritative in grade 9  and permissive with authoritarian in grades 9 and  10 in psychotic ism.",Non-OADS,/arxiv_data1/oa_pdf/54/b0/ijph-42-570.PMC3744253.pdf
"570-580  576                                                                                                        Available at:    http://ijph.tums.ac.i r Discussion     Significant differences were found in the hope, self - esteem and psychoticism means of each percep tion  of the parental styles.",Non-OADS,/arxiv_data1/oa_pdf/54/b0/ijph-42-570.PMC3744253.pdf
: The Interrelations among the Perception of Parental Styles …    Available at:    http://ijph.tums.ac.ir                                                                                                                               577 than the autho ritarian group and lower than the  authoritative group.,Non-OADS,/arxiv_data1/oa_pdf/54/b0/ijph-42-570.PMC3744253.pdf
"570-580  578                                                                                                        Available at:    http://ijph.tums.ac.i r Ethical considerations     Ethical issues (Including plagiarism, Informed  Consent, misconduct, data fabrication and/or fals i- fication, double publication and/or submis sion,  redundancy, etc) have been ob served by the a u- thors.",Non-OADS,/arxiv_data1/oa_pdf/54/b0/ijph-42-570.PMC3744253.pdf
: The Interrelations among the Perception of Parental Styles …    Available at:    http://ijph.tums.ac.ir                                                                                                                               579 20.,Non-OADS,/arxiv_data1/oa_pdf/54/b0/ijph-42-570.PMC3744253.pdf
"570-580  580                                                                                                        Available at:    http://ijph.tums.ac.i r International Journal of Existential Psycholo gy &  Psychopatherapy, 3(1): 1-13.",Non-OADS,/arxiv_data1/oa_pdf/54/b0/ijph-42-570.PMC3744253.pdf
"581-587                                                       Original Article   581   Available at:    http://ijph.tums.ac.ir        Mapping the Obesity in Iran by Bayesian Spatial Model     Maryam FARHADIAN  1,*Abbas MOGHIMBEIGI  1,2, Mohsen AL IABADI  3    1.",Non-OADS,/arxiv_data1/oa_pdf/d1/ed/ijph-42-581.PMC3744254.pdf
": Mapping the Obesity in Iran  …    Available at:    http://ijph.tums.ac.ir   582 mortality  or disease,  and to compile  them  in geo- graphic  maps  (6).",Non-OADS,/arxiv_data1/oa_pdf/d1/ed/ijph-42-581.PMC3744254.pdf
"581-587  583   Available at:    http://ijph.tums.ac.ir  sampled, then  iy is a binomial ran dom varia ble,  iy  ~ Bin ( iN, ip), where  ip is the proportion  infected at each location.",OADS,/arxiv_data1/oa_pdf/d1/ed/ijph-42-581.PMC3744254.pdf
: Mapping the Obesity in Iran  …    Available at:    http://ijph.tums.ac.ir   584      Fig.,Non-OADS,/arxiv_data1/oa_pdf/d1/ed/ijph-42-581.PMC3744254.pdf
"581-587  585   Available at:    http://ijph.tums.ac.ir  21 Hamadan  110216  41276  595762  589657  19 24 0.91 0.003  0.70 0.003   22 Golestan  127641  62534  564785  553394  11 12 1.17 0.003  1.19 0.005   23 Gilan  238229  88273  869449  848779  3 14 1.51 0.003  1.08 0.003   24 Fars 244915  163214  1521210  1554416   13 0.77 0.001  1.09 0.002   25 Esfahan  310010  190093  1606271  1682241  18 11 0.96 0.001  1.19 0.003   26 East Azerbai - jan 335408  147349  1251521  1292538  5 10  1.47 0.003  1.20 0.003   27 Char mahal  Bakhteyari  46981  26931  291807  289582  22 19  0.77 0.003  0.96 0.006   28 Boshehr  45562  31908  290206  332370  26 17 0.74 0.003  0.99 0.005   29 Ardabil  105462  57365  421849  415690  7 3 1.34 0.004  1.50 0.006   30 Hormozgan  52408  41064  440405  471998  30 21 0.54 0.002  0.89 0.004   BMI= Body Mass Index, OR=Odds Ratio, SE=Standard Error     Today, mapping diseases are of great interest for  health authori ties, due to its significance to diag - nose the risk factors.",Non-OADS,/arxiv_data1/oa_pdf/d1/ed/ijph-42-581.PMC3744254.pdf
: Mapping the Obesity in Iran  …    Available at:    http://ijph.tums.ac.ir   586 likelihood (19).,Non-OADS,/arxiv_data1/oa_pdf/d1/ed/ijph-42-581.PMC3744254.pdf
581-587  587   Available at:    http://ijph.tums.ac.ir  13.,Non-OADS,/arxiv_data1/oa_pdf/d1/ed/ijph-42-581.PMC3744254.pdf
"6, Jun 2013 , pp.588-593                                                             Original Article   588   Available at:    http://ijph.tums.ac.ir        Descriptive Aspects of Injection Drug Users in Iran’s National  Harm Reduction Program by Methadone Maintenance Treat - ment     Sharareh ESKANDARIEH 1, Ali NIKFARJAM 1, Termeh TARJOMAN  1  Abassali NASEHI  1, *Firoozeh JAFARI  2, Mohammad -Bagher SABERI -ZAFARG - HANDI3    1.",Non-OADS,/arxiv_data1/oa_pdf/b9/f8/ijph-42-588.PMC3744255.pdf
: Descriptive Aspects of Injection Drug Users  …  Available at:    http://ijph.tums.ac.ir                                                                                                                             589 (11).,Non-OADS,/arxiv_data1/oa_pdf/b9/f8/ijph-42-588.PMC3744255.pdf
588-593  590                                                                                                       Available at:    http://ijph.tums.ac.ir  more than 5 years.,Non-OADS,/arxiv_data1/oa_pdf/b9/f8/ijph-42-588.PMC3744255.pdf
: Descriptive Aspects of Injection Drug Users  …  Available at:    http://ijph.tums.ac.ir                                                                                                                             591 Discussion     Descriptive aspects of demographic and behavior  characteristics among IDUs who took part in  MMT pro gram was addressed in this study.,Non-OADS,/arxiv_data1/oa_pdf/b9/f8/ijph-42-588.PMC3744255.pdf
"588-593  592                                                                                                       Available at:    http://ijph.tums.ac.ir  sion, redundancy, etc) have been completely ob - served by the authors.",Non-OADS,/arxiv_data1/oa_pdf/b9/f8/ijph-42-588.PMC3744255.pdf
Available from:   http://www.who.int/hrh/resources/sub - stances/en/index.html   2.,Non-OADS,/arxiv_data1/oa_pdf/b9/f8/ijph-42-588.PMC3744255.pdf
": Descriptive Aspects of Injection Drug Users  …  Available at:    http://ijph.tums.ac.ir                                                                                                                             593 among Male Injection Drug User s in Detention,  Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/b9/f8/ijph-42-588.PMC3744255.pdf
Available from:   http://www.unrol.org/file s/RSA200MARY[1].,Non-OADS,/arxiv_data1/oa_pdf/b9/f8/ijph-42-588.PMC3744255.pdf
"6, Jun 2013 , pp.594-601                                                           Original Article   594   Available at:    http://ijph.tums.ac.ir         Reporting of Ethical Considerations Associated with Clinical Trials  Published in Iranian Dental Journals between 2001 and 2011     * Nader NAVABI 1, Arash SHAHRAVAN 1, Ali MODABERI  2    1.",Non-OADS,/arxiv_data1/oa_pdf/31/73/ijph-42-594.PMC3744256.pdf
: Reporting of Ethical Considerations Associated with Clinical  …    Available at:    http://ijph.tums.ac.ir                                                                                                                            595 therapeutic techniques are widely int roduced and  used in dentistry and RCTs are re quired to  confirm these treatment modalities (13).,Non-OADS,/arxiv_data1/oa_pdf/31/73/ijph-42-594.PMC3744256.pdf
594-601    596                                                                                                        Available at:    http://ijph.tums.ac.ir  respectively.,Non-OADS,/arxiv_data1/oa_pdf/31/73/ijph-42-594.PMC3744256.pdf
: Reporting of Ethical Considerations Associated with Clinical  …    Available at:    http://ijph.tums.ac.ir                                                                                                                            597  10.3350.41 0.82 0 0.4115.2834.71 6.614.3464.46 042.14 04.9539.66 04.1389.57 49.5999.18 100 99.59 84.72 65.2993.3995.46 35.54100 57.86100 95.05 60.34100 95.87 q1 q2 q3 q4 q5 q6 q7 q8 q9 q10 q11 q12 q13 q14 q15 q16 q17 Yes  No    Fig.,Non-OADS,/arxiv_data1/oa_pdf/31/73/ijph-42-594.PMC3744256.pdf
"594-601    598                                                                                                        Available at:    http://ijph.tums.ac.ir  Discussion     Ethical guidelines and principles are not always  without any changes and both can undergo  changes under certain conditions, i.e.",Non-OADS,/arxiv_data1/oa_pdf/31/73/ijph-42-594.PMC3744256.pdf
": Reporting of Ethical Considerations Associated with Clinical  …    Available at:    http://ijph.tums.ac.ir                                                                                                                            599 hazards are cumulative, radiog raphic techniques  should only be used in studies in which there is a  definitive need for radiographic data (4).",Non-OADS,/arxiv_data1/oa_pdf/31/73/ijph-42-594.PMC3744256.pdf
"594-601    600                                                                                                        Available at:    http://ijph.tums.ac.ir  falsifi cation, double publication and/or submis - sion, redundancy, etc) have been completely ob - served by the authors.",Non-OADS,/arxiv_data1/oa_pdf/31/73/ijph-42-594.PMC3744256.pdf
University of Bristol  Faculty of Science Human Research Ethics  Committee ( http://www.bps.org.uk ).,Non-OADS,/arxiv_data1/oa_pdf/31/73/ijph-42-594.PMC3744256.pdf
: Reporting of Ethical Considerations Associated with Clinical  …    Available at:    http://ijph.tums.ac.ir                                                                                                                            601 26.,Non-OADS,/arxiv_data1/oa_pdf/31/73/ijph-42-594.PMC3744256.pdf
"602-609                                                                            Original Article   602   Available at:    http://ijph.tums.ac.ir         Brewer's Yeast Improves Blood Pressure in Type 2 Diabetes  Melli tus     Payam HOSSEINZADEH  1, Abolghassem DJAZAYERY  2, Seyed -Ali  MOSTAFAVI2,Mohammad Hassan JAVANBAKHT  2, Hoda DERAKHSHANIAN  2,  Abbas RAHIMIFO ROUSHANI  3, ٭Mahmoud DJALALI 2    1. International Campus, Tehran University of Medical Sciences, Tehran, Iran   2.",Non-OADS,/arxiv_data1/oa_pdf/d9/5f/ijph-42-602.PMC3744257.pdf
": Brewer's Yeast Improves Blood Pressure …  Available at:    http://ijph.tums.ac.i r                                                                                                                             603 insulin, and its receptors on target cell membranes.",Non-OADS,/arxiv_data1/oa_pdf/d9/5f/ijph-42-602.PMC3744257.pdf
602-609    604                                                                                                        Available at:    http://ijph.tums.ac.ir  ments by a trained dietitian in the same and stan - dard situations.,Non-OADS,/arxiv_data1/oa_pdf/d9/5f/ijph-42-602.PMC3744257.pdf
": Brewer's Yeast Improves Blood Pressure …  Available at:    http://ijph.tums.ac.i r                                                                                                                             605 Nutrients intake   In terms of energy, macronutrients and micronu - trients in the beginning and at the end of the  intervention, study groups were not significantly  different from each other (Independent t -test, Ta -ble 2).",Non-OADS,/arxiv_data1/oa_pdf/d9/5f/ijph-42-602.PMC3744257.pdf
"602-609    606                                                                                                        Available at:    http://ijph.tums.ac.ir  Blood pressure and Serum lipid profile   There were no significant differences for blood  pressure and serum lipoproteins between two  groups at baseline (Independent t-test, Table 3).",Non-OADS,/arxiv_data1/oa_pdf/d9/5f/ijph-42-602.PMC3744257.pdf
": Brewer's Yeast Improves Blood Pressure …    Available at:    http://ijph.tums.ac.ir                                                                                                                              607 Table3:  Blood pressure and Serum lipoproteins in study groups before and after intervention ٭    Variable  † Brewer’s yeast group  ‡Placebo group   SBP (mmHg)     B.I 16.44b±131.5 17.1±125.7   A.I 14.90 a, b± 127.4  127.6 ±18.4a  DBP  (mmHg)     B.I 84.72 ±8.4d 80.7±10.1  A.I 79.04 ±9.0 c, d 81.3±9.9 c  Total Cholesterol  (mg/dl)     B.I 192.5 ±41.7 193.0 ±54.37   A.I 191.7 ±41.2 200.2 ±59.16   Triglyceride (mg/dl)     B.I 166.4 ±74.5e 191.9 ±95.4  A.I 144.1 ±61.9e 186.0 ±93.3  LDL  (mg/dl)     B.I 114.7 ±28.7f 100.3 ±36.53   A.I 103.7 ±26.1f 107.8 ±34.00   HDL  (mg/dl)     B.I 50.6±7.9 g 11.3±53.5  A.I 55.3±7.8 g 10.6±52.4  * Mean ± SD/B.I: Before Intervention /A.I: After Intervention / Subjects: 42(11men, 31 women) / ‡  Subjects:42(10men, 32 women) / SBP: Systolic Blood Pressure /a, c  0.05 P< (Covariance  )b, d, e, f, g0.05 P<  (Paired  t-test)DBP: Diastolic Blood Pressure              Discussion      In this study, taking 1800 mg of brewer's yeast per  day reduced systolic and diastolic blood pressures  in pa tients with type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/d9/5f/ijph-42-602.PMC3744257.pdf
"602-609    608                                                                                                        Available at:    http://ijph.tums.ac.ir  significantly increased HDL -c in brewer's yeast  consumers, no significant differences could be  detected com pared with placebo group at the end  of the study.",Non-OADS,/arxiv_data1/oa_pdf/d9/5f/ijph-42-602.PMC3744257.pdf
": Brewer's Yeast Improves Blood Pressure …    Available at:    http://ijph.tums.ac.ir                                                                                                                              609 Population : Past,Present and Future.",Non-OADS,/arxiv_data1/oa_pdf/d9/5f/ijph-42-602.PMC3744257.pdf
"610-619                                                         Original Article   610   Available at:    http://ijph.tums.ac.ir        Parallel Quality Assessment of Emergency Departments by  Euro pean Foundation for Quality Management Model and Ira - nian National Program for Hospital Evaluation     Mohammad Hasan IMANI NASAB  1, 2, Bahram MOHAGHEGH  1, Nader KHALESI  1,  *Ebrahim JAAFARIPOOYAN  3    1.",Non-OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
: Parallel Quality Assessment of Emergency Departments  …    Available at:    http://ijph.tums.ac.ir                                                                                                                             611 awards [e.g.,Non-OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
"610-619  612                                                                                                        Available at:    http://ijph.tum s.ac.ir  Iranian National Qu ality Award (INQA) was de - signed based on the EFQM model in 2003,  follow ing some modifications in the criteria, sub - criteria and the weight of original model.",Non-OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
": Parallel Quality Assessment of Emergency Departments  …    Available at:    http://ijph.tums.ac.ir                                                                                                                             613 Methods      Conducted in the second half of 2012, the study  investigated all EDs located in the hospitals with  more than 300 beds affiliated with TUMS, as they  had a well -developed ED.",Non-OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
610-619  614                                                                                                        Available at:    http://ijph.tum s.ac.ir  recognizable.,Non-OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
: Parallel Quality Assessment of Emergency Departments  …    Available at:    http://ijph.tums.ac.ir                                                                                                                             615 most symmetry.,Non-OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
610-619  616                                                                                                        Available at:    http://ijph.tum s.ac.ir  Discussion     A raft of models has nowadays emerged for  assess ing and improving the quality in organiza - tions (34).,Non-OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
": Parallel Quality Assessment of Emergency Departments  …    Available at:    http://ijph.tums.ac.ir                                                                                                                             617 dinal or cross -sectional descriptive studies has  serious limitations, the repetition of same results  in different times and places might strengthen the  hypothesis of causality.",Non-OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
"610-619  618                                                                                                        Available at:    http://ijph.tum s.ac.ir  Bulletin of the World Health Organization , 78(6):  717-31.",Non-OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
Available from:   http://www.efqm.org/en/PdfResources/Rec ognition%20Brochure%202012.pdf .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
Available  from:  http://mdar.behdasht .gov.ir/uploads/165_826_Aei n-name-ejraei.pdf.,OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
Available from:   http://mdar.behdasht.gov.ir/%5Cuploads%5C165_ 708_EFQM%202.pdf .,OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
Available from:   http://www.iranaward.org/90/hem.pdf  [Accessed 23  February 2013]  .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
Available from:  http://www.dolat.ir/PDF/Program.pdf .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
Available from:    http://ww1.efqm.org/en/PdfResources/PUB0723_I nEx_en_v2.1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
: Parallel Quality Assessment of Emergency Departments  …    Available at:    http://ijph.tums.ac.ir                                                                                                                             619 (2012).,Non-OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
Available from:   http://medcare.behdasht.gov.ir/uploads/312_1394_t asise%20bimarestan.pdf .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
Availa ble from: http://www.efqm.org/en  .,Non-OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
Available from:  http://www.spac.ir/Portal/File/ShowFile.asp x?ID=90fa4381 -ca1c-4d41-885a- 8e889d572e3d .,OADS,/arxiv_data1/oa_pdf/40/c3/ijph-42-610.PMC3744258.pdf
"6, Jun 2013 , pp.620-625                                                              Original Article   620   Available at:    http://ijph.tums.ac.ir         Molecular Genotyping of Toxoplasma gondii  in Human  Spontane ous Aborted Fetuses in Shiraz, Southern Iran     Qasem ASGARI  1, Maysam FEKRI  1, Ahmad MONABATI  2, Moh sen KALANTARY  3, Iraj  MOHAMMADPOUR  1, Mohammad Hossein MOTAZEDIAN  1,*Bahador SARKARI 4    1.",Non-OADS,/arxiv_data1/oa_pdf/ef/9c/ijph-42-620.PMC3744259.pdf
": Molecular Genotyping of Toxoplasma gondii  …    Available at:    http://ijph.tums.ac.ir                                                                                                                            621 retarda tion, hydrocephaly, microcephaly, seizures  and retinal damage.",Non-OADS,/arxiv_data1/oa_pdf/ef/9c/ijph-42-620.PMC3744259.pdf
620-625    622                                                                                                       Available at:    http://ijph.tums.ac.ir  Amplification of the 3' end was performed with  SAG2F3 (5'-TCTGGTTCTCCGAAGT GACTCC -3')  and SAG2R3 (5' -TCAAAGCGTGCATTATCGC -3')  primers for the first round of amplification and  with the inter nal SAG2F2  (5'-ATTCTCATGCCTC   CGCTTC -3') and SAG2R (5' -AACGTTTCACGAA   GGCA CAC -3') primers for the second round of  amplific ation.,Non-OADS,/arxiv_data1/oa_pdf/ef/9c/ijph-42-620.PMC3744259.pdf
: Molecular Genotyping of Toxoplasma gondii  …    Available at:    http://ijph.tums.ac.ir                                                                                                                            623     Fig.,Non-OADS,/arxiv_data1/oa_pdf/ef/9c/ijph-42-620.PMC3744259.pdf
"620-625    624                                                                                                       Available at:    http://ijph.tums.ac.ir  isolates, type II was the most prevalent genotype  found in 33 (87%) and type I was found in 5 (13%)  of the isolates (21).",Non-OADS,/arxiv_data1/oa_pdf/ef/9c/ijph-42-620.PMC3744259.pdf
": Molecular Genotyping of Toxoplasma gondii  …    Available at:    http://ijph.tums.ac.ir                                                                                                                            625 study of 4,048 obstetric p atients.",Non-OADS,/arxiv_data1/oa_pdf/ef/9c/ijph-42-620.PMC3744259.pdf
"6, Jun 2013 , pp.626-634                                                           Original Article   626   Available at:    http://ijph.tums.ac.ir         Antenatal Micronutrient Supplementation Relationship with Child - ren's Weight and Height from Birth up to the Age of 18 Months     Hossein JABBARI  1, Fariba BAKHSHIAN  2, Mohammad ASGARI  3, Mohammadreza  SATTARI  4, Mohammad NAGHAVI -BEHZAD  5, *Simin Ozar MASHAYEKHI  6    1.",Non-OADS,/arxiv_data1/oa_pdf/aa/3b/ijph-42-626.PMC3744260.pdf
: Antenatal Micronutrient Supplementation …    Available at:    http://ijph.tums.ac.ir                                                                                                                               627 Nowadays there are more than 17000 health houses  in rural aria o f Iran (15).,Non-OADS,/arxiv_data1/oa_pdf/aa/3b/ijph-42-626.PMC3744260.pdf
"626-634    628                                                                                                       Available at:    http://ijph.tums.ac.ir    the subjects were divided into three groups; su b- jects who took less than 60 tablets, subjects who  took 60 -120 tablets and subjects who took more  than 120 tablets.",Non-OADS,/arxiv_data1/oa_pdf/aa/3b/ijph-42-626.PMC3744260.pdf
: Antenatal Micronutrient Supplementation …    Available at:    http://ijph.tums.ac.ir                                                                                                                               629       Table 2:  Results of multilevel regression analysis for variables related to the weight  of children      At Birth  6  Months  12 Months  18 Months   Variables  B SE P B SE P B SE P B SE P  Education 1# 0.00 ---- ---- 0.00 ---- ---- 0.00 ---- ---- 0.00 ---- ----  Education 2  -13.97  21.98  0.525  199.33  47.11  <0.001  90.17  54.17  0.096  192.95  94.57  0.041   Education 3  -48.78  22.71  0.032  175.37  48.52  <0.001  91.18  55.78  0.102  263.14  103.08  0.011   Education 4  0.28 36.01  0.994  223.18  76.46  0.004  202.94  88.78  0.022  399.57  144.50  0.006   Education 5  20.40  94.76  0.830  -65.94  197.22  0.738  -101.33  237.64  0.670  10.31  415.85  0.980   Education 6  40.76  232.80  0.861  56.30  483.79  0.907  85.50  560.45  0.879  1331.37  1215.10  0.273   Mother’s age at birth  -0.90 1.97 0.648  -3.22 4.18 0.440  -5.92 4.83 0.220  -14.22  7.52 0.059   Pregnancy Number  22.94  6.29 <0.001  -1.97 13.49  0.884  -6.35 15.55  0.683  28.60  29.85  0.338   Care Starts month  -10.69  6.06 0.078  -13.21  13.48  0.327  -6.79 15.00  0.651  -47.36  24.63  0.055   Mother's Weight  6.68 0.80 <0.001  18.24  1.68 <0.001  19.70  1.95 <0.001  22.59  3.03 <0.001   Not using Multivitamin# 0.00 ---- ---- 0.00 ---- ---- 0.00 ---- ---- 0.00 ---- ----  Using 1 -60  Multivitamins tablet  22.77  19.88  0.252  67.95  42.77  0.112  32.95  49.27  0.504  48.41  90.73  0.594   Using 61 – 120  Multivitamins tablet  -6.20 23.65  0.793  16.10  50.47  0.750  -98.54  58.10  0.090  21.49  100.74  0.831   Using >120  Multivitamins tablet  -49.83  32.70  0.127  37.86  69.13  0.584  -102.72  79.70  0.197  96.82  130.40  0.458   Not using Ferrous # 0.00 ---- ---- 0.00 ---- ---- 0.00 ---- ---- 0.00 ---- ----  Using 1 -60  Ferrous tablet  47.98  35.95  0.182  -27.45  76.47  0.720  -127.93  89.35  0.152  -123.57  145.50  0.396   Using 61 –120  Ferrous tablet  37.60  34.57  0.277  22.52  73.59  0.760  -6.62 85.92  0.939  15.88  142.12  0.911   Using >120  Ferrous tablet  92.62  35.49  0.009  -12.05  75.58  0.873  10.20  88.08  0.908  5.76 147.02  0.969   # : Reference Category                                                                                     B: Regression Coefficient                                                                        SE: Standard Error,Non-OADS,/arxiv_data1/oa_pdf/aa/3b/ijph-42-626.PMC3744260.pdf
"626-634    630                                                                                                       Available at:    http://ijph.tums.ac.ir    Results at birth   In this time window, pregnancy number, mothers  weight and iron supplementation level showed  signifi cant relationship with weight ( P<0.05).",Non-OADS,/arxiv_data1/oa_pdf/aa/3b/ijph-42-626.PMC3744260.pdf
": Antenatal Micronutrient Supplementation …    Available at:    http://ijph.tums.ac.ir                                                                                                                               631 Results at birth   There was a significant relationship between gra - vid number, mothers' weight, care starts month  and iron supplementation level with newborn  height ( P<0.05).",Non-OADS,/arxiv_data1/oa_pdf/aa/3b/ijph-42-626.PMC3744260.pdf
626-634    632                                                                                                       Available at:    http://ijph.tums.ac.ir    tionship between height at age of 2.5 years with  iron and folic acid usage or micronutrients usage  (32).,Non-OADS,/arxiv_data1/oa_pdf/aa/3b/ijph-42-626.PMC3744260.pdf
: Antenatal Micronutrient Supplementation …    Available at:    http://ijph.tums.ac.ir                                                                                                                               633 sity of Medical Sciences (Tabriz - Iran).,Non-OADS,/arxiv_data1/oa_pdf/aa/3b/ijph-42-626.PMC3744260.pdf
626-634    634                                                                                                       Available at:    http://ijph.tums.ac.ir    21.,Non-OADS,/arxiv_data1/oa_pdf/aa/3b/ijph-42-626.PMC3744260.pdf
"6, Jun 2013 , pp.635-638                                                       National Report   635   Available at:    http://ijph.tums.ac.ir         Higher Education Initiatives for Disaster and Emergency Health  in Iran     *Ali ARDALAN  1,2, Alireza MESDAGHINIA  3, Gholamreza MASOUMI  4,5, Kourosh  HOLA KOUIE NAIENI  6, Elham AHMADNEZHAD  1,2    1.",Non-OADS,/arxiv_data1/oa_pdf/de/43/ijph-42-635.PMC3744261.pdf
": Higher Education Initiatives for Disaster …  Available at:    http://ijph.tums.ac.ir   636 are recorded in the country that led to 155,878  and 4,955 deaths, respectively (1).",Non-OADS,/arxiv_data1/oa_pdf/de/43/ijph-42-635.PMC3744261.pdf
"635-638  637   Available at:    http://ijph.tums.ac.ir  Table 1:  Curriculum of MPH and PhD disaster programs     MPH with disaster concentration    Basic courses (14 credits in total): Epidemiology & research methods, biostatistics, health economics,  environmental health, nutrition, health care management, global health and application of computer  sciences.",Non-OADS,/arxiv_data1/oa_pdf/de/43/ijph-42-635.PMC3744261.pdf
: Higher Education Initiatives for Disaster …  Available at:    http://ijph.tums.ac.ir   638 Public Health Institutes and technical consultancy  provided by World Health Organization (WHO).,Non-OADS,/arxiv_data1/oa_pdf/de/43/ijph-42-635.PMC3744261.pdf
"6, Jun 2013 , pp.639-642                                        Short Communication   639   Available at:    http://ijph.tums.ac.ir         Number of Family Members, a New Influencing Factor to Affect  the Risk of Melamine -Associated Urinary Stones     Changjiang LIU  1, * Hui LI  2, Kedi YANG  1, Haixia YANG  2    1.",Non-OADS,/arxiv_data1/oa_pdf/00/ea/ijph-42-639.PMC3744262.pdf
"Number of Family Members   …    Available at:    http://ijph.tums.ac.ir   640 months , 25 boys and 10 girls) were diagnosed with  urinary stones and constituted the case group; 155  (aged 12.4 ± 4.2 months, 99 boys and 56 girls) did  not have urinary stones and constituted the con - trol group.",Non-OADS,/arxiv_data1/oa_pdf/00/ea/ijph-42-639.PMC3744262.pdf
"639-642  641   Available at:    http://ijph.tums.ac.ir  Table 2:  Comparisons of medical histories between the case and control groups     Contents  Case group  Control group  χ2 P value   Past medical history of urinary stones of infants and  children (yes, %)  1 (2.9)  6 (3.9)  0.083  0.774   Medication history of infants and children (yes, %)  21 (60.0)  63 (40.7)  4.642  0.031*   Family history of urinary stones (yes, %)  1 (2.9)  12 (7.7)  2.892  0.717   Medication  history of mother during pregnancy  (yes, %)  5 (14.3)  25 (16.1)  0.073  0.787   Note: *.",Non-OADS,/arxiv_data1/oa_pdf/00/ea/ijph-42-639.PMC3744262.pdf
Number of Family Members   …    Available at:    http://ijph.tums.ac.ir   642 Acknowledg ements     The authors declare that there is no conflict of  interest.,Non-OADS,/arxiv_data1/oa_pdf/00/ea/ijph-42-639.PMC3744262.pdf
"6, Jun 2013 , p.643                                                      Letter to  the Editor   643   Available at:    http://ijph.tums.ac.ir         Increasing International Divorce and Decreasing International  Marriage in South Korea     Sang Eun LEE, Jae Wook JUNG, *Yong Han KIM     Dept.",Non-OADS,/arxiv_data1/oa_pdf/5b/59/ijph-42-643.PMC3744263.pdf
Available from http://www.kosis.kr  (Korean)  [cited 2013 Mar 4th].,Non-OADS,/arxiv_data1/oa_pdf/5b/59/ijph-42-643.PMC3744263.pdf
"6, Jun 2013 , pp.644-645                                                 Letter to the Editor   644   Available at:    http://ijph.tums.ac.ir         Historical Issues of Optic neuritis and Sensory Disorder in   Persian Traditional Medicine     Mohsen PARVIZ  1, Mohammad Ali SAHRAIAN  2, Hossein REZAEIZADEH  3    1.",Non-OADS,/arxiv_data1/oa_pdf/51/eb/ijph-42-644.PMC3744264.pdf
: Historical Issues of Optic neuritis …    Available at:    http://ijph.tums.ac.ir                                                                                                                            645 begins a new chapter entitled diseases pertaining  to sensation of touch.,Non-OADS,/arxiv_data1/oa_pdf/51/eb/ijph-42-644.PMC3744264.pdf
1: 169 -172  13. https://en.wiki pedia.org/wiki/'Ali_ibn_al al-Majusi .,Non-OADS,/arxiv_data1/oa_pdf/51/eb/ijph-42-644.PMC3744264.pdf
14. http://en.wikipedia.org/wiki/Averroes   15. http://www.britannica.com/EBchecked/topic/45 .,Non-OADS,/arxiv_data1/oa_pdf/51/eb/ijph-42-644.PMC3744264.pdf
"646-647                                                   Letter to the Editor   646   Available at:    http://ijph.tums.ac.ir         Ergogenic Aids Use in Iranian Adolescents     *Asghar MOHAMMADPOORASL  1, Saharnaz  NEDJAT  2, 3, Akbar  FOTOUHI  2    1.",Non-OADS,/arxiv_data1/oa_pdf/7c/85/ijph-42-646.PMC3744265.pdf
: Ergogenic Aids Use in Iranian …    Available at:    http://ijph.tums.ac.ir                                                                                                                          647 Acknowledgement     We would like to thank Tehran University of  Medi cal Sciences and  Tabriz University of Medical  Sciences for financial support of this study.,Non-OADS,/arxiv_data1/oa_pdf/7c/85/ijph-42-646.PMC3744265.pdf
"648-649                                                 Letter to the Editor   648   Available at:    http://ijph.tums.ac.ir         Liver - Heart  Inter - Relationship in Fatty Liver Disease Based on  the Avicenna’s Point of View     Ebrahim KHADEM 1, Mohsen NASIRI TOOSI 2, Reza ILKHANI1    1.",Non-OADS,/arxiv_data1/oa_pdf/5e/31/ijph-42-648.PMC3744266.pdf
": Liver - Heart  Inter - Relationship in Fatty Liver …    Available at:    http://ijph.tums.ac.ir                                                                                                                             649 Rate and Frequence, Increase in Breathing Rate  and Frequence (tachypnea), Flushing, etc (10).",Non-OADS,/arxiv_data1/oa_pdf/5e/31/ijph-42-648.PMC3744266.pdf
650-651                                                  Letter to the Editor   650   Available at:    http://ijph.tums.ac.ir         The Death of Lichtenstein Hernioplasty under Local Anesthesia  in China     Guo-Sheng WANG     Dept.,Non-OADS,/arxiv_data1/oa_pdf/7a/24/ijph-42-650.PMC3744267.pdf
: The Death of Lichtenstein Hernioplasty …  Available at:    http://ijph.tums.ac.ir                                                                                                                         651 choices will not hurt patients.,Non-OADS,/arxiv_data1/oa_pdf/7a/24/ijph-42-650.PMC3744267.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/f2/jpr-6-625.PMC3744360.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2013:6 625–634Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  625Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S4865 3evolution in pharmacologic thinking around   the natural analgesic palmitoylethanolamide:   from nonspecific resistance to PPAR- α agonist   and effective nutraceutical Jan M Keppel Hesselink Department of Pharmacology,   University of witten/Herdecke,   witten, Germany Correspondence: Jan M Keppel Hesselink   Department of Pharmacology, University  of Witten/Herdecke, Alfred-Herrhausen  Straße 50, 58448 witten, Germany   Tel +31 65 170 0527   email jan@neuropathie.n uAbstract:  The history of development of new concepts in pharmacology is a highly interesting  topic.",Non-OADS,/arxiv_data1/oa_pdf/46/f2/jpr-6-625.PMC3744360.pdf
Or use: http://dvpr.es/133WKT E,Non-OADS,/arxiv_data1/oa_pdf/46/f2/jpr-6-625.PMC3744360.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/46/f2/jpr-6-625.PMC3744360.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/f2/jpr-6-625.PMC3744360.pdf
Virulence 2013; 4:213-22;  PMID:23334178; http://dx.doi.org/10.4161/viru.23380,Non-OADS,/arxiv_data1/oa_pdf/5f/e7/gmic-4-265.PMC3744509.pdf
Virulence 2013; 4:315-23;  PMID:23552827; http://dx.doi.org/10.4161/viru.24318 health economic evaluations of rotavirus vaccination Two licensed vaccines are available to prevent  rotavirus gastroenteritis in infants.,Non-OADS,/arxiv_data1/oa_pdf/5f/e7/gmic-4-265.PMC3744509.pdf
"www.landesbioscience.com  Gut Microbes  267Gut Micr obes 4:4, 267–268; July/August 2013; © 2013 Landes BioscienceTHE  INSIDE  PASSA GE THE  INSIDE  PASSA GE Keywords:  iron, Listeria , Shigella ,  UPEC, RNA thermometer, PrfA, ShuA,  heme Submitted: 06/18/2013Accepted: 06/18/2013http://dx.doi.org/10.4161/gmic.25726 Correspondence to: V.K.",Non-OADS,/arxiv_data1/oa_pdf/de/46/gmic-4-267.PMC3744510.pdf
Nat  Rev Microbiol 2012; 10:255-65; PMID:22421878;  http://dx.doi.org/10.1038/nrmicro2730 2.,OADS,/arxiv_data1/oa_pdf/de/46/gmic-4-267.PMC3744510.pdf
Future  Microbiol 2012; 7:839-52; PMID:22827306; http://dx.doi.org/10.2217/fmb.12.573.,Non-OADS,/arxiv_data1/oa_pdf/de/46/gmic-4-267.PMC3744510.pdf
PLoS Pathog 2012; 8:e1002518; PMID:22359501; http://dx.doi.org/10.1371/journal.ppat.1002518 4.,Non-OADS,/arxiv_data1/oa_pdf/de/46/gmic-4-267.PMC3744510.pdf
PLoS One  2013; 8:e63781; PMID:23704938; http://dx.doi.org/10.1371/journal.pone.00637815.,Non-OADS,/arxiv_data1/oa_pdf/de/46/gmic-4-267.PMC3744510.pdf
Biometals 2006; 19:173-80; PMID:16718602; http://dx.doi.org/10.1007/s10534-005-4577-x,Non-OADS,/arxiv_data1/oa_pdf/de/46/gmic-4-267.PMC3744510.pdf
"Gut Microbes 4:4, 306–315; July/August 2013; © 2013 Landes Bioscience RESEARCH  PAPER 306 Gut Microbes  Volume 4 Issue 4*Correspondence to: Manuel Ferrer; Email: mferrer@icp.csic.es Submitted: 04/18/13; Revised: 06/04/13; Accepted: 06/07/13http://dx.doi.org/10.4161/gmic.25321Introduction The human gastrointestinal tract (GIT) is home to trillions of  finely tuned, interacting microbes, which are defined as the gut microbiota.",Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
( B) Association between the fasting blood glucose level and total glycosidase activity in obese subjects; inset in ( B) represents the association  between HOMA-IR index28 (calculated by an automatic web calculator; http://www.hcvsociety.org/files/HOMACalc.htm) and total glycosidase activity.,OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
"314 Gut Microbes  Volume 4 Issue 4represented in the entire metabolic network.41,42 Customized  computer programs written in R27 and Perl (http://www.perl.",Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
N at Biotechnol  2009; 27:344-6; PMID:19352371; http://dx.doi.org/10.1038/nbt0409-344 2.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Gastroenterology 2005; 128:175-91; PMID:15633135; http://dx.doi.org/10.1053/j.gastro.2004.10.043 3.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Nature 2010; 464:59-65; PMID:20203603; http://dx.doi.org/10.1038/nature08821 4.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Nature 2011; 474:327-36; PMID:21677749; http://dx.doi.org/10.1038/nature10213 5.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Environ Microbiol 2013; 15:211-26; PMID:22891823; http://dx.doi.org/10.1111/j.1462-2920.2012.02845.x 7.,OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
N utr Rev 2012; 70(Suppl 1):S10-3;  PMID:22861801; http://dx.doi.org/10.1111/j.1753-4887.2012.00499.x 8.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Cell 2012; 150:470-80; PMID:22863002; http://dx.doi.org/10.1016/j.cell.2012.07.008 9.,OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Nat Rev Microbiol 2011; 9:233-43; PMID:21358670; http://dx.doi.org/10.1038/nrmicro2536 10.,OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Gut 2012; PMID:23236009; http://dx.doi.org/10.1136/gutjnl-2012-30318411.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Gastroenterology 2011; 140:976-86; PMID:21129376; http://dx.doi.org/10.1053/j.gastro.2010.11.049 12.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Gut 2012; 61:1642-3; PMID:22490526; http://dx.doi.org/10.1136/gutjnl-2012-302137,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Nature 2012; 488:621-6; PMID:22914093; http://dx.doi.org/10.1038/nature11400 35.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
"Gastroenterology 2012; 143:913-6, e7; PMID:22728514; http://dx.doi.org/10.1053/j.gastro.2012.06.031 36.",Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Diabetes Obes Metab 2012; 14:112-20; PMID:21812894; http://dx.doi.org/10.1111/j.1463-1326.2011.01483.x 37.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Cell Host Microbe 2011; 10:336-47; PMID:22018234; http://dx.doi.org/10.1016/j.chom.2011.10.002 38.,OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
BMC Public Health 2009; 9:414; PMID:19912668; http://dx.doi.org/10.1186/1471-2458-9-414 39.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
PLoS One 2012; 7:e51521; PMID:23251564; http://dx.doi.org/10.1371/journal.pone.0051521 40.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
N ucleic  Acids Res 2000; 28:304-5; PMID:10592255; http://dx.doi.org/10.1093/nar/28.1.304 41.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
T rends Biochem Sci 2008; 33:101-3; PMID:18276143; http://dx.doi.org/10.1016/j.tibs.2008.01.001 42.,OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Nucleic Acids Res 2011; 39(suppl 2):W412-5; PMID:21546551; http://dx.doi.org/10.1093/nar/gkr31324.,OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Genome Res 2010; 20:1605-12; PMID:20841432; http://dx.doi.org/10.1101/gr.108332.110 25.,OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Obes Rev 2012; 13:799-809; PMID:22686435; http://dx.doi.org/10.1111/j.1467-789X.2012.01009.x 26.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
"Gastroenterology 2010; 138:65-72, e1-2; PMID:19931537; http://dx.doi.org/10.1053/j.gas-tro.2009.11.045 27.",Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
PLoS One 2011; 6:e21041; PMID:21695082; http://dx.doi.org/10.1371/journal.pone.0021041 29.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Gut Microbes 2010; 1:254-68; PMID:21327032; http://dx.doi.org/10.4161/gmic.1.4.12778 30.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Am J Clin Nutr 2011; 94:58-65; PMID:21543530; http://dx.doi.org/10.3945/ajcn.110.010132 31.,OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Cell Host Microbe 2008; 4:447-57; PMID:18996345; http://dx.doi.org/10.1016/j.chom.2008.09.007 32.,OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Curr Opin Clin Nutr Metab Care 2010; 13:432-8; PMID:20531179; http://dx.doi.org/10.1097/MCO.0b013e32833a8b60 33.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Curr Opin Biotechnol 2010; 21:539-50; PMID:20817507; http://dx.doi.org/10.1016/j.copbio.2010.08.003 16.,OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Int J Obes (Lond) 2011; 35:522-9; PMID:21386800; http://dx.doi.org/10.1038/ijo.2011.27 18.,OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
PLoS One 2010; 5:e9074; PMID:20161775; http://dx.doi.org/10.1371/journal.pone.0009074 19.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Future Microbiol 2012; 7:91-109; PMID:22191449; http://dx.doi.org/10.2217/fmb.11.142 20.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
"Lancet 1996; 348:1455-6,  author reply 1455-6; PMID:8937307; http://dx.doi.org/10.1016/S0140-6736(04)70104-X 21.",Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Cell Host Microbe 2008; 3:213-23; PMID:18407065; http://dx.doi.org/10.1016/j.chom.2008.02.015 22.,OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Microbiology 2010; 156:3216-23; PMID:20705661; http://dx.doi.org/10.1099/mic.0.040618-0 23.,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
Nucleic Acids Res 2009; 37(Database issue):D233-8; PMID:18838391; http://dx.doi.org/10.1093/nar/gkn663,OADS,/arxiv_data1/oa_pdf/7a/e9/gmic-4-306.PMC3744515.pdf
"Quigley; Email: equigley@tmhs.org Submitted: 03/13/13; Revised: 06/10/13; Accepted: 06/20/13http://dx.doi.org/10.4161/gmic.25487Introduction There is persuasive evidence from several sources indicating that  the gut microbiota has an influence on the development and maintenance, not only of the mucosal, 1,2 but also the systemic  immune response.3,4 This raises the therapeutic vista of modi - fying the systemic immune response by enteric microbes.",Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Nature 2004; 430:257- 63; PMID:15241424; http://dx.doi.org/10.1038/nature02761 2.,OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Cell 2010; 140:859-70; PMID:20303876; http://dx.doi.org/10.1016/j.cell.2010.01.023 3.,OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Immunity 2010; 32:815-27; PMID:20620945; http://dx.doi.org/10.1016/j.immuni.2010.06.001 5.,OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Science 2011; 331:337-41; PMID:21205640; http://dx.doi.org/10.1126/science.11984696.,OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
PLoS Pathog 2008; 4:e1000112; PMID:18670628; http://dx.doi.org/10.1371/journal.ppat.1000112 8.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Gut 2003; 52:975-80; PMID:12801954; http://dx.doi.org/10.1136/gut.52.7.975 9.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Aliment Pharmacol Ther 2001; 15:1219-25; PMID:11472326; http://dx.doi.org/10.1046/j.1365-2036.2001.01027.x10.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
"Neurogastroenterol Motil 2010; 22:1029-35, e268; PMID:20518856; http://dx.doi.org/10.1111/j.1365-2982.2010.01520.x 11.",Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Gut Microbes 2012; 3:261-6; PMID:22572827; http://dx.doi.org/10.4161/gmic.20358 12.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Gut 2012; 61:354-66; PMID:22052061; http://dx.doi.org/10.1136/gutjnl-2011-300936 13.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Cell Cycle 2009; 8:3885-92; PMID:19887916; http://dx.doi.org/10.4161/cc.8.23.10068,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Gut 2012; 61:78-85; PMID:21940721; http://dx.doi.org/10.1136/gutjnl-2011-300370 15.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Gut 2006; 55:426-31; PMID:16474109; http://dx.doi.org/10.1136/gut.2005.069476 16.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Brain Behav Immun 2009; 23:327-37; PMID:19111923; http://dx.doi.org/10.1016/j.bbi.2008.11.005 17.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Clin Sci (Lond) 2008; 114:561-6; PMID:18031285; http://dx.doi.org/10.1042/CS20070274 18.,OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Am J Clin Dermatol 2010; 11:423-32; PMID:20429617; http://dx.doi.org/10.2165/11319310-000000000-00000 21.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Acta Derm Venereol 2008; 88:113-6; PMID:18311435; http://dx.doi.org/10.2340/00015555-0427 22.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
J Crohns Colitis 2011; 5:423-9; PMID:21939916; http://dx.doi.org/10.1016/j.crohns.2011.05.003 23.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Ann Intern Med 2006; 145:35-42; PMID:16818927; http://dx.doi.org/10.7326/0003-4819-145-1-200607040-00129 27.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
N Engl J Med 2001; 344:1959-65; PMID:11430324; http://dx.doi.org/10.1056/NEJM200106283442601 28.,OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Gut 2005; 54:242-9; PMID:15647189; http://dx.doi.org/10.1136/gut.2004.04483429.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Aliment Pharmacol Ther 2012; 35:327-34; PMID:22150569; http://dx.doi.org/10.1111/j.1365-2036.2011.04939.x.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Inflamm Bowel Dis 2009; 15:760-8; PMID:19067432; http://dx.doi.org/10.1002/ibd.20816 31.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
J Allergy Clin Immunol 2005; 115:1254-9; PMID:15940143; http://dx.doi.org/10.1016/j.jaci.2005.03.047 32.,OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Clin Exp Allergy 2008; 38:611-8; PMID:18266878; http://dx.doi.org/10.1111/j.1365-2222.2008.02942.x 33.,OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Br J Surg 2007; 94:546-54; PMID:17443852; http://dx.doi.org/10.1002/bjs.5705 34.,OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Scand J Rheumatol 2003; 32:211-5; PMID:14626627; http://dx.doi.org/10.1080/03009740310003695 35.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Br J Nutr 2010; 104:1831-8; PMID:20815975; http://dx.doi.org/10.1017/S0007114510002874 36.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Nucleic Acids Res 2007; 35:5511-9; PMID:17704137; http://dx.doi.org/10.1093/nar/gkm547 37.,OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
J Clin Invest 2008; 118:3533-6; PMID:18982159; http://dx.doi.org/10.1172/JCI37346 38.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Annu Rev  Immunol 2001; 19:163-96; PMID:11244034; http://dx.doi.org/10.1146/annurev.immunol.19.1.163 39.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
N Engl J Med 2005; 352:20-8; PMID:15635109; http://dx.doi.org/10.1056/NEJMoa042378 40.,OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Arthritis Rheum 2011; 63:382-90; PMID:21279995; http://dx.doi.org/10.1002/art.30117 41.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Int J Dermatol 2005; 44:82-3; PMID:15663670; http://dx.doi.org/10.1111/j.1365-4632.2004.02082.x42.,OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Clin Exp Dermatol 2010; 35:645-9; PMID:19843085; http://dx.doi.org/10.1111/j.1365-2230.2009.03704.x 43.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Am J Gastroenterol 2010; 105:2235-43; PMID:20407431; http://dx.doi.org/10.1038/ajg.2010.159 44.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
J Clin Gastroenterol 2005; 39:540-3; PMID:15942443; http://dx.doi.org/10.1097/01.mcg.0000165671.25272.0f 45.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Br J Nutr 2007; 98:969-77; PMID:17617944; http://dx.doi.org/10.1017/S0007114507764723 46.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Liver Int 2009; 29:1110-5; PMID:19490420; http://dx.doi.org/10.1111/j.1478-3231.2009.02020.x 47.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Anaerobe 2010; 16:195-200; PMID:20159049; http://dx.doi.org/10.1016/j.anaerobe.2010.02.001 48.,OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
J Invest Dermatol 2009; 129:827-33; PMID:18830267; http://dx.doi.org/10.1038/jid.2008.308 49.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
J T ransl Med 2009; 7:96; PMID:19909538; http://dx.doi.org/10.1186/1479-5876-7-96 50.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Clin Nutr 2005; 24:211-9; PMID:15784480; http://dx.doi.org/10.1016/j.clnu.2004.08.008 53.,OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
World J Gastroenterol 2008; 14:2029-36; PMID:18395902; http://dx.doi.org/10.3748/wjg.14.2029 54.,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Ann Intern Med 1994; 121:953-9; PMID:7978722; http://dx.doi.org/10.7326/0003-4819-121-12-199412150-00009,Non-OADS,/arxiv_data1/oa_pdf/86/17/gmic-4-325.PMC3744517.pdf
Lias SG ( http://webbook.nist.gov ) Ionization energy evaluation.,OADS,/arxiv_data1/oa_pdf/b3/a5/894_2013_Article_1926.PMC3744648.pdf
Bartmess JE ( http://webbook.nist.gov ) Negative ion energetics da- ta.,OADS,/arxiv_data1/oa_pdf/b3/a5/894_2013_Article_1926.PMC3744648.pdf
"The link with societies and communities is reflected in everything from the 2020 Aichi biodiversity targets ( http://www.cbd.int/sp/targets/ ) through to research funding (e.g., Suich 2012 ) and the practices of organisations focused on conservation and natural resource management (Levine 2002 ).",Non-OADS,/arxiv_data1/oa_pdf/14/42/10745_2013_Article_9594.PMC3744651.pdf
"URL http://www.cbs.gov.np/nation al_report_introduction.php Chambers, R. (1992).",Non-OADS,/arxiv_data1/oa_pdf/14/42/10745_2013_Article_9594.PMC3744651.pdf
"Available from: http://www.espa.ac.uk/files/espa/Povertyframework.pdf West, P. (2006).",Non-OADS,/arxiv_data1/oa_pdf/14/42/10745_2013_Article_9594.PMC3744651.pdf
"A. Ma ńka:W. Nowicki ( *):G. Nowicka Faculty of Chemistry, Adam Mickiewicz University,Umultowska 89b,PL 61-714 Pozna ń, Poland e-mail: gwnow@amu.edu.pl URL: http://www.staff.amu.edu.pl/ ∼gwnowJ Mol Model (2013) 19:3659 –3670 DOI 10.1007/s00894-013-1875-z",Non-OADS,/arxiv_data1/oa_pdf/ed/58/894_2013_Article_1875.PMC3744652.pdf
"Several web servers have been recently developed for protein-protein interaction sites prediction, using differentcomputational methodology and providing different levels of accuracy: a)Cons-PPISP http://pipe.scs.fsu.edu/ppisp.html method uses PSI-Blast sequence profile and solvent accessibil- ity as the input to the artificial neural network [ 23];4060 J Mol Model (2013) 19:4059 –4070",OADS,/arxiv_data1/oa_pdf/f4/83/894_2013_Article_1886.PMC3744667.pdf
"b)Promate http://bioportal.weizmann.ac.il/promate is based on Bayesian representation of secondary structure, atoms distribution, amino-acid pairing, and sequence conserva-tion [ 24]; c)PINUP http://sparks.informatics.iupui.edu/PINUP/ uses an empirical scoring function; consisting of the side-chain energy term, the term proportional to solvent acces- sible area, and the term accounting for sequence conser- vation; to predict protein binding site [ 25]; d)PPI-Pred http://bmbpcu36.leeds.ac.uk/ppi_pred/ takes six properties (including surface shape and its electro- static potential) as input to the support vector machineapproach [ 26]; e)SPPIDER http://sppider.cchmc.org/ is based on artificial neural network method, which uses predicted solventaccessibility [ 27]; f)Meta-PPISP http://pipe.scs.fsu.edu/meta-pisp.html pro- vides the meta web server that is built on top of the rawscores from cons-PPISP, Promate and PINUP [ 28].",OADS,/arxiv_data1/oa_pdf/f4/83/894_2013_Article_1886.PMC3744667.pdf
"To select the proper subset of descriptors, we applied the consensus fuzzy clustering tech- nique [ 38] to extract high quality physico-chemical indices from the set of 544 indices provided by the AAindex1 database ( http://www.genome.jp/aaindex/ ).",OADS,/arxiv_data1/oa_pdf/f4/83/894_2013_Article_1886.PMC3744667.pdf
"For our analysis, we selected two major databases containing experimentalinformation about protein-protein interactions, namely Protein Data Bank (PDB) [ 42], where one can find the three-dimensional structures of protein complexes, andDatabase of Interacting Proteins (DIP, http://dip.doe- mbi.ucla.edu/dip )[43], where the known interactions among protein pairs are stored.",OADS,/arxiv_data1/oa_pdf/f4/83/894_2013_Article_1886.PMC3744667.pdf
The amino acid sequences are extracted from file dip20091230.seq file (http://dip.doe-mbi.ucla.edu/dip/ ) using the corresponding UniProtKb id.,OADS,/arxiv_data1/oa_pdf/f4/83/894_2013_Article_1886.PMC3744667.pdf
The complete da- tabases are available freely to download for academic users from our website http://code.google.com/p/cmater-bioinfo/ .,OADS,/arxiv_data1/oa_pdf/f4/83/894_2013_Article_1886.PMC3744667.pdf
"Detailed de- scription of the clustering method, software andSupplementary material are available for academic users at http://sysbio.icm.edu.pl/aaindex/AAindex/ .",Non-OADS,/arxiv_data1/oa_pdf/f4/83/894_2013_Article_1886.PMC3744667.pdf
The training datasets and the source code for PPIcons tool are available in publicdomain at http://code.google.com/p/cmater-bioinfo/ .,OADS,/arxiv_data1/oa_pdf/f4/83/894_2013_Article_1886.PMC3744667.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2013.28.8.1117 • J Korean Med Sci 2013; 28: 1117-1119 Choosing the Target Journal: Do Authors Need a Comprehensive  Approach?",Non-OADS,/arxiv_data1/oa_pdf/55/bb/jkms-28-1117.PMC3744695.pdf
"Gasparyan AY • Choosing the Target Journal1118  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1117This practice overburdens the editors and reviewers, delays  publication of potentially valuable works and frustrates the au-thors, to name just a few pitfalls.",Non-OADS,/arxiv_data1/oa_pdf/55/bb/jkms-28-1117.PMC3744695.pdf
REFERENCES 1. http://howtopublishinjournals.com/2013/05/27/key-factors-when-se- lecting-a-journal-poll-results/?goback=.anp_2569570_1369928456758_1  [accessed on 1 June 2013].,Non-OADS,/arxiv_data1/oa_pdf/55/bb/jkms-28-1117.PMC3744695.pdf
Gasparyan AY • Choosing the Target Journalhttp://jkms.org   1119  http://dx.doi.org/10.3346/jkms.2013.28.8.11177.,Non-OADS,/arxiv_data1/oa_pdf/55/bb/jkms-28-1117.PMC3744695.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2013.28.8.1120 • J Korean Med Sci 2013; 28: 1120-1121 Global Trends in Medical Journal Publishing Youngsuk Chi Chairman of Elsevier EDITORIAL Medicine General & Social Medicine Academic journal publishing dates back to the 17th century,  with the establishment of Journal des sçavans and Philosophical Transactions of the Royal Society in 1665.",Non-OADS,/arxiv_data1/oa_pdf/02/2f/jkms-28-1120.PMC3744696.pdf
Chi YS • Trends in Medical Publishinghttp://jkms.org   1121  http://dx.doi.org/10.3346/jkms.2013.28.8.1120accurate search results.,OADS,/arxiv_data1/oa_pdf/02/2f/jkms-28-1120.PMC3744696.pdf
http://www.technologyreview.com/news/514346/the-data-made-me-do-it [accessed on 3 May 2013].,Non-OADS,/arxiv_data1/oa_pdf/02/2f/jkms-28-1120.PMC3744696.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Associations between Cigarette Smoking and Total Mortality  Differ Depending on Serum Concentrations of Persistent Organic Pollutants among the Elderly There are substantial variations of relative risks (RR) in smoking-related mortality by country and time.",Non-OADS,/arxiv_data1/oa_pdf/71/1c/jkms-28-1122.PMC3744697.pdf
"Key Words:  Smoking; Mortality; Persistent Organic Pollutants; Polychlorinated Biphenyls;  Organochlorine PesticidesYu-Mi Lee,1 Sang-Geun Bae,1  Seon-Hwa Lee,1 David R. Jacobs Jr,2,3  and Duk-Hee Lee1 1Department of Preventive Medicine, School of  Medicine, Kyungpook National University, Daegu,  Korea; 2Division of Epidemiology, School of Public  Health, University of Minnesota, Minneapolis, Minnesota, USA;  3Department of Nutrition,  University of Oslo, Oslo, Norway Received: 26 February 2013 Accepted: 22 May 2013 Address for Correspondence: Duk-Hee Lee, MD Department of Preventive Medicine, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro,   Jung-gu, Daegu 700-842, Korea Tel: +82.53-420-4866, Fax: +82.53-425-2447 E-mail address: lee_dh@knu.ac.kr This research was supported by Basic Science Research Program  through the National Research Foundation of Korea (NRF)  funded by the Ministry of Education, Science and Technology  (MEST) (2012-0002254) and by the Korea Health Industry Development Institute funded by the Ministry of Health &  Welfare (A111716-1202-0000100).http://dx.doi.org/10.3346/jkms.2013.28.8.1122 • J Korean Med Sci 2013; 28: 1122-1129ORIGINAL ARTICLE Occupation & Environmental Medicine INTRODUCTION Cigarette smoking is the leading cause of mortality as a risk fac - tor for lung cancer, coronary heart disease, stroke, chronic ob- structive pulmonary disease (COPD), and other diseases (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/71/1c/jkms-28-1122.PMC3744697.pdf
• Persistent Organic Pollutants and Smoking-Related Mortalityhttp://jkms.org   1123  http://dx.doi.org/10.3346/jkms.2013.28.8.1122we recently reported that an interaction between obesity and  POPs on mortality in elderly (13).,Non-OADS,/arxiv_data1/oa_pdf/71/1c/jkms-28-1122.PMC3744697.pdf
• Persistent Organic Pollutants and Smoking-Related Mortality1124  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1122ten informed consent was obtained from all subjects before  they took part in the study.,Non-OADS,/arxiv_data1/oa_pdf/71/1c/jkms-28-1122.PMC3744697.pdf
"• Persistent Organic Pollutants and Smoking-Related Mortalityhttp://jkms.org   1125  http://dx.doi.org/10.3346/jkms.2013.28.8.1122Interaction between smoking and POPs on mortality Table 3 shows P  values for interactions of cigarette smoking  with concentrations of individual POPs in prediction of total mortality after adjusting for age, gender, race/ethnicity, BMI and physical activity.",OADS,/arxiv_data1/oa_pdf/71/1c/jkms-28-1122.PMC3744697.pdf
• Persistent Organic Pollutants and Smoking-Related Mortality1126  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1122Table 4.,Non-OADS,/arxiv_data1/oa_pdf/71/1c/jkms-28-1122.PMC3744697.pdf
• Persistent Organic Pollutants and Smoking-Related Mortalityhttp://jkms.org   1127  http://dx.doi.org/10.3346/jkms.2013.28.8.1122which the baseline examination was performed between 1957  and 1964 (2).,Non-OADS,/arxiv_data1/oa_pdf/71/1c/jkms-28-1122.PMC3744697.pdf
• Persistent Organic Pollutants and Smoking-Related Mortality1128  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1122REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/71/1c/jkms-28-1122.PMC3744697.pdf
Avaliable at http://wwwn.cdc.gov/nchs/nhanes/search/nhanes03_04.aspx [accessed on 12 December 2012].,OADS,/arxiv_data1/oa_pdf/71/1c/jkms-28-1122.PMC3744697.pdf
Avail-able at http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/l28_c_met_%20PCBs_and_Persistent_Pesticides.pdf [accessed on 27 September 2012].,Non-OADS,/arxiv_data1/oa_pdf/71/1c/jkms-28-1122.PMC3744697.pdf
Available at http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/l28_c_met_dioxins.pdf [accessed on 27 September 2012].,OADS,/arxiv_data1/oa_pdf/71/1c/jkms-28-1122.PMC3744697.pdf
• Persistent Organic Pollutants and Smoking-Related Mortality http://jkms.orghttp://dx.doi.org/10.3346/jkms.2013.28.8.1122Supplementary Table S1.,Non-OADS,/arxiv_data1/oa_pdf/71/1c/jkms-28-1122.PMC3744697.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Screening of Dihydropyrimidine Dehydrogenase Genetic  Variants by Direct Sequencing in Different Ethnic Groups Dihydropyrimidine dehydrogenase (DPYD) is an enzyme that regulates the rate-limiting step in pyrimidine metabolism, especially catabolism of fluorouracil, a chemotherapeutic agent for cancer.",Non-OADS,/arxiv_data1/oa_pdf/59/0f/jkms-28-1129.PMC3744698.pdf
"Key Words:  Ethnic Gropus; Pharmacogenetics; Dihydropyrimidine Dehydrogenase;  FluorouracilJoong-Gon Shin,1 Hyun Sub Cheong,2  Jason Yongha Kim,1 Lyoung Hyo Kim,2  Chang Soo Han,2 Ji On Kim,2   Hae Deun Kim,3 Young Hoon Kim,3  Myeon Woo Chung,3 Soon Young Han,4  and Hyoung Doo Shin1,2 1Department of Life Science, Sogang University,  Seoul; 2Department of Genetic Epidemiology, SNP  Genetics, Inc., Seoul; 3Clinical Research Division, and  4Toxicological Evaluation and Research Department,  National Institute of Food and Drug Safety  Evaluation, Osong Health Technology Administration Complex, Osong, Korea Received: 28 December 2012 Accepted: 7 June 2013 Address for Correspondence: Hyoung Doo Shin, PhD  Department of Life Science, Sogang University,  35 Baekbeom-ro, Mapo-gu, Seoul 121-742, Korea Tel: +82.2-705-8615, Fax: +82.2-3273-1680 E-mail: hdshin@sogang.ac.kr  This research was supported by a grant (11182MFDS658) from  Ministry of Food and Drug Safety.http://dx.doi.org/10.3346/jkms.2013.28.8.1129 • J Korean Med Sci 2013; 28: 1129-1136ORIGINAL ARTICLE Human Genetics & Genomics INTRODUCTION Pharmacogenetics focuses on identifying the role of a gene of  interest that mediates drug-dependent mechanisms or triggers adverse effects.",Non-OADS,/arxiv_data1/oa_pdf/59/0f/jkms-28-1129.PMC3744698.pdf
"• Screening of DPYD Genetic Variants1130  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1129samples from other ethnic groups was obtained from a large  panel of anonymous, unrelated DNA samples from the Human Variation Panel, available through the Coriell Institute for Medi-cal Research (Camden, NJ, USA).",OADS,/arxiv_data1/oa_pdf/59/0f/jkms-28-1129.PMC3744698.pdf
Primers for the amplification and sequencing analysis were designed using Primer3 software (http://frodo.wi.mit.edu) based on the se- quence of DPYD.,OADS,/arxiv_data1/oa_pdf/59/0f/jkms-28-1129.PMC3744698.pdf
"For in silico analysis, we used FastSNP (http://fastsnp.ibms.sinica.edu.tw), Expasy (http://expasy.org/tools), and UTRScan (http://itbtools.ba.itb.cnr.it/utrscan) programs to predict the function of novel SNPs.",OADS,/arxiv_data1/oa_pdf/59/0f/jkms-28-1129.PMC3744698.pdf
• Screening of DPYD Genetic Variantshttp://jkms.org   1131  http://dx.doi.org/10.3346/jkms.2013.28.8.1129Table 1.,Non-OADS,/arxiv_data1/oa_pdf/59/0f/jkms-28-1129.PMC3744698.pdf
• Screening of DPYD Genetic Variants1132  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1129to that of previous studies (Supplementary Table 1).,Non-OADS,/arxiv_data1/oa_pdf/59/0f/jkms-28-1129.PMC3744698.pdf
• Screening of DPYD Genetic Variantshttp://jkms.org   1133  http://dx.doi.org/10.3346/jkms.2013.28.8.1129455-9.,Non-OADS,/arxiv_data1/oa_pdf/59/0f/jkms-28-1129.PMC3744698.pdf
• Screening of DPYD Genetic Variants http://jkms.orghttp://dx.doi.org/10.3346/jkms.2013.28.8.1129 T C 1745C>T 265A>G7828T>G 51C>T 09T>C 00A>G 81A>G 94T>A04T>C 13A>G 07C>T 4412A>G 52G>A 595A>G78A>G 31C>T 266C>T 491C>T 3913T>C 158G>A2928G>A 159A>G783C>T 178G>A 8940A>C 8438A>G4C>T 160G>A 7711G>A 267G>A 58C>T 47T>G 33C>T0474T>C 482G>A 93C>T92G>A 87C>A14263G>A 9309 6952A>G 32898A>G 296G>A 68502A>G 8000C>T 64703A>G 9321G>A 6384A>G 290C>T 4343T>C 1679T>G 96998C>A268G>T 5690A>G-609C> -442A>rs7298 1 rs18012rs6178 7 +1803 5 +1804 0 +1806 0 +1993 8 +1999 9+1994 0 +2001 1 +2002 0 rs5568 4 +2011 5 rs2297 5+2213 7 +2215 3 rs18012 rs2786 4 rs5629 3 rs1801 1rs6162 2 rs1801 1rs2786 7 rs2811 1 rs1207 8 rs7272 8+53860 4 rs1801 1 rs1213 7 rs18012 +8386 5 +8418 4 +8425 3rs5616 0 rs1042 4 rs2915 9rs2915 9 +8431 8rs1175 1 rs72549 rs5606 6 rs1152 3 rs6668 2 rs1149 6 rs5791 8 rs1163 6 rs5569 9 rs5605 6 rs39182 rs7410 4 rs6051 1 rs1140 9rs18012 rs4128 5 KR HC KR HC JP AA EA KR vs. HC KR vs. JP KR vs. AA KR vs. EA MAF -log Fisher’s Exact Test P0.5 0.4 0.30.2 0.1 0.0 35 30 2520 15 10 50KR KR vs HC KR vs JP KR vs AA KR vs EAJP EAHC AASupplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/59/0f/jkms-28-1129.PMC3744698.pdf
• Screening of DPYD Genetic Variants http://jkms.orghttp://dx.doi.org/10.3346/jkms.2013.28.8.1129Supplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/59/0f/jkms-28-1129.PMC3744698.pdf
• Screening of DPYD Genetic Variants http://jkms.orghttp://dx.doi.org/10.3346/jkms.2013.28.8.1129Supplementary Table 2.,Non-OADS,/arxiv_data1/oa_pdf/59/0f/jkms-28-1129.PMC3744698.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Tofacitinib Prevents Radiographic Progression in Rheumatoid  Arthritis Tofacitinib, a novel Janus kinase inhibitor, may prevent structural damage in rheumatoid arthritis (RA).",Non-OADS,/arxiv_data1/oa_pdf/13/95/jkms-28-1134.PMC3744699.pdf
"http://dx.doi.org/10.3346/jkms.2013.28.8.1134 • J Korean Med Sci 2013; 28: 1134-1138ORIGINAL ARTICLE Immunology, Allergic Disorders & Rheumatology INTRODUCTION Rheumatoid arthritis (RA) is a chronic inflammatory polyarthri- tis leading to progressive structural damage of joints (1).",Non-OADS,/arxiv_data1/oa_pdf/13/95/jkms-28-1134.PMC3744699.pdf
"• Prevention of Radiographic Progression with Tofacitinibhttp://jkms.org   1135  http://dx.doi.org/10.3346/jkms.2013.28.8.1134compared with those before the administration in 17 patients  of tofacitinib group, excluding 4 patients in whom less than 90 days had elapsed after the original radiographs had been taken.",Non-OADS,/arxiv_data1/oa_pdf/13/95/jkms-28-1134.PMC3744699.pdf
• Prevention of Radiographic Progression with Tofacitinib1136  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1134DISCUSSION We showed in this report that tofacitinib can retard radiograph- ic progression of hand joints in DMARD-refractory RA patients compared with conventional DMARD treatment.,Non-OADS,/arxiv_data1/oa_pdf/13/95/jkms-28-1134.PMC3744699.pdf
• Prevention of Radiographic Progression with Tofacitinibhttp://jkms.org   1137  http://dx.doi.org/10.3346/jkms.2013.28.8.1134modified forms are commonly used for clinical trial purpose.,Non-OADS,/arxiv_data1/oa_pdf/13/95/jkms-28-1134.PMC3744699.pdf
• Prevention of Radiographic Progression with Tofacitinib1138  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1134graphic outcome in patients with rheumatoid arthritis.,Non-OADS,/arxiv_data1/oa_pdf/13/95/jkms-28-1134.PMC3744699.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Effects of Antihypertensive Drugs on Bone Mineral Density  in Ovariectomized Mice The effects of several antihypertensive drugs on bone mineral density (BMD) and micro-architectural changes in ovariectomized (OVX) mice were investigated.",Non-OADS,/arxiv_data1/oa_pdf/20/2b/jkms-28-1139.PMC3744700.pdf
"Received: 7 March 2013 Accepted: 21 May 2013 Address for Correspondence:  Yeon Sik Hong, MD  Division of Rheumatology, Department of Internal Medicine,  The Catholic University of Korea, Incheon St. Mary’s Hospital,   56 Dongsu-ro, Bupyeong-gu, Incheon 430-720, Korea Tel: +82.32-1544-9004, Fax: +82.32-280-5987 E-mail: rhcow1@catholic.ac.kr This work was supported by the Basic Science Research  Program, National Research Foundation (NRF) of Korea, Ministry  of Education, Science and Technology (2009-0074198); the  Korea Healthcare Technology R&D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea (A092258); and the  Basic Science Research Program, NRF, Ministry of Education,  Science and Technology (2010-0003446).http://dx.doi.org/10.3346/jkms.2013.28.8.1139 • J Korean Med Sci 2013; 28: 1139-1144ORIGINAL ARTICLE Immunology, Allergic Disorders & Rheumatology INTRODUCTION Osteoporosis is characterized by an increase in bone fragility,  resulting in fractures caused by minor trauma or even of a spontaneous nature.",Non-OADS,/arxiv_data1/oa_pdf/20/2b/jkms-28-1139.PMC3744700.pdf
"• Thiazide and Telmisartan Reduce Bone Loss in Ovariectomized Mice1140  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1139were purchased from Orient Bio (Seongnam, Korea).",Non-OADS,/arxiv_data1/oa_pdf/20/2b/jkms-28-1139.PMC3744700.pdf
• Thiazide and Telmisartan Reduce Bone Loss in Ovariectomized Micehttp://jkms.org   1141  http://dx.doi.org/10.3346/jkms.2013.28.8.1139Fig.,Non-OADS,/arxiv_data1/oa_pdf/20/2b/jkms-28-1139.PMC3744700.pdf
"• Thiazide and Telmisartan Reduce Bone Loss in Ovariectomized Mice1142  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1139were compared with mice with atrophied uteri, BMD decreased  significantly (P < 0.001, Fig.",Non-OADS,/arxiv_data1/oa_pdf/20/2b/jkms-28-1139.PMC3744700.pdf
"• Thiazide and Telmisartan Reduce Bone Loss in Ovariectomized Micehttp://jkms.org   1143  http://dx.doi.org/10.3346/jkms.2013.28.8.1139ceptor blocker (ARB), olmesartan, attenuated the ovariectomy- induced decrease in BMD (23).",Non-OADS,/arxiv_data1/oa_pdf/20/2b/jkms-28-1139.PMC3744700.pdf
• Thiazide and Telmisartan Reduce Bone Loss in Ovariectomized Mice1144  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1139croarchitecture in ovariectomized mice.,Non-OADS,/arxiv_data1/oa_pdf/20/2b/jkms-28-1139.PMC3744700.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Serum Level of Interleukin-33 and Soluble ST2 and Their  Association with Disease Activity in Patients with Behcet’s Disease Interleukin (IL)-33 is an important mediator of innate immunity.",Non-OADS,/arxiv_data1/oa_pdf/bd/18/jkms-28-1145.PMC3744701.pdf
"http://dx.doi.org/10.3346/jkms.2013.28.8.1145 • J Korean Med Sci 2013; 28: 1145-1153ORIGINAL ARTICLE Immunology, Allergic Disorders & Rheumatology INTRODUCTION  Interleukin 33 (IL-33), a recently identified member of the IL-1  family, is a ligand for the orphan receptor ST2 (also known as IL-1RL1).",Non-OADS,/arxiv_data1/oa_pdf/bd/18/jkms-28-1145.PMC3744701.pdf
• IL-33 and sST2 in BD1146  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1145went routine laboratory assessments at their clinic visit.,Non-OADS,/arxiv_data1/oa_pdf/bd/18/jkms-28-1145.PMC3744701.pdf
"• IL-33 and sST2 in BDhttp://jkms.org   1147  http://dx.doi.org/10.3346/jkms.2013.28.8.1145uveitis (36%), gastrointestinal (GI) tract involvement (13%),  central nervous system (CNS) involvement (8%), and thrombo-sis (6%).",Non-OADS,/arxiv_data1/oa_pdf/bd/18/jkms-28-1145.PMC3744701.pdf
"• IL-33 and sST2 in BD1148  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1145(r= -0.227; P= 0.133, r= 0.164; P= 0.282, respectively).",OADS,/arxiv_data1/oa_pdf/bd/18/jkms-28-1145.PMC3744701.pdf
"• IL-33 and sST2 in BDhttp://jkms.org   1149  http://dx.doi.org/10.3346/jkms.2013.28.8.1145closporin (P = 0.871), or sulfasalazine (P = 0.333).",Non-OADS,/arxiv_data1/oa_pdf/bd/18/jkms-28-1145.PMC3744701.pdf
"• IL-33 and sST2 in BD1150  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1145tion was found between serum sST2 and acute phase reactants  (erythrocyte sedimentation rate [ESR] and C-reactive protein [CRP]) (ESR, r = 0.389; P= 0.004; CRP , r = 0.445; P= 0.002).",OADS,/arxiv_data1/oa_pdf/bd/18/jkms-28-1145.PMC3744701.pdf
"• IL-33 and sST2 in BDhttp://jkms.org   1151  http://dx.doi.org/10.3346/jkms.2013.28.8.1145Factors associated with the clinical and laboratory BD  activity index We showed that sST2 level was correlated with thrombosis, GI tract involvement, current colchicine use, disease activity score (BDCAF and IBDDAM), and acute phase reactants (ESR and  CRP).",OADS,/arxiv_data1/oa_pdf/bd/18/jkms-28-1145.PMC3744701.pdf
• IL-33 and sST2 in BD1152  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1145pathogenesis of BD but could also be a disease activity marker.,Non-OADS,/arxiv_data1/oa_pdf/bd/18/jkms-28-1145.PMC3744701.pdf
• IL-33 and sST2 in BDhttp://jkms.org   1153  http://dx.doi.org/10.3346/jkms.2013.28.8.1145DISCLOSURE The authors have no conflict of interests to declare.,Non-OADS,/arxiv_data1/oa_pdf/bd/18/jkms-28-1145.PMC3744701.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-635715-Hydroxyprostaglandin Dehydrogenase in Colorectal Mucosa  as a Potential Biomarker for Predicting Colorectal Neoplasms  15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is downregulated during the early stages of colorectal carcinogenesis.",Non-OADS,/arxiv_data1/oa_pdf/49/2b/jkms-28-1154.PMC3744702.pdf
"A062254  and HI10C2014).http://dx.doi.org/10.3346/jkms.2013.28.8.1154 • J Korean Med Sci 2013; 28: 1154-1160ORIGINAL ARTICLE Oncology & Hematology INTRODUCTION Colorectal cancer (CRC) is the second-leading cause of cancer- related deaths (1), and approximately 143,460 new cases are di-agnosed each year in the United States (2).",Non-OADS,/arxiv_data1/oa_pdf/49/2b/jkms-28-1154.PMC3744702.pdf
• 15-PGDH for Predicting Colorectal Neoplasmshttp://jkms.org   1155  http://dx.doi.org/10.3346/jkms.2013.28.8.1154for cancer.,Non-OADS,/arxiv_data1/oa_pdf/49/2b/jkms-28-1154.PMC3744702.pdf
• 15-PGDH for Predicting Colorectal Neoplasms1156  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1154Ethics statement The study protocol was reviewed and approved by the institu-tional review board of Asan Medical Center (IRB No.,Non-OADS,/arxiv_data1/oa_pdf/49/2b/jkms-28-1154.PMC3744702.pdf
"• 15-PGDH for Predicting Colorectal Neoplasmshttp://jkms.org   1157  http://dx.doi.org/10.3346/jkms.2013.28.8.1154sion in normal-appearing colorectal mucosa were most likely  to have SA (odds ratio, 10.5; 95% confidence interval, 0.01-0.74).",Non-OADS,/arxiv_data1/oa_pdf/49/2b/jkms-28-1154.PMC3744702.pdf
• 15-PGDH for Predicting Colorectal Neoplasms1158  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1154to the baseline 15-PGDH mRNA expression levels of normal- appearing colorectal mucosa.,Non-OADS,/arxiv_data1/oa_pdf/49/2b/jkms-28-1154.PMC3744702.pdf
• 15-PGDH for Predicting Colorectal Neoplasmshttp://jkms.org   1159  http://dx.doi.org/10.3346/jkms.2013.28.8.1154markedly sensitizes normally resistant C57BL/6J mice to colon  tumor induction by carcinogen azoxymethane (9).,Non-OADS,/arxiv_data1/oa_pdf/49/2b/jkms-28-1154.PMC3744702.pdf
• 15-PGDH for Predicting Colorectal Neoplasms1160  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1154Field effect of human colon carcinoma on normal mucosa: relevance of  carcinoembryonic antigen expression.,Non-OADS,/arxiv_data1/oa_pdf/49/2b/jkms-28-1154.PMC3744702.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357An Integrative Model of the Cardiovascular System Coupling  Heart Cellular Mechanics with Arterial Network Hemodynamics The current study proposes a model of the cardiovascular system that couples heart cell mechanics with arterial hemodynamics to examine the physiological role of arterial blood pressure (BP) in left ventricular hypertrophy (LVH).",Non-OADS,/arxiv_data1/oa_pdf/f4/a3/jkms-28-1161.PMC3744703.pdf
"Received: 29 June 2012 Accepted: 15 May 2013 Address for Correspondence: Eun Bo Shim, PhD Department of Mechanical and Biomedical Engineering, Kangwon National University, 1 Kangwondaehak-gil,   Chuncheon 200-701, Korea Tel: +82.33-250-6318, Fax: +82.33-257-6595 E-mail: ebshim@kangwon.ac.kr This work was supported by the IT R&D program of MOTIE/KEIT  (10044910, Development of Multi-modality Imaging and 3D  Simulation-Based Integrative Diagnosis-Treatment Support  Software System for Cardiovascular Diseases).http://dx.doi.org/10.3346/jkms.2013.28.8.1161 • J Korean Med Sci 2013; 28: 1161-1168ORIGINAL ARTICLE Cardiovascular Disorders INTRODUCTION There have been a number of recent studies examining the re- lationship between arterial wall stiffening and cardiac cellular overload (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/f4/a3/jkms-28-1161.PMC3744703.pdf
• Computer Model of Cardiovascular System1162  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1161clinical observations.,Non-OADS,/arxiv_data1/oa_pdf/f4/a3/jkms-28-1161.PMC3744703.pdf
• Computer Model of Cardiovascular Systemhttp://jkms.org   1163  http://dx.doi.org/10.3346/jkms.2013.28.8.11612.,Non-OADS,/arxiv_data1/oa_pdf/f4/a3/jkms-28-1161.PMC3744703.pdf
"• Computer Model of Cardiovascular System1164  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1161total length of the four arteries was 37.9 cm, and the length of  the thoracic aorta was about half (48.8%) of the total length, with a mean diameter of 2 cm.",Non-OADS,/arxiv_data1/oa_pdf/f4/a3/jkms-28-1161.PMC3744703.pdf
• Computer Model of Cardiovascular Systemhttp://jkms.org   1165  http://dx.doi.org/10.3346/jkms.2013.28.8.1161stroke volume was approximately 73 mL.,OADS,/arxiv_data1/oa_pdf/f4/a3/jkms-28-1161.PMC3744703.pdf
• Computer Model of Cardiovascular System1166  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1161 CBEL (nm) CBCF (mN/mm2) [TCa*]+[T*] (µM) LV pressure (mmHg) Half sarcomere length (µM) Time (sec) Time (sec)Time (sec) Time (sec)Time (sec)En 2En 4En 0.0 0.5 0.0 0.50.0 0.5 0.0 0.50.0 0.58 6 4 2 30 20 10 00.16 0.05 0.00 150 100 50 01.1 1.0 0.9 0.8 Ventricular relaxation Increase of arterial stiffness Increase of arterial stiffnessIncrease of arterial stiffnessIncrease of arterial stiffnessAtrial  contractionAortic notch Ventricular contraction A DB EC Fig.,Non-OADS,/arxiv_data1/oa_pdf/f4/a3/jkms-28-1161.PMC3744703.pdf
• Computer Model of Cardiovascular Systemhttp://jkms.org   1167  http://dx.doi.org/10.3346/jkms.2013.28.8.1161chanics in the human circulatory system.,Non-OADS,/arxiv_data1/oa_pdf/f4/a3/jkms-28-1161.PMC3744703.pdf
• Computer Model of Cardiovascular System1168  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1161DISCLOSURE The authors have no conflicts of interest to disclose.,Non-OADS,/arxiv_data1/oa_pdf/f4/a3/jkms-28-1161.PMC3744703.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Evaluation of Cardiovascular Anomalies in Patients with  Asymptomatic Turner Syndrome Using Multidetector Computed Tomography Turner syndrome is well known to be associated with significant cardiovascular abnormalities.",Non-OADS,/arxiv_data1/oa_pdf/99/99/jkms-28-1169.PMC3744704.pdf
"Key Words:  Turner Syndrome; Adolescent; Cardiovascular Malformation; Multidetector  Computed TomographySun Hee Lee,1,* Ji Mi Jung,2,*   Min Seob Song,3 Seok jin Choi,4   and Woo Yeong Chung2 1Department of Pediatrics, Sungae Hospital, Seoul;   2Department of Pediatrics, Busan Paik Hospital, Inje  University College of Medicine, Busan; 3Department  of Pediatrics, Haeundae Paik Hospital, Inje University  College of Medicine, Busan; 4Department of  Radiology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea *Sun Hee Lee and Ji Mi Jung are co-first authors.Received: 7 September 2012 Accepted: 23 May 2013 Address for Correspondence: Woo Yeong Chung, MD Department of Pediatrics, Busan Paik Hospital, Inje University  College of Medicine, 75 Bokji-ro, Busanjin-gu, Busan 614-735,  Korea Tel: +82.51-890-6280, Fax: +82.51-895-7785 E-mail: chungwy@chol.comhttp://dx.doi.org/10.3346/jkms.2013.28.8.1169 • J Korean Med Sci 2013; 28: 1169-1173ORIGINAL ARTICLE Cardiovascular Disorders INTRODUCTION Turner syndrome is a disease caused by a total or partial loss of  an X chromosome in women, showing a frequency of 1 per 2,500-4,000 live-born females (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/99/99/jkms-28-1169.PMC3744704.pdf
"• Cardiovascular Anomalies in Turner Syndrome in Korea1170  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1169 Blood pressure, electrocardiograph, and MDCT were mea- sured for each subject on visits from August 2007 to February  2009.",Non-OADS,/arxiv_data1/oa_pdf/99/99/jkms-28-1169.PMC3744704.pdf
"• Cardiovascular Anomalies in Turner Syndrome in Koreahttp://jkms.org   1171  http://dx.doi.org/10.3346/jkms.2013.28.8.1169alence of 13%-34% (6), and Korean research shows a rate of  7.8% (22).",Non-OADS,/arxiv_data1/oa_pdf/99/99/jkms-28-1169.PMC3744704.pdf
"• Cardiovascular Anomalies in Turner Syndrome in Korea1172  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1169control group, and this result also predicts the increased risk of  aortic dissection risk in Turner syndrome.",Non-OADS,/arxiv_data1/oa_pdf/99/99/jkms-28-1169.PMC3744704.pdf
• Cardiovascular Anomalies in Turner Syndrome in Koreahttp://jkms.org   1173  http://dx.doi.org/10.3346/jkms.2013.28.8.116913.,Non-OADS,/arxiv_data1/oa_pdf/99/99/jkms-28-1169.PMC3744704.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Risk Factors between Patients with Lone and Non-Lone Atrial  Fibrillation Clinical factors such as tall stature, lean body mass, obstructive sleep apnea, alcohol or caffeine, smoking, endurance sports, and genetic factors are proposed as risk factors for lone atrial fibrillation (LAF).",Non-OADS,/arxiv_data1/oa_pdf/a8/4d/jkms-28-1174.PMC3744705.pdf
"Key Words:  Lone Atrial Fibrillation; Risk FactorsSung Ho Lee,1,2 Seung-Jung Park,1  Kyeongmin Byeon,1 Young Keun On,1  June Soo Kim,1 Dong-Gu Shin,3   Jeong Gwan Cho,4 Yoon-Nyun Kim,5  Young-Hoon Kim,6   and KORAF Investigators 1Division of Cardiology, Department of Medicine,  Samsung Medical Center, Sungkyunkwan University  School of Medicine, Seoul; 2Division of Cardiology,  Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul;  3Division of  Cardiology, Yeungnam University Medical Center, Daegu;  4Division of Cardiology, Chonnam National  University Hospital, Gwangju; 5Division of  Cardiology, Keimyung University College of Medicine, Daegu;  6Division of Cardiology, Korea  University Medical Center, Seoul, Korea Received: 11 January 2013 Accepted: 25 June 2013 Address for Correspondence: June Soo Kim, MD Cardiac and Vascular Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 135-710, Korea  Tel: +82.2-3410-3414, Fax: +82.2-3410-3849 E-mail: juneskim@skku.eduhttp://dx.doi.org/10.3346/jkms.2013.28.8.1174 • J Korean Med Sci 2013; 28: 1174-1180ORIGINAL ARTICLE Cardiovascular Disorders INTRODUCTION Atrial fibrillation (AF) is the most common tachyarrhythmia in  adults (1) and is associated with increased morbidity and mor - tality, especially congestive heart failure, stroke, and death.",Non-OADS,/arxiv_data1/oa_pdf/a8/4d/jkms-28-1174.PMC3744705.pdf
"• Risk Factors in Lone Atrial Fibrillationhttp://jkms.org   1175  http://dx.doi.org/10.3346/jkms.2013.28.8.1174artery disease, valvular heart disease, cardiomyopathy, periph- eral vascular disease, and congenital heart disease), other dis - ease (diabetes mellitus, neoplasms, hyperthyroidism, obstruc - tive sleep apnea, chronic obstructive pulmonary disease, hypo-thyroidism, and chronic renal failure), risk factors (smoking  status, alcohol drinking, and caffeinated beverage intake), and  triggering factors for paroxysmal AF (emotional stress, use of caffeinated beverages, heavy meals, alcohol use, sleeping, exer - cise, and smoking).",Non-OADS,/arxiv_data1/oa_pdf/a8/4d/jkms-28-1174.PMC3744705.pdf
"• Risk Factors in Lone Atrial Fibrillation1176  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1174vascular diseases were hypertension (42.9%), hyperlipidemia  (15.4%), congestive heart failure (13.2%), coronary artery dis - ease (12.5%), valvular heart disease (7.8%), cardiomyopathy (2.6%), peripheral vascular disease (0.6%), and congenital heart disease (0.4%).",Non-OADS,/arxiv_data1/oa_pdf/a8/4d/jkms-28-1174.PMC3744705.pdf
"• Risk Factors in Lone Atrial Fibrillationhttp://jkms.org   1177  http://dx.doi.org/10.3346/jkms.2013.28.8.1174ed beverage intake of more than 2 cups per day (OR, 1.66; 95%  CI, 1.20-2.29, P < 0.01) were independently associated with  LAF (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/a8/4d/jkms-28-1174.PMC3744705.pdf
"• Risk Factors in Lone Atrial Fibrillation1178  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1174ratio of 3:1 to 4:1 for LAF (4), we found that LAF patients were  more predominant male (male to female ratio; 4.6:1).",Non-OADS,/arxiv_data1/oa_pdf/a8/4d/jkms-28-1174.PMC3744705.pdf
• Risk Factors in Lone Atrial Fibrillationhttp://jkms.org   1179  http://dx.doi.org/10.3346/jkms.2013.28.8.1174AF burden in patients with LAF .,Non-OADS,/arxiv_data1/oa_pdf/a8/4d/jkms-28-1174.PMC3744705.pdf
• Risk Factors in Lone Atrial Fibrillation1180  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1174in lone atrial fibrillation.,Non-OADS,/arxiv_data1/oa_pdf/a8/4d/jkms-28-1174.PMC3744705.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Urinary Biomarkers for Early Detection of Recovery in Patients  with Acute Kidney Injury Urinary biomarkers of acute kidney injury (AKI) have been revealed recently to be useful for prior prediction of AKI.",Non-OADS,/arxiv_data1/oa_pdf/b8/e8/jkms-28-1181.PMC3744706.pdf
"Received: 2 November 2012 Accepted: 22 May 2013 Address for Correspondence: Sang Choel Lee, MD Department of Internal Medicine, College of Medicine, Kwandong University, 579 Bungil-Bumil-ro,  Gangneung 210-701, Korea Tel: +82.31-810-5400, Fax: +82.31-969-0500 E-mail: sunnylsc@hanafos.com This work was supported by an investigational grant funded by  the Myongji Hospital, College of Medicine, Kwandong University  (2009-01-03).http://dx.doi.org/10.3346/jkms.2013.28.8.1181 • J Korean Med Sci 2013; 28: 1181-1186ORIGINAL ARTICLE Nephrology INTRODUCTION Acute kidney injury (AKI) is a common and serious complica- tion for hospitalised patients.",Non-OADS,/arxiv_data1/oa_pdf/b8/e8/jkms-28-1181.PMC3744706.pdf
• Urinary Biomarkers for Acute Kidney Injury 1182  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1181ceding 3 months.,Non-OADS,/arxiv_data1/oa_pdf/b8/e8/jkms-28-1181.PMC3744706.pdf
• Urinary Biomarkers for Acute Kidney Injury http://jkms.org   1183  http://dx.doi.org/10.3346/jkms.2013.28.8.1181approval No.,Non-OADS,/arxiv_data1/oa_pdf/b8/e8/jkms-28-1181.PMC3744706.pdf
• Urinary Biomarkers for Acute Kidney Injury 1184  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.11812).,Non-OADS,/arxiv_data1/oa_pdf/b8/e8/jkms-28-1181.PMC3744706.pdf
• Urinary Biomarkers for Acute Kidney Injury http://jkms.org   1185  http://dx.doi.org/10.3346/jkms.2013.28.8.1181urine NGAL but not plasma creatinine.,Non-OADS,/arxiv_data1/oa_pdf/b8/e8/jkms-28-1181.PMC3744706.pdf
• Urinary Biomarkers for Acute Kidney Injury 1186  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1181sis and death among survivors of acute kidney injury requiring dialysis.,Non-OADS,/arxiv_data1/oa_pdf/b8/e8/jkms-28-1181.PMC3744706.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Higher Prevalence of Klebsiella pneumoniae Extended-Spectrum  β-Lactamase in Patients on Renal Replacement Therapy The prevalence of antibiotic resistance is higher in patients undergoing renal replacement  therapy (RRT) than in patients who did not undergo RRT.",Non-OADS,/arxiv_data1/oa_pdf/31/c6/jkms-28-1187.PMC3744707.pdf
(20110841).http://dx.doi.org/10.3346/jkms.2013.28.8.1187 • J Korean Med Sci 2013; 28: 1187-1193ORIGINAL ARTICLE Nephrology INTRODUCTION There is an increasing rate of antibiotic-resistant Klebsiella  pneumoniae (KP) strains that produce extended-spectrum  β-lactamase (ESBL).,Non-OADS,/arxiv_data1/oa_pdf/31/c6/jkms-28-1187.PMC3744707.pdf
• Renal Replacement Therapy as a Risk Factor for Klebsiella pneumonia ESBL1188  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1187grouped those patients with KP by the presence of ESBL: an  ESBL(-) KP group (KP[-]) and an ESBL(+) KP group (KP[+]).,Non-OADS,/arxiv_data1/oa_pdf/31/c6/jkms-28-1187.PMC3744707.pdf
"• Renal Replacement Therapy as a Risk Factor for Klebsiella pneumonia ESBLhttp://jkms.org   1189  http://dx.doi.org/10.3346/jkms.2013.28.8.1187Prevalence of KP at culture sites and percentage of  antibiotics used initiallyIn blood cultures, KP(-) was present in 3.5% of patients, and KP(+) was present in 1.0% of patients.",Non-OADS,/arxiv_data1/oa_pdf/31/c6/jkms-28-1187.PMC3744707.pdf
• Renal Replacement Therapy as a Risk Factor for Klebsiella pneumonia ESBL1190  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1187days) ( P< 0.001).,Non-OADS,/arxiv_data1/oa_pdf/31/c6/jkms-28-1187.PMC3744707.pdf
• Renal Replacement Therapy as a Risk Factor for Klebsiella pneumonia ESBLhttp://jkms.org   1191  http://dx.doi.org/10.3346/jkms.2013.28.8.1187tenance RRT (Table 4).,Non-OADS,/arxiv_data1/oa_pdf/31/c6/jkms-28-1187.PMC3744707.pdf
"• Renal Replacement Therapy as a Risk Factor for Klebsiella pneumonia ESBL1192  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1187for the prevention of ESBL infection, the patient who has ESBL  infection should have dialysis in isolated room.",Non-OADS,/arxiv_data1/oa_pdf/31/c6/jkms-28-1187.PMC3744707.pdf
• Renal Replacement Therapy as a Risk Factor for Klebsiella pneumonia ESBLhttp://jkms.org   1193  http://dx.doi.org/10.3346/jkms.2013.28.8.118724.,Non-OADS,/arxiv_data1/oa_pdf/31/c6/jkms-28-1187.PMC3744707.pdf
Available at http://www.cdc.gov/dialysis/guide-lines/index.html [accessed on 9 March 2013].,Non-OADS,/arxiv_data1/oa_pdf/31/c6/jkms-28-1187.PMC3744707.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Incidence, Etiology, and Outcomes of Rhabdomyolysis in a Single  Tertiary Referral Center We have encountered numerous cases of rhabdomyolysis associated with acute pesticide intoxication; however, the cause, incidence, and treatment outcomes of rhabdomyolysis have not been studied.",Non-OADS,/arxiv_data1/oa_pdf/42/7b/jkms-28-1194.PMC3744708.pdf
"PJ008246)”, under the auspices of the  Rural Development Administration, Republic of Korea.http://dx.doi.org/10.3346/jkms.2013.28.8.1194 • J Korean Med Sci 2013; 28: 1194-1199ORIGINAL ARTICLE Nephrology INTRODUCTION Various causes of rhabdomyolysis have been described, such as  exertion, crush injuries, ischemia, metabolic disorders, abnor - mal body temperatures, infection, autoimmune muscle dam-age, and drugs and/or toxins (1).",Non-OADS,/arxiv_data1/oa_pdf/42/7b/jkms-28-1194.PMC3744708.pdf
"• Incidence and Etiology of Rhabdomyolysishttp://jkms.org   1195  http://dx.doi.org/10.3346/jkms.2013.28.8.1194times that of the lowest level during the observation period ret - rospectively, when the glomerular filtration rate decreased  > 75% of the lowest level during the admission, when the se- rum creatinine level increased over 4 mg/dL without a history  of renal disease, when there was an acute rise of serum creati- nine ≥ 0.5 mg/dL, and when the urine output decreased to  < 0.3 mL/[kg .h], or if anuria persisted for > 12 hr.",Non-OADS,/arxiv_data1/oa_pdf/42/7b/jkms-28-1194.PMC3744708.pdf
"• Incidence and Etiology of Rhabdomyolysis1196  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1194myolysis and non-rhabdomyolysis patients who ingested pesti- cides, there were no differences in age, time lag to hospital ad-mission, or the incidence of alcohol coingestion.",Non-OADS,/arxiv_data1/oa_pdf/42/7b/jkms-28-1194.PMC3744708.pdf
• Incidence and Etiology of Rhabdomyolysishttp://jkms.org   1197  http://dx.doi.org/10.3346/jkms.2013.28.8.1194 Peak CK levels were significantly lower in the pesticide class  than those in the non-pesticide chemical classes (P = 0.01) or  those in the physical class ( P= 0.01).,Non-OADS,/arxiv_data1/oa_pdf/42/7b/jkms-28-1194.PMC3744708.pdf
"• Incidence and Etiology of Rhabdomyolysis1198  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1194conventional blood purification technique using hemodialysis  (AK 95S Hemodialysis Machine [Gambro, Lund, Sweden]; blood flow, 250 mL/min and dialysate flow, 500 mL/min).",Non-OADS,/arxiv_data1/oa_pdf/42/7b/jkms-28-1194.PMC3744708.pdf
• Incidence and Etiology of Rhabdomyolysishttp://jkms.org   1199  http://dx.doi.org/10.3346/jkms.2013.28.8.1194col (Phila) 2008; 46: 890-1.,Non-OADS,/arxiv_data1/oa_pdf/42/7b/jkms-28-1194.PMC3744708.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Systematic Review and Meta-Analysis of Pulmonary  Hypertension Specific Therapy for Exercise Capacity in Chronic Obstructive Pulmonary Disease Some patients with chronic obstructive pulmonary disease (COPD) have pulmonary hypertension (PH) that adversely affects survival.",Non-OADS,/arxiv_data1/oa_pdf/5e/fd/jkms-28-1200.PMC3744709.pdf
"Key Words:  COPD; Pulmonary Hypertension; Vasodilator; ExerciseJinkyeong Park,1 Ju Hee Song,2  Dong-Ah Park,3 Jae Seoung Lee,2  Sang-Do Lee,2 and Yeon-Mok Oh,2 1Department of Pulmonary and Critical Care  Medicine Wonkwang University, Sanbon Hospital,  Gunpo; 2Department of Pulmonary and Critical Care  Medicine, and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul;  3Office of Health Technology Evaluation, National  Evidence-Based Healthcare Collaborating Agency, Seoul, Korea Received: 6 May 2013 Accepted: 3 June 2013 Address for Correspondence:  Yeon-Mok Oh, MD Department of Pulmonary and Critical Care Medicine, and  Clinical Research Center for Chronic Obstructive Airway  Diseases, Asan Medical Center, University of Ulsan College of  Medicine, 88 Olympic-ro 43-gil, Sonpa-gu, Seoul 138-736,  KoreaTel: +82.2-3010-3136, Fax: +82.2-3010-6968  E-mail: ymoh55@amc.seoul.kr This study was supported by a grant from the Korea Healthcare  Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A102065).http://dx.doi.org/10.3346/jkms.2013.28.8.1200 • J Korean Med Sci 2013; 28: 1200-1206ORIGINAL ARTICLE Respiratory Diseases INTRODUCTION Pulmonary hypertension (PH) is more common among patients  with severe airflow limitation.",Non-OADS,/arxiv_data1/oa_pdf/5e/fd/jkms-28-1200.PMC3744709.pdf
• Pulmonary Hypertension Specific Treatment for COPDhttp://jkms.org   1201  http://dx.doi.org/10.3346/jkms.2013.28.8.1200PH patients with COPD.,Non-OADS,/arxiv_data1/oa_pdf/5e/fd/jkms-28-1200.PMC3744709.pdf
"MATERIALS AND METHODS Search methods for identification of studies We searched Ovid-MEDLINE (1948 to October 2011), Ovid-EM - BASE (1980 to October 2011), Cochrane Register of Controlled Trials (CENTRAL) of the Cochrane Library (issue 4, 2011) using the search filter in the Ovid database (SIGN; http://www.sign.",OADS,/arxiv_data1/oa_pdf/5e/fd/jkms-28-1200.PMC3744709.pdf
"Finally, we also searched an international data base  (http://www.clinicaltrial.gov) for trial registration to identify ongoing or recently completed trials.",Non-OADS,/arxiv_data1/oa_pdf/5e/fd/jkms-28-1200.PMC3744709.pdf
• Pulmonary Hypertension Specific Treatment for COPD1202  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1200respectively.,Non-OADS,/arxiv_data1/oa_pdf/5e/fd/jkms-28-1200.PMC3744709.pdf
• Pulmonary Hypertension Specific Treatment for COPDhttp://jkms.org   1203  http://dx.doi.org/10.3346/jkms.2013.28.8.1200ment.,Non-OADS,/arxiv_data1/oa_pdf/5e/fd/jkms-28-1200.PMC3744709.pdf
"• Pulmonary Hypertension Specific Treatment for COPD1204  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1200dilator in the intention-to-treat population with COPD were  available for four trials and were analyzed by inverse variation method, as shown in Fig.",Non-OADS,/arxiv_data1/oa_pdf/5e/fd/jkms-28-1200.PMC3744709.pdf
• Pulmonary Hypertension Specific Treatment for COPDhttp://jkms.org   1205  http://dx.doi.org/10.3346/jkms.2013.28.8.1200were available for two RCT trials (Fig.,Non-OADS,/arxiv_data1/oa_pdf/5e/fd/jkms-28-1200.PMC3744709.pdf
• Pulmonary Hypertension Specific Treatment for COPD1206  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1200improvement of the exercise capacity.,Non-OADS,/arxiv_data1/oa_pdf/5e/fd/jkms-28-1200.PMC3744709.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Model for End-Stage Liver Disease Score-Based System  Predicts Short Term Mortality Better Than the Current Child-Turcotte-Pugh Score-Based Allocation System during Waiting for Deceased Liver Transplantation To adopt the model for end-stage liver disease (MELD) score-based system in Korea, the feasibility should be evaluated by analysis of Korean database.",Non-OADS,/arxiv_data1/oa_pdf/94/83/jkms-28-1207.PMC3744710.pdf
"Key Words:  Liver Diseases; Waiting Lists; Survival; Mortality; Liver Transplantation; MELD  ScoreGeun Hong, Kwang-Woong Lee,   Sukwon Suh, Tae Yoo, Hyeyoung Kim, Min-Su Park, Youngrok Choi,  Nam-Joon Yi, and Kyung-Suk Suh Department of Surgery, Seoul National University College of Medicine, Seoul, Korea Received: 21 January 2013 Accepted: 28 June 2013 Address for Correspondence: Kwang-Woong Lee, MD Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea Tel: +82.2-2072-2511, Fax: +82.2-766-3975 E-mail: kwleegs@gmail.com  This research was not supported by a financial grant.http://dx.doi.org/10.3346/jkms.2013.28.8.1207 • J Korean Med Sci 2013; 28: 1207-1212ORIGINAL ARTICLE Gastroenterology & Hepatology INTRODUCTION Despite of increment of liver transplantation (LT), there are still  growing numbers of accumulated patients in waiting list in Ko-rea.",Non-OADS,/arxiv_data1/oa_pdf/94/83/jkms-28-1207.PMC3744710.pdf
• Feasibility of MELD Score-Based Allocation System 1208  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1207score-based system and to suggest adequate cut-off to stratify  waiting list mortality among Korean population.,Non-OADS,/arxiv_data1/oa_pdf/94/83/jkms-28-1207.PMC3744710.pdf
• Feasibility of MELD Score-Based Allocation System http://jkms.org   1209  http://dx.doi.org/10.3346/jkms.2013.28.8.1207underwent LT during 6 months follow-up.,Non-OADS,/arxiv_data1/oa_pdf/94/83/jkms-28-1207.PMC3744710.pdf
• Feasibility of MELD Score-Based Allocation System 1210  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1207ate the feasibility of MELD system in Korea compared with the  current allocation system by analyzing Korean database.,OADS,/arxiv_data1/oa_pdf/94/83/jkms-28-1207.PMC3744710.pdf
• Feasibility of MELD Score-Based Allocation System http://jkms.org   1211  http://dx.doi.org/10.3346/jkms.2013.28.8.1207solution for allocation dilemma (Status 1 vs Status 2A) in cases  of HBV related fulminant hepatitis.,Non-OADS,/arxiv_data1/oa_pdf/94/83/jkms-28-1207.PMC3744710.pdf
• Feasibility of MELD Score-Based Allocation System 1212  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1207score-based system in that it uses objective data and it can pre- dict short-term mortality better.,Non-OADS,/arxiv_data1/oa_pdf/94/83/jkms-28-1207.PMC3744710.pdf
Available at  http://optn.transplant.hrsa.gov/organDatasource/OrganSpecificPoli-cies.asp?display=Liver [accessed on January 2013].,Non-OADS,/arxiv_data1/oa_pdf/94/83/jkms-28-1207.PMC3744710.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Impact of Inosine Triphosphatase Variants on   Hemoglobin Level and Sustained Virologic Response of Chronic Hepatitis C in Korean Two variants of the inosine triphosphatase (ITPA: rs1127354, rs7270101) gene cause ITPA deficiency and protect against the hemolytic toxicity of ribavirin.",Non-OADS,/arxiv_data1/oa_pdf/09/32/jkms-28-1213.PMC3744711.pdf
"Received: 26 January 2013 Accepted: 22 May 2013 Address for Correspondence: Young Kul Jung, MD Gachon University Gil Medical Center, Department of Internal Medicine, 24 Namdong-daero 774 beon-gil, Namdong-gu, Incheon 405-760, Korea Tel: +82.32-460-8930, Fax: +82.32-460-3408 E-mail: 93cool@hanmail.net This research was supported by Gachon University Gil Medical  Center research fund (2011).http://dx.doi.org/10.3346/jkms.2013.28.8.1213 • J Korean Med Sci 2013; 28: 1213-1219ORIGINAL ARTICLE Gastroenterology & Hepatology INTRODUCTION  Hepatitis C virus (HCV) infection affects approximately 170 mil- lion people worldwide, and 3-4 million individuals are newly infected each year (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/09/32/jkms-28-1213.PMC3744711.pdf
• The impact of ITPA on Hgb and SVR in CHC1214  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1213CHC patients treated with PEG-IFN plus RBV .,Non-OADS,/arxiv_data1/oa_pdf/09/32/jkms-28-1213.PMC3744711.pdf
"• The Impact of ITPA on Hgb and SVR in CHChttp://jkms.org   1215  http://dx.doi.org/10.3346/jkms.2013.28.8.1213after 4 weeks of treatment, and EVR as an undetectable or a ≥ 2  log drop in serum HCV RNA after 12 weeks of treatment.",Non-OADS,/arxiv_data1/oa_pdf/09/32/jkms-28-1213.PMC3744711.pdf
"• The impact of ITPA on Hgb and SVR in CHC1216  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1213Modification of RBV dose after 4, 8, and 12 weeks of  treatment by ITPA genotypeRBV dose modifications were as followings; a reduction of 200 mg when the Hgb level was < 10 g/dL and stopped when the Hgb level was < 8 g/dL.",Non-OADS,/arxiv_data1/oa_pdf/09/32/jkms-28-1213.PMC3744711.pdf
"• The Impact of ITPA on Hgb and SVR in CHChttp://jkms.org   1217  http://dx.doi.org/10.3346/jkms.2013.28.8.1213(P= 0.282), and by 78% and 71% (P = 0.726) of non-genotype 1.",OADS,/arxiv_data1/oa_pdf/09/32/jkms-28-1213.PMC3744711.pdf
• The impact of ITPA on Hgb and SVR in CHC1218  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1213RBV is influenced by ITPA variants (11).,Non-OADS,/arxiv_data1/oa_pdf/09/32/jkms-28-1213.PMC3744711.pdf
"• The Impact of ITPA on Hgb and SVR in CHChttp://jkms.org   1219  http://dx.doi.org/10.3346/jkms.2013.28.8.1213Noventa F , Stanzial AM, Solero P , Corrocher R. Hemolytic anemia in - duced by ribavirin therapy in patients with chronic hepatitis C virus in- fection: role of membrane oxidative damage.",Non-OADS,/arxiv_data1/oa_pdf/09/32/jkms-28-1213.PMC3744711.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Optimal Duration of Medical Treatment in Superior Mesenteric  Artery Syndrome in Children The aim of this study was to investigate the outcome, and optimal duration of medical treatment in children with superior mesenteric artery syndrome (SMAS).",Non-OADS,/arxiv_data1/oa_pdf/e6/7c/jkms-28-1220.PMC3744712.pdf
"Key Words:  Superior Mesenteric Artery Syndrome; Medical Treatment, Outcome; ChildrenMyung Seok Shin1 and Jae Young Kim2 1Department of Pediatrics, College of Medicine,  Catholic University of Korea, St. Mary’s Hospital,  Daejeon; 2Department of Pediatrics, Chungnam  National University School of Medicine, Daejeon, Korea Received: 4 June 2013 Accepted: 13 June 2013 Address for Correspondence: Jae Young Kim, MD Department of Pediatrics, Chungnam National University School of Medicine, 266 Munhwa-ro, Jung-gu, Daejeon 301-747, KoreaTel: +82.42-240-7249, Fax: +82.42-255-3158   E-mail: pedkim@cnuh.co.krhttp://dx.doi.org/10.3346/jkms.2013.28.8.1220 • J Korean Med Sci 2013; 28: 1220-1225ORIGINAL ARTICLE  Pediatrics INTRODUCTION Superior mesenteric artery syndrome (SMAS) is a symptom  complex resulting from vascular compression of the third por - tion of the duodenum between the superior mesenteric artery (SMA) and the aorta (1).",Non-OADS,/arxiv_data1/oa_pdf/e6/7c/jkms-28-1220.PMC3744712.pdf
Shin MS and Kim JY • Treatment of Superior Mesenteric Artery Syndrome in Childrenhttp://jkms.org   1221  http://dx.doi.org/10.3346/jkms.2013.28.8.1220Growth Charts drafted by the Korea Centers for Disease Control  and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/e6/7c/jkms-28-1220.PMC3744712.pdf
Shin MS and Kim JY • Treatment of Superior Mesenteric Artery Syndrome in Children1222  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1220Clinical course and outcome All patients began with conservative treatment.,Non-OADS,/arxiv_data1/oa_pdf/e6/7c/jkms-28-1220.PMC3744712.pdf
Shin MS and Kim JY • Treatment of Superior Mesenteric Artery Syndrome in Childrenhttp://jkms.org   1223  http://dx.doi.org/10.3346/jkms.2013.28.8.1220for-height Z-score was -1.56.,OADS,/arxiv_data1/oa_pdf/e6/7c/jkms-28-1220.PMC3744712.pdf
"Shin MS and Kim JY • Treatment of Superior Mesenteric Artery Syndrome in Children1224  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1220vicious cycle (5, 14).",Non-OADS,/arxiv_data1/oa_pdf/e6/7c/jkms-28-1220.PMC3744712.pdf
Shin MS and Kim JY • Treatment of Superior Mesenteric Artery Syndrome in Childrenhttp://jkms.org   1225  http://dx.doi.org/10.3346/jkms.2013.28.8.1220in a vicious cycle.,Non-OADS,/arxiv_data1/oa_pdf/e6/7c/jkms-28-1220.PMC3744712.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Intra-Amniotic Infection/Inflammation as a Risk Factor for  Subsequent Ruptured Membranes after Clinically Indicated Amniocentesis in Preterm Labor The aim of this study was to determine whether intra-amniotic infection/inflammation (IAI) was associated with subsequent ruptured membranes in women with preterm labor and intact membranes who had a clinically indicated amniocentesis.",Non-OADS,/arxiv_data1/oa_pdf/7b/b4/jkms-28-1226.PMC3744713.pdf
"Key Words:  Amniocentesis; C-Reactive Protein; Intra-Amniotic Infection/Inflammation;  Obstetric Labor, Premature; Ruptured MembranesSung Youn Lee, Kyo Hoon Park,   Eun Ha Jeong, Kyung Joon Oh, Aeli Ryu, and Ahra Kim Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea Received: 21 May 2013 Accepted: 3 June 2013 Address for Correspondence: Kyo Hoon Park, MD Department of Obstetrics and Gynecology Seoul National  University Bundang Hospital, 82 Gumi-ro 173-beon-gil,  Bundang-gu, Seongnam 463-707, Korea Tel: +82.31-787-7252, Fax: +82.31-787-4054 E-mail: pkh0419@snubh.orghttp://dx.doi.org/10.3346/jkms.2013.28.8.1226 • J Korean Med Sci 2013; 28: 1226-1232ORIGINAL ARTICLE Obstetrics & Gynecology INTRODUCTION Intra-amniotic infection/inflammation has been implicated in  the mechanism responsible for preterm labor and has been found in at least 20% of women in preterm labor and intact membranes (1-5).",Non-OADS,/arxiv_data1/oa_pdf/7b/b4/jkms-28-1226.PMC3744713.pdf
• Ruptured Membranes Following Amniocentesishttp://jkms.org   1227  http://dx.doi.org/10.3346/jkms.2013.28.8.1226was associated with subsequent PPROM in women with pre- term labor and intact membranes who had a clinically indicat - ed amniocentesis.,Non-OADS,/arxiv_data1/oa_pdf/7b/b4/jkms-28-1226.PMC3744713.pdf
"• Ruptured Membranes Following Amniocentesis1228  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1226cervical dilatation with the exposure of amniotic membranes to  the vagina, and the development of clinical signs of chorioam-nionitis.",Non-OADS,/arxiv_data1/oa_pdf/7b/b4/jkms-28-1226.PMC3744713.pdf
• Ruptured Membranes Following Amniocentesishttp://jkms.org   1229  http://dx.doi.org/10.3346/jkms.2013.28.8.1226tent to which multicollinearity is a problem in a model.,Non-OADS,/arxiv_data1/oa_pdf/7b/b4/jkms-28-1226.PMC3744713.pdf
• Ruptured Membranes Following Amniocentesis1230  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.12263) delivered within 7 days of amniocentesis and 71% (10/14) of  these cases had elevated levels of AF IL-6 at the time of amnio-centesis.,Non-OADS,/arxiv_data1/oa_pdf/7b/b4/jkms-28-1226.PMC3744713.pdf
• Ruptured Membranes Following Amniocentesishttp://jkms.org   1231  http://dx.doi.org/10.3346/jkms.2013.28.8.1226ered their infants at term.,Non-OADS,/arxiv_data1/oa_pdf/7b/b4/jkms-28-1226.PMC3744713.pdf
"• Ruptured Membranes Following Amniocentesis1232  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1226prognostic value of amniotic fluid white blood cell count, glucose, inter - leukin-6, and gram stain in patients with preterm labor and intact  membranes.",Non-OADS,/arxiv_data1/oa_pdf/7b/b4/jkms-28-1226.PMC3744713.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Interfractional Variation of Radiation Target and Adaptive  Radiotherapy for Totally Resected Glioblastoma This study aimed to evaluate the effects of volume adapted re-planning for radiotherapy (RT) after gross total resection (GTR) for glioblastoma.",Non-OADS,/arxiv_data1/oa_pdf/ea/65/jkms-28-1233.PMC3744714.pdf
"Key Words:  Glioblastomas; Surgery; Brain; Radiotherapy, Image-GuidedTae Gyu Kim1 and Do Hoon Lim2 1Department of Radiation Oncology, Samsung  Changwon Hospital, Sungkyunkwan University  School of Medicine, Changwon; 2Department of  Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Received: 15 March 2013 Accepted: 14 May 2013 Address for Correspondence: Do Hoon Lim, MD Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 135-710, Korea  Tel: +82.2-3410-2613, Fax: +82.2-3410-2619 E-mail: dh8.lim@samsung.comhttp://dx.doi.org/10.3346/jkms.2013.28.8.1233 • J Korean Med Sci 2013; 28: 1233-1237ORIGINAL ARTICLE Neuroscience INTRODUCTION Radiotherapy (RT) is an essential modality for the treatment of  the patients with glioblastoma, and there have been many tech-nical advances in RT techniques that have prolonged the sur - vival period.",Non-OADS,/arxiv_data1/oa_pdf/ea/65/jkms-28-1233.PMC3744714.pdf
Kim TG and Lim DH • Adaptive Radiotherapy according to Target Change for Glioblastoma1234  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1233prescription dose to the PTV was 50 Gy with a daily fraction of 2  Gy.,Non-OADS,/arxiv_data1/oa_pdf/ea/65/jkms-28-1233.PMC3744714.pdf
"Kim TG and Lim DH • Adaptive Radiotherapy according to Target Change for Glioblastomahttp://jkms.org   1235  http://dx.doi.org/10.3346/jkms.2013.28.8.1233Change in surgical defect volume The surgical defect volumes on CT0, GTV1, and GTV2 were 19.6-198.5 mL (median, 65.4 mL), 12.3-142.1 mL (median, 33.7 mL), and 7.9-96.3 mL (median, 25.1 mL), respectively.",OADS,/arxiv_data1/oa_pdf/ea/65/jkms-28-1233.PMC3744714.pdf
"Kim TG and Lim DH • Adaptive Radiotherapy according to Target Change for Glioblastoma1236  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1233volume decreased; however, the reduction ratio of the volume  rose inversely.",OADS,/arxiv_data1/oa_pdf/ea/65/jkms-28-1233.PMC3744714.pdf
"Kim TG and Lim DH • Adaptive Radiotherapy according to Target Change for Glioblastomahttp://jkms.org   1237  http://dx.doi.org/10.3346/jkms.2013.28.8.1233ing volume-adapted re-planning for boost RT, particularly, an  approximate 50% decrease in volume with high dose radiation.",Non-OADS,/arxiv_data1/oa_pdf/ea/65/jkms-28-1233.PMC3744714.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Antinociceptive Effects of Amiloride and Benzamil in  Neuropathic Pain Model Rats Amiloride and benzamil showed antinocicepitve effects in several pain models through the inhibition of acid sensing ion channels (ASICs).",Non-OADS,/arxiv_data1/oa_pdf/fa/0b/jkms-28-1238.PMC3744715.pdf
"Key Words:   Amiloride; Benzamil; Acid Sensing Ion Channels; Spinal Nerve Ligation;  Spinal Cord Dorsal HornSeongtae Jeong,1 Seong Heon Lee,1   Yeo Ok Kim,3 and Myung Ha Yoon1,2,3  1Department of Anesthesiology and Pain Medicine,  Chonnam National University, Medical School,  Gwangju; 2Brain Korea 21 Project, Center for  Biomedical Human Resources at Chonnam National  University, Gwangju; 3Chonnam National University  Research Institute of Medical Sciences, Gwangju,  Korea Received: 29 December 2012 Accepted: 22 May 2013 Address for Correspondence: Myung Ha Yoon, MD Department of Anesthesiology and Pain Medicine,   Chonnam National University, Medical School, 160 Baekseo-ro,  Dong-gu, Gwangju 501-746, Korea Tel: +82.62-220-6893, Fax: +82.62-232-6294  E-mail: mhyoon@jnu.ac.krhttp://dx.doi.org/10.3346/jkms.2013.28.8.1238 • J Korean Med Sci 2013; 28: 1238-1243ORIGINAL ARTICLE Anesthesiology & Pain INTRODUCTION Neuropathic pain is a complex, chronic pain state typically ac - companied by disease of the somatosensory system that is as - sociated with abnormal sensations, such as allodynia, hyperal- gesia, and spontaneous pain (1).",Non-OADS,/arxiv_data1/oa_pdf/fa/0b/jkms-28-1238.PMC3744715.pdf
"• Amiloride and Benzamil in Neuropathic Ratshttp://jkms.org   1239  http://dx.doi.org/10.3346/jkms.2013.28.8.1238period, animals were housed with free access to a standard rat  diet and tap water in a room under a 12/12-h light/dark cycle.",Non-OADS,/arxiv_data1/oa_pdf/fa/0b/jkms-28-1238.PMC3744715.pdf
• Amiloride and Benzamil in Neuropathic Rats1240  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1238Table 1.,Non-OADS,/arxiv_data1/oa_pdf/fa/0b/jkms-28-1238.PMC3744715.pdf
• Amiloride and Benzamil in Neuropathic Ratshttp://jkms.org   1241  http://dx.doi.org/10.3346/jkms.2013.28.8.1238sidered to indicate statistical significance.,Non-OADS,/arxiv_data1/oa_pdf/fa/0b/jkms-28-1238.PMC3744715.pdf
• Amiloride and Benzamil in Neuropathic Rats1242  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1238nous opioid mechanisms related to the ASIC1a channel.,Non-OADS,/arxiv_data1/oa_pdf/fa/0b/jkms-28-1238.PMC3744715.pdf
• Amiloride and Benzamil in Neuropathic Ratshttp://jkms.org   1243  http://dx.doi.org/10.3346/jkms.2013.28.8.123811.,Non-OADS,/arxiv_data1/oa_pdf/fa/0b/jkms-28-1238.PMC3744715.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Effectiveness of Mechanical Embolectomy for Septic Embolus in  the Cerebral Artery Complicated with Infective Endocarditis There has been a controversy over data of thrombolytic and endovascular surgical treatment about cerebral infarction secondary to infective endocarditis.",Non-OADS,/arxiv_data1/oa_pdf/f7/40/jkms-28-1244.PMC3744716.pdf
"Key Words:  Mechanical Embolectomy; Acute Ischemic Stroke; Infective EndocarditisGimoon Kang,1 Tae Ki Yang,2  Joon Hyouk Choi,1 and Sang Taek Heo1 Departments of 1Internal Medicine, 2Neurosurgery,  Jeju National University School of Medicine, Jeju,  Korea Received: 30 November 2012 Accepted: 10 April 2013 Address for Correspondence: Sang Taek Heo, MD Division of Infectious Diseases, Department of Internal Medicine, Jeju National University School of Medicine, 102 Jejudaehak-ro, Jeju 690-756, Korea Tel: +82.64-717-1296, Fax: +82.64-717-1131 E-mail: neosangtaek@naver.comhttp://dx.doi.org/10.3346/jkms.2013.28.8.1244 • J Korean Med Sci 2013; 28: 1244-1247CASE REPORT Infectious Diseases, Microbiology & Parasitology INTRODUCTION Neurological deficits in the setting of infective endocarditis (IE)  are critical conditions.",Non-OADS,/arxiv_data1/oa_pdf/f7/40/jkms-28-1244.PMC3744716.pdf
"• Mechanical Embolectomy for Stroke with Infective Endocarditishttp://jkms.org   1245  http://dx.doi.org/10.3346/jkms.2013.28.8.1244sy and aphasia, which also improved gradually.",Non-OADS,/arxiv_data1/oa_pdf/f7/40/jkms-28-1244.PMC3744716.pdf
"• Mechanical Embolectomy for Stroke with Infective Endocarditis1246  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1244group of all intracranial infarctions, but is an important cause of  neurologic complications in patients with IE.",Non-OADS,/arxiv_data1/oa_pdf/f7/40/jkms-28-1244.PMC3744716.pdf
• Mechanical Embolectomy for Stroke with Infective Endocarditishttp://jkms.org   1247  http://dx.doi.org/10.3346/jkms.2013.28.8.1244the brain (11).,Non-OADS,/arxiv_data1/oa_pdf/f7/40/jkms-28-1244.PMC3744716.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Imatinib Plasma Monitoring-Guided Dose Modification for  Managing Imatinib-Related Toxicities in Gastrointestinal Stromal Tumor Patients Imatinib, the first-line treatment in patients with advanced gastrointestinal stromal tumors (GIST), is generally well tolerated, although some patients have difficulty tolerating the standard dose of 400 mg/day.",Non-OADS,/arxiv_data1/oa_pdf/8f/59/jkms-28-1248.PMC3744717.pdf
"Key Words:  Gastrointestinal Stromal Tumors (GIST); Imatinib; Imatinib Plasma  Monitoring; Dose-ModificationShinkyo Yoon, Min-Hee Ryu,   Changhoon Yoo, Mo Youl Beck,  Baek-Yeol Ryoo, and Yoon-Koo Kang Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Received: 19 September 2012 Accepted: 14 May 2013 Address for Correspondence: Yoon-Koo Kang, MD Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea Tel: +82.2-3010-3230, Fax: +82.2-3010-8227 E-mail: ykkang@amc.seoul.kr *Financial support for medical editorial assistance was provided  by Novartis Pharmaceuticals.http://dx.doi.org/10.3346/jkms.2013.28.8.1248 • J Korean Med Sci 2013; 28: 1248-1252CASE REPORT Oncology & Hematology INTRODUCTION The introduction of imatinib mesylate (Glivec®/Gleevec®, No - vartis, Basel, Switzerland) has improved outcomes for patients  with advanced gastrointestinal stromal tumor (GIST), and ima-tinib is now considered the standard first-line treatment in pa-tients with metastatic or unresectable GIST (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/8f/59/jkms-28-1248.PMC3744717.pdf
"• Imatinib Dose Modification in Gastrointestinal Stromal Tumorhttp://jkms.org   1249  http://dx.doi.org/10.3346/jkms.2013.28.8.1248GIST with multiple liver metastases and peritoneal seeding on  May 25, 2010.",Non-OADS,/arxiv_data1/oa_pdf/8f/59/jkms-28-1248.PMC3744717.pdf
"• Imatinib Dose Modification in Gastrointestinal Stromal Tumor1250  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1248studies have shown that GIST patients with the c-KIT  exon 9  mutation may benefit from higher than normal exposure to ima- tinib (3, 9, 10).",Non-OADS,/arxiv_data1/oa_pdf/8f/59/jkms-28-1248.PMC3744717.pdf
"• Imatinib Dose Modification in Gastrointestinal Stromal Tumorhttp://jkms.org   1251  http://dx.doi.org/10.3346/jkms.2013.28.8.1248DISCUSSION Imatinib is metabolized in the liver, predominantly by cyto- chrome P450 (CYP) 3A4 (12).",Non-OADS,/arxiv_data1/oa_pdf/8f/59/jkms-28-1248.PMC3744717.pdf
• Imatinib Dose Modification in Gastrointestinal Stromal Tumor1252  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1248clinical benefit in patients with unresectable/metastatic gastrointestinal  stromal tumors.,Non-OADS,/arxiv_data1/oa_pdf/8f/59/jkms-28-1248.PMC3744717.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Intramedullary Spinal Cord Metastasis in Renal Cell Carcinoma:  A Case Report of the Surgical Experience Intramedullary spinal cord metastasis (ISCM) from renal cell carcinoma (RCC) is rare manifestation and most of them are treated by adjuvant treatment modalities like radiotherapy.",Non-OADS,/arxiv_data1/oa_pdf/dd/a2/jkms-28-1253.PMC3744718.pdf
"Key Words:  Intramedullary Spinal Cord Neoplasm; Metastasis; Renal Cell CarcinomaJeongill Park, Seok-Won Chung,   Kyoung-Tae Kim, Dae-Chul Cho,  Jeong-Hyun Hwang,  Joo-Kyung Sung, and Dakeun Lee  Department of Neurosurgery, Kyungpook National University Hospital, Daegu, Korea Received: 24 December 2012 Accepted: 3 April 2013 Address for Correspondence: Seok-Won Chung, MD  Department of Neurosurgery, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 700-721, Korea  Tel: +82.53-200-5647, Fax: +82.53-423-0504  E-mail: neurochung79@gmail.comhttp://dx.doi.org/10.3346/jkms.2013.28.8.1253 • J Korean Med Sci 2013; 28: 1253-1256CASE REPORT Oncology & Hematology INTRODUCTION Although metastatic neoplasms of the spine are common, pure  intramedullary spinal cord metastasis (ISCM) is a rare manifes - tation of systemic cancer, which indicates the occurrence of re-mote dissemination, and thus, the terminal phase of cancer (1-3).",Non-OADS,/arxiv_data1/oa_pdf/dd/a2/jkms-28-1253.PMC3744718.pdf
"• Renal Cell Carcinoma Metastasized to Spinal Cord1254  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1253Cavitron Ultrasonic Aspirator (CUSA, Valleylab, USA) was per - formed.",Non-OADS,/arxiv_data1/oa_pdf/dd/a2/jkms-28-1253.PMC3744718.pdf
• Renal Cell Carcinoma Metastasized to Spinal Cordhttp://jkms.org   1255  http://dx.doi.org/10.3346/jkms.2013.28.8.1253ticles and summarized them into 3 pathologic mechanisms.,OADS,/arxiv_data1/oa_pdf/dd/a2/jkms-28-1253.PMC3744718.pdf
"• Renal Cell Carcinoma Metastasized to Spinal Cord1256  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1253rological deficit, especially for the patients with radio-resistant  primary tumor, such as RCC.",Non-OADS,/arxiv_data1/oa_pdf/dd/a2/jkms-28-1253.PMC3744718.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Therapeutic Hypothermia Following Emergent Coronary Artery  Bypass Grafting After Failed Percutaneous Coronary Intervention in a Comatose Post-Cardiac Arrest Patient  We report the case of 60-yr-old female in which therapeutic hypothermia (TH) was successfully induced maintaining the target temperature of 34°C for 12 hr despite a risk of hypothermia-induced coagulation abnormalities following an emergent coronary artery bypass grafting (CABG) due to failed percutaneous coronary intervention, who suffered a cardiac arrest.",Non-OADS,/arxiv_data1/oa_pdf/b9/39/jkms-28-1257.PMC3744719.pdf
"Key Words:  Hypothermia; Cardiac Arrest; Coronary Artery Bypass Grafting Seung Pill Choi,1 Jung Hee Wee,1  Jeong Ho Park,1 Kyu Nam Park,1  Sung Jin Hong,2 and Sun Hee Lee3 Departments of 1Emergency Medicine,  2Anesthesiology and Pain Medicine, and 3Thoracic  and Cardiovascular Surgery, College of Medicine,  The Catholic University of Korea, Seoul, Korea  Received: 7 December 2012 Accepted: 27 February 2013 Address for Correspondence: Sun Hee Lee, MD Department of Thoracic and Cardiovascular Surgery, Yeouido St. Mary’s Hospital, 10 63-ro, Yeoungdeungpo-gu, Seoul 150-713, Korea  Tel: +82.2-3779-1020, Fax: +82.2-761-8440 E-mail: shleemd@catholic.ac.krhttp://dx.doi.org/10.3346/jkms.2013.28.8.1257 • J Korean Med Sci 2013; 28: 1257-1259CASE REPORT Emergency & Critical Care Medicine INTRODUCTION For post-cardiac arrest care, early coronary reperfusion is best  achieved with primary percutaneous coronary intervention (PCI) and should be initiated as indicated in non-cardiac arrest patients, such as those with ST elevation myocardial infarction (STEMI) (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/b9/39/jkms-28-1257.PMC3744719.pdf
"• Therapeutic Hypothermia after Emergent CABG in a Cardiac Arrest Patient1258  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.8.1257plied because of her unstable vital signs, and she was transferred  to the operating room for an emergent CABG at approximately 4 hr after ROSC.",Non-OADS,/arxiv_data1/oa_pdf/b9/39/jkms-28-1257.PMC3744719.pdf
• Therapeutic Hypothermia after Emergent CABG in a Cardiac Arrest Patienthttp://jkms.org   1259  http://dx.doi.org/10.3346/jkms.2013.28.8.1257mic patients.,Non-OADS,/arxiv_data1/oa_pdf/b9/39/jkms-28-1257.PMC3744719.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2013.28.8.1260 • J Korean Med Sci 2013; 28: 1260CORRESPONDENCE Erratum: Addition of a Co-Author Shinje Moon,1 Wooseok Kwak,1 Sangwon Lee,1 Won Kim,2 Jaeyeon Oh,3 and Seung-Ki Youn1 1Division of Epidemic Intelligence Service, Korea Centers for Disease Control and Prevention, Cheongwon; 2Division of Health Policy, Seoul Metropolitan   Government, Seoul; 3Healthcare Department of Dongdaemun-gu Public Health Center, Seoul, Korea To the Editor:  The authors regret that one co-author was missing in the following article: “Epidemiological Characteristics of the First   water-Borne Outbreak of Cryptosporidiosis in Seoul, Korea” , J Korean Med Sci 2013;28:983-989.",Non-OADS,/arxiv_data1/oa_pdf/c9/56/jkms-28-1260.PMC3744720.pdf
"In the United States alone, 785000 people have a new coro - nary event each year with an estimated direct and indirect cost of  $1 10 billion.1)2) Regrettably, the initial diagnosis of CAD often occurs  only after an event yields significant disability or worse, sudden car -Review http://dx.doi.org/10.4070/kcj.2013.43.7.435 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Physiologic Assessment of Coronary Artery Disease   by Cardiac Computed Tomography Minisha Kochar, MD1 and James K. Min, MD2,3 1Division of Cardiology, Kaiser Permanente, Panorama City, CA, 2Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA,  3Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA Coronary artery disease (CAD) remains the leading cause of death and morbidity worldwide.",Non-OADS,/arxiv_data1/oa_pdf/d7/1c/kcj-43-435.PMC3744730.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.diac death.",Non-OADS,/arxiv_data1/oa_pdf/d7/1c/kcj-43-435.PMC3744730.pdf
436 Physiologic Assessment of CAD http://dx.doi.org/10.4070/kcj.2013.43.7.435 www.e-kcj.org sive strategies are inadequate to properly identify individuals who  are suitable for further invasive angiographic assessment.,Non-OADS,/arxiv_data1/oa_pdf/d7/1c/kcj-43-435.PMC3744730.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.7.435 www.e-kcj.org of individual lesions.22) Fractional flow reserve is widely considered the gold standard  physiologic test for assessment of lesion-specific ischemia.18)23) In  comparison to stress testing methods that identify either global  myocardial ischemia or territory specific ischemia, FFR provides an added advantage of assessing ischemia at the lesion level, thereby providing the clinician with important information regarding the hemodynamic significance of specific stenoses.",Non-OADS,/arxiv_data1/oa_pdf/d7/1c/kcj-43-435.PMC3744730.pdf
438 Physiologic Assessment of CAD http://dx.doi.org/10.4070/kcj.2013.43.7.435 www.e-kcj.org in a 25% overall improvement in overall diagnostic accuracy of FFR CT  over CT alone (84% vs. 59%).,Non-OADS,/arxiv_data1/oa_pdf/d7/1c/kcj-43-435.PMC3744730.pdf
http://dx.doi.org/10.4070/kcj.2013.43.7.435 www.e-kcj.org alitative myocardial CTP utilizes a visual perception of contrast den- sity in different regions within the myocardium to distinguish nor-mal from hypoperfused tissue.,Non-OADS,/arxiv_data1/oa_pdf/d7/1c/kcj-43-435.PMC3744730.pdf
"440 Physiologic Assessment of CAD http://dx.doi.org/10.4070/kcj.2013.43.7.435 www.e-kcj.org and therefore can not always mimic exercise-induced perfusion  abnormalities.38)42-44) In addition, atherosclerosis limits the vasodilat - ing effect of adenosine.",Non-OADS,/arxiv_data1/oa_pdf/d7/1c/kcj-43-435.PMC3744730.pdf
http://dx.doi.org/10.4070/kcj.2013.43.7.435 www.e-kcj.org computed tomography for detecting angiographically significant coro - nary artery stenosis in an unselected consecutive patient population:  comparison with conventional invasive angiography.,Non-OADS,/arxiv_data1/oa_pdf/d7/1c/kcj-43-435.PMC3744730.pdf
442 Physiologic Assessment of CAD http://dx.doi.org/10.4070/kcj.2013.43.7.435 www.e-kcj.org fusion in patients presenting with acute chest pain to the emergency  department: comparison with SPECT-myocardial perfusion imaging.,Non-OADS,/arxiv_data1/oa_pdf/d7/1c/kcj-43-435.PMC3744730.pdf
"Because pharma - ceutical drugs and interventional devices in cardiovascular diseases (CVDs) cannot ignore declining effects, controversial debates on the Review http://dx.doi.org/10.4070/kcj.2013.43.7.443 Print ISSN 1738-5520 • On-line ISSN 1738-5555 The Decline Effect in Cardiovascular Medicine:   Is the Effect of Cardiovascular Medicine and   Stent on Cardiovascular Events Decline Over the Years?",Non-OADS,/arxiv_data1/oa_pdf/a2/fa/kcj-43-443.PMC3744731.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.application of drugs and devices continued.",Non-OADS,/arxiv_data1/oa_pdf/a2/fa/kcj-43-443.PMC3744731.pdf
444 The Decline Effect in CVDs http://dx.doi.org/10.4070/kcj.2013.43.7.443 www.e-kcj.org cies of scientists and scientific journals indicate preference of posi - tive data over null results.,Non-OADS,/arxiv_data1/oa_pdf/a2/fa/kcj-43-443.PMC3744731.pdf
http://dx.doi.org/10.4070/kcj.2013.43.7.443 www.e-kcj.org be investigated.29) The debate on the optimal dose of aspirin for patients undergo - ing revascularization or after an acute coronary syndrome (ACS) ev- ent continues.,Non-OADS,/arxiv_data1/oa_pdf/a2/fa/kcj-43-443.PMC3744731.pdf
446 The Decline Effect in CVDs http://dx.doi.org/10.4070/kcj.2013.43.7.443 www.e-kcj.org graft thrombosis.,Non-OADS,/arxiv_data1/oa_pdf/a2/fa/kcj-43-443.PMC3744731.pdf
http://dx.doi.org/10.4070/kcj.2013.43.7.443 www.e-kcj.org adrenergic receptor.,Non-OADS,/arxiv_data1/oa_pdf/a2/fa/kcj-43-443.PMC3744731.pdf
"448 The Decline Effect in CVDs http://dx.doi.org/10.4070/kcj.2013.43.7.443 www.e-kcj.org artery (ULMCA) disease based on the efficacy and survival advan - tage of CABG in reference to medical therapy.77)78) In 1977, the practice of PCI was introduced, and it impacted on  significant changes in revascularization strategy of CADs.",Non-OADS,/arxiv_data1/oa_pdf/a2/fa/kcj-43-443.PMC3744731.pdf
http://dx.doi.org/10.4070/kcj.2013.43.7.443 www.e-kcj.org outcome reporting biased.,Non-OADS,/arxiv_data1/oa_pdf/a2/fa/kcj-43-443.PMC3744731.pdf
450 The Decline Effect in CVDs http://dx.doi.org/10.4070/kcj.2013.43.7.443 www.e-kcj.org coronary disease: Cambridge Heart Antioxidant Study (CHAOS).,Non-OADS,/arxiv_data1/oa_pdf/a2/fa/kcj-43-443.PMC3744731.pdf
Available from: http://www.uspreventiveservicestaskforce.org/uspstf09/aspirincvd/aspcv - drs.htm.,Non-OADS,/arxiv_data1/oa_pdf/a2/fa/kcj-43-443.PMC3744731.pdf
http://dx.doi.org/10.4070/kcj.2013.43.7.443 www.e-kcj.org diovascular disease: U.S. Preventive Services Task Force recommen - dation statement.,Non-OADS,/arxiv_data1/oa_pdf/a2/fa/kcj-43-443.PMC3744731.pdf
Available from: http://www.fda.gov/Drugs/Drugsafety/PostmarketDrugsafetyinformationforPa - tientsandProviders/DrugsafetyinformationforHeathcareProfession - als/ucm190787.htm.,Non-OADS,/arxiv_data1/oa_pdf/a2/fa/kcj-43-443.PMC3744731.pdf
452 The Decline Effect in CVDs http://dx.doi.org/10.4070/kcj.2013.43.7.443 www.e-kcj.org pass surgery on survival patterns in subsets of patients with left main  coronary artery disease.,Non-OADS,/arxiv_data1/oa_pdf/a2/fa/kcj-43-443.PMC3744731.pdf
"Worldwide, osteoporosis is the most com- mon bone disease in humans, characterized by the consequence of Original Article http://dx.doi.org/10.4070/kcj.2013.43.7.453 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Gender Difference in Bone Loss and Vascular   Calcification Associated with Age Dong-Hyeon Lee, MD1, Ho-Joong Youn, MD1, Jeong Eun Yi, MD1, Jung Yeon Chin, MD1,  Tae-Seok Kim, MD1,  Hae-Ok Jung, MD1, Kiyuk Chang, MD1, Yun-Seok Choi, MD1, and Jung-Im Jung, MD2 1Division of Cardiology, Departments of Internal Medicine and 2Radiology, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicne, Seoul, Korea Background and Objectives:  It is widely known that both bone loss and vascular calcification are age-related processes.",Non-OADS,/arxiv_data1/oa_pdf/16/e9/kcj-43-453.PMC3744732.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.continued bone loss and structural deterioration of bone tissue and  disruption of bone architecture, compromised bone strength, and an increase in the risk of fracture.",Non-OADS,/arxiv_data1/oa_pdf/16/e9/kcj-43-453.PMC3744732.pdf
"454 Gender Difference between BMD and CAC Score http://dx.doi.org/10.4070/kcj.2013.43.7.453 www.e-kcj.org bone loss and vascular calcification, the underlying pathophysio - logic mechanisms that are identified in bone metabolism and vascu - lar homoeostasis have not been defined.",Non-OADS,/arxiv_data1/oa_pdf/16/e9/kcj-43-453.PMC3744732.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.7.453 www.e-kcj.org construction slice width=0.75 mm, reconstruction slice interval=  0.4 mm, kernel=B26f, field of view=25 cm.",Non-OADS,/arxiv_data1/oa_pdf/16/e9/kcj-43-453.PMC3744732.pdf
"456 Gender Difference between BMD and CAC Score http://dx.doi.org/10.4070/kcj.2013.43.7.453 www.e-kcj.org 85±9 cm, p<0.001), SBP (126 ±14 mm Hg : 122 ±16 mm Hg, p<0.001),  and DBP (76 ±10 mm Hg : 70 ±10 mm Hg, p<0.001) in demographic  data, total cholesterol (201 ±37 mg/dL : 205 ±38 mg/dL, p=0.016),  triglyceride (134 ±89 mg/dL : 98 ±67 mg/dL, p<0.001), HDL-C (48 ±  1 1 mg/dL : 56 ±13 mg/dL, p<0.001), fasting blood sugar (102 ±27  mg/dL : 96 ±24 mg/dL, p<0.001), and calcitonin (3.4 ±2.3 ng/L : 2.7 ±  1.9 ng/L, p=0.002) in laboratory findings, BMD at the level of lumbar  spine (-total: 1.213 ±0.176 g/cm2 : 1.087 ±0.168 g/cm2, p<0.001), and  femur (-total: 1.024 ±0.131 g/cm2 : 0.910 ±0.127 g/cm2, p<0.001), to - tal CAC score (68 ±227 : 27 ±1 16, p<0.001), and volume score (52 ±  179 mm3 : 20±88 mm3, p<0.001) for coronary artery calcification, res- pectively.",Non-OADS,/arxiv_data1/oa_pdf/16/e9/kcj-43-453.PMC3744732.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.7.453 www.e-kcj.org mm Hg; p<0.001), and DBP (67 ±10 mm Hg : 70 ±9 mm Hg : 72 ±9  mm Hg; p<0.001, respectively) in demographic data, serum total  cholesterol concentration (198 ±37 mg/dL : 206 ±39 mg/dL : 207 ±37  mg/dL; p=0.042), and fasting blood sugar (92 ±21 mg/dL : 96 ±22 mg/ dL : 100 ±30 mg/dL; p=0.003), HbA1c (5.5 ±0.6 % : 5.8 ±1.0% : 5.9 ±  0.9%; p<0.001), bsALP (14.3 ±7.8 IU/L : 19.6 ±1 1.3 IU/L : 21.7 ±13.6  IU/L; p<0.001), and CTX-I level (0.34 ±0.16 μg/L : 0.44 ±0.23 μg/L : 0.51±0.36 μg/L; p<0.001, respectively) in laboratory findings, total  CAC score (9 ±54 : 18 ±99 : 45 ±161; p=0.002), and volume score (8 ±  49 : 13 ±70 : 34 ±124; p=0.002, respectively) (Table 2).",OADS,/arxiv_data1/oa_pdf/16/e9/kcj-43-453.PMC3744732.pdf
458 Gender Difference between BMD and CAC Score http://dx.doi.org/10.4070/kcj.2013.43.7.453 www.e-kcj.org Table 2.,Non-OADS,/arxiv_data1/oa_pdf/16/e9/kcj-43-453.PMC3744732.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.7.453 www.e-kcj.org (M : F=48 ±144 : 9 ±54, p<0.001) and osteopenia groups (M : F=  93±288 : 18 ±99, p<0.001, respectively), but not in the osteoporosis  group (M : F=77 ±198 : 45 ±161, p=0.095) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/16/e9/kcj-43-453.PMC3744732.pdf
"460 Gender Difference between BMD and CAC Score http://dx.doi.org/10.4070/kcj.2013.43.7.453 www.e-kcj.org Additionally, in this study, there was an inverse correlation be - tween BMD and age.",OADS,/arxiv_data1/oa_pdf/16/e9/kcj-43-453.PMC3744732.pdf
http://dx.doi.org/10.4070/kcj.2013.43.7.453 www.e-kcj.org Study Group.,Non-OADS,/arxiv_data1/oa_pdf/16/e9/kcj-43-453.PMC3744732.pdf
Available from: http://www.iscd.org.,Non-OADS,/arxiv_data1/oa_pdf/16/e9/kcj-43-453.PMC3744732.pdf
"Increased numbers of coronary intensive care units, reperfusion techniques for percuta -Original Article http://dx.doi.org/10.4070/kcj.2013.43.7.462 Print ISSN 1738-5520 • On-line ISSN 1738-5555 The Impact of Trimetazidine Treatment on Left Ventricular Functions and Plasma Brain Natriuretic Peptide Levels in Patients with   Non-ST Segment Elevation Myocardial Infarction Undergoing   Percutaneous Coronary Intervention Selami Demirelli, MD1, S¸ule Karakelleo g˘lu, MD2, Fuat Gündo g˘du, MD2, Muhammed Hakan Ta s¸, MD2, Ahmet Kaya, MD3, Hakan Duman, MD4, Hüsnü De g˘irmenci, MD5, Hikmet Hamur, MD6, and Ziya S¸ims¸ek, MD2 1Department of Cardiology, Erzurum Regional Training and Research Hospital, Erzurum,  2Department of Cardiology, Faculty of Medicine, Atatürk University, Erzurum,  3Department of Cardiology, Faculty of Medicine Ordu University, Ordu,  4Department of Cardiology, Rize State Hospital, Rize, 5Department of Cardiology, Erzurum Palandöken State Hospital, Erzurum,  6Department of Cardiology, Mengücek Gazi Regional Training and Research Hospital, Erzincan, Turkey Background and Objectives:  The aim of this study was to investigate the impact of treatment with oral trimetazidine (TMZ) applied before  and after percutaneous coronary interventions (PCI) on short-term left ventricular functions and plasma brain natriuretic peptide (BNP) levels  in patients with non-ST segment elevation myocardial infarction (NSTEMI) undergoing PCI.",Non-OADS,/arxiv_data1/oa_pdf/e0/c1/kcj-43-462.PMC3744733.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.neous coronary interventions (PCIs), and advanced medical thera - pies, including several pharmacological agents, have resulted in a  significantly prolonged life expectancy.",Non-OADS,/arxiv_data1/oa_pdf/e0/c1/kcj-43-462.PMC3744733.pdf
http://dx.doi.org/10.4070/kcj.2013.43.7.462 www.e-kcj.org apies are currently ongoing.,OADS,/arxiv_data1/oa_pdf/e0/c1/kcj-43-462.PMC3744733.pdf
"464 Impact of Trimetazidine Treatment on Left Ventricular Functions http://dx.doi.org/10.4070/kcj.2013.43.7.462 www.e-kcj.org continuous variables, the independent Student t-test was used.",Non-OADS,/arxiv_data1/oa_pdf/e0/c1/kcj-43-462.PMC3744733.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.7.462 www.e-kcj.org 44 pg/mL, 73.0 ±16 pg/mL and 29.0 ±8 pg/mL; control group-85.0 ±  37 pg/mL, 80.3 ±43 pg/mL and 50.6 ±33 pg/mL at the baseline, at 1  day and at 30 days, respectively (Fig.",Non-OADS,/arxiv_data1/oa_pdf/e0/c1/kcj-43-462.PMC3744733.pdf
"466 Impact of Trimetazidine Treatment on Left Ventricular Functions http://dx.doi.org/10.4070/kcj.2013.43.7.462 www.e-kcj.org dosis and, thereby, preserves cellular homeostasis by reducing the  oxidation of fatty acids and reactivating the glucose pathway.14-16) Trimetazidine preserves myocardial contractile function, reducing  ischemic damage and reperfusion damage following ischemia.17)  Fragasso et al.18) investigated the effects of conventional therapy  plus TMZ on New York Heart Association (NYHA) functional class, exercise tolerance, quality of life, and LV function in patients with heart failure, irrespective of the underlying etiology (i.e.",Non-OADS,/arxiv_data1/oa_pdf/e0/c1/kcj-43-462.PMC3744733.pdf
http://dx.doi.org/10.4070/kcj.2013.43.7.462 www.e-kcj.org 18.,Non-OADS,/arxiv_data1/oa_pdf/e0/c1/kcj-43-462.PMC3744733.pdf
"468 Copyright © 2013 The Korean Society of CardiologyKorean Circulation Journal Introduction Endothelial dysfunction and subsequent coronary artery spasm Original Article http://dx.doi.org/10.4070/kcj.2013.43.7.468 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Significant Response to Lower Acetylcholine Dose Is Associated   with Worse Clinical and Angiographic Characteristics   in Patients with Vasospastic Angina Sung Il Im, MD1, Woong Gil Choi, MD1,2, Seung-Woon Rha, MD1, Byoung Geol Choi, BS1, Se Yeon Choi, BS1,  Sun Won Kim, MD1, Jin Oh Na, MD1, Cheol Ung Choi, MD1, Hong Euy Lim, MD1, Jin Won Kim, MD1,  Eung Ju Kim, MD1, Chang Gyu Park, MD1, Hong Seog Seo, MD1, and Dong Joo Oh, MD1 1Cardiovascular Center, Korea University Guro Hospital, Seoul, 2Cardiology Department, Konkuk University Chungju Hospital, Chungju, Korea Background and Objectives:  The intracoronary injection of acetylcholine (Ach) has been shown to induce coronary spasms in patients  with variant angina.",Non-OADS,/arxiv_data1/oa_pdf/45/dc/kcj-43-468.PMC3744734.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/dc/kcj-43-468.PMC3744734.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.7.468 www.e-kcj.org administration of ergonovine, an intracoronary Ach provocation test  has been employed in the clinical setting.",Non-OADS,/arxiv_data1/oa_pdf/45/dc/kcj-43-468.PMC3744734.pdf
"470 Vasospastic Angina, Acetylcholine Dose http://dx.doi.org/10.4070/kcj.2013.43.7.468 www.e-kcj.org insulin.",Non-OADS,/arxiv_data1/oa_pdf/45/dc/kcj-43-468.PMC3744734.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.7.468 www.e-kcj.org elevation and AV blockage during the Ach provocation test, and 2)  more associated with a higher incidence of baseline spasms and se-vere spasms, suggesting a higher degree of vulnerability and pro - found endothelial dysfunction to constrictor stimuli as compared with patients who show a significant response to a higher Ach dose.",Non-OADS,/arxiv_data1/oa_pdf/45/dc/kcj-43-468.PMC3744734.pdf
"472 Vasospastic Angina, Acetylcholine Dose http://dx.doi.org/10.4070/kcj.2013.43.7.468 www.e-kcj.org coronary Ach is paradoxical and indicative of widespread endothe - lial dysfunction.4)1 1) For evaluating the constrictor response of each  left and right coronary artery separately, intracoronary Ach has the  advantage over ergonovine of an extremely short half-life.",Non-OADS,/arxiv_data1/oa_pdf/45/dc/kcj-43-468.PMC3744734.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.7.468 www.e-kcj.org the positive provocation rate for CAS was higher in our study than  that observed in previous reporting.22) Fifth, because we enrolled all  patients who had chest pain (without concern about typical or aty-pical chest pain), without significant coronary artery stenosis, the typical expected (+) rate of spasm may have been higher in this study.",Non-OADS,/arxiv_data1/oa_pdf/45/dc/kcj-43-468.PMC3744734.pdf
"474 Copyright © 2013 The Korean Society of CardiologyKorean Circulation Journal Introduction During the past decade, clinical electrophysiologic studies (EPS) Original Article http://dx.doi.org/10.4070/kcj.2013.43.7.474 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Inadvertently Developed Ventricular Fibrillation   during Electrophysiologic Study and Catheter Ablation:   Incidence, Cause, and Prognosis Yae Min Park, MD1, Hyun Soo Lee, MPH1, Ra Seung Lim, RT1, Jong-Il Choi, MD1, Hong Euy Lim, MD1,  Sang Weon Park, MD1, In Suck Choi, MD2, and Young-Hoon Kim, MD1 1Division of Cardiology, Korea University College of Medicine, Seoul,  2Division of Cardiology, Department of Internal Medicine, Gachon University, Incheon, Korea Background and Objectives:  Ventricular fibrillation (VF) can inadvertently occur during electrophysiologic study (EPS) or catheter abla - tion.",Non-OADS,/arxiv_data1/oa_pdf/d9/16/kcj-43-474.PMC3744735.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.have become an accepted part of the diagnostic evaluation to gu- ide the treatment of patients with various cardiac arrhythmias.1)2)  Sometimes, electrophysiologists try to intentionally induce ventri-cular fibrillation (VF) or ventricular tachycardia (VT) by programm-ed stimulation so as to diagnose previously undocumented or un - diagnosed ventricular arrhythmia in certain patients during EPS.",Non-OADS,/arxiv_data1/oa_pdf/d9/16/kcj-43-474.PMC3744735.pdf
http://dx.doi.org/10.4070/kcj.2013.43.7.474 www.e-kcj.org veloped VF on the recurrence of cardiac events or ventricular arrhy- thmia during long-term follow-up among patients undergoing EPS without a history of VF.,Non-OADS,/arxiv_data1/oa_pdf/d9/16/kcj-43-474.PMC3744735.pdf
"476 Inadvertent VF during EPS  http://dx.doi.org/10.4070/kcj.2013.43.7.474 www.e-kcj.org Results Patient characteristics  Among the 2624 patients, 1 1 developed inadvertent VF (0.42%).",OADS,/arxiv_data1/oa_pdf/d9/16/kcj-43-474.PMC3744735.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.7.474 www.e-kcj.org after internal cardioversion or rapid RV pacing, whereas 3 patients  (27.3%) developed VF spontaneously.",Non-OADS,/arxiv_data1/oa_pdf/d9/16/kcj-43-474.PMC3744735.pdf
"478 Inadvertent VF during EPS  http://dx.doi.org/10.4070/kcj.2013.43.7.474 www.e-kcj.org Clinical outcomes during follow up  At a mean follow-up period of 17.4 ±15.5 months, all patients  were alive and doing well without cardiac events arising.",Non-OADS,/arxiv_data1/oa_pdf/d9/16/kcj-43-474.PMC3744735.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.7.474 www.e-kcj.org ronization of the DC shock (55%) under isoproterenol infusion, fol- lowed by spontaneous VF induction during isoproterenol infusion (27%).",Non-OADS,/arxiv_data1/oa_pdf/d9/16/kcj-43-474.PMC3744735.pdf
480 Inadvertent VF during EPS  http://dx.doi.org/10.4070/kcj.2013.43.7.474 www.e-kcj.org using prompt external shock.,Non-OADS,/arxiv_data1/oa_pdf/d9/16/kcj-43-474.PMC3744735.pdf
"481 Copyright © 2013 The Korean Society of CardiologyKorean Circulation Journal Introduction Cardiovascular risk factors, such as hypertension, obesity, hyper - cholesterolemia, diabetes mellitus, and chronic smoking, stimulate  the production of reactive oxygen species (ROS) in the vascular wall.1) Original Article http://dx.doi.org/10.4070/kcj.2013.43.7.481 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Cardiac Rehabilitation Increases Exercise Capacity   with a Reduction of Oxidative Stress Taira Fukuda, MD1,2, Miwa Kurano, BS2, Kazuya Fukumura, BS2, Tomohiro Yasuda, PhD2, Haruko Iida, MD2,  Toshihiro Morita, MD2, Yumiko Yamamoto, MD3, Nami Takano, MD3, Issei Komuro, MD3, and Toshiaki Nakajima, MD2 1Health Center, Hitotsubashi University, Tokyo, 2Department of Ischemic Circulatory Physiology, University of Tokyo, Tokyo,  3Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan  Background and Objectives:  Reactive oxygen species (ROS) mediate various signaling pathways that underlie vascular inflammation in  atherogenesis and cardiovascular diseases.",Non-OADS,/arxiv_data1/oa_pdf/ee/8c/kcj-43-481.PMC3744736.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Additionally, increases in ROS, such as superoxide and hydrogen pe- roxide (H 2O2), have been reported in patients with cardiovascular  diseases2) and chronic heart failure (CHF).3)4)  Decreased nitric oxide (NO) production due to changes in the ex- pression and activity of endothelial NO synthase and increased de-gradation of NO, through a reaction with superoxide, accounts for the reduction in endothelium-dependent vascular relaxation.",Non-OADS,/arxiv_data1/oa_pdf/ee/8c/kcj-43-481.PMC3744736.pdf
"482 Cardiac Rehabilitation and Oxidative Stress http://dx.doi.org/10.4070/kcj.2013.43.7.481 www.e-kcj.org a small amount of superoxide is normally produced as a byproduct  of the use of molecular oxygen during mitochondrial oxidative ph-osphorylation, 7) superoxide is inactivated by either NO or SOD, and  SOD rapidly converts superoxide to H 2O2 (which is, itself, broken  down by GPX and catalase to water).8) However, studies in relation  to oxidant stress and antioxidant defense mechanisms in patients with cardiovascular diseases remain quite scarce.",Non-OADS,/arxiv_data1/oa_pdf/ee/8c/kcj-43-481.PMC3744736.pdf
http://dx.doi.org/10.4070/kcj.2013.43.7.481 www.e-kcj.org by the Ethics Committee of the University of Tokyo.,Non-OADS,/arxiv_data1/oa_pdf/ee/8c/kcj-43-481.PMC3744736.pdf
"484 Cardiac Rehabilitation and Oxidative Stress http://dx.doi.org/10.4070/kcj.2013.43.7.481 www.e-kcj.org months vs. pre-CR, 325 ±63 vs. 351 ±97 CARR U, p<0.005) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/ee/8c/kcj-43-481.PMC3744736.pdf
http://dx.doi.org/10.4070/kcj.2013.43.7.481 www.e-kcj.org lated with the % changes of BNP.,OADS,/arxiv_data1/oa_pdf/ee/8c/kcj-43-481.PMC3744736.pdf
"486 Cardiac Rehabilitation and Oxidative Stress http://dx.doi.org/10.4070/kcj.2013.43.7.481 www.e-kcj.org tablished cardiovascular diseases, there was no relationship observed  between d-ROMs and BAP.",OADS,/arxiv_data1/oa_pdf/ee/8c/kcj-43-481.PMC3744736.pdf
http://dx.doi.org/10.4070/kcj.2013.43.7.481 www.e-kcj.org 9.,Non-OADS,/arxiv_data1/oa_pdf/ee/8c/kcj-43-481.PMC3744736.pdf
"He was a current smoker with 20 pack-years Case Report http://dx.doi.org/10.4070/kcj.2013.43.7.488 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Intercoronary Communication between the Circumflex and   Right Coronary Arteries Coexisted with Coronary Vasospasm Soo Hyun Kim, MD1, Dae-Hyeok Kim, MD2, Woong Gil Choi, MD1, Seoung Il Woo, MD2, In Suk Choi, MD3, Jun Kwan, MD2, Keum Soo Park, MD2, and Sung-Hee Shin, MD2 1Division of Cardiology, Department of Internal Medicine, Konkuk University College of Medicine, Chungju, 2Division of Cardiology, Department of Internal Medicine, Inha University College of Medicine, Incheon,  3Division of Cardiology, Department of Internal Medicine, Gachon University, Incheon, Korea Intercoronary arterial connection between normal coronary arteries is a rare variant of coronary anatomy in which there is open-ended  circulation.",Non-OADS,/arxiv_data1/oa_pdf/37/a4/kcj-43-488.PMC3744737.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.and used to have chest pain on exertion intermittently.",Non-OADS,/arxiv_data1/oa_pdf/37/a4/kcj-43-488.PMC3744737.pdf
http://dx.doi.org/10.4070/kcj.2013.43.7.488 www.e-kcj.org features and histological structure.,OADS,/arxiv_data1/oa_pdf/37/a4/kcj-43-488.PMC3744737.pdf
490 Intercoronary Communication and Coronary Vasospasm http://dx.doi.org/10.4070/kcj.2013.43.7.488 www.e-kcj.org in our case.,Non-OADS,/arxiv_data1/oa_pdf/37/a4/kcj-43-488.PMC3744737.pdf
"Patients may present with clinical  scenarios ranging from angina pectoris to cardiogenic shock to Case Report http://dx.doi.org/10.4070/kcj.2013.43.7.491 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Spontaneous Coronary Artery Dissection Mimicking Coronary   Spasm Diagnosed by Intravascular Ultrasonography Hyemoon Chung, MD1, Sung-Joo Lee, MD2, Jong-Kwan Park, MD3, In Suk Choi, MD4,  Ho Yeon Won, MD5, Sohee Kim, MD1, Jung-Joon Cha, MD1, and Byoung Kwon Lee, MD1 1Cardiology Division, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul,  2Cardiology Division, Department of Internal Medicine, Chungju Medical Center, Chungju,  3Cardiology Division, Department of Internal Medicine, NHIC Ilsan Hospital, Goyang, 4Cardiology Division, Department of Internal Medicine, Gachon University, Incheon,  5Cardiology Division, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea Spontaneous coronary artery dissection (SCAD) is a rare and occasionally life-threatening cause of acute coronary syndrome.",Non-OADS,/arxiv_data1/oa_pdf/bb/dc/kcj-43-491.PMC3744738.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.sudden cardiac death,4) and it may be a potentially life-threatening  condition if not recognized.",Non-OADS,/arxiv_data1/oa_pdf/bb/dc/kcj-43-491.PMC3744738.pdf
"492 Spontaneous Coronary Artery Dissection Mimicking Coronary Spasm http://dx.doi.org/10.4070/kcj.2013.43.7.491 www.e-kcj.org tion, her blood pressure was 1 16/70 mm Hg and her heart rate was  75 beats/min.",OADS,/arxiv_data1/oa_pdf/bb/dc/kcj-43-491.PMC3744738.pdf
http://dx.doi.org/10.4070/kcj.2013.43.7.491 www.e-kcj.org Fig.,OADS,/arxiv_data1/oa_pdf/bb/dc/kcj-43-491.PMC3744738.pdf
494 Spontaneous Coronary Artery Dissection Mimicking Coronary Spasm http://dx.doi.org/10.4070/kcj.2013.43.7.491 www.e-kcj.org nal branch.,Non-OADS,/arxiv_data1/oa_pdf/bb/dc/kcj-43-491.PMC3744738.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.7.491 www.e-kcj.org erythematous); medication (such as an oral contraceptive, 5 FU, fen - fluramine, cyclosporine); cocaine use; hypertension and cystic medi - al necrosis; variant angina and physical exercise.10) The most common  conditions related to SCAD are coronary atherosclerosis and con - ditions associated with the peripartum period.",Non-OADS,/arxiv_data1/oa_pdf/bb/dc/kcj-43-491.PMC3744738.pdf
496 Spontaneous Coronary Artery Dissection Mimicking Coronary Spasm http://dx.doi.org/10.4070/kcj.2013.43.7.491 www.e-kcj.org tool for diagnosis and therapeutic planning for SCAD.,Non-OADS,/arxiv_data1/oa_pdf/bb/dc/kcj-43-491.PMC3744738.pdf
"Case A 62-year-old man was transferred to our hospital because of Case Report http://dx.doi.org/10.4070/kcj.2013.43.7.497 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Pulmonary Alveolar Hemorrhage after Clopidogrel Use   for ST Elevation Myocardial Infarction Youngjoong Kim, MD1, Joohan Lim, MD2, Jonggu Lim, MD1,  Soohyun Kim, MD1, Taeyoung Jung, MD1, and Woonggil Choi, MD1 1Division of Cardiology, Department of Internal Medicine, Konkuk University College of Medicine, Chungju,  2Division of Hemato-Oncology, Department of Internal Medicine, Inha University College of Medicine, Incheon, Korea Combination treatment of antiplatelet drugs containing aspirin and clopidogrel reduces systemic ischemic events after percutaneous  coronary intervention (PCI) in high risk patients.",Non-OADS,/arxiv_data1/oa_pdf/75/f0/kcj-43-497.PMC3744739.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.chest pain.",Non-OADS,/arxiv_data1/oa_pdf/75/f0/kcj-43-497.PMC3744739.pdf
498 Pulmonary Alveolar Hemorrhage after Clopidogrel Use http://dx.doi.org/10.4070/kcj.2013.43.7.497 www.e-kcj.org a central distribution in both upper lobes (Fig.,Non-OADS,/arxiv_data1/oa_pdf/75/f0/kcj-43-497.PMC3744739.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.7.497 www.e-kcj.org nary alveolar hemorrhage are Wegener’s granulomatosis, micro - scopic polyangitis, Goodpasture’s syndrome, antiphospholipid an - tibody syndrome, infection, toxin, pulmonary embolism, mitral st- enosis, and malignancy.",Non-OADS,/arxiv_data1/oa_pdf/75/f0/kcj-43-497.PMC3744739.pdf
"Herein, we report a rare case of NCPE presenting as a delayed- type manifestation with a review of the literature.Case Report http://dx.doi.org/10.4070/kcj.2013.43.7.500 Print ISSN 1738-5520 • On-line ISSN 1738-5555 A Delayed, Unusual Non-Cardiogenic Pulmonary Edema after   Intravascular Administration of Non-Ionic, Low Osmolar   Radiocontrast Media for Coronary Angiography Min-Ho Kang, MD and Jong-Chun Nah, MD Division of Cardiology, Department of Medicine, Seoul Paik Hospital, Inje University School of Medicine, Seoul, Korea Non-cardiogenic pulmonary edema (NCPE) is a rare adverse reaction to iodinated radiocontrast media (RCM), in which all previous cases  were immediate reactions.",Non-OADS,/arxiv_data1/oa_pdf/84/19/kcj-43-500.PMC3744740.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case A 56-year-old male was admitted to the outpatient clinic with a  6-day history of chest pain on exertion lasting for over 10 minutes  per episode.",Non-OADS,/arxiv_data1/oa_pdf/84/19/kcj-43-500.PMC3744740.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.7.500 www.e-kcj.org gioedema, rales or wheezing in the lung field.",Non-OADS,/arxiv_data1/oa_pdf/84/19/kcj-43-500.PMC3744740.pdf
"502 Non-Cardiogenic Pulmonary Edema to Non-Ionic Contrast Agent for Coronary Angiography http://dx.doi.org/10.4070/kcj.2013.43.7.500 www.e-kcj.org Discussion Today, non-ionic, low osmolar RCM such as non-ionic monomer:  Iohexol (Omnipaque), iopamidol (Isovue), Ioversol (Optiray) and non- ionic dimer: Iodixanol (Visipaque, iso-osmolar to plasma, 290 mosm/kg water) are widely used, while ionic RCM are hardly available in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/84/19/kcj-43-500.PMC3744740.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.7.500 www.e-kcj.org tions.9-13) Although systemic symptoms with more immediate-type  manifestations such as hypotension, dyspnea, abdominal pain and  fever have been occasionally reported,1)8)14) a late-onset NCPE, such  as our case has not yet been reported.",Non-OADS,/arxiv_data1/oa_pdf/84/19/kcj-43-500.PMC3744740.pdf
"We report the first Korean case of PH developed in a patient with  primary Sjögren’s syndrome.Case Report http://dx.doi.org/10.4070/kcj.2013.43.7.504 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Severe Pulmonary Hypertension in Primary Sjögren’s Syndrome Ji-An Hwang, MD1, Tae-Hyun Yang, MD1, Ji-Young Lee, MD1, Dong-Wan Koo, MD1,  In Suk Choi, MD2, Sun-Young Cho, MD1, and Min-Sung Kim, MD1 1Division of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Cardiovascular Research Institute, Busan Paik Hospital, Busan,  2Cardiology Division, Department of Internal Medicine, Gachon University, Incheon, Korea A 65 year-old female with a history of xerostomia and xerophthalmia was presented with dyspnea on exertion (New York Heart Associa - tion class III).",Non-OADS,/arxiv_data1/oa_pdf/1a/ac/kcj-43-504.PMC3744741.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case A 65-year-old female was presented with dyspnea on exertion  (New York Heart Association, NYHA class III) for over a period of 1  year.",Non-OADS,/arxiv_data1/oa_pdf/1a/ac/kcj-43-504.PMC3744741.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.7.504 www.e-kcj.org Anti-human immunodeficiency virus antibodies, hepatitis B virus  antigen and antibodies, and anti-hepatitis C antibodies were all negative.",OADS,/arxiv_data1/oa_pdf/1a/ac/kcj-43-504.PMC3744741.pdf
506 Severe Pulmonary Hypertension in Primary Sjögren’s Syndrome http://dx.doi.org/10.4070/kcj.2013.43.7.504 www.e-kcj.org sure of 7 mm Hg (Fig.,Non-OADS,/arxiv_data1/oa_pdf/1a/ac/kcj-43-504.PMC3744741.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.7.504 www.e-kcj.org ticosteroids and/or other immunosuppressants would also be used  in CTD-PAH, considering that immune or inflammatory mechanisms play an important role in the genesis or progression of PAH, par - ticularly in CTD-PAH.",Non-OADS,/arxiv_data1/oa_pdf/1a/ac/kcj-43-504.PMC3744741.pdf
"The transesophageal echocardiography (TEE) and coronary  angiography (CAG) were performed at the Kumamoto University Images in Cardiovascular Medicine http://dx.doi.org/10.4070/kcj.2013.43.7.508 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Bicuspid Aortic Valve and Coronary Artery Stenosis in the Cardiac CT Satoru Suzuki, MD and Seiji Ozawa, MD  Ozawa Clinic, Kumamoto City, Japan Received:  December 20, 2012 / Revision Received: January 29, 2013 / Accepted: February 14, 2013 Correspondence: Satoru Suzuki, MD, Ozawa Clinic, 4-3-20 Minami-kumamoto, Chuoh-ku, Kumamoto City 860-0812, Japan Tel: 81-96-371-2231, Fax: 81-96-371-2234, E-mail: s-satoru@kumamoto-u.ac.jp • The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/5f/af/kcj-43-508.PMC3744742.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Hospital.",Non-OADS,/arxiv_data1/oa_pdf/5f/af/kcj-43-508.PMC3744742.pdf
http://dx.doi.org/10.4070/kcj.2013.43.7.508  www.e-kcj.orgFig.,OADS,/arxiv_data1/oa_pdf/5f/af/kcj-43-508.PMC3744742.pdf
Available from: http://emed.com.,Non-OADS,/arxiv_data1/oa_pdf/03/ac/IJO-61-306.PMC3744789.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8f/d3/srep02456.PMC3744794.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2456 | DOI: 10.1038/srep02456 13",Non-OADS,/arxiv_data1/oa_pdf/8f/d3/srep02456.PMC3744794.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/47/8d/srep02451.PMC3744795.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2451 | DOI: 10.1038/srep02451 5",Non-OADS,/arxiv_data1/oa_pdf/47/8d/srep02451.PMC3744795.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4d/9e/srep02457.PMC3744796.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2457 | DOI: 10.1038/srep02457 5",Non-OADS,/arxiv_data1/oa_pdf/4d/9e/srep02457.PMC3744796.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/18/23/srep02454.PMC3744797.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2454 | DOI: 10.1038/srep02454 6",Non-OADS,/arxiv_data1/oa_pdf/18/23/srep02454.PMC3744797.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/83/04/srep02452.PMC3744798.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2452 | DOI: 10.1038/srep02452 6",Non-OADS,/arxiv_data1/oa_pdf/83/04/srep02452.PMC3744798.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9c/79/srep02458.PMC3744799.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2458 | DOI: 10.1038/srep02458 5",Non-OADS,/arxiv_data1/oa_pdf/9c/79/srep02458.PMC3744799.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2453 | DOI: 10.1038/srep02453 4",Non-OADS,/arxiv_data1/oa_pdf/7e/e6/srep02453.PMC3744800.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/62/d6/srep02337.PMC3744801.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2337 | DOI: 10.1038/srep02337 5",Non-OADS,/arxiv_data1/oa_pdf/62/d6/srep02337.PMC3744801.pdf
"Developmental Cell Article Oskar Is Targeted for Degradation by the Sequential Action of Par-1, GSK-3, and the SCF-SlimbUbiquitin Ligase Eurico Morais-de-Sa ´,1,2,3,4Antonio Vega-Rioja,1,2,3,5Vı´tor Trovisco,1,2and Daniel St Johnston1,2,* 1The Gurdon Institute 2Department of Genetics University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK 3These authors contributed equally to this work 4Present address: Instituto de Biologia Molecular e Celular (IBMC), Porto 4150-180, Portugal 5Present address: Servicio Regional de Inmunologı ´a y Alergia, Hospital Universitario Virgen Macarena, Seville 41009, Spain *Correspondence: d.stjohnston@gurdon.cam.ac.uk http://dx.doi.org/10.1016/j.devcel.2013.06.011 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/e3/f1/main.PMC3744808.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, two ﬁgures, and one movie and can be found with this article online athttp://dx.doi.org/10.1016/j.devcel.2013.06.011 .",Non-OADS,/arxiv_data1/oa_pdf/e3/f1/main.PMC3744808.pdf
Available from: http://www.ijic.org/docs/psychia-try.pdf [11]  Niveau G. Preventing human rights abuses in psychiatric estab-lishments: The work of the CPT.,Non-OADS,/arxiv_data1/oa_pdf/f9/1e/CPEMH-9-110.PMC3744855.pdf
Available from: http://www.who.int/mental_hea-lth/policy/resource_book_MHLeg.pdf [14]  European Committee for the Prevention of Torture and Inhuman or Degrading Treatment or Punishment (CPT): The CPT standards.,Non-OADS,/arxiv_data1/oa_pdf/f9/1e/CPEMH-9-110.PMC3744855.pdf
Available from: http://www.cpt.coe.-int/en/documents/eng-standards.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f9/1e/CPEMH-9-110.PMC3744855.pdf
"Available from: http://www.nice.org.uk/CG25 [17]  Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nerven-heilkunde (DGPPN): S2 Praxisleitlinien in Psychiatrie und Psycho-therapie Band 2: Behandlungsleitlinie Therapeutische Maßnahmen bei aggressivem Verhalten in der Psychiatrie und Psychotherapie.",Non-OADS,/arxiv_data1/oa_pdf/f9/1e/CPEMH-9-110.PMC3744855.pdf
Available from: http://leitlinien.net/ [18]  Richter D. Non-physical conﬂict management and de-escalation.,Non-OADS,/arxiv_data1/oa_pdf/f9/1e/CPEMH-9-110.PMC3744855.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/1e/CPEMH-9-110.PMC3744855.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/bb/c6/2544.PMC3744946.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f6/bb/2494.PMC3744947.pdf
"Like all of the AP complexes, AP-5 is evolutionarily ancient (Hirst  et al., 2011) and ubiquitously expressed (http://biogps.org/, www   .ncbi.nlm.nih.gov/UniGene/), although its expression profile in de - veloping chick embryos (Hirst et al., 2013) suggests that it may be  particularly important in neurons.",Non-OADS,/arxiv_data1/oa_pdf/35/70/2558.PMC3744948.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/35/70/2558.PMC3744948.pdf
"(A) The domain organization of SPG15 was predicted by  DOMpred, and then homology searching with each domain was carried out using HHpred (http://toolkit.tuebingen   .mpg.de/hhpred).",OADS,/arxiv_data1/oa_pdf/35/70/2558.PMC3744948.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/62/e7/2491.PMC3744949.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b3/a3/2528.PMC3744950.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0d/2f/2582.PMC3744951.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a8/9d/2515.PMC3744952.pdf
"Generation and purification of antibodies DNA fragments encoding a full or a partial amino acid sequence of  PCNA (CMS101C; gene locus in Cyanidioschyzon merolae  Genome  Project, http://merolae.biol.s.u-tokyo.ac.jp/), SMC2 (CMG189C),  SMC4 (CME029C), CAP-D2 (CMR484C), CAP-G (CMS422C), CAP- D3 (CMQ236C), and CAP-G2 (CMA089C) were PCR amplified using  specific primers containing restriction sequences or the adaptor se - quence for In-Fusion reaction (Supplemental Table S1).",Non-OADS,/arxiv_data1/oa_pdf/a8/9d/2515.PMC3744952.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/cd/fe/2570.PMC3744953.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/11/4a/2506.PMC3744954.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/a5/aft074.PMC3745087.pdf
"Available at:http://nottingham.ac.uk/mcop/documents/papers/issue10-mcop-issn2044-4230.pdf (7 December 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/b7/a5/aft074.PMC3745087.pdf
"Available at: http://nottingham.ac.uk/mcop/ documents/papers/iss ue4-mcop-issn2044-4230.pdf (10 December 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/b7/a5/aft074.PMC3745087.pdf
"Available at: http://www.netscc.ac.uk/ hsdr/projdetails.php?ref=08-1809-227 (7 December 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/b7/a5/aft074.PMC3745087.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/a8/ijgm-6-665.PMC3745288.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2013:6 665–669International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  665Case reportopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJGM.S4739 7Warfarin-induced calciphylaxis: a case report   and review of literature Chadi saifan Marc saad elie el-Charabaty suzanne el-sayegh staten Island University Hospital,   staten Island, NY, Usa Correspondence: Chadi saifan   staten Island University Hospital,   475 seaview avenue, staten Island,   NY 10305, Usa   tel +1 718 226 9000   Fax +1 718 226 6586   email chadisaifan@hotmail.co mAbstract:  Calciphylaxis is a challenging complication of end-stage renal disease, with an  unknown underlying mechanism.",Non-OADS,/arxiv_data1/oa_pdf/80/a8/ijgm-6-665.PMC3745288.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/80/a8/ijgm-6-665.PMC3745288.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/a8/ijgm-6-665.PMC3745288.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f1/50/ott-6-1073.PMC3745289.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1073–1077OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1073Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S4839 7adjuvant chemotherapy for luminal a breast  cancer: a prospective study comparing two  popular chemotherapy regimens Yasser abdel Kader Tamer el-nahas amr sakr Department of clinical Oncology,   cairo University, cairo, egypt correspondence: Tamer el-nahas   Department of clinical Oncology,   cairo University, 1 al saray street,   al Manial, cairo, egypt   Fax +20 2 3347 7771   email elnahas@sphinxcure.co mIntroduction:  Based on the variable benefit of taxanes in the adjuvant setting of early breast  cancer in certain tumor phenotypes, especially in human epidermal growth factor receptor  (HER)2-positive and triple-negative disease, and with the observation of a lesser benefit in  luminal A, this research article aimed at exploring the value of docetaxel in patients with an  estrogen receptor-positive, HER2-negative disease phenotype, who might not derive the same  benefits as those with other phenotypes.",Non-OADS,/arxiv_data1/oa_pdf/f1/50/ott-6-1073.PMC3745289.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f1/50/ott-6-1073.PMC3745289.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/50/ott-6-1073.PMC3745289.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/a4/ott-6-1079.PMC3745290.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1079–1095OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1079Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S4822 4Combining molecular targeted agents   with radiation therapy for malignant gliomas Claudia Scaringi1 Riccardo Maurizi enrici1 Giuseppe Minniti1,2 1Department of Radiation Oncology,   Sant’Andrea Hospital, University  Sapienza, Rome, italy; 2Department of  Neuroscience, Neuromed institute,   Pozzilli, italy Correspondence: Giuseppe Minniti   Department of Radiation Oncology,   Sant’Andrea Hospital, via di   Grottarossa 1035, 00189 Roma, italy   Tel +39 063 377 6034   Fax +39 063 377 6608   email gminniti@ospedalesantandrea.i tAbstract:  The expansion in understanding the molecular biology that characterizes cancer  cells has led to the rapid development of new agents to target important molecular pathways  associated with aberrant activation or suppression of cellular signal transduction pathways  involved in gliomagenesis, including epidermal growth factor receptor, vascular endothelial  growth factor receptor, mammalian target of rapamycin, and integrins signaling pathways.",Non-OADS,/arxiv_data1/oa_pdf/d0/a4/ott-6-1079.PMC3745290.pdf
"Bethesda, MD:  National Institutes of Health; Available from: http://www.clinicaltrials.",Non-OADS,/arxiv_data1/oa_pdf/d0/a4/ott-6-1079.PMC3745290.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d0/a4/ott-6-1079.PMC3745290.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/a4/ott-6-1079.PMC3745290.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/b4/ceor-5-399.PMC3745291.pdf
Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinicoEconomics and Outcomes Research 2013:5 399–406ClinicoEconomics and Outcomes Research Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/65/b4/ceor-5-399.PMC3745291.pdf
"Or use: http://dvpr.es/1bM4eU nDove press submit your manuscript | www.dovepress.co m Dove press  399ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S4901 0impact of scribes on patient interaction,  productivity, and revenue in a cardiology   clinic: a prospective study alan J Bank1 Christopher Obetz2 ann Konrardy2 akbar Khan1 Kamalesh M Pillai1 Benjamin J McKinley1 Ryan M gage1 Mark a T urnbull1 William O Kenney1 1United heart and Vascular Clinic,    st Paul, M n, Usa; 2abbott  northwestern hospital,    Minneapolis, M n, Usa Correspondence: alan J Bank   United heart & Vascular Clinic,   225 n smith ave, suite 400   st Paul, Mn 55102, Usa   Tel +1 651 241 2819   Fax +1 651 241 2818   Email alan.bank@allina.co mObjective:  Scribes have been used in the emergency department to improve physician  productivity and patient interaction.",Non-OADS,/arxiv_data1/oa_pdf/65/b4/ceor-5-399.PMC3745291.pdf
Available from: http://dx.doi.org/10.2139/ssrn.195228 7.,Non-OADS,/arxiv_data1/oa_pdf/65/b4/ceor-5-399.PMC3745291.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/65/b4/ceor-5-399.PMC3745291.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/b4/ceor-5-399.PMC3745291.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b6/71/ceor-5-381.PMC3745292.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinicoEconomics and Outcomes Research 2013:5 381–397ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  381ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S4899 4Economic evaluation of highly purified human  menopausal gonadotropin versus recombinant  human follicle-stimulating hormone in fresh  and frozen in vitro fertilization/intracytoplasmic  sperm-injection cycles in sweden Jaro Wex ahmed M abou-setta Pharmarchitecture, london, UK Correspondence: Jaro Wex   Pharmarchitecture, 145-157 st John   street, london EC1V 4PY, UK   Tel +44 2030 511 424   Fax +44 2030 511 435   Email jaro.wex@pharmarchitecture.co mAbstract:  Gonadotropin-releasing hormone-analog type, fertilization method, and number of  embryos available for cryopreservation should be incorporated into economic evaluations of  highly purified human menopausal gonadotropin (HP-hMG) and recombinant human follicle- stimulating hormone (r-hFSH), as they may affect treatment costs.",Non-OADS,/arxiv_data1/oa_pdf/b6/71/ceor-5-381.PMC3745292.pdf
"Available from: http://www.ucr.uu.se/qivf/ index.php/behandlingsresulta t. Accessed July 3 , 2013.",Non-OADS,/arxiv_data1/oa_pdf/b6/71/ceor-5-381.PMC3745292.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/b6/71/ceor-5-381.PMC3745292.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/71/ceor-5-381.PMC3745292.pdf
Available  from: http://www.upv.es/deioac/Investigacion/human%20reproduction.,Non-OADS,/arxiv_data1/oa_pdf/b6/71/ceor-5-381.PMC3745292.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/d4/opth-7-1597.PMC3745294.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 1597–1601Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1597Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S4778 0surgical results of combined pars plana vitrectomy  and phacoemulsification for vitreous hemorrhage  in PDr handan Canan1 selçuk sizmaz2 Rana Altan-Yayciog ˘lu1 1Department of Ophthalmology,   adana Teaching and Medical research  Center, Baskent University school  of Medicine, 2Department of  Ophthalmology, Cukurova University  school of Medicine, Yuregir, adana,   T urkey Correspondence: handan Canan   Baskent University, Faculty of Medicine,  adana Teaching and Medical research  Center, Dadaloglu M 39 sk no 6,   01250 Yuregir, adana, Turkey   Tel +90 32 2327 2727 ext 2104   Fax +90 32 2327 1274   email handanakkaya@yahoo.co mBackground:  The purpose of this study was to evaluate the effectiveness, safety, and  incidence  of complications after combined clear corneal phacoemulsification with intraocular lens implan - tation and pars plana vitrectomy in eyes with proliferative diabetic retinopathy coexistent with  significant cataract.",Non-OADS,/arxiv_data1/oa_pdf/bc/d4/opth-7-1597.PMC3745294.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/bc/d4/opth-7-1597.PMC3745294.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/d4/opth-7-1597.PMC3745294.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c3/2e/opth-7-1609.PMC3745295.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 1609–1614Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1609Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S4933 6Hyperautofluorescent ring in eyes   with macular holes Tatsuhiko sato Kazuyuki emi Yui Osawa Hajime Bando Osaka rosai Hospital Clinical  research Center for Occupational  sensory Organ Disability, sakai, Japan Correspondence: Tatsuhiko sato   Osaka rosai Hospital Clinical research   Center for Occupational sensory Organ   Disability, 1179-3 Nagasone-cho, Kita-ku,   sakai, 591-8025, Japan   Tel +817 2252 3561   Fax +817 2258 8720   email t-satou@orh.go.j pBackground:  Fundus autofluorescence studies in eyes with macular holes (MHs) have shown a  hyperautofluorescent spot corresponding to the hole and a hypoautofluorescent ring correspond - ing to the fluid cuff surrounding the hole.",Non-OADS,/arxiv_data1/oa_pdf/c3/2e/opth-7-1609.PMC3745295.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c3/2e/opth-7-1609.PMC3745295.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/2e/opth-7-1609.PMC3745295.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/95/6e/opth-7-1603.PMC3745296.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 1603–1604Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1603Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S5010 7Letter to the editor David A Atchison1,2 Andreas Hartwig3 1School of Optometry and Vision  Science, 2Institute of Health and  Biomedical Innovation, Queensland  University of technology, Brisbane,   QLD, Australia; 3Hartwig research  Center, Heikendorf, Germany Correspondence: Andreas Hartwig   Hartwig research Center,   Heikendorf, Germany   email andreas.hartwig@firma-hartwig.d eDear editor We read with interest the article entitled ‘Population spherical aberration: associations  with ametropia, age, corneal curvature, and image quality’ by Kingston and Cox.1  The authors provided higher order aberrations data for a sample of 1,124 eyes and  performed correlation analyses to compare higher order aberrations with refraction  and biometry data, such as spherical equivalent power and corneal curvature.",Non-OADS,/arxiv_data1/oa_pdf/95/6e/opth-7-1603.PMC3745296.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/95/6e/opth-7-1603.PMC3745296.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/6e/opth-7-1603.PMC3745296.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/01/73/opth-7-1605.PMC3745297.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 1605–1608Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1605ORIGINAL ReseARChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S4939 6Primary posterior capsular opacification in Indian  rural population undergoing cataract surgery   for hypermature senile cataract Rajesh subhash Joshi Department of Ophthalmology,   Vasatrao Naik Government Medical  College, Yavatmal, India Correspondence: Rajesh subhash Joshi   Department of Ophthalmology, Vasatrao  Naik Government Medical College,  Yavatmal-4000001, India.",Non-OADS,/arxiv_data1/oa_pdf/01/73/opth-7-1605.PMC3745297.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/01/73/opth-7-1605.PMC3745297.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/01/73/opth-7-1605.PMC3745297.pdf
Available from: http://www.censusindia.net /.,OADS,/arxiv_data1/oa_pdf/01/73/opth-7-1605.PMC3745297.pdf
"www.landesbioscience.com Plant Signaling & Behavior e22411-1Plant Signaling & Behavior 8:1, e22411; January 2013; © 2013 Landes Bioscience RESEARCH PAPER RESEARCH PAPER *Correspondence to: Azri Wassim; Email: azwassim@yahoo.fr Submitted: 08/06/12, Revised: 09/28/12, Accepted: 09/29/12 http://dx.doi.org/10.4161/psb.22411 Citation: Wassim A, Ichrak B, Saïda A. Putative role of proteins involved in detoxification of reactive oxygen species in the early response   to gravitropic stimulation of poplar stems.",OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Plant Signal Behav 2013; 8:e22411; PMID: 23104108; http://dx.doi.org10.4161/psb.22411.Introduction Plants can reorient their growth direction by sensing organ  tilt relative to the direction of gravity.,Non-OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
J Biol Chem  1997; 272:217-21; PMID:8995250; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Plant Physiol  2001; 126:1055-60; PMID:11457956; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Plant Physiol  2006; 141:323-9; PMID:16760482; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Plant Cell  2005; 17:1866-75; PMID:15987996; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Mass Spectrom  Rev 2006; 25:1-53; PMID:15957154; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
J Clin Invest 1992; 89:1006- 13; PMID:1311714; http://dx.doi.org/10.1172/ JCI115641.,Non-OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Curr Opin Plant Biol 2004; 7:323- 8; PMID:15134754; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Annu Rev Plant  Biol 2004; 55:373-99; PMID:15377225; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Science  1995; 270:296-9; PMID:7569979; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Adv Space Res 2001; 27:957- 60; PMID:11596639; http://dx.doi.org/10.1016/ S0273-1177(01)00171-5.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Plant Physiol  2006; 140:746-60; PMID:16384898; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
J Exp Bot 2003; 54:1013- 22; PMID:12598571; http://dx.doi.org/10.1093/jxb/ erg104.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Physiol Plant 2009; 136:193-208; PMID:19453506;  http://dx.doi.org/10.1111/j.1399-3054.2009.01230.x.Table 2.,Non-OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
gStatistical probability of true positive identification of predicted proteins calculated by MASCOT (http://www.matrixscience.com).,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
The oligonucleotides primers were constructed based on spe - cific Populus  EST database [http://genome.jgi-psf.org] the  EST detected with the BLAST program.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
"The reference genes  18S RNA and Ubiquitin transcripts (POPTR_0012s01250,  Phytozome http://www.phytozome.",Non-OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
The housekeeping genes were combined into an index using  the BestKeeper software tool (http://www.wzw.tum.de/gene- quantifaccation/bestkeeper.html).35 Target gene abundance  was conventionally normalized using this BestKeeper Index (I)  using the delta-delta method mathematical model36 and genes  18S rRNA and Ubiquitin transcripts were used at the reference.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Plant Physiol  2004; 136:2790-805; PMID:15347791; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
FEBS Lett 2005; 579:1243-8; PMID:15710420;  http://dx.doi.org/10.1016/j.febslet.2005.01.018.16.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Plant Physiol  2011; 157:1884-99; PMID:22010108; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Plant Mol  Biol Rep 1993; 11:113-6; http://dx.doi.org/10.1007/ BF02670468.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Biotechnol Lett 2004; 26:509-15;  PMID:15127793; http://dx.doi.org/10.1023/ B:BILE.0000019559.84305.47.,Non-OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Physiol Plant 1997; 100:241-54; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Plant Physiol  1998; 116:659-69; PMID:9490766; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Plant  Cell Physiol 2000; 41:1279-85; PMID:11092914;  http://dx.doi.org/10.1093/pcp/pcd061.,Non-OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Biochem Biophys Res Commun  2003; 305:862-8; PMID:12767910; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Cell 1992; 70:21-30; PMID:1623521;  http://dx.doi.org/10.1016/0092-8674(92)90530-P .,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Physiol Plant  2000; 110:209-14; http://dx.doi.org/10.1034/j.1399- 3054.2000.110210.x.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Physiol Plant 1962; 15:473-92; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Planta 2004; 219:784- 9; PMID:15164287; http://dx.doi.org/10.1007/ s00425-004-1284-8.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Proteomics 2005; 5:654-66; PMID:15669000;  http://dx.doi.org/10.1002/pmic.200401015.19.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Phytochemistry  2005; 66:1519-28; PMID:15964037; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Plant Physiol 2002; 130:720- 8; PMID:12376639; http://dx.doi.org/10.1104/ pp.009688.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Plant Physiol 2003; 131:317-25;  PMID:12529539; http://dx.doi.org/10.1104/ pp.010017.,Non-OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Plant J  2002; 32:891-904; PMID:12492832; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
FEBS Lett 1998; 428:47-51;  PMID:9645472; http://dx.doi.org/10.1016/S0014- 5793(98)00483-9.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
Plant  J 2003; 34:187-203; PMID:12694594; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/86/psb-8-e22411.PMC3745552.pdf
"www.landesbioscience.com Plant Signaling & Behavior e22510-1Plant Signaling & Behavior 8:1, e22510; January 2013; © 2013 Landes Bioscience ReSeaR ch P aPeR ReSeaR ch P aPeR *Correspondence to: Kazuyuki Kuchitsu; Email: kuchitsu@rs.noda.tus.ac.jp Submitted: 09/13/12; Revised: 10/10/12; Accepted: 10/10/12http://dx.doi.org/10.4161/psb.22510Citation: Hanamata S, Kurusu T, Okada M, Suda A, Kawamura K, Tsukada E, Kuchitsu K. In vivo imaging and quantitative monitoring  of autophagic flux in tobacco BY-2 cells.",OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
"Plant Signal Behav 2013; 8:e22510; PMID: 23123450; http://dx.doi.org10.4161/psb.22510.Introduction Macroautophagy (hereafter referred to as autophagy) is an evolu - tionarily conserved system for degradation of intracellular com - ponents through the vacuole/lysosome, which has been shown  to play essential roles in the growth, development and survival of eukaryotic cells.",OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
"23 Four isoforms of ATG8  genes  named NtAtg8a, b, c, d have been found from the EST database  (http://mrg.psc.riken.go.jp/strc/index.htm).",OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Nat Rev Mol Cell Biol 2009; 10:458- 67; PMID:19491929; http://dx.doi.org/10.1038/ nrm2708.,Non-OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Plant  Cell Physiol 2012; 53:1355-65; PMID:22764279;  http://dx.doi.org/10.1093/pcp/pcs099.,Non-OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Cell 2010; 140:313- 26; PMID:20144757; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Int J Plant Genomics  2009; 2009:451357; PMID:19730746; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Plant J 2008; 55:1010-24; PMID:18547393;  http://dx.doi.org/10.1111/j.1365-313X.2008.03570.x.,OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Plant Cell 2004; 16:2967- 83; PMID:15494556; http://dx.doi.org/10.1105/ tpc.104.025395.10.,OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Plant Signal Behav 2011; 6:1946- 9; PMID:22105025; http://dx.doi.org/10.4161/ psb.6.12.18297.,OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Plant J 2005; 42:598-608; PMID:15860017;  http://dx.doi.org/10.1111/j.1365-313X.2005.02396.x.,OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Cell 2009; 137:773-83; PMID:19450522;  http://dx.doi.org/10.1016/j.cell.2009.02.036.,OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Int J Biochem Cell Biol 2004; 36:2491-502;  PMID:15325587; http://dx.doi.org/10.1016/j.bio- cel.2004.02.005.,OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Annu Rev Cell  Dev Biol 2011; 27:107-32; PMID:21801009; http://dx.doi.org/10.1146/annurev-cellbio-092910-154005.,OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Protoplasma 2012; 249:285-99;  PMID:21660427; http://dx.doi.org/10.1007/s00709- 011-0296-z.,Non-OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Plant Physiol 2005; 138:2097- 110; PMID:16040659; http://dx.doi.org/10.1104/ pp.105.060673.18.,Non-OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Plant Cell  2009; 21:2914-27; PMID:19773385; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
J Exp Bot 2005; 56:2839-49; PMID:16157655;  http://dx.doi.org/10.1093/jxb/eri276.,OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
J Biol Chem 2004; 279:29889- 94; PMID:15138258; http://dx.doi.org/10.1074/jbc.M404399200.,OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
J Vis Exp 2011; 18:2779; PMID:21788936; http://dx.doi.org/10.3791/2779.,Non-OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
J Plant Res 2011; 124:315-24;  PMID:21409543; http://dx.doi.org/10.1007/s10265- 011-0408-z.,OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Annu Rev Genet  2009; 43:67-93; PMID:19653858; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Autophagy 2011; 7:993- 1010; PMID:21606687; http://dx.doi.org/10.4161/ auto.7.9.16389.,Non-OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
International Review of Cytology 1992; 132:1- 30; http://dx.doi.org/10.1016/S0074-7696(08)62452- 3.,Non-OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Plant Physiol 1985; 79:568-70;  PMID:16664453; http://dx.doi.org/10.1104/ pp.79.2.568.32.,Non-OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Plant Physiol 2001; 126:78-86; PMID:11351072;  http://dx.doi.org/10.1104/pp.126.1.78.,Non-OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
J Biol Chem  2004; 279:47704-10; PMID:15355958; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Plant Physiol  2007; 143:291-9; PMID:17098847; http://dx.doi.org/10.1104/pp.106.092106.,Non-OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
Biochem Biophys Res Commun 1995;  210:126-32; PMID:7741731; http://dx.doi.org/10.1006/bbrc.1995.1636.,OADS,/arxiv_data1/oa_pdf/19/84/psb-8-e22510.PMC3745557.pdf
"www.landesbioscience.com Plant Signaling & Behavior e22534-18Plant Signaling & Behavior 8:1, e22534; January 2013; © 2013 Landes Bioscience RESEARCH PAPER RESEARCH PAPER *Correspondence to: Ryo Tabata; Email: tabata@sci.kumamoto-u.ac.jp Submitted: 09/01/12; Revised: 10/12/12; Accepted: 10/12/12 http://dx.doi.org/10.4161/psb.22534 Citation: Tabata R, Kamiya T, Shigenobu S, Yamaguchi K, Yamada M, Hasebe M, Fujiwara T, Sawa S. Identification of an EMS-induced causal mutation   in a gene required for boron-mediated root development by low-coverage genome re-sequencing in Arabidopsis .",OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
"Plant Signal Behav 2013; 8:e22534;   PMID: 23104114; http://dx.doi.org10.4161/psb.22534.Introduction Next-generation sequencing (NGS) technologies have super - seded conventional Sanger sequencing by capillary electro - phoresis in many instances of large-scale analysis, such as de  novo sequencing, transcriptomics, DNA methylation analy - sis, metagenomics and population genetic studies.1-4 These  new technologies also provide a powerful tool for identifying  ethyl methanesulfonate (EMS)- and N-ethyl-N-nitrosourea  (ENU)-induced the mutations by whole-genome re-sequenc - ing.",Non-OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Supplemental Material Supplemental material may be found here: http://landesbioscience.com/journals/psb/article.22534stringency” using the default parameters (major parameters:  dibayes.reads.min.mapping.qv = 8; dibayes.reads.only.uniquely.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
An Integrative Genomics Viewer (IGV) (http://www.broadin - stitute.org/igv/)40 was used to visualize the mapped reads and  called SNPs along with gene models.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Nature 2009; 458:337- 41; PMID:19212322; http://dx.doi.org/10.1038/ nature07743.,Non-OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Nature 2010; 463:311-7; PMID:20010809;  http://dx.doi.org/10.1038/nature08696.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Nat Rev Genet 2010; 11:31-46;  PMID:19997069; http://dx.doi.org/10.1038/nrg2626.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Nat Methods 2008;  5:865-7; PMID:18677319; http://dx.doi.org/10.1038/ nmeth.1249.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Genome Res 2008; 18:1638-42;  PMID:18775913; http://dx.doi.org/10.1101/ gr.077776.108.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Nat Methods 2009; 6:550-1; PMID:19644454;  http://dx.doi.org/10.1038/nmeth0809-550.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Nucleic Acids Res 1991; 19:6553- 8; PMID:1684420; http://dx.doi.org/10.1093/ nar/19.23.6553.9.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Proc Natl Acad Sci U S A 1991; 88:9828- 32; PMID:1682921; http://dx.doi.org/10.1073/ pnas.88.21.9828.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Plant J 2011; 67:715-25;  PMID:21518053; http://dx.doi.org/10.1111/j.1365- 313X.2011.04619.x.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Plant Physiol  2010; 153:652-4; PMID:20388671; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Plant Cell Physiol 2011; 52:716- 22; PMID:21398646; http://dx.doi.org/10.1093/pcp/ pcr029.,Non-OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Nat Rev Genet 2011; 12:443-51; PMID:21587300;  http://dx.doi.org/10.1038/nrg2986.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Annu Rev Plant Biol 2004; 55:109-39;  PMID:15377216; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Nature 2002; 420:337- 40; PMID:12447444; http://dx.doi.org/10.1038/ nature01139.17.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Plant Cell  2006; 18:1498-509; PMID:16679457; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
T rends Plant Sci 2008; 13:451-7; PMID:18603465;  http://dx.doi.org/10.1016/j.tplants.2008.05.007.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Proc Natl Acad Sci U S A  2010; 107:5220-5; PMID:20194745; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
J Biol Chem 2011; 286:6175- 83; PMID:21148314; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Mutat Res 1984; 134:113-42;  PMID:6390190; http://dx.doi.org/10.1016/0165- 1110(84)90007-1.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Cell 1993; 72:427- 41; PMID:8431946; http://dx.doi.org/10.1016/0092- 8674(93)90119-B.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Proc Natl Acad Sci U S A 1997; 94:2085- 90; PMID:9050909; http://dx.doi.org/10.1073/ pnas.94.5.2085.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Science  2001; 294:846-9; PMID:11679668; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Plant Cell 2007; 19:2500- 15; PMID:17693536; http://dx.doi.org/10.1105/ tpc.106.049965.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Nat Biotechnol 2011; 29:24- 6; PMID:21221095; http://dx.doi.org/10.1038/ nbt.1754.31.,Non-OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Physiol Plant  2011; 142:170-8; PMID:21338369; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Plant Physiol 2011;  157:1313-26; PMID:21949212; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Physiol Plant 1999; 106:311-7;  PMID:11858262; http://dx.doi.org/10.1034/j.1399- 3054.1999.106308.x.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Biochem Biophys Res Commun 2001; 280:196- 203; PMID:11162499; http://dx.doi.org/10.1006/ bbrc.2000.4062.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Development 2010; 137:3911- 20; PMID:20978082; http://dx.doi.org/10.1242/ dev.048199.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Plant Cell 2005; 17:2542-53;  PMID:16055633; http://dx.doi.org/10.1105/ tpc.105.034009.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
Nature  2005; 436:793-800; PMID:16100779; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/d8/psb-8-e22534.PMC3745560.pdf
"PMID: 22932758.Keywords:  pH measurement, HPTS,  apoplast Abbreviations:  HPTS, 8-Hydroxypyrene- 1,3,6-trisulfonic acid; IAA, indol acetic  acid Submitted: 10/17/12 Accepted: 10/18/12 http://dx.doi.org/10.4161/psb.22587 Citation: Villiers F, Kwak J.",Non-OADS,/arxiv_data1/oa_pdf/06/63/psb-8-e22587.PMC3745564.pdf
Plant  Signal Behav 2013; 8:e22587; PMID:  23221761; http://dx.doi.org10.4161/ psb.22587.,OADS,/arxiv_data1/oa_pdf/06/63/psb-8-e22587.PMC3745564.pdf
Protoplasma 2010; 247:215- 31; PMID:20658253; http://dx.doi.org/10.1007/ s00709-010-0182-0.,Non-OADS,/arxiv_data1/oa_pdf/06/63/psb-8-e22587.PMC3745564.pdf
Plant Physiol 2004; 134:898-908; PMID:15020753;  http://dx.doi.org/10.1104/pp.103.032508.,Non-OADS,/arxiv_data1/oa_pdf/06/63/psb-8-e22587.PMC3745564.pdf
Plant Physiol 2012;160:1293- 302; PMID:22932758; http://dx.doi.org/10.1104/ pp.112.201442.,Non-OADS,/arxiv_data1/oa_pdf/06/63/psb-8-e22587.PMC3745564.pdf
Proteomics 2005; 5:737-45; PMID:15682462;  http://dx.doi.org/10.1002/pmic.200401119.,OADS,/arxiv_data1/oa_pdf/06/63/psb-8-e22587.PMC3745564.pdf
Plant Cell 2003; 15:2940-51; PMID:14630965;  http://dx.doi.org/10.1105/tpc.015248.,OADS,/arxiv_data1/oa_pdf/06/63/psb-8-e22587.PMC3745564.pdf
Chem Rev 2010; 110:2709-28;  PMID:19831417; http://dx.doi.org/10.1021/ cr900249z.,OADS,/arxiv_data1/oa_pdf/06/63/psb-8-e22587.PMC3745564.pdf
"PGNs from both  Gram-positive and Gram-negative bacteria can elicit defense  responses in plants.6-8 Chitin is a homopolymer of β-1,4-linked  GlcNAc (chitooligosaccharides), the major structural component  *Correspondence to: Gary Stacey; Email: staceyg@missouri.edu Submitted: 10/19/12; Accepted: 10/19/12 http://dx.doi.org/10.4161/psb.22598 Citation: Tanaka K, Nguyen C, Liang Y, Cao Y, Stacey G. Role of LysM  receptors in chitin-triggered plant innate immunity.",Non-OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
"Plant Signal Behav 2013;  8:e22598; PMID: 23221760; http://dx.doi.org10.4161/psb.22598.Recent research findings clearly indicate that lysin motif  (LysM)-containing cell surface receptors are involved in the  recognition of specific oligosaccharide elicitors (chitin and  peptidoglycan), which trigger an innate immunity response in  plants.",OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Cell 2006; 124:803- 14; PMID:16497589; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Annu Rev Immunol 2002; 20:197-216;  PMID:11861602; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Nature  2006; 444:323-9; PMID:17108957; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Glycobiology  2010; 20:406-19; PMID:20018942; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
J Biol Chem 2005; 280:33660-8; PMID:16048996;  http://dx.doi.org/10.1074/jbc.M506254200.6.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Chem Biol  2008; 15:438-48; PMID:18482696; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
J Biol Chem  2007; 282:32338-48; PMID:17761682; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Plant Cell 2010; 22:973- 90; PMID:20348432; http://dx.doi.org/10.1105/ tpc.109.069658.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Curr Opin Immunol 2008; 20:684- 9; PMID:18938241; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Proc Natl Acad Sci USA 2007; 104:19613-8;  PMID:18042724; http://dx.doi.org/10.1073/ pnas.0705147104.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Plant Cell 2008; 20:471-81;  PMID:18263776; http://dx.doi.org/10.1105/ tpc.107.056754.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
BMC Plant  Biol 2010; 10:288; PMID:21190588; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Plant Cell Physiol 2012; 53:1696-706;  PMID:22891159; http://dx.doi.org/10.1093/pcp/ pcs113.,Non-OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Plant Physiol  2012; 160:396-406; PMID:22744984; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Mol Plant Microbe Interact 1998; 11:537- 43; PMID:9612952; http://dx.doi.org/10.1094/ MPMI.1998.11.6.537.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
J Biol Chem 2010; 285:2996- 3004; PMID:19951949; http://dx.doi.org/10.1074/ jbc.M109.027540.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
J Biol Chem 2010; 285:28902- 11; PMID:20610395; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Physiol Mol Plant  Pathol 2001; 59:223-33; http://dx.doi.org/10.1006/ pmpp.2001.0364.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Mol Plant Pathol 2004; 5:125-35; PMID:20565589;  http://dx.doi.org/10.1111/j.1364-3703.2004.00215.x.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Science 2012; 336:1160-4; PMID:22654057;  http://dx.doi.org/10.1126/science.1218867.,Non-OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Plant J  2010; 64:204-14; PMID:21070404; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
J Exp Bot 2012;  In press; PMID:23028020; http://dx.doi.org/10.1093/ jxb/ers248.14.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
BMC Evol  Biol 2009; 9:183; PMID:19650916; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Plant Physiol  2007; 144:623-36; PMID:17449649; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Mol Microbiol 2008; 68:838-47;  PMID:18430080; http://dx.doi.org/10.1111/j.1365- 2958.2008.06211.x.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
FEMS Microbiol  Lett 1992; 70:257-64; PMID:1352512; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
J Biol Chem  2003; 278:23874-81; PMID:12684515; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Plant Cell 2012; 24:3406- 19; PMID:22872757; http://dx.doi.org/10.1105/ tpc.112.102475.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Plant Growth Regul  2011; 63:243-9; http://dx.doi.org/10.1007/s10725- 010-9521-6.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Mol Plant  2012; 5:1113-24; PMID:22461667; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
J Immunol  2009; 182:3573-82; PMID:19265136; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Plant J 2010; 63:791-800; PMID:20561260;  http://dx.doi.org/10.1111/j.1365-313X.2010.04282.x.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Int J Clin  Lab Res 1996; 26:7-14; PMID:8739850; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Science 1997; 277:815- 8; PMID:9242610; http://dx.doi.org/10.1126/sci - ence.277.5327.815.34.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
T rends Plant Sci  2012; 17:495-502; PMID:22578284; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Plant Cell  2004; 16:1220-34; PMID:15105442; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Plant Physiol  2011; 155:1988-98; PMID:21346172; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
Curr Opin Plant Biol 2012; In press;  PMID:22981427; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b3/6f/psb-8-e22598.PMC3745565.pdf
"www.landesbioscience.com Plant Signaling & Behavior e22642-33Plant Signaling & Behavior 8:1, e22642; January 2013; © 2013 Landes Bioscience RESEARCH PAPER RESEARCH PAPER *Correspondence to: Mahmoud A. Nawwar and Ashraf B. Abdel; Email: mahmoudnawwarhesham@yahoo.com and abnaim@yahoo.com Submitted: 09/06/12; Revised: 10/21/12; Accepted: 10/22/12 http://dx.doi.org/10.4161/psb.22642 Citation: Nawwar M, Swilam N, Hashim A, Al-Abd A, Abdel-Naim A, Lindequist U. Cytotoxic isoferulic acidamide from Myricaria germanica  (Tamaricaceae).",Non-OADS,/arxiv_data1/oa_pdf/1f/87/psb-8-e22642.PMC3745567.pdf
"Plant  Signal Behav 2013; 8:e22642; PMID: 23123452; http://dx.doi.org10.4161/psb.22642.Introduction Natural products, including plant phenolics, provide a major  source of chemical diversity that has consistently proven its value  for the development of novel drugs for more effective antineo - plastic agents.",Non-OADS,/arxiv_data1/oa_pdf/1f/87/psb-8-e22642.PMC3745567.pdf
T rends Pharmacol  Sci 1999; 20:196-8; PMID:10354614; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/87/psb-8-e22642.PMC3745567.pdf
Phytother Res 1987; 1:44-7;  http://dx.doi.org/10.1002/ptr.2650010110.,Non-OADS,/arxiv_data1/oa_pdf/1f/87/psb-8-e22642.PMC3745567.pdf
Phytochemistry 1976; 15:231-2;  http://dx.doi.org/10.1016/S0031-9422(00)89100-1.,OADS,/arxiv_data1/oa_pdf/1f/87/psb-8-e22642.PMC3745567.pdf
Phytochemistry  2000; 55:169-76; PMID:11065291; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/87/psb-8-e22642.PMC3745567.pdf
Tetrahedron Lett 1984; 25:49-52;  http://dx.doi.org/10.1016/S0040-4039(01)91145-1.,Non-OADS,/arxiv_data1/oa_pdf/1f/87/psb-8-e22642.PMC3745567.pdf
Phytochemistry 1994; 36:1035-7;  http://dx.doi.org/10.1016/S0031-9422(00)90486-2.,OADS,/arxiv_data1/oa_pdf/1f/87/psb-8-e22642.PMC3745567.pdf
Chin J Nat Med 2012; 10:16-9;  http://dx.doi.org/10.3724/SP .J.1009.2012.00016.,Non-OADS,/arxiv_data1/oa_pdf/1f/87/psb-8-e22642.PMC3745567.pdf
Phytochemistry 2005; 66:2468- 73; PMID:16137726; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/87/psb-8-e22642.PMC3745567.pdf
Phytochemistry  1988; 27:2375-95; http://dx.doi.org/10.1016/0031- 9422(88)87003-1.,OADS,/arxiv_data1/oa_pdf/1f/87/psb-8-e22642.PMC3745567.pdf
Phytochemistry 1981; 20:2446-8; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/87/psb-8-e22642.PMC3745567.pdf
Phytochemistry  1982; 21:2515-24; http://dx.doi.org/10.1016/S0031- 9422(00)82415-2.,Non-OADS,/arxiv_data1/oa_pdf/1f/87/psb-8-e22642.PMC3745567.pdf
J Natl Cancer Inst  1990; 82:1107-12; PMID:2359136; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/87/psb-8-e22642.PMC3745567.pdf
Hepatology 2012; 55:1840-51; PMID:22223166;  http://dx.doi.org/10.1002/hep.25566.,Non-OADS,/arxiv_data1/oa_pdf/1f/87/psb-8-e22642.PMC3745567.pdf
"www.landesbioscience.com Plant Signaling & Behavior e22672-64Plant Signaling & Behavior 8:1, e22672; January 2013; © 2013 Landes Bioscience RESEARCH PAPER RESEARCH PAPER *Correspondence to: Denis A. Vysotskii; Email: den_vis@mail.ru Submitted: 09/18/12; Revised: 10/23/12; Accepted: 10/25/12 http://dx.doi.org/10.4161/psb.22672 Citation: Vysotskii D, de Vries-van Leeuwen I, Souer E, Babakov A, de Boer A. ABF transcription factors of Thellungiella salsuginea : Structure, expression profiles  and interaction with 14-3-3 regulatory proteins.",OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Plant Signal Behav 2013; 8:e22672; PMID: 23221757; http://dx.doi.org10.4161/psb.22672.Introduction The phytohormone abscisic acid (ABA) is one of the key factors  that govern diverse developmental and adaptation processes in  the plant.,Non-OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
The detailed β-galactosidase activity protocol is described  at http://labs.fhcrc.org/gottschling/Yeast%20Protocols/Bgal.,Non-OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Curr Opin Plant Biol 2006; 9:436- 42; PMID:16759898; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Annu Rev Plant Biol 2002; 53:247-73;  PMID:12221975; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Plant J 2010; 61:1041-52;  PMID:20409277; http://dx.doi.org/10.1111/j.1365- 313X.2010.04124.x.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Annu Rev Plant Biol 2010; 61:561-91;  PMID:20192751; http://dx.doi.org/10.1146/annurev- arplant-042809-112226.7.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
J Cell Sci 2002; 115:4891- 900; PMID:12432076; http://dx.doi.org/10.1242/ jcs.00175.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Plant Physiol 2002;  130:2129-41; PMID:12481097; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Plant Cell Environ  2009; 32:439-47; PMID:19143991; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Plant  Sci 2005; 169:612-9; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Plant Physiol 2006; 140:647- 60; PMID:16407442; http://dx.doi.org/10.1104/ pp.105.073916.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Plant Cell Physiol 2009; 50:429- 38; PMID:19179350; http://dx.doi.org/10.1093/pcp/ pcp012.,Non-OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
J Biochem Mol Biol 2007; 40:349- 57; PMID:17562286; http://dx.doi.org/10.5483/ BMBRep.2007.40.3.349.,Non-OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Ann  Bot 2006; 98:965-74; PMID:16943217; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Nucleic Acids Res 2008;  36(Web Server issue):W465-9; PMID:18424797;  http://dx.doi.org/10.1093/nar/gkn180.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Nucleic Acids Res 2002;  30:e36; PMID:11972351; http://dx.doi.org/10.1093/ nar/30.9.e36.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Nucleic Acids Res 1992;  20:1425; PMID:1561104; http://dx.doi.org/10.1093/ nar/20.6.1425.21.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Russ J Plant Physiol 2012; 59:255-65;  http://dx.doi.org/10.1134/S1021443712020185.,Non-OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Biol Plant 2010; 54:201-12; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
T rends Plant Sci 2001;  6:66-71; PMID:11173290; http://dx.doi.org/10.1016/ S1360-1385(00)01838-0.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Plant Physiol 2004; 135:1718- 37; PMID:15247369; http://dx.doi.org/10.1104/ pp.104.041723.,Non-OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Plant Physiol 2005; 138:127-30; PMID:15888685;  http://dx.doi.org/10.1104/pp.105.059972.,Non-OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Plant Cell  2005; 17:3470-88; PMID:16284313; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Plant  J 2005; 44:939-49; PMID:16359387; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Plant Cell 2007; 19:485- 94; PMID:17307925; http://dx.doi.org/10.1105/ tpc.106.048538.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Proc Natl Acad Sci U S  A 2000; 97:11632-7; PMID:11005831; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
T rends Plant Sci 2002; 7:106-11; PMID:11906833;  http://dx.doi.org/10.1016/S1360-1385(01)02223-3.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Proc Natl Acad Sci U S A  2006; 103:1988-93; PMID:16446457; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Plant Physiol 2005; 139:1750- 61; PMID:16299177; http://dx.doi.org/10.1104/ pp.105.069757.,Non-OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
PLoS One 2010; 5:e13935;  PMID:21085673; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Plant J 2007; 49:289-301;  PMID:17241451; http://dx.doi.org/10.1111/j.1365- 313X.2006.02955.x.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Phytochemistry 2011; 72:27-36; PMID:21055780;  http://dx.doi.org/10.1016/j.phytochem.2010.10.005.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
Proc Natl Acad Sci U S A 1992; 89:11490- 4; PMID:1454838; http://dx.doi.org/10.1073/ pnas.89.23.11490.,OADS,/arxiv_data1/oa_pdf/93/2c/psb-8-e22672.PMC3745569.pdf
"www.landesbioscience.com Plant Signaling & Behavior e22734-25Plant Signaling & Behavior 8:1, e22734; January 2013; © 2013 Landes BioscienceREVIEW Introduction Cyclophilins, one of the three protein subfamilies of immu - nophilin superfamily, (besides FK506 binding proteins and  *Correspondence to: Ashwani Pareek; Email: ashwanip@mail.jnu.ac.in Submitted: 09/02/12; Revised: 10/31/12; Accepted: 10/31/12 http://dx.doi.org/10.4161/psb.22734 Citation: Kumari S, Roy S, Singh P , Singla-Pareek S, Pareek A. Cyclophilins:  Proteins in search of function.",Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
"Plant Signal Behav 2013; 8:e22734; PMID:  23123451; http://dx.doi.org10.4161/psb.22734.Cyclophilins constitute a subgroup of large family of proteins  called immunophilins, which also include FKBPs and Parvulins.",Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Curr  Top Med Chem 2003; 3:1315-47; PMID:12871165;  http://dx.doi.org/10.2174/1568026033451862.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Nature 1989;  341:758-60; PMID:2477715; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Biochemistry 1998; 37:5953- 60; PMID:9558330; http://dx.doi.org/10.1021/ bi973162p.4.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Science 1984; 226:544- 7; PMID:6238408; http://dx.doi.org/10.1126/sci - ence.6238408.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Cell  Mol Life Sci 2006; 63:2889-900; PMID:17075696;  http://dx.doi.org/10.1007/s00018-006-6215-3.8.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
J Biol Chem  2005; 280:24308-14; PMID:15845546; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Nature 1989; 337:473-5; PMID:2644542;  http://dx.doi.org/10.1038/337473a0.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Front Biosci 2004;  9:2420-46; PMID:15353296; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Proc Natl Acad Sci USA 1995; 92:6319- 23; PMID:7603990; http://dx.doi.org/10.1073/ pnas.92.14.6319.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Proc Natl Acad Sci USA  1997; 94:13093-8; PMID:9371805; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Mol Cell Biol 2007; 27:3601- 11; PMID:17339332; http://dx.doi.org/10.1128/ MCB.02187-06.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Biochemistry 1996; 35:5550- 61; PMID:8611546; http://dx.doi.org/10.1021/ bi953035y.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
J Biol Chem  1995; 270:2588-94; PMID:7852322; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
EMBO  J 1998; 17:1577-87; PMID:9501079; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Proc Natl Acad Sci USA 2008; 105:16386- 91; PMID:18845687; http://dx.doi.org/10.1073/ pnas.0808204105.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Proteomics 2006; 6:896-909; PMID:16400686;  http://dx.doi.org/10.1002/pmic.200500155.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Plant Mol  Biol 1997; 35:873-92; PMID:9426607; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Planta  2008; 228:687-700; PMID:18594858; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Planta 2006; 224:133- 44; PMID:16395583; http://dx.doi.org/10.1007/ s00425-005-0202-z.28.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Nature 1991; 353:276-9; PMID:1896075;  http://dx.doi.org/10.1038/353276a0.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Protein Eng  1994; 7:597-603; PMID:8073029; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Proc Natl Acad Sci USA 1993; 90:3324- 8; PMID:8475075; http://dx.doi.org/10.1073/ pnas.90.8.3324.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Structure  2001; 9:431-8; PMID:11377203; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Proc Natl Acad Sci USA 1990; 87:9519-23;  PMID:1702215; http://dx.doi.org/10.1073/ pnas.87.24.9519.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
J Mol Biol  1991; 218:397-412; PMID:2010917; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Biochemistry 1996; 35:3636- 40; PMID:8639516; http://dx.doi.org/10.1021/ bi9520803.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Science 1996; 274:1718-20; PMID:8939864;  http://dx.doi.org/10.1126/science.274.5293.1718.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Proc Natl Acad Sci USA 2007; 104:15947- 52; PMID:17909185; http://dx.doi.org/10.1073/ pnas.0707851104.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Annu Rev Plant Physiol  Plant Mol Biol 2000; 51:141-65; PMID:15012189;  http://dx.doi.org/10.1146/annurev.arplant.51.1.141.12.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Arch Biochem Biophys 1999; 371:149- 62; PMID:10545201; http://dx.doi.org/10.1006/ abbi.1999.1434.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
RNA 2006; 12:631- 43; PMID:16497658; http://dx.doi.org/10.1261/ rna.2226106.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Nature 1996; 383:637-40;  PMID:8857542; http://dx.doi.org/10.1038/383637a0.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Mol Cell 1998; 1:203-11; PMID:9659917;  http://dx.doi.org/10.1016/S1097-2765(00)80021-0.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
J Biol Chem 2002; 277:31134- 41; PMID:12077116; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Regulation of the tyrosine kinase Itk by the peptidyl- prolyl isomerase cyclophilin A. Proc Natl Acad Sci USA  2002; 99:1899-904; PMID:11830645; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Mol Microbiol 2001; 42:257-67; PMID:11679083;  http://dx.doi.org/10.1046/j.1365-2958.2001.02634.x.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
EMBO  J 2002; 21:470-80; PMID:11823439; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Science  1996; 274:1715-7; PMID:8939863; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
J Biol Chem 2001; 276:38762- 73; PMID:11514552; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Curr Top  Med Chem 2003; 3:1392-409; PMID:12871171;  http://dx.doi.org/10.2174/1568026033451899.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Plant  Sci 1992; 84:171-8; http://dx.doi.org/10.1016/0168- 9452(92)90131-5.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Plant  Physiol Biochem 2008; 46:868-74; PMID:18603440;  http://dx.doi.org/10.1016/j.plaphy.2008.05.013.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Plant Physiol Biochem 2011; 49:1264-71;  PMID:22000049; http://dx.doi.org/10.1016/j.pla - phy.2011.09.001.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Mol Cells  2010; 29:567-74; PMID:20496120; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Proc Natl Acad Sci  USA 1993; 90:5853-7; PMID:7685914; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Mol Biol Cell  2003; 14:4238-49; PMID:14517332; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Science 2001; 291:2405- 7; PMID:11264535; http://dx.doi.org/10.1126/sci - ence.1057144.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Plant J 2012; 71:712-23;  PMID:22463079; http://dx.doi.org/10.1111/j.1365- 313X.2012.05013.x.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Plant Sci 2000; 152:123-34; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Plant Cell Physiol 1999; 40:77- 87; PMID:10189705; http://dx.doi.org/10.1093/ oxfordjournals.pcp.a029477.57.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Plant Cell 2007; 19:2403- 16; PMID:17704213; http://dx.doi.org/10.1105/ tpc.107.053579.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
FEBS Lett  2006; 580:3671-6; PMID:16765949; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Eukaryot Cell 2005; 4:230-41; PMID:15701785;  http://dx.doi.org/10.1128/EC.4.2.230-241.2005.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Plant Physiol 2004; 134:1244- 7; PMID:15084723; http://dx.doi.org/10.1104/ pp.104.041186.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
BMC Plant  Biol 2010; 10:253; PMID:21087465; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
Mol Biotechnol 2009; 42:195-204;  PMID:19214808; http://dx.doi.org/10.1007/s12033- 009-9153-0.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
BMC Plant  Biol 2011; 11:34; PMID:21324151; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/fd/psb-8-e22734.PMC3745578.pdf
"Plant Cell Environ 2012; In press; PMID:22978428; http://dx.doi.org /10.1111/p ce.120 09.Keywords:  alternative oxidase, biotic  stress, manganese superoxide dismutase,  mitochondrial electron transport chain, nitric oxide, organelle signaling, salicylic acid, superoxide burst Submitted: 11/01/12Accepted: 11/01/12http://dx.doi.org/10.4161/psb.22749Citation: Cvetkovska M, Alber N,  Vanlerberghe G. The signaling role of a mitochondrial superoxide burst dur - ing stress.",OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant Signal Behav 2013; 8:e22749; PMID: 23221746; http://dx.doi.org10.4161/psb.22749.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
J Exp Bot 2012; 63:1735-50; PMID:22131156; http://dx.doi.org/10.1093/jxb/err374.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant Physiol 2008; 147:1858-73; PMID:18567827; http://dx.doi.org/10.1104/pp.108.121384.,Non-OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant Physiol 2009; 150:1286-96;  PMID:19482916; http://dx.doi.org/10.1104/pp.109.139782.,Non-OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Curr Opin Plant Biol 2011; 14:707-14; PMID:21816662; http://dx.doi.org/10.1016/j.pbi.2011.07.005.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Curr Opin Plant Biol 2011; 14:691-9; PMID:21862390; http://dx.doi.org/10.1016/j.pbi.2011.07.014.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant Biol (Stuttg) 2011; 13:233-42; PMID:21309969; http://dx.doi.org/10.1111/j.1438-8677.2010.00403.x.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Trends Plant Sci 2011; 16:300-9; PMID:21482172; http://dx.doi.org/10.1016/j.tplants.2011.03.007.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Nature 2011; 478:264-8; PMID:21964330; http://dx.doi.org/10.1038/nature10427.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant J 2012; 69:589-600; PMID:21988537; http://dx.doi.org/10.1111/j.1365-313X.2011.04814.x.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Annu Rev Plant Physiol Plant Mol Biol 2001; 52:561-91; PMID:11337409; http://dx.doi.org/10.1146/annurev.arplant.52.1.561.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Trends Endocrinol Metab 2009; 20:332-40; PMID:19733481; http://dx.doi.org/10.1016/j.tem.2009.04.001.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
"Plant Physiol 2008; 147:101-14; PMID:18337490; http://dx.doi.org/10.1104/pp.107.113613.in pv phaseolicola  using the AOX knock - down plants, this was now accompanied  by a large and sustained increase in whole leaf H 2O2.23 While this could perhaps be  explained by the mitochondrial O2- burst  providing all the substrate for this H2O2  rise, another intriguing possibility is that the mitochondrial O 2- burst lead to acti - vation of NADPH oxidase.",Non-OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant J 2002; 29:269-79; PMID:11844105; http://dx.doi.org/10.1046/j.1365-313X.2002.01216.x.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant Cell 2003; 15:1212-26; PMID:12724545; http://dx.doi.org/10.1105/tpc.009464.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant Physiol  2003; 132:1518-28; PMID:12857832; http://dx.doi.org/10.1104/pp.102.017640.,Non-OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant Physiol 2011; 156:185-201; PMID:21372201; http://dx.doi.org/10.1104/pp.110.169797.supported the O2- burst by lessening the  conversion of O2- to H2O2 in the matrix.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant Cell Environ 2011; 34:1803-18; PMID:21676000; http://dx.doi.org/10.1111/j.1365-3040.2011.02376.x.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant Physiol 1999; 121:793-803; PMID:10557227; http://dx.doi.org/10.1104/pp.121.3.793.,Non-OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Physiol Plant 2007; 129:253-66; http://dx.doi.org/10.1111/j.1399-3054.2006.00775.x.,Non-OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant J  2002; 30:431-46; PMID:12028573; http://dx.doi.org/10.1046/j.1365-313X.2002.01301.x.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant Physiol 2004; 134:492-501; PMID:14684840; http://dx.doi.org/10.1104/pp.103.031039.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
J Bioenerg Biomembr 2011; 43:237-46; PMID:21611778; http://dx.doi.org/10.1007/s10863-011-9357-4.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
FEBS Lett 1996; 398:155-8; PMID:8977097; http://dx.doi.org/10.1016/S0014-5793(96)01230-6.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Free Radic Res 2011; 45:37-52; PMID:20942571; http://dx.doi.org/10.3109/10715762.2010.516254.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Biochim Biophys Acta 2010; 1797:897-906; PMID:20122895; http://dx.doi.org/10.1016/j.bbabio.2010.01.032.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant J 2000; 23:609-21; PMID:10972887; http://dx.doi.org/10.1046/j.1365-313x.2000.00825.x.32.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant Cell 2012; 24:1815-33; PMID:22652060; http://dx.doi.org/10.1105/tpc.112.098707.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant J 2002; 30:567-79; PMID:12047631; http://dx.doi.org/10.1046/j.1365-313X.2002.01314.x.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
J Exp Bot 2004; 55:605-12; PMID:14966215; http://dx.doi.org/10.1093/jxb/erh076.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant Physiol 2002; 129:1858-65; PMID:12177499; http://dx.doi.org/10.1104/pp.003855.,Non-OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant Cell 2002; 14:1235-51; PMID:12084824; http://dx.doi.org/10.1105/tpc.010433.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant Cell 2012; 24:3349-65; PMID:22942382; http://dx.doi.org/10.1105/tpc.112.101006.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant J 2007; 50:1093-106; PMID:17461782; http://dx.doi.org/10.1111/j.1365-313X.2007.03115.x.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
PLoS One 2011; 6:e23776; PMID:21912606; http://dx.doi.org/10.1371/journal.pone.0023776.,Non-OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Planta 2012; 235:603-14; PMID:22002624; http://dx.doi.org/10.1007/s00425-011-1524-7.20.,Non-OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Trends Plant Sci 2011; 16:160-8; PMID:21185769; http://dx.doi.org/10.1016/j.tplants.2010.11.007.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Annu Rev Plant Biol 2011; 62:79-104; PMID:21332361; http://dx.doi.org/10.1146/annurev-arplant-042110-103857.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
New Phytol 2012; 195:32-9; PMID:22537177; http://dx.doi.org/10.1111/j.1469-8137.2012.04166.x.,Non-OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Physiol Plant 2009; 137:392-406; PMID:19549065; http://dx.doi.org/10.1111/j.1399-3054.2009.01254.x.,Non-OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
J Exp Bot 2008; 59:501-20; PMID:18079135; http://dx.doi.org/10.1093/jxb/erm239.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Cell Death Differ 2011; 18:1241-6; PMID:21494263; http://dx.doi.org/10.1038/cdd.2011.36.,Non-OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
FEBS Lett 2005; 579:3814- 20; PMID:15978583; http://dx.doi.org/10.1016/j.febslet.2005.05.078.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant Cell 2006; 18:397-411; PMID:16387834; http://dx.doi.org/10.1105/tpc.105.036251.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant Physiol 2007; 143:1817-26; PMID:17277088; http://dx.doi.org/10.1104/pp.106.090902.,Non-OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Plant Cell Environ 2012; 35:1121-36;  PMID:22211396; http://dx.doi.org/10.1111/j.1365-3040.2011.02477.x.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
Cell 2008; 134:279-90; PMID:18662543; http://dx.doi.org/10.1016/j.cell.2008.06.017.,OADS,/arxiv_data1/oa_pdf/98/65/psb-8-e22749.PMC3745582.pdf
"www.landesbioscience.com Plant Signaling & Behavior e22763-94Plant Signaling & Behavior 8:1, e22763; January 2013; © 2013 Landes Bioscience RESEARCH PAPER RESEARCH PAPER *Correspondence to: Narendra Tuteja; Email: narendra@icgeb.res.in Submitted: 10/06/12; Revised: 11/02/12; Accepted: 11/02/12 http://dx.doi.org/10.4161/psb.22763 Citation: Pathi K, Tuteja N. High-frequency regeneration via multiple shoot induction of an elite recalcitrant cotton ( Gossypium hirsutum  L. cv.",Non-OADS,/arxiv_data1/oa_pdf/f1/ca/psb-8-e22763.PMC3745583.pdf
Plant Signal Behav 2013; 8:e22763; PMID: 23221745; http://dx.doi.org10.4161/psb.22763.Introduction Cotton ( Gossypium hirsutum  L.) is one of the most commercially  important fiber crops in the world.,Non-OADS,/arxiv_data1/oa_pdf/f1/ca/psb-8-e22763.PMC3745583.pdf
2003; 73:21-35; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/ca/psb-8-e22763.PMC3745583.pdf
Plant  Sci 2005; 168:1227-33; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/ca/psb-8-e22763.PMC3745583.pdf
Planta 1979; 145:305-7; http://dx.doi.org/10.1007/ BF00454456.,Non-OADS,/arxiv_data1/oa_pdf/f1/ca/psb-8-e22763.PMC3745583.pdf
Plant  Mol Biol 1987; 10:105-16; http://dx.doi.org/10.1007/ BF00016148.,OADS,/arxiv_data1/oa_pdf/f1/ca/psb-8-e22763.PMC3745583.pdf
Plant Mol Biol Rep 1998; 16:1-10;  http://dx.doi.org/10.1023/A:1007438104369.,OADS,/arxiv_data1/oa_pdf/f1/ca/psb-8-e22763.PMC3745583.pdf
BioTechnology 1993; 11:596-8; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/ca/psb-8-e22763.PMC3745583.pdf
Plant Cell Rep 1991; 10:12-6; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/ca/psb-8-e22763.PMC3745583.pdf
Plant Cell Rep 1998; 17:273-8; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/ca/psb-8-e22763.PMC3745583.pdf
Cult 1999; 54:185-91; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/ca/psb-8-e22763.PMC3745583.pdf
Plant  Cell Rep 1987; 6:231-4; http://dx.doi.org/10.1007/ BF00268487.,OADS,/arxiv_data1/oa_pdf/f1/ca/psb-8-e22763.PMC3745583.pdf
In  Vitro Cell Dev Biol 1988; 24:951-4; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/ca/psb-8-e22763.PMC3745583.pdf
Plant Cell Rep 2003; 21:955-60; PMID:12835904;  http://dx.doi.org/10.1007/s00299-003-0613-x.,OADS,/arxiv_data1/oa_pdf/f1/ca/psb-8-e22763.PMC3745583.pdf
Plant Cell Tissue Organ Cult 2010; 101:323-30;  http://dx.doi.org/10.1007/s11240-010-9691-y.,Non-OADS,/arxiv_data1/oa_pdf/f1/ca/psb-8-e22763.PMC3745583.pdf
Biol Plant 2008; 52:201-8; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/ca/psb-8-e22763.PMC3745583.pdf
Physiol Plant 1962; 15:473-97; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/ca/psb-8-e22763.PMC3745583.pdf
IOP FDAWeb.http://www.fda.gov/downloads/medicaldevices/safety/ alertsandnotices/UCM262760.pdf .,OADS,/arxiv_data1/oa_pdf/f7/37/192_2013_Article_2069.PMC3745620.pdf
"Films were then scanned by an Epson V750 Pro Scanner into.tif format and then quantitatedusing ImageJ software ( http://rsb.info.nih.gov/ij/ ), following the methods outlined in the document http://www.lukemiller.",OADS,/arxiv_data1/oa_pdf/17/c9/335_2013_Article_9462.PMC3745623.pdf
"Conflict of Interest:  None declared.Department of Nuclear Medicine and PET,  Singapore General Hospital, Singapore - 169608   E-mail: ajitpadhy1@yahoo.co.uk Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.",Non-OADS,/arxiv_data1/oa_pdf/1f/c6/WJNM-12-1.PMC3745626.pdf
Available from: http://www.drugs.com/sfx/zoledronic‑acid‑  side‑effects.html [Last accessed on 2013 Jun 02].,Non-OADS,/arxiv_data1/oa_pdf/09/6e/WJNM-12-14.PMC3745627.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/09/6e/WJNM-12-14.PMC3745627.pdf
Available from: http://www.amgen.com.,Non-OADS,/arxiv_data1/oa_pdf/d8/47/WJNM-12-19.PMC3745628.pdf
Available from: http://www.who.int/cancer/detection/ breastcancer/en/inde×1.html.,Non-OADS,/arxiv_data1/oa_pdf/c5/bb/WJNM-12-27.PMC3745630.pdf
Available from: http://www.asnc.,Non-OADS,/arxiv_data1/oa_pdf/20/17/WJNM-12-3.PMC3745631.pdf
"Available from: http://nucleus.iaea.org/HHW/Human_ Health_Latest/IPET_Conference/index.html, http://nucleus.",OADS,/arxiv_data1/oa_pdf/c8/fd/WJNM-12-33.PMC3745632.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/17/49/WJNM-12-38.PMC3745633.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/17/49/WJNM-12-38.PMC3745633.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/71/ff/SJG-19-141.PMC3745654.pdf
Available from: http://clinicaltrials.gov/ct2/show/ NCT01284634?term=cannabidiol and rank=5.,Non-OADS,/arxiv_data1/oa_pdf/76/78/SJG-19-144.PMC3745655.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01217112.,Non-OADS,/arxiv_data1/oa_pdf/76/78/SJG-19-144.PMC3745655.pdf
Available from: http://www.givenimaging.com.,Non-OADS,/arxiv_data1/oa_pdf/be/83/SJG-19-160.PMC3745657.pdf
Available from: http://www.who.int/csr/disease/hepatitis/ whocdscsrlyo2003/en/index4.html#incidence.,Non-OADS,/arxiv_data1/oa_pdf/7d/2c/SJG-19-165.PMC3745658.pdf
Available from: http://www.who.int/immunization_monitoring/data/data_regions/en/index.html.,OADS,/arxiv_data1/oa_pdf/7d/2c/SJG-19-165.PMC3745658.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/SJG-19-172.PMC3745659.pdf
Available from: http://www.openepi.com/ OE2.3].,Non-OADS,/arxiv_data1/oa_pdf/b0/60/SJG-19-182.PMC3745661.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/b0/60/SJG-19-182.PMC3745661.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/b0/60/SJG-19-182.PMC3745661.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.,Non-OADS,/arxiv_data1/oa_pdf/bc/26/SJG-19-187.PMC3745662.pdf
Available  from: http://www.cebm.net/index/aspx?o=5653.,OADS,/arxiv_data1/oa_pdf/6e/56/IJOrtho-47-323.PMC3745684.pdf
"Source of Support:  Nil, Conflict of Interest:  None Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.",Non-OADS,/arxiv_data1/oa_pdf/6e/56/IJOrtho-47-323.PMC3745684.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/05/1c/IJOrtho-47-352.PMC3745688.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/05/1c/IJOrtho-47-352.PMC3745688.pdf
Available from: http://www.sonoworld.com/TheFetus/page.,Non-OADS,/arxiv_data1/oa_pdf/a4/d4/IJOrtho-47-413.PMC3745698.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/aa/82/IJOrtho-47-417.PMC3745699.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/fb/ert188.PMC3745720.pdf
Available at: http://faostat.fao.org   (consulted June 2013).,Non-OADS,/arxiv_data1/oa_pdf/ce/fb/ert188.PMC3745720.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/cf/ert189.PMC3745721.pdf
Information about markers is available at http://www.maizegdb.org/.,OADS,/arxiv_data1/oa_pdf/e5/cf/ert189.PMC3745721.pdf
The complete microarray data have been deposited in NCBI’s Gene Expression Omnibus and are accessible through GEO Series acces- sion number GSE41956 (http://www.ncbi.nlm.nih.gov/geo/query/ acc.cgi?acc=GSE41956).,OADS,/arxiv_data1/oa_pdf/e5/cf/ert189.PMC3745721.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/b9/ert190.PMC3745722.pdf
"Gene annotation and ontology analysis Gene sequences associated with each identifier were downloaded  (transcripts.Phypa1_1.FilteredModels3.fasta.gz, available at  http://genome.jgi-psf.org/Phypa1_1/Phypa1_1.download.ftp.html )  (Rensing et  al.",OADS,/arxiv_data1/oa_pdf/8a/b9/ert190.PMC3745722.pdf
Primers were selected using Primer3 ( http://frodo.wi.mit.edu/ primer3/ ).,OADS,/arxiv_data1/oa_pdf/8a/b9/ert190.PMC3745722.pdf
Available at: http://www.bryoecol.mtu.edu .,Non-OADS,/arxiv_data1/oa_pdf/8a/b9/ert190.PMC3745722.pdf
Available at: http://www.bryoecol.mtu.edu .,Non-OADS,/arxiv_data1/oa_pdf/8a/b9/ert190.PMC3745722.pdf
"C, from Herbario virtual de la Universidad de  Alicante: http://www.herbariovirtual.ua.es/hoja_salsola_genistoides.htm with permission, accessed 2 April 2013; F, I, O, by HA; L, from AlmeriNatura: http://www.almerinatura.com/, accessed 2 April 2013 with permission.",Non-OADS,/arxiv_data1/oa_pdf/29/e8/ert191.PMC3745723.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/0c/ert192.PMC3745724.pdf
The surface of green area in each well was quantified upon image acquisition using ImageJ software (http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/50/db/ert195.PMC3745725.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/67/ert198.PMC3745726.pdf
"SSR primer  sequences were analysed using BLASTN tools in Phytozome v8.0 (http://www.phytozome.net/search.php), and annotated genes over - lapping with SSR loci were selected as candidates.",OADS,/arxiv_data1/oa_pdf/40/67/ert198.PMC3745726.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/5e/ert203.PMC3745728.pdf
Gene ontology (GO) terms were retrieved from the TAIR  website ( http://arabidopsis.org ).,OADS,/arxiv_data1/oa_pdf/c1/5e/ert203.PMC3745728.pdf
The final retrieved genomic sequence contigs were cross  checked with EST data from NCBI ( http://blast.ncbi.nlm.nih.gov/ Blast.cgi ) and the DFCI Triticum aestivum  Gene Index ( http:// compbio.dfci.harvard.edu/cgi-bin/tgi/gimain.pl?gudb=wheat ).,OADS,/arxiv_data1/oa_pdf/73/0c/ert205.PMC3745729.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/02/ert206.PMC3745730.pdf
Protein sequences were analysed  using PROSITE Scan ( http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.,OADS,/arxiv_data1/oa_pdf/cf/02/ert206.PMC3745730.pdf
"pl?page=npsa_prosite.html ) for prediction of the conserved domains  and motifs, SignalP ( http://www.cbs.dtu.dk/services/SignalP/ ) for pre - diction of the signal peptide, and TMpred ( http://www.ch.embnet.",OADS,/arxiv_data1/oa_pdf/cf/02/ert206.PMC3745730.pdf
http://www.ncbi.nlm.nih.gov/ entrez/viewer.fcgi?Db=nucleotide&val=11990496 .,OADS,/arxiv_data1/oa_pdf/cf/02/ert206.PMC3745730.pdf
"3723–3733, 2013 doi:10.1093/jxb/ert207  Advance Access publication 19 July, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/73/ert207.PMC3745731.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/00/ert209.PMC3745732.pdf
"Estimation of parameter values for APSIM-Wheat-G Using the observed calibration data from the 2  years of trials at  South Perth, the effects of the VRN1  and Ppd-D1  genes were esti - mated using the restricted maximum likelihood (REML) method  in ASReml (version 3, http://www.vsni.co.uk/software/asreml ).",OADS,/arxiv_data1/oa_pdf/50/00/ert209.PMC3745732.pdf
"3803–3815, 2013 doi:10.1093/jxb/ert210  Advance Access publication 19 July, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/04/ert210.PMC3745733.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/3a/ert211.PMC3745734.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/a9/ert213.PMC3745735.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/fd/ert214.PMC3745736.pdf
"Identification of putative cis-acting elements  in the gene promoter was performed using the following software:  PLANTCARE ( http://bioinformatics.psb.ugent.be/webtools/plant- care/html ), PLACE ( http://www.dna.affrc.go.jp/PLACE ), and  MatInspector ( http://www.genomatix.de/online_help/help_matin- spector/matinspector_help.html ).",OADS,/arxiv_data1/oa_pdf/8a/fd/ert214.PMC3745736.pdf
"3787–3802, 2013 doi:10.1093/jxb/ert215   This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/d5/ert215.PMC3745737.pdf
"When the  second leaves were fully expanded, protoplasts were isolated from  leaves used for transfection with DNA constructs or dsRNAs based  on the protocol for maize mesophyll protoplasts provided online by  J.  Sheen’s laboratory ( http://genetics.mgh.harvard.edu/sheenweb )  with minor modifications.",Non-OADS,/arxiv_data1/oa_pdf/d4/d5/ert215.PMC3745737.pdf
"3843–3854, 2013 doi:10.1093/jxb/ert216  Advance Access publication 23 July, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/fa/ert216.PMC3745738.pdf
Materials and methods Materials and growth conditions Wild-type A. thaliana  ecotype Columbia (Col-0) and T-DNA inser - tion mutant ( http://signal.salk.edu/ ; Alonso et al.,OADS,/arxiv_data1/oa_pdf/e8/fa/ert216.PMC3745738.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/70/ert217.PMC3745739.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/3c/ert218.PMC3745740.pdf
The analyses of floral bud ESTs in the OrchidBase  (http://orchidbase.itps.ncku.edu.tw/est/home2012.aspx ) have  been initiated for Phalaenopsis aphrodite  subsp.,OADS,/arxiv_data1/oa_pdf/69/3c/ert218.PMC3745740.pdf
Construction of pCymMV-Gateway plasmids The putative TFs of 152 ESTs were identified from 5593 orchid  floral ESTs in the Arabidopsis thaliana  TF database at the  Arabidopsis  Gene Regulatory Information Server (AGRIS)  (http://arabidopsis.med.ohio-state.edu ) (Tsai et  al.,OADS,/arxiv_data1/oa_pdf/69/3c/ert218.PMC3745740.pdf
"3885–3898, 2013 doi:10.1093/jxb/ert219  Advance Access publication 23 July, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/65/ert219.PMC3745741.pdf
All putative novel transcriptionally active regions (nTARs)  marked as splice variants of known genes or located within intronic  regions were disregarded and for the 18  291 remaining nTARs  BLASTx searches were performed against Swiss-Prot and trEMBL  and all predicted rice proteins ( http://rice.plantbiology.msu.edu/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/65/ert219.PMC3745741.pdf
"3911–3922, 2013 doi:10.1093/jxb/ert223  Advance Access publication 25 July, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/21/ert223.PMC3745742.pdf
"The T-DNA insertion mutant  line AT5G47390 , which is termed mybh  (GK-783B02: NASC ID  N365026), was obtained from the Nottingham Arabidopsis  Stock  Centre ( http://arabidopsis.info ).",Non-OADS,/arxiv_data1/oa_pdf/59/21/ert223.PMC3745742.pdf
Additional information about the Gateway site-specific cloning  protocols is provided online by the manufacturer ( http://www.inv- itrogen.com/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/21/ert223.PMC3745742.pdf
"Onion ( Allium cepa ) epidermal cells were grown on MS agar prior  to transfection by particle bombardment (Bio-Rad, http://www.bio- rad.com/ ).",Non-OADS,/arxiv_data1/oa_pdf/59/21/ert223.PMC3745742.pdf
"After bombardment, the cells were placed in the dark  at 23 °C for 18–48  h. Green fluorescent protein (GFP) fluorescence  was visualized via confocal lase- scanning fluorescence microscopy  (LSM 5 Exciter; Carl-Zeiss, http://www.zeiss.com/ ).",OADS,/arxiv_data1/oa_pdf/59/21/ert223.PMC3745742.pdf
Available at: http://www.r-project.org .,Non-OADS,/arxiv_data1/oa_pdf/f4/3c/253_2013_Article_4898.PMC3745828.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.1.22 Pediatric Gastroenterology, Hepatology & Nutrition 2013 March 1 6(1):22-27PGHN Review Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic  Fatty Liver Disease Ji Sook Park, Ji Hyun Seo and Hee-Shang Youn Department of Pediatrics, Gyeongsang National University School of Medicine, Jinju, Korea The prevalence of obesity is increasing worldwide.",Non-OADS,/arxiv_data1/oa_pdf/48/39/pghn-16-22.PMC3746040.pdf
"Tel: +82-55-750-8156, Fax: +82-55-752-988 9, E-mail: csassi@hanmail.net Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　The prevalence of obesity is  on the rise globally.",Non-OADS,/arxiv_data1/oa_pdf/48/39/pghn-16-22.PMC3746040.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.1.1 Pediatric Gastroenterology, Hepatology & Nutrition 2013 March 1 6(1):1-9PGHN Invited Review PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Recent Trends in the Endoscopic Management of Variceal  Bleeding in Children Seung Jin Kim and Kyung Mo Kim Department of Pediatrics, Asan Medical Center Children’s Ho spital, University of Ulsan College of Medicine, Seoul, Kore a Variceal bleeding results in significant morbidity and mo rtality in both children and adults.",Non-OADS,/arxiv_data1/oa_pdf/22/fb/pghn-16-1.PMC3746041.pdf
"(Pediatr  Gastroenterol Hepatol Nutr 2013; 16: 1 ∼9) Key Words:  Esophageal and gastric varices, Prevention & Control, Therapeutics, Child  Received：February 14, 2013, Revised：February 23, 2013, Accepted ：February 25, 2013 Corresponding author: Kyung Mo Kim, Department of Pediatrics, Asan Medical Center Chi ldren’s Hospital, University of Ulsan College of  Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Kore a. Tel: +82-2-3010-3380, Fax: +82-2-473-3725, E-mail: kmkim@amc .seoul.kr Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Variceal bleeding is one of the most serious compli- cations of portal hypertension in children and adults  alike [1-3].",Non-OADS,/arxiv_data1/oa_pdf/22/fb/pghn-16-1.PMC3746041.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.1.53 Pediatric Gastroenterology, Hepatology & Nutrition 2013 March 1 6(1):53-60PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Life-Threatening Lower Gastro intestinal Hemorrhage in  Pediatric Crohn’s Disease  Earl Kim *,§, Yunkoo Kang*,§, Mi Jung Lee†,§, Young Nyun Park‡ and Hong Koh *,§ Departments  of *Pediatrics and †Diagnostic Radiology, Research Institute of Radiologic Science, ‡Department of  Pathology, Yonsei University College of Medicine, §Severance Pediatric Liver Dise ase Research Group, Severance  Children’s Hospital, Seoul, Korea In Crohn’s disease, mild gastrointestinal bleeding oft en occurs; however massive gastrointestinal hemorrhage,  which can have a dramatic effect on a patient’s vital sign, is rare.",Non-OADS,/arxiv_data1/oa_pdf/5f/4b/pghn-16-53.PMC3746042.pdf
"Tel: +82-2-2228-2053, Fax: +82-2-393 -9118, E-mail : khong@yuhs.ac Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permit s unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Crohn’s disease is an inflammatory disease of un- known etiology and can occur in any gastrointestinal  tract from the oral cavity to  the anus [1].",Non-OADS,/arxiv_data1/oa_pdf/5f/4b/pghn-16-53.PMC3746042.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.1.49 Pediatric Gastroenterology, Hepatology & Nutrition 2013 March 1 6(1):49-52PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Congenital Antral Web in Premature Baby So-Hyun Nam, Soo Hyun Koo*, Mi Lim Ch ung*, Yu Jin Jung* and Yun-Jung Lim† Departments of Pediatric Surgery, *Pediatrics and †Radiology, Inje University Haeund ae Paik Hospital, Busan, Korea Antral web is a rare cause of gastric outlet obstruction in neonate.",Non-OADS,/arxiv_data1/oa_pdf/30/0a/pghn-16-49.PMC3746043.pdf
"Tel: +82-51-797-0260, Fax: + 82-51-797-0276, E-mail: namsh@paik.ac.kr  Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Gastrointestinal congenital anomalies occur in  one of every 10,000 neonates.",Non-OADS,/arxiv_data1/oa_pdf/30/0a/pghn-16-49.PMC3746043.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.1.41 Pediatric Gastroenterology, Hepatology & Nutrition 2013 March 1 6(1):41-48PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Received：February 18, 2013, Revised：March 15, 2013, Accepted：Ma rch 18, 2013 Corresponding author:  Hann Tchah, Division of Gastroenterology, Hepatology and Nutri tion, Department of Pediatrics, Gachon University Gil Medical Center, 21, Namdong-daero 774 beon-gil, Namdong-gu, Inc heon 405-760, Korea.",Non-OADS,/arxiv_data1/oa_pdf/7b/25/pghn-16-41.PMC3746044.pdf
"Tel: +82-32-460-8429, Fax: +82-32-460-3224 , E-mail: onecar@gilhospital.com Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.Clinical Features of Symptoma tic Meckel's Diverticulum in  Children: Comparison of Scintig raphic and Non-scintigraphic  Diagnosis Jung Hee Rho, Jae Sook Kim*, Sang Yong Kim†, Soon Ki Kim*, Yoon Mi Choi‡, Sung Min Kim§, Hann Tchah, In Sang Jeon, Dong Woo Son, Ee ll Ryoo, Kang Ho Cho, Deok Young Choi and  Yoon Mi Kim∥ Department of Pediatrics, Gachon University Gil Medical Center, *Inha University Hospital, †The Catholic University o f  Korea, Incheon St. Mary’s Hospital, ‡Department of Pediatric Surgery, Inha University Hospital, §Gachon University Gi l  Medical Center, ∥Department of Nursing Science, College of Nursing, Gachon University, Incheon, Korea Purpose: Meckel's diverticulum (MD) has various clinical manifestations, and diagnosis or selectection of proper  diagnostic tools is not easy.",Non-OADS,/arxiv_data1/oa_pdf/7b/25/pghn-16-41.PMC3746044.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.1.17 Pediatric Gastroenterology, Hepatology & Nutrition 2013 March 1 6(1):17-21PGHN Review Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Gut Microbiota in Inflammatory Bowel Disease Jung Ok Shim Department of Pediatrics, Korea Universi ty College of Medicine, Seoul, Korea The gut mucosal barrier plays an important role in maintaining a delicate immune homeostasis.",Non-OADS,/arxiv_data1/oa_pdf/a2/78/pghn-16-17.PMC3746045.pdf
"Tel: +82-2-2626-3157, Fax: +82-2-2626-1249, E-mail: shim jo@korea.ac.kr Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Different genetic, immunologic, and environ- mental factors are implicat ed in the pathogenesis  of inflammatory bowel disease (IBD).",Non-OADS,/arxiv_data1/oa_pdf/a2/78/pghn-16-17.PMC3746045.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.1.10 Pediatric Gastroenterology, Hepatology & Nutrition 2013 March 1 6(1):10-16PGHN Review Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Recent Achievements in Stem  Cell Therapy for Pediatric  Gastrointestinal Tract Disease   Sun Hwan Bae Department of Pediatrics, School of Me dicine, Konkuk University, Seoul, Korea  The field of stem cell research has been rapidly expanding.",Non-OADS,/arxiv_data1/oa_pdf/bf/9a/pghn-16-10.PMC3746046.pdf
"Tel: +82 ‐2‐2030‐7554, Fax: +82 ‐2‐2030‐7749, E-mail: baedori@hanafos.com Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Stem cells are defined as the primitive and rela- tively unspecialized cells in fetal and adult tissues  that have properties of self-renewal (longevity)  and the ability to produce all the differentiated cell types of that tissue (multipotency) [1].",Non-OADS,/arxiv_data1/oa_pdf/bf/9a/pghn-16-10.PMC3746046.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.1.28 Pediatric Gastroenterology, Hepatology & Nutrition 2013 March 1 6(1):28-33PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Anorectal Malformations Associated  with Esophageal Atresia in Neonates Shin Yun Byun, Ryoung Kyoung Lim,  Kyung Hee Park, Yong Hoon Cho * and Hae Young Kim * Departments of Pediatrics and *Surgery, Pusan Nation al University School of Medicine, Yangsan, Korea Purpose:  Anorectal malformations are often associated wit h other anomalies, reporting frequency with 40-70%.",Non-OADS,/arxiv_data1/oa_pdf/66/da/pghn-16-28.PMC3746047.pdf
"Tel: +82-55-360-2471, Fax: +82-55-360-2 154, E-mail: choyh70@pusan.ac.kr Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Anorectal malformations occur approximately in  1/1,500 to 1/5,000 live births [1,2].",Non-OADS,/arxiv_data1/oa_pdf/66/da/pghn-16-28.PMC3746047.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.1.34 Pediatric Gastroenterology, Hepatology & Nutrition 2013 March 1 6(1):34-40PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Influencing Factors to Results of  the Urease Test: Age, Samplin g Site, Histopathologic Fi ndings, and Density of Helicobacter  pylori  Ji-Hyun Seo, Hee-Shang Youn, Jung-Je Park *, Jung Sook Yeom, Ji Sook Park, Jin-Su Jun, Jae-Youn g  Lim, Chan-Hoo Park, Hyang-Ok Woo, Gyung-Hyuck Ko†, Seung-Chul Baik‡, Woo-Kon Lee‡,  Myung-Je Cho‡ and Kwang-Ho Rhee‡ Departments of Pediatrics, *Otolaryngology, †Pathology and ‡Microbiology, Institute of Health Sciences , School of  Medicine, Gyeongsang National University, Jinju, Korea Purpose: We investigated the positivity rate and the time period to the positive color change of the urease test in  children and adults and assessed the correlation of the urease test to histopathologic findings.",Non-OADS,/arxiv_data1/oa_pdf/7a/f3/pghn-16-34.PMC3746048.pdf
"Tel: +82-55-750-8158, Fax: + 82-55-752-9339, E-mail: hsyoun@gnu.ac.kr Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　In most cases, Helicobacter pylori infection occurs pri-marily in childhood [1].",Non-OADS,/arxiv_data1/oa_pdf/7a/f3/pghn-16-34.PMC3746048.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.1.61 Pediatric Gastroenterology, Hepatology & Nutrition 2013 March 1 6(1):61-64PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Epstein-Barr Virus Infection with Acute Pancreatitis Associated  with Cholestatic Hepatitis  Seok-Jin Kang, Ka-Hyun Yoon and Jin-Bok Hwang Department of Pediatrics, Keimyung University School of Medicine, Daegu, Korea Infection-induced acute hepatitis complicated with acute pancreatitis is associated with hepatitis A virus, hepatitis  B virus or hepatitis E virus.",Non-OADS,/arxiv_data1/oa_pdf/4d/84/pghn-16-61.PMC3746049.pdf
"Tel: +82-53-250-73 31, Fax: +82-53-250-7783, E-mail: pedgi@kmu.ac.kr Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Acute hepatitis compli cated with acute pan- creatitis is often associat ed with infectious agent  such as hepatitis A virus [1], hepatitis B virus [2] or  hepatitis E virus [3].",Non-OADS,/arxiv_data1/oa_pdf/4d/84/pghn-16-61.PMC3746049.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2012.15.4.197 Pediatric Gastroenterology, Hepatology & Nutrition 2012 Decembe r 15(4):197-209PGHN Invited Review PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Received：December 26, 2012, Revised：December 27, 2012, Accepted ：December 28, 2012 Corresponding author:  Jeong Kee Seo, Division of Pediatric Gastroenterology, Hepatol ogy and Nutrition, Department of Pediatrics, Seoul  National University Children's Hospital, 101, Daehak-ro, Jongno -gu, Seoul 110-769, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ec/2e/pghn-15-197.PMC3746050.pdf
"Tel: +82-2-2072-3468, Fax: +82-2-743 -3455, E-mail:  jkseo@snu.ac.kr Copyright ⓒ 2012 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permit s unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.Diagnosis of Wilson Disease in Young Children: Molecular  Genetic Testing and a Paradigm Shift from the Laboratory Diagnosis Jeong Kee Seo Division of Pediatric Gastroenterology, Hepatology and Nutr ition, Department of Pediatrics, College of Medicine, Seou l National University, Seoul, Korea Wilson disease (WD) is an autosomal recessive disorder of copper metabolism that results in accumulation of copper  primarily in the liver, brain and cornea.",Non-OADS,/arxiv_data1/oa_pdf/ec/2e/pghn-15-197.PMC3746050.pdf
The functional assays in the yeast mutant Ccc2p  model confirmed 508 WD ca using variants includ- ing 267 missense mutations in 644 variants which  were identified by diagnostic sequencing of ATP7B (http://www.wilsondiseas e.med.ualberta.ca/data- base.asp).,OADS,/arxiv_data1/oa_pdf/ec/2e/pghn-15-197.PMC3746050.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2012.15.4.229 Pediatric Gastroenterology, Hepatology & Nutrition 2012 Decembe r 15(4):229-236PGHN Review Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION How to Do in Persistent Diarrh ea of Children?",Non-OADS,/arxiv_data1/oa_pdf/83/66/pghn-15-229.PMC3746051.pdf
"Tel: +82-41-550-3968, Fax: +82-41-550-3 949, E-mail: pdlks@dankook.ac.kr  Copyright ⓒ 2012 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permit s unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Diarrhea is the excessive loss of fluids and electro- lytes in the stool [1].",Non-OADS,/arxiv_data1/oa_pdf/83/66/pghn-15-229.PMC3746051.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2012.15.4.250 Pediatric Gastroenterology, Hepatology & Nutrition 2012 Decembe r 15(4):250-255PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Juvenile Polyp and Colonoscopic Polypectomy in Childhood Byung Gee Lee*, Sung Hyun Shin, Young Ah Lee* , Joo Hee Wi, Yeoun Joo Lee, and Jae Hong Par k Department of Pediatrics, Pusan National University Sc hool of Medicine, *Good Gang -An Hospital, Busan, Korea Purpose: This study aimed to evaluate the clinical features of juvenile polyp and the usefulness of polypectomy with  entire colonoscopy in children.Methods: We retrospectively reviewed the medical records of 83 children who were diagnosed with having  juvenile  polyps.",Non-OADS,/arxiv_data1/oa_pdf/b5/00/pghn-15-250.PMC3746052.pdf
"Tel: +82-55-360-2180, Fax: +82-55-360-2 181, E-mail:  jhongpark@pusan.ac.kr Copyright ⓒ 2012 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permit s unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Polyps are the most common causes of colorectal  bleeding in children  [1,2].",Non-OADS,/arxiv_data1/oa_pdf/b5/00/pghn-15-250.PMC3746052.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2012.15.4.210 Pediatric Gastroenterology, Hepatology & Nutrition 2012 Decembe r 15(4):210-219PGHN Review Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Community Management of Acute Malnutrition in the  Developing World Se-Eun Park, Sungtae Kim, Cyprian Ouma *, Mesfin Loha *, Thomas F Wierzba† and Nam Seon Beck† World Vision Korea, Seoul, Korea, *World Vision Eastern Africa Regi onal Office, Nairobi, Kenya, †The International  Vaccine Institute, Seoul, Korea Globally, acute malnutrition triggers more than 50% of childhood mortality in children under 5 years old, which implies  that about 3.5 million children die of malnutrition each y ear.",Non-OADS,/arxiv_data1/oa_pdf/2d/71/pghn-15-210.PMC3746053.pdf
"Tel: +82-2-8 81-1315, Fax: +82-2-881-1164, E ‐mail: nsbeck@ivi.int Copyright ⓒ 2012 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permit s unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Although the term malnutrition refers to both un- der-nutrition and over-nut rition, it generally in-dicates under-nutrition including protein-energy  malnutrition and deficiency of micronutrients.",Non-OADS,/arxiv_data1/oa_pdf/2d/71/pghn-15-210.PMC3746053.pdf
"Time Frame for the Management of a Child with Severe Malnutrition ActivityInitial treatment (day) Rehabilitation (week) Follow up (week) 1-2 3-7 2-6 7-26 Treat or prevent: 　Hypoglycemia 　Hypothermia  　Dehydration  Correct electrolyte imbalance Treat infection Correct micronutrient 　deficiencies Begin feeding Increase feeding to recover lost  weight (“catch-up growth”) Stimulate emotional & sensorial development Prepare for discharge     w i t h o u t  i r o n       w i t h  i r o n Cited from ‘Management of Severe Malnutrition: a manual for phys icians and other senior health workers, World Health Organizati on, Geneva, 1999 (available online at http://www.who.int/nutr ition/publications/en/manage_severe_malnutrition_eng.pdf).MANAGEMENT OF SEVERE ACUTE  MALNUTRITION 　The Ethiopian famine in the mid-70s required ef- forts to treat large numbers of children with severe acute malnutrition [19].",Non-OADS,/arxiv_data1/oa_pdf/2d/71/pghn-15-210.PMC3746053.pdf
"Comparison of the Nutritional Composition of Milk  Based Formula, F100 and Ready to Use Therapeutic Food (RUTF) Per 100 KJ F100 RTUF Moisture content Energy (kJ)Protein (g) Lipid (g) Potassium (mg)Calcium (mg) Phosphorus (mg) Magnesium (mg)Zinc (mg) Copper (mg) Iodine (μg) Selenium ( μg) Iron (mg) Thiamine (mg)Riboflavin (mg) Vitamin B-6 (mg) Vitamin B-12 ( μg) Vitamin C (mg) Folic acid ( μg) Niacin (mg)Biotin (μg) Pantothenic acid (mg) Retinol ( μg) Vitamin D ( μg) Vitamin K ( μg) Vitamin E (mg)Isoosmolar 414 6.0 12.2 513.6140.9 140.9 38.2 5.0 0.7 33.4 9.6 1.0 0.20.7 0.2 0.7 23.4 93.2 2.4 28.7 1.4 372.7 6.9 6.9 9.32.5% maximum 2,281 6.0 15.8 487.3140.9 152.9 40.6 6.2 0.7 47.814.3 5.0 0.20.7 0.2 0.7 23.2 93.2 2.4 28.7 1.4 398.9 6.9 9.3 8.8 Cited and modified from ‘Community-Based Management o f  Severe Acute Malnutrition, A Joint Statement by the World  Health Organization, the World Food Programme, the United  Nations System Standing Committee on Nutrition and the United Nations Children’s Fund, May 2007 (available online at  http://www.who.int/nutrition/topics/Statement _community _  based_man_sev_acute_mal_eng.pdf) and Diop el et al., 2003 [37].infrastructure and the paucit y of skilled health staff,  which is estimated to be fewer than four doctors and 22 nurses per 100,000 people [30], and in addition,  hospital based management of malnutrition attains a  low coverage rate, which is worsened in situations where dispersed communities live in chronic poverty.",Non-OADS,/arxiv_data1/oa_pdf/2d/71/pghn-15-210.PMC3746053.pdf
"Composition of F 75 and F 100 Diet ConstituentsAmount F 75 F 100 Energy Protein LactosePotassium Sodium MagnesiumZinc Copper Percentage of energy from:　Protein  　Fat Osmolarity75 kcal (315 kJ) 0.9 g 1.3 g3.6 mmol 0.6 mmol 0.43 mmol2.0 mg 0.25 mg 5% 32% 333 mOsmol/L100 kcal (420 kJ) 2.9 g 4.2 g5.9 mmol 1.9 mmol 0.73 mmol2.3 mg 0.25 mg 12% 53% 419 mOsmol/L Cited from ‘Management of Severe Malnutrition: A manual for  physicians and other senior health workers, World Health  Organization, Geneva, 1999 (availab le online at http://www.who.",Non-OADS,/arxiv_data1/oa_pdf/2d/71/pghn-15-210.PMC3746053.pdf
"Available at http://www.who.int/nutgrowthdb/jme_uni cef_ who_wb.pdf (Accessed on Nov 10, 2012).",Non-OADS,/arxiv_data1/oa_pdf/2d/71/pghn-15-210.PMC3746053.pdf
"Available at: http://www.dcp2.org/file/17/wp1.pdf (Accessed on Nov 10, 2012).",Non-OADS,/arxiv_data1/oa_pdf/2d/71/pghn-15-210.PMC3746053.pdf
"Available at:  http://www.who.int/nutrition/publications/severemal nutrition/9789241598163_eng.pdf (Accessed on Nov 5, 2012).",Non-OADS,/arxiv_data1/oa_pdf/2d/71/pghn-15-210.PMC3746053.pdf
"Available at: http://www.unscn.org/layout/modules/resources/files/ Policy_paper_No_5.pdf (Acc essed on Dec 4, 2012).",Non-OADS,/arxiv_data1/oa_pdf/2d/71/pghn-15-210.PMC3746053.pdf
"http://apps.who.int/globalatlas/docs/HRH/ HTML/ SASA_Aug08.htm (Accessed on Nov 10, 2012).",OADS,/arxiv_data1/oa_pdf/2d/71/pghn-15-210.PMC3746053.pdf
"Avail-able at: http://fex.ennonline.net/2/treatment (Accessed on Dec 4, 2012).",Non-OADS,/arxiv_data1/oa_pdf/2d/71/pghn-15-210.PMC3746053.pdf
Available at:  http://fex.ennonline.net/ 24/clinical (Accessed on Nov 11 2012).,Non-OADS,/arxiv_data1/oa_pdf/2d/71/pghn-15-210.PMC3746053.pdf
"Available at http://www.ennonline.net/pool/files/ife/ supplement23.pdf (Access ed on Nov 11, 2012).",OADS,/arxiv_data1/oa_pdf/2d/71/pghn-15-210.PMC3746053.pdf
"Available  at http://www.spherehandbook.org/en/management- of-acute-malnutrition-and -micronutrient-deficien  cies-standard-2-severe-acu te-malnutrition/ (Accessed  on Nov 20, 2012).",Non-OADS,/arxiv_data1/oa_pdf/2d/71/pghn-15-210.PMC3746053.pdf
"Accessible at: http://www.who.int/nutrition/ topics/Meeting_report.pdf (Accessed on Nov 11, 2012).",Non-OADS,/arxiv_data1/oa_pdf/2d/71/pghn-15-210.PMC3746053.pdf
"Available at http://dspace.itg.be/bitstream/10390/4986/ 1/1998shso0011.pdf (Assessed on Dec 4, 2012).",OADS,/arxiv_data1/oa_pdf/2d/71/pghn-15-210.PMC3746053.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2012.15.4.220 Pediatric Gastroenterology, Hepatology & Nutrition 2012 Decembe r 15(4):220-228PGHN Review Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Gastro-Esophageal Reflux Dise ase in Healthy Older Children  and Adolescents Kie Young Park and Soo Hee Chang * Department of Pediatrics, Gangneung Asan Hospital, College of Medicine, Ulsan University, Gangneung, *De partmen t of Pediatrics, Bundang Jesaeng General Hospital, Seongnam, Korea Gastro-esophageal reflux disease (GERD) in otherwise healthy older children and adolescents is commonly encoun- tered in pediatric clinics and poses a complex treatment pr oblem involving changes of diets and lifestyle.",Non-OADS,/arxiv_data1/oa_pdf/11/2e/pghn-15-220.PMC3746054.pdf
"Tel: +82-31-779-0278, Fax:  +82-31-779-0894, E-mail: babydr@chol.com Copyright ⓒ 2012 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permit s unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Gastro-esophageal reflux disease (GERD) in oth- erwise healthy older children and adolescents is a significant source of morb idity [1-3].",Non-OADS,/arxiv_data1/oa_pdf/11/2e/pghn-15-220.PMC3746054.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2012.15.4.243 Pediatric Gastroenterology, Hepatology & Nutrition 2012 Decembe r 15(4):243-249PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Efficacy of Early Infliximab Treatment for Pediatric Crohn’s  Disease: A Three-year Follow-up Yun Seok Lee, Sang Hun Baek, Mi Jin Kim* , Yoo Min Lee, Yoon Lee and Yon Ho Choe Department of Pediatrics, Samsung Me dical Center, School of Medicine, Sungkyunkwan University, Seoul, *De partmen t of Pediatrics, Myongji Hospital, College of Medicine, Kwandong University, Goyang, Korea Purpose: To investigate the efficacy of early infliximab use and to follow the progress of pediatric cases of Crohn’s disease for 3 years.",Non-OADS,/arxiv_data1/oa_pdf/28/9f/pghn-15-243.PMC3746055.pdf
"Tel: +82 ‐2-3410 ‐3539, Fax: +82 ‐2‐3410-0839, E ‐mail: i101016@skku.edu Copyright ⓒ 2012 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permit s unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Crohn’s disease (CD) is a chronic inflammatory disorder involving any part of the gastrointestinal  tract, characterized by relapsing and remitting epi- sode [1-3].",Non-OADS,/arxiv_data1/oa_pdf/28/9f/pghn-15-243.PMC3746055.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2012.15.4.237 Pediatric Gastroenterology, Hepatology & Nutrition 2012 Decembe r 15(4):237-242PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Efficacy of Proton Pump Inhibi tor-based Triple Therapy and  Bismuth-based Quadruple Therapy for Helicobacter pylori   Eradication in Korean Children Jeana  Hong *,† and Hye Ran Yang†,‡ Department of Pediatrics, *Kangwon National University Hospital, Chuncheon, †Seoul National University Bundang  Hospital, Seongnam, ‡Seoul National University Coll ege of Medicine, Seoul, Korea Purpose: The aim of this study was to assess and compare the efficacies of proton pump inhibitor-based triple therapy  and bismuth-based quadruple therapy as first-line treatments for Helicobacter pylori  eradication in Korean children.",Non-OADS,/arxiv_data1/oa_pdf/e5/28/pghn-15-237.PMC3746056.pdf
"Tel: +82-31-787-7285, Fax:  +82-31-787-4054, E-mail:  hryang@snubh.org Copyright ⓒ 2012 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permit s unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Helicobacter pylori  is a gram-negative, spiral-shaped  bacterium which colonizes in the gastric mucosa and often causes gastritis or peptic ulcer disease in  both adults and children [1].",Non-OADS,/arxiv_data1/oa_pdf/e5/28/pghn-15-237.PMC3746056.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2012.15.4.272 Pediatric Gastroenterology, Hepatology & Nutrition 2012 Decembe r 15(4):272-275PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Acute Pancreatitis Induced by Azathioprine and  6-mercaptopurine Proven by Single and Low Dose Challenge Testing in a Child with Crohn Disease  Geum-Chae-Won Yi, Ka-Hyun Yoon and Jin-Bok Hwang Department of Pediatrics, Keimyung University School of Medicine, Daegu, Korea We report here a case of drug-induced acute pancreatitis proved by elimination and single, low dose challenge test  in a child with Crohn disease.",Non-OADS,/arxiv_data1/oa_pdf/6c/b8/pghn-15-272.PMC3746057.pdf
"Tel: +82-53-250-7331, Fax: +82-53-250-778 3, E-mail: pedgi@kmu.ac.kr Copyright ⓒ 2012 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permit s unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　In a patient with infl ammatory bowel disease  (IBD), the incidence of acute pancreatitis is higher than healthy people.",Non-OADS,/arxiv_data1/oa_pdf/6c/b8/pghn-15-272.PMC3746057.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2012.15.4.266 Pediatric Gastroenterology, Hepatology & Nutrition 2012 Decembe r 15(4):266-271PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION A Case of Small Bowel Ulcer Associated with Helicobacter  pylori  Eun Young Kim, Ji Hyun Kim, Saet Byul  Woo, Jeong Won Lee, Kon Hee Lee,  Su Rin Shin* and Jee Hyun Lee Departments of Pediatrics and *Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of  Medicine, Seoul, Korea The etiology of peptic ulcer disease in children may be primary, associated with Helicobacter pylori infection, or secon- dary, relied on underlying disease.",Non-OADS,/arxiv_data1/oa_pdf/32/62/pghn-15-266.PMC3746058.pdf
"Tel: +82-2-829-5145, Fax : +82-2-829-5358, E-mail: izzih@medimail.co.kr Copyright ⓒ 2012 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permit s unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Peptic ulcer generally refers to gastric and duo- denal ulcers.",Non-OADS,/arxiv_data1/oa_pdf/32/62/pghn-15-266.PMC3746058.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2012.15.4.256 Pediatric Gastroenterology, Hepatology & Nutrition 2012 Decembe r 15(4):256-265PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION The Efficacy of Pharmacological Treatment in Pediatric  Nonalcoholic Fatty Liver Disease  Taeshik Cho, Yong Joo Kim and Seung Sam Paik * Departments of Pediatrics and *Pathology, Hanyan g University College of Medicine, Seoul, Korea Purpose: With growing number of obese children,  the prevalence of nonalcoholic fatty liver disease (NAFLD) in pedia- tric population is increasing.",Non-OADS,/arxiv_data1/oa_pdf/47/08/pghn-15-256.PMC3746059.pdf
